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SUMMARY
The thesis describes the results from investigations into RNA synthesis 
in the dimorphic fungus Candida albicans. Methods were described, and 
evaluated, for the preparation of protoplasts and nuclei - two in vitro 
systems that were used to study RNA synthesis. It was found that most 
radiolabelled precursor was incorporated into low molecular weight RNA by 
nuclei. In contrast, the precursor was associated with higher molecular 
weight RNA species from protoplasts, from which the nuclei were prepared. 
Contamination by RNases was a serious problem in the preparation of this 
in vitro system from protoplasts.
The RNA polymerases were purified from yeast and part-purified from 
mycelial C . albicans. Three classes of RNA polymerase were resolved by 
ion exchange chromatography of cell-free extract from yeast, whilst only 
one was found in mycelia. Some characteristics of RNA polymerases from 
the yeast were described. All three isozymes had optimal activity in vitro 
when the media contained mono and divalent ion concentrations that were 
similar to those reported for Saccharomyces cerevlsiae - a yeast often 
compared with C. albicans. In addition, the three isozymes from C. albicans 
had similar Km values for CTP to that of these enzymes from other eukaryotes. 
RNA polymerases I and III from yeast C. albicans showed similar sensitivi­
ties to <*.— amanitin as the corresponding isozymes from S. cerevisiae.
RNA polymerase II was far more insensitive to the amatoxin than the corres­
ponding enzyme from higher eukaryotes.
A variety of nucleoside analogues were suggested as potential anti­
fungal agents warranting further investigations. These were capable of 
inhibiting RNA synthesis by C. albicans in vitro and/or in vivo assays.
Studies were also made on RNA synthesis during germ tube formation - 
the initial stage of the yeast-mycelial transformation. It was found that 
it was necessary to cultivate C, albicans yeast in nutritionally impoverished 
media and starved for 24 hr to achieve reproducible germ tube formation.
The strain of C. albicans used in this research formed germ tubes when 
incubated in imidazole HC1 buffer containing serum, N-acetgl glucosamine, 
glucose or glucose plus glutamine at temperatures above 35 C.. During
germ tube formation there was an increase in the RNA content per unit 
yeast cell. Both the rate and maximum amount of radiolabelled precursor 
incorporated into RNA depended upon the conditions used to induce germ 
tube formation. Some inhibitors of RNA synthesis were capable of inhibit­
ing germ tube formation. It was found that the ratio of high to low 
molecular weight RNA species changed over the period of germ tube formation.
The thesis concludes by evaluating the results of this research and 
suggests further directions for future research.
— X  -
ABBREVIATIONS
adenosine diphosphate ADP
adenosine monophosphate AMP
adenosine triphosphate 
„ -3
ATP
10 Amperes mA
base pairs bp
Becquerel Bq
bovine serum albumin BSA
Centigrade ° C.
counts per minute c .p .m
Curie Ci
cytidine diphosphate CDP
cytidine monophosphate CMP
cytidine triphosphate CTP
de-oxyribonucleic acid DNA
dimethyl sulphoxide DMSO
dithiothreitol dTT
double stranded ds
ethylenediaminetetra acetic acid EDTA
glucose glu
glucose/beef extract broth G • B ■ E .
glutamine gin
gramme g
guanosine diphosphate GDP
guanosine monophosphate GMP
guanosine triphosphate GTP
heterogenous nuclear ribonucleic acid hnRNA
hour hr
litres L
xi -
messenger ribonucleic acid mRNA
minimum inhibitory concentration MIC
minute(s) min
molecular weight M.W.
N-acetyl glucosamine NAG
National Collection of Pathogenic Fungi NCPF
Newtons N
nucleoside triphosphate NTP
optical density O.D.
Pearson product moment coefficient of correlation r
phenylmethyl sulfonylfluoride PMSF
polyacrylamide gel electrophoresis PAGE
revolutions per minute (r.p.m.) r.p.m.
ribonucleic acid RNA
ribosomal ribonucleic acid rRNA
Sabourauds dextrose agar S . D • A .
Sabourauds dextrose broth S .D.B.
seconds sec
Shepherd and Sullivan S . and S .
sodium dodecylsulphate SDS
Svedberg units S
trichloroacetic acid TCA
Tetramethylethylenediamine TEMED
Tris(hydroxymethy1)aminomethane Tris
uridine diphosphate UDP
uridine monophosphate UMP
uridine triphosphate UTP
ultra violet uv
weight/volume w/v
volume/volume v/v
yeast extract/peptone broth YEP
- xii - 
PREFACE
Many species of fungi are potentially pathogenic in man. The dimorphic 
fungus Candida albicans is possibly responsible for the greatest number of 
such infections in man. Although there are antifungal agents which are 
used against C, albicans, most have drawbacks such as showing toxicity to 
the host. Only the recently introduced antifungal agent ketoconazole has 
the advantage that it appears to have minimal side effects. RNA synthesis was 
studied as a possible target site for novel inhibitors of C. albicans that 
would not affect the mammalian host. This thesis will describe the results 
of such investigations.
The introductory chapter will examine some biochemical, epidemiological 
and physiological aspects of C. albicans and antifungal agents currently 
employed against various forms of candidosis. In addition, this chapter will 
review some aspects of eukaryotic RNA synthesis. Chapter 2 will describe 
the techniques required for research into any aspect of a pathogen, such as 
C. albicans, and the methods used to investigate RNA synthesis in this 
organism. The next four chapters will be concerned with evaluating the 
results obtained from investigations into RNA synthesis in C, albicans. The 
first of these chapters will describe and discuss the preparation of two 
in vitro systems that may be used to study RNA synthesis. The next chapter 
will describe the purification, and some characteristics, of RNA polymerases 
from yeast and the partial purification of this enzyme from mycelial 
C. albicans. The results obtained in these two chapters will be compared 
with other eukaryotes in general and Saocharomycea cerevlaiae in particular. 
Chapter 5 will describe investigations into the effects of the inhibitor 
lomofungin on growth and RNA synthesis in C. albicans. (Lomofungin is a 
reputed inhibitor of these processes in other fungi). The effects of some 
nucleoside analogues on RNA synthesis in C, albicans were investigated 
using in vitro and in vivo systems prepared as described in the preceeding
two chapters. The yeast-mycelial transformation is a distinguishing
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characteristic of C. albicans, which may be important in the invasion 
of the host. Conditions will be described for the reproducible induction 
of germ tubes from the strain of C. albicans used for most of this research. 
RNA synthesis and the RNA species synthesised during the initial stages will 
be analysed in the hope of further understanding this morphological change. 
The final chapter will discuss the results of the thesis and suggest possible
directions for future research.
1CHAPTER 1 RNA SYNTHESIS IN Candida albicans
1.1 Introduction
The yeast Candida albicans is a pathogenic dimorphic fungus which is 
responsible for the largest number of infections of fungal aetiology in 
humans. Almost certainly, the most prevalent type of infection reported 
is vaginal candidosis in women of childbearing age. Recent (i.e. 1984) 
Department of Health statistics have shown an increase in the incidence 
of women showing symptoms of this disease over the past few years ( 89 ). 
Although treatment has improved recently, relapses are very common and 
a totally satisfactory systemic treatment is not yet-available. There 
thus exists a huge market for suitable antifungal agents. Although there 
are pharmaceutical preparations available, it was not until the recent 
introduction of ketoconazole that a suitable treatment for candidosis could 
be taken orally. In order to assist in the development of other desirable 
antifungal agents that could be ingested orally, RNA synthesis was studied 
as a potential target site. RNA synthesis was chosen as it was hoped to 
find exploitable differences between this process in C. albicans and higher 
mammaIs.
In addition to existing as a pathogen, C. albicans may reside as a 
commensal in the human or animal host. Dimorphism may play an important 
role in the conversion from commensal to parasitic existence (see 6.1 ) .
The involvement of RNA synthesis in this transformation was investigated 
to give an insight into this poorly understood phenomenon. This thesis 
will examine how successful these two aims were and'also how apt RNA synthesis 
is as a site for novel inhibitors.
1.2.1 C. albicans - Characteristic morphology
C. albicans may exist in two distinct morphological forms. It can 
exist as a unicellular yeast (blastospore) or as an aggregate of multicellular 
hyphae (mycelia). C. albicans is taxonomically classified as an 
asporogenous yeast which may not be assigned to any of the more homogenous
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yeast genera. In addition, it is unable to form a sexual stage in its life 
cycle. Therefore, its relationship to "classic" yeast genera, such as 
Saccharomvces. is obscure.
A wide variety of media have been described which promote the growth 
of either form of C. albicans. Most of these media favour growth of the 
yeast form in vitro. A yeast may be defined as "a fungus whose predominant 
morphological form is unicellular" (220). (It is this morphological 
characteristic that lead Lodder and Kreger Van Rij to classify the Candida 
genus as yeasts). Macroscopically.C. albicans yeast colonies have a white, 
creamy, moist and shiny appearance on solid media. Microscopically, the 
yeast blastospores are ovoid in shape, approximately 4 - 6  i^m by 6 - 8 ¿jm 
Blastospores arise through mitotic cell division (budding). The daughter 
cell grows, for a period of time, from a small, selected site on the apex 
of the parent. A septum (cross wall) is formed between the two cells just 
prior to separation (Fig. 1.1).
Aside from the inability to form a sexual stage in the life cycle, the 
principle characteristic of the Candida genus is the ability to form chains 
of elongated yeast cells (pseudo-hyphae). Pseudo-hyphae are formed by a 
process similar to blastospore development. However, the daughter cells 
remain attached to the parent. In addition, subsequent daughter cells are 
more narrow and elongated than the original parent cell (Fig. 1.2).
Many workers have confused hyphae with pseudo-hyphae even though their 
mode of formation is different. Hyphal formation is characterised by 
cellular material growing from the blastospore in narrow cylindrical tubes. 
This process is termed germ tube formation. In certain media (e.g. some 
peptone broths) blastospores may be produced along the hyphal shoot. 
However, in media such as serum more hyphal branches may be formed as 
the hypha extends (Fig. 1.3). All hyphae usually aggregate as mycelia and 
can be seen macroscopically as large "clumps" of cells in suitable media.
C. albicans is able to form chlamydospores in certain nutritionally 
impoverished media containing surfactants. These characteristic out-
- 3 -
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growths of cellular material are attached to the main body of yeast or 
hyphal cells by a suspensor cell. Chlamydospores have a thick double­
layered cell wall: the outer layer containing /3(l - 3)glucans and other 
polysaccharides,whilst the inner is mostly protein (176). This cell wall 
surrounds a cell membrane, within which are large amounts of storage lipids, 
polysaccharides and proteins (263). It has been suggested that 
chlamydospores are a dormant phase of the fungus (17 ).
The appearance of chlamydospores and germ tubes are generally accepted 
as positive presumptive evidence for the identification of C. albicans.
However, other Candida species, such as C. tropicalis. have been reported 
as having the ability to form chlamydospores (154). In addition, there 
are some strains of C. albicans that do not readily form germ tubes. As a 
result, many medical mycologists use such physiological and biochemical 
properties as the ability to ferment and assimilate suitable compounds as 
tools for the identification of C. albicans.
1.2.2 C. albicans - Biochemical and physiological properties
In recent years there has been an increase in the number of papers 
dealing with the biochemistry and physiology of C. albicans. However, in 
comparison to the extensive literature concerned with these aspects in 
another yeast, Saccharomvces cerevisiae. such studies on C. albicans are 
far from complete. A great deal of the new research is concerned with 
studies on the mode of action of inhibitors (see 1.2.5) and the dimorphic trans­
formation (see chapter 6).
C. albicans is able to grow using a variety of compounds as sole carbon or 
nitrogen sources. In the laboratory more complex media are used to cultivate the 
organism. These conditions usually result in cultivation of the yeast form of 
C. albicans. Growth is possible on media that have a pH in the range 3 - 8  and 
an incubation temperature of 20 - 40° C.. Growth of C. albicans is usually much 
slower in synthetic media compared to that in ill-defined, complex media. As a 
consequence, cultivation of large quantities of the organism rapidly for biochemical
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investigations usually involves growth in peptone-glucose media. Fairly high 
growth rates have been reported in these media. Indeed, doubling times, in the 
exponential phase of growth, of 70 min are not unusual (109).
Studies of C. albicans have so far indicated that the biochemistry of this 
organism is typical of other lower eukoryotes such as S. cerevisiae. Much research 
on the metabolism of C. albicans has investigated oxidative phosphorylation and 
carbohydrate utilisation. As an aerobic eukoryote possessing mltrochondria, the 
oxidative phosphorylation mechanism of C. albicans is reportedly similar, to 
that of S. cerevisiae (410). However, despite possessing all the enzymes necessary 
for anaerobic glycolysis (299)^ C. albicans is unable to grow anaerobically (266).
In addition^ it has also been found that C. albicans possesses all the enzymes of the 
hexose monophosphate pathway and most of those required for the tricarboxylic acid 
cycle (299). Hexoses may be diverted from glycolysis to form polysaccharides (64 ). 
The enzymes responsible for the synthesis of glucans and mannans have been exten­
sively studied. These polysaccharides are important cell wall constituents of 
C. albicans and other fungi (85, 240).
The cell wall and membrane have both been fairly well studied - the latter as 
it is believed to be a site of action for a variety of inhibitors (see 1.2.5). The 
cell wall maintains the distinctive ovoid shape of C. albicans and also acts as a 
boundary between the cell and environment. Early research showed that the cell wall 
possessed large quantities of glucans and mannans with small amounts of protein, 
lipid and chitin (65). The glucans and mannans consist of backbones of hexose 
(glucose in the former, mannose in the latter) residues which contain extensive 
branches and cross links. The glucans have a /2(1 - 6) linked glucose backbone 
with /3(l - 3) linked branch points. Mannans contain «-(l - 2) branch points of 
mannose units attached to an <x (1 - 6) linked mannose backbone (287). There may 
be as many as eight layers of polysaccharide in the cell wall (294).
The polysaccharides have often been found associated with proteins as 
glucoprotelns, mannoproteins or glucomannoproteins (189) Recent studies have 
shown that there are differences between strains in the length of side chains of 
mannose residues from extracted mannoproteins (304) These mannoproteins have been
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implicated in affecting the ability of C. albicans to bind to buccal epithelial 
cells (96, 320). They may thus have an important role to play in the invasion of 
mucous epithelia. The cell wall glucoproteins and mannoproteins are the antigenic 
determinants by which strains of C, albicans can be differentiated into one of two 
types. Hasenclever's group first demonstrated this phenomenon and termed the two 
antigenic types group A and group B (153, 155). The former type (group A) possessed 
the same complement of antigens as the other type (group B), plus at least two 
further antigens (370).
Enclosed within the cell wall is the cell membrane. This contains both free 
sterols and sterol esters, triglycerides and carboxylic acids of a chain length 
C^g (239). Phosphatidylcholine and phosphatidylethanolamine have been found to be 
the major phospholipids (102), The quantitive levels of the various membrane lipids 
have been shown to vary from strain to strain (149) and can also be changed by the 
chemical composition of the media ( 1 94-^« The cell membrane is also the site of a 
variety of lipid soluble enzymes. These include such enzymes as (1 - 3) glucan 
synthetase (125)and chitin synthetase (73>*enzymes implicated in the dimorphic 
transformation (see chapter 6).
The limited research into the molecular biology and macromolecular synthesis of 
£j_^lbican£ has shown similarities between these and appropriate processes in 
S. cerevisiae. Such similarities have tempted several workers to use this non­
pathogen as a model for drug and inhibitor studies (212). However, as mentioned in 
1.2.1, C. albicans differs from S. cerevisiae in two important respects: 
the inability of the former to produce a sexual stage and the ability to 
form hyphae and pseudo-hyphae under suitable conditions.
1.2.3 C. albicans - Ecology and Epidemiology
Ci_albicansi is distributed worldwide and found in terrestrial and aquatic 
environments. As the causal agent responsible for candidosis, the fungus 
has been found In man and the primates and other warm blooded mammals (122).
C. albicans may be recovered from a variety of superficial sites on 
individual organisms showing no symptoms of candidosis. As such, a number
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of reviews of yeast epidemiology have drawn the conclusion that C. albicans t 
and a few other yeast species, are common and harmless commensals (98, 122 
23®. The fungi have been recovered from samples taken from mucous membranes 
and the digestive tracts of "normal" individuals.
Studies into the frequency of recovery of C. albicans from the mouths of 
"normal" individuals have reported the presence of the fungus in between 2 
and 237. of test subjects (236,278). However, in hospitalised individuals 
the presence of the yeast, from oral sources, may be as high as 707. (24 ).
The oral populations of yeasts are not static and have been found to fluctuate 
day by day and with the age of the individuals (122). C. albicans has also 
been recovered from faecal samples with recovery frequencies of around 157.
(94 ). Most publications concerning the frequency of recovery of C. albicans 
from human sources use the vagina as the source. The frequency of recovery 
of C. albicans is higher in women suffering symptoms of vaginal thrush than 
hospitalised or "normal" individuals. C. albicans is most often recovered 
from samples taken from women of childbearing age (278). Samples from other 
sites, such as skin, oesophagus and stomach, have been found to contain 
C. albicans. These are usually taken from hospital patients showing signs 
of other debilitating illnesses (278). A high proportion (60 - 707.) of 
C. albicans isolates, from all sites, have been found to be of the A 
serotype (156).
1.2.4 C. albicans - Candidosis and pre-disposing factors of the host
Section 1.2.3 indicated that many people harbour within them conmensal 
yeasts, such as C. albicans, which have a potential to become pathogenic. 
Indeed, it has been suggested that "C. albicans is a better clinician and 
can discover abnormalities in persons much earlier in the course of the 
development of such abnormalities than we can with our chemical tests" (400). 
There are esentlally four types of candidal infection. Mucosal infections 
are those of the mucus membranes, such as mouth and vagina. Cutaneous 
infections affect skin and nails. Muco-cutaneous candidal infections are
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those affecting both mucosal and cutaneous sites. This form of infection, 
and systemic candidoses, affecting the internal organs, are by far the most 
serious clinically.
A whole variety of pre-disposing factors can account for susceptibility 
of individuals to candidosis. These can be classified as "natural", dietary, 
mechnical and iatrogenic medical factors (278). "Natural" factors include 
diabetes mellitus (and other debilitating diseases and disorders) and 
digressions from normal physiological status (e.g. pregnancy). The excess 
or deficiency of foodstuffs may alter the composition of endogenous flora 
permitting alterations in the levels of C. albicans. Mechanical factors 
such as trauma (e.g. burns) or local tissue disruption (e.g. wearing dentures) 
may permit invasion of the affected tissue area by C. albicans.
Possibly the most important factor for serious infection by C. albicans 
at present is that arising as a consequence of iatrogenic medical factors.
The incidence of such serious infections is increasing as new techniques in 
medicine have been introduced. Treatment with antibiotics or corticosteroids 
alters the gut floral population of treated individuals. This has been 
found to result in an increase in the incidence of individuals showing 
symptoms of candidosis (278). Surgical procedures - such as the introduction 
of a catheter into the blood vessels or urinary tract - may also be 
accompanied by serious candidosis.
The range of situations that can dispose an individual to either local 
or widespread candidal infections is extensive. The possibility of serious 
systemic candidosis in severly ill hospital patients is considerable. Thus, 
where systemic candidosis is diagnosed, the primary consideration for treat­
ment should be to attempt to minimise the many factors that can potentiate 
the disease.
In present day medicinal practice vaginal candidosis is commonly seen. 
There is thus a good deal of interest shown in this disease . This may be 
illustrated by the large number of publications concerned with the carriage 
of fungi in the vagina and also trials with antifungal agents (see 1.2.5).
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The classical lesions of the disease are a white discharge from the vagina 
coupled with soreness,inflammation and itching of the affected area. How­
ever, accurate diagnosis may only be confirmed by detection of C. albicans 
in swabs.
Many authors believe that vaginal candidosis has become more common 
in the post-antibiotic and post-oral contraceptive age. However, definitive 
proof is not easy to find(27e). The fact that the number of diagnoses of 
vaginal candidosis has risen annually(89), may be an indication of increasing 
numbers of women contracting the disease or physicians are increasingly 
correctly interpreting the symptoms. VaginaL thrush is commonly seen during 
pregnancy. In addition, the prevalence of vaginal yeasts is higher with 
women taking oral contraceptives compared to those who are not (278). Some 
authorities believe that the increased wearing of occlusive nylon tights 
may increase the likelihood of contracting the symptoms.
A consequence of the increasing numbers of women contracting the 
disease has been that many pharmaceutical companies have made strenuous 
efforts to produce suitable antifungal agents. There are probably more 
formulations of pharmaceuticals currently available for the treatment of 
vaginal candidosis than for any other type of candidal infection. These 
drugs - the mode of action of which will be discussed in 1.2.5 - 
may be supplied as creams, lotions or pessaries. The literature 
available on treatment of vaginal candidosis suggests that most cases will 
respond to topical treatment alone. However, the extent of re-infection, or 
possible relapse of the disease, means that an aggressive schedule of treat­
ment must be attempted for some patients at least (278).
Oral thrush is another mucosal infection which, although less cotimon 
than vaginal candidosis, may be observed in elderly, debilitated patients.
New born infants may also be susceptible to C. albicans infections because 
of their immature antimicrobial defences. This disease may be treated using 
similar topical regimes as that for vaginal candidosis. Extensive topical 
regimes are also necessary for cutaneous candidoses of the skin and nails.
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In contrast to candidal infections of mucous membranes, not fatal and 
conmonly seen in medical practice, systemic candidoses affecting the central 
nervous system, and heart, used to be fatal until the introduction of 
suitable antifungal agents. Candidal infections of bone and joint, 
respiratory and genito-urinary tracks and kidney have all been reported.
The severity of these systemic candidal infections is in proportion to 
the extent which the host's immune response system is suppressed. In 
addition, chronic muco-cutaneous candidosis may arise as a consequence 
of a deficient immune system. Thus, fatal widespread lesions arising due 
to infection by C. albicans are only now usually seen in patients with 
extreme debilitation (278).
1.2.5 C. albicans - Antifungal agents currently available for the treatment of 
Candidosis
The only suitable treatment for superficial candidosis up to the 1950's 
was provided by formulations containing Gentian violet and similar non­
specific antiseptics (400). Nystatin, the first specific antifungal agent, 
was discovered in 1950 (158). Since then, the literature concerned with 
compounds that show inhibitory activity against fungi has increased
enormously.
The route from in vitro efficacy of a compound, to commercial availability 
for treatment, is both time consuming and expensive. Firstly, a compound 
must be identified that shows in vitro inhibitory activity against C. albicans 
- and hopefully other fungi. This must then be followed by investigations 
into the mechanism of action of this potential drug. A successful candidate 
should show differential sensitivity between mammalian cells (the host) and 
the fungus (the pathogen). This must be followed by detailed pharmacokinetic 
studies on in vivo models - infected laboratory animals. This should 
indicate whether the candidate drug is safe for clinical trials on human 
volunteers - the penultimate step before the compound is licensed for 
general medical use.
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The cost of research and development of a potentially successful anti­
fungal agent has been estimated at £25 million ( 3 i e ) .  Only the large multi­
national drug companies of the western world - financed by profits from 
pharmaceutical sales - can afford such costs. As a consequenc^ research can 
only be directed towards illnesses and infections of sufficient magnitude 
that guarantee financial reward. Mucosal candidal infections are widespread 
(see 1 . 2 . 4 )  and thus represent a large market for potential novel inhibitors. 
Any drug that shows good inhibitory activity against less common fungi, or 
has high production costs, is unlikely to be developed. It is therefore 
perhaps not surprising that there are few pharmaceutical agents that are 
widely used in antifungal chemotherapy. These are the polyene 
antibiotics, the substituted imidazoles and the nucleoside analogues.
The two polyene antibiotics most commonly employed as antifungal agents 
are nystatin and amphotericin B (see Fig. 1.4). Other polyene antibiotics, 
which have been used against candidal infections, include candicidin, pimaricit 
trichomycin and hamycin. These polyenes are isolated from a variety of 
Streptomvces species (148). Minimum inhibitory concentrations (MIC) of 
0.4 pg/ml (0.4 ^ iM) to 50 jug/ml (53 /iM) for nystatin and less than 1 /lg/ml
(1 jM ) are usually reported for these two common antibiotics in vitro 
against C. albicans (318). These M IC values may be affected by the media 
composition. The MIC is not affected by the inoculum size or incubation 
time (118,165).
The mode of action of these drugs is believed to be that they bind with 
sterol components of the cell membrane, which is ergosterol in susceptible 
fungi. This binding alters the permeability of the membrane to allow leakage 
of cytoplasmic materials < 31 ©>. Resistance to nystatin and amphotericin B 
has only been induced in vitro by growth on media containing the polyene 
antibiotics. These drug resistant strains show reduced virulence when 
Infected in laboratory animals (278).
Clinically, amphotericin B is the most important polyene antifungal agent. 
Although nystatin is used fairly extensively for treatment of superficial
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Fig. 1.4 Some antifungal agents currently used against 0. albicans
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candidoses, the toxicity of this compound to the mammalian host system 
reduces its usefulness. Amphotericin B has been applied to virtually every 
form of candidosis. However, this compound also shows toxicity towards 
humans, although the side effects are less severe than other polyene anti­
fungal agents. The main side effects are kidney damage, uraemia and 
hypokalemia (2 78).
One possible method of reducing the effective cidal concentration 
pf a compound, when treating candidosis, is to use the drug in synergystic 
combination with amphotericin B. It has been known for some time that anti­
bacterial therapy can be improved by the use of two antibiotics acting 
synergistically against a particular organism (177). A synergistic in vitro 
antifungal response has been found using sub-lethal levels of amphotericin B 
with any of the following:- ascorbic acid and cysteine (26 ), tetracycline 
and actinomycin D (206), 5-fluorocytosine (253) and rifampicin (27 ). It 
is believed that the levels of amphotericin B used enable a sufficient 
number of "holes" to develop in the membrane, allowing access of the anti­
biotics to their sites of action (254).
The polyene antibiotics have now been superseded by the mono-N- 
substituted imidazoles for the treatment of superficial fungal infections. 
High cure rates have been reported for clotrimazole - the first such compound 
used against vaginal candidosis (278). Other substituted imidazoles now 
used against superficial infections Include miconazole, econazole and, 
recently, ketoconazole (see Fig. 1.4). The minimum inhibitory concen­
trations of the substituted Imidazoles in vitro against C. albicans vary from 
0.02 jig/ml (0.06 juM) to 4 pg/ml (11.6 <>iM) for clotrimazole (278,318). The 
other substituted imidazoles show minimum inhibitory concentrations of 
similar magnitudes (343). The wide variation of such values may be accounted 
for by inoculum density (151), media composition (407), pH (417) and 
morphological form (183), all of which can alter the sensitivity shown by 
'C1_albicansi to the substituted imidazoles. In addition, the minimimum 
Inhibitory concentration may be affected by the incubation period and also
the method used to determine the value (145).
The mode of action of the substituted imidazoles is believed to be 
inhibition of ergosterol biosynthesis. Van den Bosche et al found that, at 
concentrations of 9.05 jig/ml (0.1 ;uM) miconazole inhibited ergosterol bio­
synthesis by blocking déméthylation of the precursor sterol at (386).
This same group found higher concentrations of substituted imidazoles were 
required for inhibition of rat liver cholesterol biosynthesis (385). Thus, 
the substituted imidazoles indirectly affect the membrane permeability of 
susceptible organisms and cause visible damage to the structure and function 
of intracellular organelles (318). However, other groups (80, 101) feel 
that the substituted imidazoles have a direct effect with the membrane 
causing rapid leakage of K ions and high and low M.W. cytoplasmic molecules.
Clotrimazole and miconazole are poorly absorbed from the digestive tract 
and consequently low serum levels are found. This may be compounded by liver 
microsomal enzymes that rapidly breakdown the active drugs (99). However, 
much higher levels in serum of water soluble kétoconazole have been obtained 
(316), which suggest a more promising role for this substituted imidazole 
against systemic candidosis.
The nucleoside analogue most widely used against C. albicans is 
undoubtedly 5-fluorocytosine (5FC) (see Fig. 1.4). Since its commercial 
introduction in the late 1960's, this fluorinated pyrimidine has been used 
successfully, primarily against systemic candidoses (276). Concentrations of 
0.1 jig/ul (0.8 i^M) to 15 /Jg/ul (116 ¿iM) are usually inhibitory to C. albicans 
ln vitro (27Ö. However, not all yeast isolates have been found to be 
sensitive to the drug. Estimates of primary resistance of between 107. (27e)
- 207. ( 13 ) of clinically isolated strains tested have been reported. The 
B serotype has been found to show a higher incidence of resistance to 5FC 
than the A ( 13). Resistance to 5FC may be easily induced in vitro by 
growth of C. albicans on media containing low levels of the drug ( 87 ).
Medical practitioners .should bear this in mind for clinical treatment of
candidosis
The mechanism by which 5FC inhibits C. albicans growth is believed to be 
by disruption of translation. 5FC is taken up into C. albicans by a 
cytosine permease. The pyrimidine is then de-aminated, phosphorylated to 
5-fluorouridine triphosphate and incorporated into RNA. The presence of the 
fluorinated pyrimidine base in the RNA disrupts the normal protein synthetic 
activity of the cell and normal development is therefore grossly impaired.
As much as 507. of the uracil may be replaced by 5-fluorouracil. Incorporation 
of 5FC into the host mamnalian cell is limited due to lack of the specifically 
required permease (29t).
As a water-soluble pyrimidine, 5FC may easily be absorbed from the gut^ 
hence the preferred formulation is in tablet form. Peak serum levels of 
5FC follow after 5 hr ingestion (273). Unfortunately, high levels of 5FC 
have been found to cause liver damage (302) and show bone marrow toxicity 
(290). This problem, coupled with the ease some strains of C. albicans 
show resistance to 5FC, indicates that there is a requirement for anti­
fungal agents that do not have these drawbacks.
Overall, with the possible exception of ketoconazole, present anti­
fungal agents show much to be desired. As indicated above, problems such 
as drug toxicity, limited absorbtion from the intestinal tract, and the 
ease of development of resistance by the fungi abound. As a consequence, 
any new drug should show a wide spectrum of activity, the possibility of 
oral administration with freedom from toxicity and low production costs.
It was to achieve such an end that RNA synthesis in clinically the most 
important species, C. albicans was studied.
RNA synthesis
These following sections of this introductory chapter will discuss some 
aspects of DNA directed RNA synthesis (i.e. transcription), with particular 
reference to eukaryotes. Included in these sections will be discussions on 
the general RNA species that are transcribed from the DNA, the organisation 
of the DNA template in the eukaryote and the general mechanisms Involved in
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the process of RNA synthesis. It must be stressed that this is in no way a 
comprehensive study of this ever-expanding field - it should be considered 
an overview of current trends and ideas in the area.
1.3.1 Transcription of DNA coded RNA species
The "central dogma" of molecular genetics is now a firmly established 
scientific principle (i.e. DNA— » RNA— »protein) (394). These processes 
apply to all living cells. In eukaryotes, the cell's complement of DNA 
may be found in the nucleus, which is delineated by a double-membraned 
nuclear envelope. The possession of a nucleus distinguishes eukaryotic 
cells from prokaryotes. Eukaryotic transcription and processing of the 
newly synthesised RNA (i.e. post-transcriptional modification) is performed 
within the confines of the nucleus. Eukaryotic protein synthesis (trans­
lation) occurs on the ribosomes (highly complex ribonucleic acid - protein 
assembly), which are located on the outer membrane of the endoplasmic 
reticulum in the cytoplasm. In contrast, prokaryotic protein synthesis 
occurs concurrently with one end of the transcribed RNA translated whilst 
the other end may still be being transcribed (394).
The DNA may be divided into 2 sorts - that which codes for RNA and 
that which is non-coding. The functions of the non-coding regions are not 
yet fully understood. However, some workers (e.g.119) believe that these 
sequences are important in determining the patterns of DNA folding in the 
nucleus (see 1.3.2). The DNA that is transcribed may be used as a template 
for translation (i.e. messenger RNA) or to form the ribosome (ribosomal RNA) 
or that which carries the amino acid in the translation step (transfer RNA). 
Although the general principle of eukaryotic DNA transcription is the same 
as in prokaryotes, the machinery necessary to control gene activation and 
repression and "unpack" the DNA is considerably more complex. In the 
eukaryote transcription of all 3 RNA species is usually followed by post 
transcriptional modifications (285).
Ribosomal RNA synthesis occurs in the nucleolus of the eukaryotic nuclei.
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The genes coding for ribosomal RNA (rRNA) are highly re-iterated. There have 
been reports of anything between 50 and 2 x 10 copies of the gene present 
in each cell (140). These multiple gene copies are linked in tandem array 
along the genome of the organism. The transcription unit is relatively 
constant in size, with a molecular weight (M.W.) of 4 x 10^ to 5 x 10 . 
However, the non-transcribed spacer region varies in length from organism 
to organism (140). In eukaryotes the rRNA unit is transcribed as a 37 S to 
45 S precursor, from which the mature rRNA species are processed. Multiple 
copies of DNA sequences coding for transfer RNA (tRNA) and another rRNA - 
5 S rRNA - are present in the eukaryotic genome in tandem arrays. These RNA 
species may also be processed to produce the mature products.
The transcribed genes which are translated during protein synthesis are 
often termed structural genes. The structural genes for eukaryote proteins 
are large complex DNA molecules. In many cases, these contain a number of 
intervening sequences not found in the mature messenger RNA (mRNA) (264). 
These intervening sequences are not found in prokaryotes. Transcription by 
the eukaryotic cell of the structural gene coded DNA produces long mRNA 
precursor molecules. These precursor molecules are commonly referred to as 
heterogenous nuclear RNA (hnRNA). The hnRNA molecule is "capped" by the 
addition of a 7-methyl guanosine residue almost immediately. On completion 
of the transcript, a poly-A polymerase enzyme adds 100 to 200 residues of 
adenylic acid to the 3* end of the RNA chain. After splicing - i.e. removal 
of the intervening sequences - the mRNA migrates as a ribonucleo-protein 
assembly to the ribosome. It is thought the 5* cap allows binding to the
ribosome. The function of the poly-A tail is not known for certain, but it 
seems to help mediate subsequent RNA processing and the migration from the 
nucleus (265). Table 1.1 shows the number of nucleotides, molecular weights 
and sedimentation coefficients of some RNA species transcribed from the DNA 
template.
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RNA
SPCC1CS
RNA POLYMERASE
RESPONSIBLE FOR 
SYNTHESIS
SEDIMENTATION
COEFFICIENT
NOUKIIU*
WEIGHT, 
(* io'6)
NUMBER OP
NUCLEOTIDES
Mammallan 28 S 1 .9 5,000
Rlbosomal RNA 18 S 0.71 2,000
5.8 S 130 - 160RNA Polymerase 1
S. cerevlsiae 2» S 1.3 6,000
Rlbosomsl RNA 17 S 0.7 2,000
5.8 S 0.06 158
Typical Mammalian Smal 1er than 6 S to Around 2.2 6,000
greater than 65 S (Anything up to 18) (Anything up to
50,000)
RNA Polymerase II
Typical «RMA Usual ly 8 S - 15 S Around 0.5 1,500
(Between 0.2 (Anything in range
to 1.1) 500 - 3,000)
Small
Hibosomsl RNA 5 S 0.06 120
RNA Polymerase III
Transfer RNA 6 S 0.03 76
Prokaryotic Prokaryotic RNA 2) S 1.05 3,000
1,500
5 S 0.06 120
Table 1.1 Th« sedi mentation coefficients, molecular weight and number of nucleotides in soaie RMA species and the
RNA polymerase isozyme responsible for their synthesis. (Taken from Stewart and Latham 0E3) ).
Table 1.2 Subunit composition of several eukaryotic RNA polymerases
The cable shows the subunits chat make up the RMA polymeraae lsosyme from 
three dlffarenc «ü^ taryotes 
a - numbers refer to M.w. x 10’3
I J ■ shown to be ldeatial polypeptodes by at least two criterion 
—  - theae polypeptides have the same N.W.
(Taken from • Paulo (2«l> m4 •• deader (310).)
¡mump!
1.3.2 Organisation of the eukaryotic DNA into chromosomes
As noted in 1.3.1^ the major difference between prokaryotes and eukaryotes
is the latter has a nucleus where most of its DNA is located. This section
will examine how the DNA is packaged in a eukaryote such as C. albicans.
Other differences are found between prokaryotes and eukaryotes, e.g. the DNA 
content of the former is usually much smaller, whilst that of the latter is 
usually tightly coupled with specialised proteins (histones). However, 
these differences may be regarded as secondary as the largest DNA complement 
of bacteria may be as large as that of the smallest DNA complement of some 
eukaryotes (119). Also one class of eukaryotes - the dinoflagellates - does 
not possess histones, although it does possess the ubiquitous nuclear 
membrane (309).
The DNA from a eukaryote is usually in the form of a linear polymer 
containing anything from 1 x 107 to 1 x 101 1 base pairs (bp). In a lower 
eukaryote, such as C. albicans.there are approximately 1.2 x 107 bp 
in the total genome (142). The folding of the DNA is an important consid­
eration for eukaryotic cells as it is essential to pack the very long polymer
in an ordered manner. In C. albicans the DNA has to fit into the nucleus
~18 3with a radius of 1 ^ im ( 36) and hence with a volume of 4 x 10 m 
assuming the nucleus forms a perfect sphere in the organism. The confor­
mation the DNA double helix may adopt depends upon a variety of external 
parameters. Under "normal" physiological conditions the most stable 
conformation of the DNA double helix is the right hand B form (93). In
such conditions a polymer of DNA (with a diameter of 2.4 nm and 0.34 run
7 -20 3between each bp) of 1 . 2  x 10 bp would occupy a volume of 2 x 10 m .
However, it is necessary to fold the DNA in such a manner that there is
easy access, when required, by the transcription enzyme(s) and factors. The
histones pay a central role in storage and packing of the DNA.
Histones are small proteins (molecular weights of 10,000 to 15,000) that
contain a high proportion of positively charged amino acids. These allow
tight binding to the DNA. Four of the five histones are present In an
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octamer in duplicate amounts. These histones - termed histone H2B, Hj
and - comprise the central core of the nucleosome - the fundamental 
packing unit of eukaryotic DNA. These histones must rank amongst the most 
highly evolutionary conserved proteins known. For example there are only 2 
differences in amino acid sequence of histone from cows and peas (173).
X-ray diffraction patterns of crystals of the nucleosomes reveal that 
146 bp of DNA are wrapped around the disc shaped histone octamer core. Each 
core is connected by a "linker" sequence of approximately 60 bp in length 
(307). The standard nucleosome consists of about 200 bp of DNA. In a lower 
eukaryote such as C. albicans one would expect a total of 5 x 10 nucleosomes. 
The strand of DNA containing the histone octomers may be visualised by 
electron microscopy giving a "beads on a string" appearance (199). The 7NA 
in this order of assembly may be termed chromatin.
The nucleosome is folded into the next level of organisation (the so 
called 30 nm chromatin fibre) (350) and held by co-operative binding of the 
5th histone - H^. Two models have been proposed for the packing of nucleo­
somes into the 30 nm chromatin fibre. Both would allow a 1 cm strand of DNA 
in the B conformation (i.e. approximately 2.9 x 107 bp) to be packed into a 
shorter strand of 0.24 mm in length (250). Thus, assuming the packaged 
chromatin of C. albicans adopts the form of a cylinder, the volume of the
30 nm chromatin fibre in this lower eukaryote may be estimated at 
-20 37 x 10 m . The DNA must be further folded into "domains" using special­
ised scaffolding proteins. Such a general folding pattern for the genome 
has been adopted in both prokaryotic (e.g. Escherichia coll) and eukaryotic 
(e.g. Man, Drosophila melanogaster) organisms ( 29 )• In eukaryotes the 
loops have an average length of 400 nm of 30 nm chromatin fibre. These fibres 
are attached to the inner nuclear membrane by a specialised laminar protein 
assembly.
1.3.3 DNA directed RNA polymerases
The DNA directed synthesis of RNA is catalysed using a DNA dependent
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RNA polymerase (nucleoside triphosphate : RNA nucleotidyl transferase, E.C. 
number 2.7.7.6). Over the past 10 - 15 years the subcellular localisation, 
subunit composition and reaction properties of these complex enzymes - from 
both eukaryote and prokaryotic sources - have been elucidated. Initial
in the early 1960*s (62) resulted in the isolation of a protein that was 
capable of DNA directed RNA synthesis in E, coli. Since then, it has been 
found that prokaryotes possess a single class of enzyme responsible for the 
synthesis of all DNA coded RNA species. The more complex transcription 
machinery of eukaryotes is reflected in most eukaryotes possessing three 
classes of RNA polymerase. This is not a definitive difference between 
prokaryotes and eukaryotes. It has been found that in at least one lower 
eukaryote - Trypanosoma cruzi - there is only one RNA polymerase isozyme (19Z)
The enzymes from both prokaryotes and eukaryotes have several factors in 
common for synthesising RNA. Firstly, both are DNA directed (i.e. the enzyme 
requires a DNA template to show activity), RNA synthesis occurs in a 5'— »3' 
direction. The enzyme is able to accurately add one of the four ribo­
nucleotide bases, that is complementary to the DNA strand, to the nascent 
RNA chain. Also, the enzymes require a divalent metal ion - almost always 
Mg"*”+ or Mn++ - to show activity. All RNA polymerases examined so far are Zn — 
containing metalloaenzymes. The Zn is tightly bound to at least one of many 
subunits that are a further characteristic of RNA polymerase. The four 
stages of DNA directed RNA synthesis will be discussed in the next section 
of this chapter (1.3.4). Also, 4.4.3 will further discuss the require­
ments for divalent metal cations of RNA polymerases in general and those of 
C. albicans in particular.
The 3 classes of RNA polymerase usually isolated from eukaryotic 
sources are termed RNA polymerases I, II and III. This terminology is based 
on that of Roeder and Rutter (311)* Each class of enzyme was distinguish­
able on the basis of its elution from DEAE-Sephadex when the salt concen­
tration of the eluting buffer was Increased. Chambon and co-workers 
proposed a nomenclature for the RNA polymerases based on their sensitivity
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to the fungal toxin ot-amanitin ( 6 3  ). In this scheme, enzymes that are
insensitive, extremely or moderately sensitive to <x-amanitin are termed 
classes A, B and C enzymes respectively. The general pattern of oc- amanitin 
sensitivity for RNA polymerases from higher eukaryotes, such as mammals, has 
led some workers to equate RNA polymerases I, II and III with A, B and C. 
However, as will be discussed in A.4.3, these may not necessarily correspond 
to RNA polymerases I, II and III. RNA polymerases I, II and III are 
responsible for the synthesis of the large 37 S - 45 S ribosomal RNA precursor 
heterogenous nuclear and small 5 S ribosomal and transfer RNA species, 
respectively.
Valenzuela et al (383) first reported inhibition of RNA polymerases I 
and II from rat liver and sea urchin by the zinc chelator 1, 10 - ortho 
phenanthro line. This suggested the necessary involvement of Zn for the 
RNA polymerases to show activity. Recent work.has suggested that, under 
certain circumstances, this compound may inhibit ensyme activity by degrad 
ingthe DNA template (97). However, other studies, using techniques 
such »s atomic absorption spectroscopy (e.g. 3 5 ?)» have suggested all nucleo­
tidyl transferases are Zn metalloenzymes. Inhibition with other Zn chelating 
agents, such as 8 - hydroxyquinoline, and the lack of inhibition using 
3,. 7 - phenanfc/irolene (which does not chelate with Zn)^  are further evidence to 
suggest Zn has an important role (112). RNA polymerases from a number of 
viral (59, 77 )» prokaryotic (146,334) and eukaryotic (180,209) sources 
have all been shown to contain zinc. Indeed, it has been found that all 
nucleotidyl transferases contain Zn . As removal of this Zn 
results in complete loss of RNA polymerase activity, it is probable that 
the Zn moiety is a necessary component for activity (286). Although very 
tightly bound, the zinc can, in certain circumstances (i.e. growth in 
Zn limiting media), be substituted by cobalt in RNA polymerase from 
prokaryotes and some lower eukaryotes (358,111). This has enabled studies 
to be made of the role of zinc in transcription.
The zinc content of RNA polymerases, from various sources, have been
found to differ widely. This may be illustrated by considering the Zn 
content of S. cerevisiae RNA polymerase II (1 g atom Zn/M.W. enzyme 
(209) ) and wheatgerm RNA polymerase II (7 g atom Zn/M.W. enzyme (286) )•
As a further comparison the Zn content of RNA polymerase II from calf thymus 
has been measured at 5 g atom Zn/M.W. enzyme ( 37). A similar spread of 
estimations of Zn content for RNA polymerase I are apparent: this isozyme 
from calf thymus has 7 g atom Zn/M.W. enzyme ( 37) compared to 2 g atom Zn/ 
M.W. enzyme from S. cerevisiae (14) and Euglena gracilis (113). The Zn 
content of RNA polymerase III has been reported to vary from 2 g Zn atom/ 
M.W. enzyme in S. cerevisiae (391.) to 4 g atom Zn/M.W. enzyme from calf 
thymus ( 3 7 ) .
The function of the zinc in RNA polymerase enzyme, and the reason why 
there is such a variation in the Zn content of the different isozymes from 
different species, is not yet fully understood. Almost certainly, at least 
1 Zn is involved in the catalytic mechanism of the enzyme (see 1.3.4). It 
is possible that the other Zn atom(s) are involved in maintaining structural 
stability. The Zn is so tightly bound that removal of this cofactor results 
in dénaturation of the enzyme (397)* Thus, other methods (e.g. n.m.r. 
studies) must be used to elucidate its role. Studies on the role of 
Zn in eukaryotic RNA polymerases should result in assigning the Zn atom to 
one or more of the many subunits that are typical of these enzymes. The two 
Zn atoms present in E. coll RNA polymerase have been assigned to particular 
subunits. This enzyme from this prokaryote has been extensively studied.
It consists of five subunits, four of which form the active core of the 
enzyme. These are termed the •! subunits (2 per enzyme core M.W. 40,000),
¡2 (M.W. 155,000) and (M.W. 160,000). Although this core enzyme can 
direct DNA dependent RNA synthesis using naked DNA, the fifth subunit, 
termed CT factor, is necessary for accurate transcription initiation of 
specific DNA sequences ( 5 0 ). One of the Zn atoms has been reportedly
iassociated with the P subunit, whilst the other may be found at the Junction 
of the fl and p' subunit (403). However, other reports assign the second
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Zn atom to the /* subunit (260). Unfortunately the unambiguous location 
of the Zn atom in the eukaryotic enzyme has not yet been realised.
The typical RNA polymerase, from both eukaryotic and prokaryotic sources, 
is a large molecule (with a molecular weight of 400,000 to 700,000) consist­
ing of multiple subunits. By no means all DNA dependent RNA polymerases are 
such large molecules - those associated with mitochondrial or chloroplast 
RNA synthesis and some viral induced enzymes (e.g. phage N^ ( 59 )) have 
molecular weights of 150,000 to 200,000 (138).
In contrast to the five subunits possessed by E. coll, most of each class 
of RNA polymerase from a eukaryotic source consists of some seven to fifteen 
polypeptides. The complexity of these enzymes has not always been fully 
realised. Some studies have failed to analyse the RNA polymerase under 
conditions which allow the subunit composition to be fully elucidated. It 
is necessary to employ gel electrophoresis conditions which allow resolution 
over the range of molecular weights of 10,000 to greater than 200,000 in 
order to determine the subunit composition. Table 1.2 shows the subunit 
composition of RNA polymerases from three eukaryotic sources.
The subunits of eukaryotic RNA polymerases may be conveniently divided 
into two groups: large (i.e. those having a M.W. greater than 
100,000) and small (i.e. those having a M.W. smaller than 60,000). RNA 
polymerase III does possess a subunit intermediate in size, at least accord­
ing to the literature cited for this isozyme shown in Table 1.2. The sub­
unit composition of the RNA polymerases cited in the table illustrates the 
complexity of these large molecules. The table shows the M.W. of the 
component subunits, of the RNA polymerases for the organisms indicated.
Other groups have reported different values for the M.W. of these subunits. 
This is presumably because M.W. estimation of large polypeptidesby PAGE is 
difficult as there are few high M.W. markers available.
RNA polymerases are composed of polypeptides, most of which are coded 
for at different genetic loci - the smaller polypeptides do not usually 
appear to arise as a consequence of proteolytic cleavage. This may be con­
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firmed by different cleavage patterns (using two dimensional gel electo- 
phoresis) and the lack of antigenic cross-reactivity between most subunits. 
However, some subunits of RNA polymerases, from the same organism, do 
appear to be identical - at least as far as these parameters are concerned 
(138). These are indicated in the table.
Unambiguous assignation of the roles the subunits play in transcription 
may not be fully achieved until techniques have been developed to reassemble 
the RNA polymerase. E. coli. and other prokaryotic RNA polymerases, may 
be reassembled from their individual subunits to form active enzyme (50). 
Unfortunately, there are no reports of this having been achieved in a 
eukaryotic enzyme. Thus,the elucidation of the subunit functions has 
necessitated other approaches. Antigenic cross-reactivity and antibody 
studies, in addition to the use of chemical probes and genetic mutations, 
have helped in unravelling the role of the RNA polymerase subunits.
As a lower eukaryote in possession of all three RNA polymerases,
S. cerevlsiae has lent itself to extensive studies on these enzymes. RNA 
polymerases constitute only a small proportion of the cells total protein, 
thus large numbers of cells are required to obtain sufficient quantities of 
the enzyme for studies. As an example only about 8 - 1 5  mg, 20 mg and 
3 - 10 ng of RNA polymerases I, II and III may be purified from 1 Kg of 
S. cerevisiae (141,142 ,384). Such large quantities of S. cerevisiae yeast 
may easily be cultivated. Also> strains of this yeast have been isolated 
that show mutant RNA polymerase activity. One mutant shows defective RNA 
polymerase II activity, the rpo B mutant, has been isolated and characterised 
Although the RNA polymerase from this mutant does not possess the subunits 
with molecular weight 32,000 or 16,500 it is believed that it is in fact 
the large 220,000 molecular weight subunit that is altered. Evidence for 
this is based on different peptide maps of this large subunit from rpo B, 
mutants and wild type strains of S. cerevisiae. Removal of the 32,000 and 
16.500 molecular weight subunits by electophoresis, or mild urea treatment, 
from the wild type enzyme did not result in the differences in RNA polymerase
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activity found (i.e. alteration of salt and temperature optima and a relative 
deficiency in RNA chain initiation and elongation) (317).
The immunological relationship between RNA polymerases, and their sub­
units, has allowed comparisons to be made both between the components of 
each class of enzyme and between RNA polymerases from different species. It 
was first reported by Hildebrandt et al (164) that there were similar 
antigenic determinants of RNA polymerases I and II from S. cerevislae. 
Antibodies raised against S. cerevlsiae RNA polymerases I could inhibit 
in vitro activity of RNA polymerase I and II and formed immuno-precipitates 
with both isozymes. Reciprocal experiments, using antibodies raised against 
RNA polymerase II showed similar results (164). Studies by Buhler et al 
( 45 ) indicated that the cross-reactivity was not due to antigenic similarit­
ies of the largest subunit of RNA polymerase I with other subunits from the 
same enzyme or any from RNA polymerase II. This group has prepared a 
detailed immunological study of S. cerevlsiae RNA polymerases, and found 
that antibodies against native RNA polymerase Ï and II and all subunits of 
RNA polymerase I showed cross-reactivity with those common to all isozymes.
In addition, the large subunits of RNA polymerase I did show some 
cross-reactivity with those of Candida tropicalis and Endomvcopsls fibuligerla. 
two distantly related fungal species. However, no cross-reactivity was 
observed with Schlzoiaccharomyces pombe. a third species of yeast ( 4 4 ).
Recent work on silkworm (Bombyx mori) RNA polymerase I has shown that 
monoclonal antibodies against the second largest subunit cross-react with 
RNA polymerases I and II from the same species Cl29 ). This finding indicates 
that these two RNA polymerases share commonly exposed antigenic determinants. 
This is a similar result to that found for S. cerevislae. reported in the 
preceding paragraph. Monoclonal antibodies have also been raised against 
RNA polymerases from higher (e.g. calf thymus (56) and rat hepatoma (312) ) 
and lower (e.g. the fungi Podospora comata (388) and S. cerevislae (169 ) ) 
eukaryotes. Results from these investigations have implicated several sub­
units in roles in the mechanism of RNA synthesis (see 1.3.4).
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RNA polymerases might have part of their sequences conserved over 
evolution. Evidence for this is provided by antibodies against RNA polymerase 
II from insects (D. melanoeaster and Chironomus tentons) showing cross­
reactivity with the same isozyme from sheep (201). Also, it has recently 
been reported that the gene coding for part of RNA polymerase II, from
D. melanogaster. hybridises with RNA species from mammalian systems (1 7 2 ).
This finding implies some degree of conservation over evolution for RNA 
polymerase II. Antibodies against S, cerevlsiae snowed some cross-reactivity 
with the largest, and one of the smallest, subunits of wheatgerm RNA poly­
merase II (4 4 ). However, this group reported little, or no, binding between 
these antibodies and either calf thymus RNA polymerase II or E, coll RNA 
polymerase. This indicates that over long periods of time the sequence and 
structure responsible for antigenic cross-reactivity may change.
The topographic arrangement of the subunits of the eukaryotic RNA
polymerase is still being elucidated. Investigations into the three
dimensional structure of E. coli RNA polymerase have been more successful.
The review by Meisenberger et al (256), on the structure of the holoenzyme,
indicated that the enzyme had a maximum dimension of 24 run. This was
determined by small angle X-ray studies of holoenzyme, core and subunits in
3solution. The volume of the holoenzyme was determined as 790 no . This 
group suggested a triangular arrangement for the subunits, with a "Y" shaped 
0~ subunit occupying the centre of the arrangement. Another group (36 4), 
has postulated a similar arrangement for the core structure. This model, 
based on small angle neutron scattering, is three elongated elipsoids with 
axial ratios of between 7 s 1 and 9 : 1 .  Recent work by Tichelaar et al (375) 
suggested that the RNA polymerase may even adopt a cylindrical shape when 
studied using scanning transmission electron microscopy. It should be borne 
in mind that the method used for measurement of the dimensions of the enzyme 
may affect the results obtained. The conditions used to investigate the 
RNA polymerase may be different from those found in vivo and could hence 
alter the structure of the enzyme
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The RNA polymerase from E. coll has a sedimentation coefficient of 15 S 
(50). As a comparison this value for RNA polymerase I from S. cerevisiae 
has been measured as 16 S (384^. Recent work by Bull and Garrido (46) has 
shown that this isozyme, and RNA polymerases II and III, are roughly spherical 
in shape. The dimensions of RNA polymerases I, II and III using scanning 
electron microscopy are 12.7 nm by 11 nm, 12.7 run by 12.2 nm and 13.6 nm 
by 11.5 nm respectively. Assuming RNA polymerase I forms a sphere of
3approximate radius 6.25 nm, the volume may be estimated as 1,020 nm . This 
value was 1,3 times that estimated by Meisenberger et al. for E, coll RNA 
polymerase of 790 nm (256). Such a ratio is similar to that reported by 
Bull and Garrido^who estimated the volume of the eukaryotic RNA polymerases 
to be 1.33 times as large as that reported bySlayterand Hall (355). This 
group also used electron microscopy techniques to measure the dimensions of
E. coll RNA polymerase. Unfortunately the localisation of specific subunits
has not yet been realised for eukaryotic RNA polymerases.
The requirement of eukaryotes for RNA polymerases with multiple subunits 
is still not yet fully understood. Recently, Grossman postulated that the 
large number of subunits may reflect a requirement, by eukaryotes, for RNA 
polymerases possessing a large number of nucleotide binding sites. This 
author believed that the nucleotide and divalent cation - as the direct 
substrate for RNA polymerase - were bound to several subunits to ensure 
high fidelity and high rates of transcription (133). It might also be 
possible that the high number of subunits possessed by eukaryotic enzymes 
is a reflection of the complex nature of eukaryotic transcription. Section 
1.3.1 discussed the highly complex nature of the stored genetic information, 
in the nucleus, as a DNA-protein assembly. The "extra" subunits may be 
required for interaction between RNA polymerase and the DNA-protein complex. 
In addition, other factors - as will be discussed in Section 1.3.4 - are 
required for accurate transcription. It is possible that the multiple sub­
units may be required to interact with these factors.
- 29 -
1.3.4 Some aspects of the transcription mechanism.
The complex process of RNA synthesis by the cell may be understood best 
by dividing this process into its component stages. Transcription of a 
DNA sequence has four steps. The binding of RNA polymerase to a specific 
site (step 1) is then followed by initiation of the RNA chain (step 2). The 
RNA chain is elongated (step 3) until, finally, the process is terminated 
(step 4). Although the general principle of prokaryotic transcription 
appears to be the same as that of eukaryotes, the former is better understood. 
This is presumably because faithful prokaryotic RNA synthesis has been 
characterised for at least the last ten years. Accurate prokaryotic trans­
cription requires only a suitable section of DNA, the RNA polymerase, the 
presence of a divalent cation and the four ribonucleoside triphosphates (61 ). 
In contrast, eukaryotic RNA polymerases require additional factors for
faithful transcription of DNA sequences. As a consequence, it was not until 
1979, when systems became available that could accurately transcribe 
eukaryotic genes in vitro (396), that advances were made.
RNA polymerases, and other DNA binding proteins, recognise 
specific DNA sequences by hydrogen bonding to base pairs and by "sensing" 
helix geometry. The B form DNA double helix - the most stable form the DNA 
adopts under physiological conditions - has two separate grooves running 
between the two strands. Portions of each bp are exposed into these two 
separate channels. The arrangement of protruding atoms in a sequence can 
be uniquely recognised by interaction with Hydrogen bonding amino acid 
residues of a protein. Thus, a sequence of amino acid residues in a DNA 
binding protein can be arranged to maximise the H-bonding between it and the 
recognised sequence. Another criterionfor recognition of a specific DNA 
sequence can be the composition of bases in that sequence. Both the exact 
tilt of the bases and the helical twist angle between the bp have been found 
to depend upon which nucleotides are next to each other in a sequence. The 
small variations in the helix will cause atoms to be displaced from their 
ideal positions - distorting the phosphate-sugar backbone of the DNA by
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+0.1 nm. It is believed by Trifonov (378) that any DNA binding protein 
should recognise this displacement.
The first stage of transcription involves the binding of the RNA poly­
merase to a specific DNA sequence,i.e. promoter recognition. It has been 
known for some time that prokaryotic RNA polymerases require two regions 
of conserved DNA sequence, located about 10 (the "Pribrow box") and 35 bp 
upstream of the transcription startsite (295,328,337,371 ). These two 
highly conserved sequences, of TTGACA , around 35 and TATAAT, around 10 bp 
upstream from the startsite, have a sequence of 15 - 21 bp between these 
regions (314). Promoters may be expected to share common structural features, 
reflecting a similar interaction with RNA polymerase. However, a comparison 
of prokaryotic promoter sequences has revealed considerable sequence diversity 
outside the two conserved regions (348). A recent compilation and analysis 
of E. coli promoter sequences has shown that mutations in the highly 
conserved sequences affect the strength of E. coll RNA polymerase-promoter 
binding (157). The subunit of the RNA polymerase is responsible for 
binding to the DNA sequence containing the promoter region (272). Different 
<S~ factors appear to be responsible for different promoter selection in 
prokaryotes (9>). It is thought that O' subunit— DNA binding results in 
changes in the secondary structure of the DNA (144).
Eukaryotic RNA polymerases require other factors for correct promoter 
recognition in addition to DNA sequences. However, there does appear to be 
some requirement for a nucleotide sequence, (jenes transcribed by RNA poly­
merase II were amongst the earliest characterised, having several control 
regions upstream of the site at which transcription is initiated. The 
development of cell-free systems that allowed selective and accurate 
initiation of transcription has enabled studies to be made on the control of 
eukaryotic gene expression (396). Two methods have been described that 
support faithful RNA polymerase II directed transcription. These are 
derived from either ammonium sulphate precipitates of cell lysates or 
suparnataants from high speed centrifugations. The latter method usually
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requires the addition of exogenous RNA polymerase II.
Promoter DNA sequences for RNA polymerase II have been found to contain 
an A-T rich region. There is typically a TATA sequence (the "Goldberg- 
HognesS box" (41)), which seems to be present at about 30 bp from the nucleo­
tide coding for the first base of the mature mRNA (the cap site). This is 
the point at which transcription begins (416). Two other DNA sequence 
elements have been implicated in the control of initiation of transcription. 
The first is located around the cap site region and is typically a PyCATTCPu 
sequence (132),whilst sequences far upstream (70 - 80 bp) from the TATA box 
constitute the second sequence - typically CCATT (28).
Deletion of the capsite and CCATT sequences may not affect efficient 
transcription of some genes in vitro, e.g. rabbity globin (131), but the CCATT 
sequence is important in promoting high efficiency transcription of this gene 
in vivo ( 130.). The cap sequence apparently directs the selection of the 
exact starting point of transcription (3 1 4 ). The TATA box appears to be 
important in directing the transcription of several genes in vitro. Evidence 
for this is provided by deletions, or single base changes, in the TATA 
sequence has been found to abolish accurate transcription of some cloned 
genes (e.g. ovalbumin (121) and Simian virus 40 (244) genes). In addition, 
deletions of a given size downstream from the TATA sequence have been found 
to result in shifting the initiation site downstream a similar distance 
(131). When cloned into a plasmid DNA, the TATA sequence can direct 
initiation of transcription 25 bp from the introduced sequence (325). These 
findings indicate that the DNA sequences in a promoter region are important 
in directing the RNA polymerase II to correct initiation site.
The ease of analysis of the RNA polymerase III transcription products, 
and the ability to initiate in vitro RNA synthesis, has permitted the study 
of transcription directed by this isozyme in nuclear preparations and recon­
stituted systems. Initial work by Wu demonstrated accurate transcription 
of a defined template - containing 5.5 SrDNA - using a supernatant from a 
high speed centrifugation prepared from KB tumour cells (404). Extracts from
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Xenopus laevis oocytes and KB cells have been fractionated to reveal at 
least three proteins required for accurate 5 S rRNA and tRNA transcription.
One of these proteins is believed to bind to internal regions of the gene.
The protein factor binds to 5 S rDNA at positions +45 to +96 (319). Similarly 
accurate transcription of the tRNA gene requires a protein factor binding to 
internal regions. There appears to be two intragenic control regions for 
transcription of the tRNA gene: the first lies near the 5' end (at positions 
+5 to +25) whilst the second lies at positions +50 to +72 (313). The DNA 
sequences of 4 tRNA^^^ genes have revealed a highly conserved sequence 
located around position -20 (166). However, the exact significance of this 
conserved region is unknown, as its deletion does nob affect in vitro trans­
cription in this system (88 ). It is probable that it is involved in in vivo 
transcription, as several groups (e.g. 344 ,360)have noted that sequences 
upstream of initiation of the tRNA gene can affect transcription. The 
promoter regions of tRNA and 5 S rRNA genes appear to be conserved in 
diverse eukaryotes (79). This indicates that the control of transcription 
of these genes may be conserved over evolution.
It is believed that transcription of the large 37 S - 45 S rRNA precursor 
by RNA polymerase I is mediated by DNA sequences both downstream and upstream 
of the start site (06,261). Expression of the’ rDNA gene trom Drosopnila 
required a promoter sequence lying in the region -43 to -27 (197).
In addition to RNA polymerase I, a supernatant from a high speed 
centrifugation was required for accurate transcription initiation. The 
rDNA genes from other organisms have been investigated to determine sequences 
that influence the activity of RNA polymerase I. These investigations have 
found a region of approximately 40 bp upstream for the start of rDNA from 
mice (136) and a sequence lying between -145 and +16 of Xenopus rDNA (267). 
required for initation by RNA polymerase I. There does not seem to be any 
great level of sequence homology between the RNA polymerase I promoter regions 
This may be illustrated by the finding that sequence homology among three 
Xeno£U£ species is restricted to the portion -11 to +4. This suggests that
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this sequence has a major role in RNA polymerase 1 recognition (15). How­
ever, other species, such as S. cerevisiae (193), Drosophila (223), mice and 
humans (115 )^ have rDNA that does not show conservation of such sequences. In 
aH  the species noted rDNA transcription begins with an A residue and the 
sequence AGGTA occurs within ten nucleotides of the initiation site.
An RNA polymerase enzyme may bind to DNA at a recognised promoter sequence 
or arbitrarily as non-specific binding (often termed non-promoter binding by 
some workers (e.g. 365)). As bacterial polymerase holoenzyme require only 
a promoter sequence for specific binding, it is not surprising that this 
process is better understood in prokaryotes. The sequence of events for 
promoter selection and RNA chain initiation by E. coll RNA polymerase on T7 
DNA and the Lac UV& promoter of E. coli DNA.have been described in some detail
N.
(120). Firstly, the bacterial RNA polymerase locates and binds selectively 
and stably to the DNA promoter sequence - forming an "I" or "closed" complex. 
This binary complex may be formed at low temperatures (0° C.) and is stable 
in the absence of nucleoside triphosphates. This complex has a half life 
for dissociation of approximately 40 min (61 ).
The holoenzyme is thought to facilitate the unwinding and separating 
of the DNA strands to form an "open" or "RS" (rapid start) complex. In 
contrast to the "I" complex, this binary "RS" complex does not form at low 
temperatures, but on forming is stable for hours in the absence of nucleo­
tides. The RNA polymerase is believed to cover approximately 30 bp on 
binding (303). Methods such as UV hyperchromaticity (1681, and DNA 
sequencing of the holoenzyme opened sequence (348) have suggested that 
between 10 and 12 bp are melted on formation of the RS complex. Other 
groups have studied the extent of DNA unwinding, based on sensitivity of 
DNA to dimethyl sulphate methylation (257) and the migration of unwound 
DNA by agarose gel electrophoresis (120). These studies have indicated 
that 15 - 17 bp may be unwound on "RS" formation. The "RS" complex allows 
the rapid formation of the first phosphodiester bond to be catalysed in the 
presence of nucleotides. This process can be termed initiation of RNA
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synthesis as the binary complex becomes a ternary complex of RNA polymerase - 
DNA-nascent RNA chain.
Eukaryotic RNA polymerases, like prokaryotic enzymes, are able to 
transcribe both double (ds) and single stranded (ss) DNA templates. Single 
stranded templates generally . promote higher rates of transcription 
by eukaryotic RNA polymerases. For example, Dezelee et al (92) have 
reported that S, cerevisiae RNA polymerases X and II transcribe un-nicked ds 
DNA very inefficiently. However, the introduction of unpaired gaps into 
the duplex DNA, by treatment with nucleases that produce ss regions, stimulate 
transcription by .these enzymes. The same group also reported that a gap of ' 
25 - 50 nucleotides in length was required for S. cerevisiae RNA polymerase 
to initiate RNA synthesis. Just as RNA polymerases from S. cerevisiae 
require nicks for efficient transcription of ds DNA, these enzymes from 
higher plants and animals are similarly stimulated (63, 103). The 
eukaryotic RNA polymerase has been found to protect 34 - 38 bp from 
nuclease digestion on binding to DNA (103).
Selective, sequence specific binding has been reported for wheatgerm 
RNA polymerase II on de-proteinised Adenovirus DNA (402), Simian virus 40 DNA 
(323) and plasmid DNA containing a cauliflower mosaic virus sequence (129).
The binding sites on Adenovirus DNA corresponded to similar binding sites for 
human placental RNA polymerase II (402). It is thought that wheatgerm RNA 
polymerase II is able to form two types of binary complex analogous to the 
"I" and "RS" complexes described for bacterial RNA polymerases. The 
stability of the binary complex of wheatgerm RNA polymerase II and SV 40 
DNA is greater on the superhelical form of the DNA compared to either 
relaxed circular or linear forms (324). This may be due to unwinding of 
the supercoiled DNA providing energy for dénaturation of the DNA strands.
It should be noted that although the reports cited above do imply some 
degree of selective binding and initiation of transcription, in no case 
has the selectivity been definitively correlated with an in vivo promoter.
As noted earlier in this section, a number of other factors are required
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to obtain faithful in__vitr£ transcription of eukaryotic genes besides 
eukaryotic RNA polymerases.
The formation of the first phosphodiester bond characterises trans­
cription initiation. It has been postulated that the Zn metal cofactor 
plays an important role in initiation and elongation in the formation of 
this bond. It was suggested in the early 1970's, the function of Zn in a
nucleotidyl transferase was to activate the 3'0H group of the ribose (354). Thi 
would facilitate a nucleoohillie attack of the primer - or growing chain - 
towards the ot phosphate group of the nucleotide entering the active site 
(Fig. 1.5). It is thought (10, 49 ) that a divalent metal ion-nucleotide 
complex serves as a substrate for this reaction. The divalent metal ion 
co-ordinates with the oxygen atoms of the /I and » phosphate and is held 
at a specific site - the nucleotide binding site - possibly through a 
hydrogen bond. The charge on the oc phosphate group is neutralised by a 
positive moiety on the enzyme and one oxygen atom of this phosphate. (It is 
possible that'aspartic acid and glutamic acid residues have essential roles 
in this process as chemical modification of these residues results in 
loss of activity (272) ). Attack of the terminal 3' OH group of the now 
growing RNA chain causes subsequent pyrophosphate release.
The events described in the preceding paragraph are also applicable to 
the elongation mechanism of the RNA chain in a 5'—» 3' direction. Both 
initiation and elongation are better understood in the prokaryote enzyme 
than for the eukaryote. Studies with the prokaryote enzyme have suggested 
roles for the subunits and their involvement in transcription. Early 
investigations into the subunits functions implicated the subunit in 
promoter recognition (see page 30 of this section) (The subunit dissociates 
from the bacterial RNA polymerase after the ternary initiation complex has 
been formed (348) ). Since then,methods such as chemical modification, cross- 
linking by photolysis (150), studies on mutants (116) and the use of subunit- 
specific antibodies (277) have helped in elucidating the roles of the sub­
units in the bacterial RNA polymerase. The /3 subunit is believed to be
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ri*. 1.5 Schematic model of active stca of RNA polymerase during RNA chain initiation.
The flgura shows a schematic representation of RNA polymerase initiating 
the first phosphodleater bond between ATP and UTP (baaed on models proposed 
by Armstrong at al ( 10), Lettke and Ueser (209) and Mlldvan s t j ^  (259) ).
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involved in both the initiation and elongation reactions (116, 150)and to 
contain a nucleoside triphosphate binding site (230) (It is worthwhile 
remembering that the /2 subunit is believed to have at least one, if not both, 
of the Zn atoms - see 1.3.3). The/9' subunit appears to be involved in DNA 
binding and assisting in promoter selection (1501, whilst the two £X sub­
units, also involved in DNA binding, contain a RNA product site (236).
Gamper and Hearst(120) postulated an "unwindase" centre, at the "front" and 
"back" of the RNA polymerase, to uncoil the two DNA strands. However, these 
functions do not appear to have been assigned to any subunit as yet.
There is evidence to suggest roles for some subunits of eukaryotic RNA 
polymerases. Research by Huet et al (170). of nucleic acid binding to 
S. cerevisiae RNA polymerase I, has implied four subunits were bound to the 
DNA. These had M.W. of 185,000, 48,000, 36,000 and 23,000. Martial
i
et al (241) have reported that pyridoxal-5 phosphate - acting as a 
nucleotide analogue - could inhibit the activity of S. cerevisiae RNA 
polymerase I. The subunits the analogue bound to could be identified. 
Reduction of the Schiff base formed with lysyl residues on the enzyme - 
by NaB C revealed the tritium label associated with both large subunits
(of M.W. 185,000 and 137,000) and the 48,000 and 36,000 subunits. The 
addition of nucleotides or DNA protected the enzyme from inactivity; the 
former protected the large subunits whilst the latter protected all four 
subunits from binding to pyridoxal-5*phosphate. These studies imply these 
four subunits are involved with DNA binding, whilst the nucleotide binding 
sites are located on the large subunits.
Cooper and Quincey (79) reported that the subunits with M.W. of 37,000 
and 48,000, from RNA polymerase I, are Involved in elongation and RNA 
synthesis at high ionic strength. It was reported that removal of the
48,000 and 37,000 subunits - to form what this group termed RNA polymerase 
A* - had altered properties in elongation and RNA synthesis at high ionic 
strength. In contrast, removal of these subunits by chromatography on 
blue dextran-Sepharose - a resin that Interacts with polypeptides that
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have nucleotide binding sites - completely inactivated the enzyme ( 47 ).
The exact function, as noted in 1,3.3, of all the subunits of the enzyme 
and their involvement in the stages of transcription still needs to be 
unravelled.
Another approach to defining subunit function of eukaryotic RNA poly­
merases is based on genetics. It was suggested in 1.3.3 that the 220,000 
M.W. subunit of RNA polymerase II may be functionally equivalent to the 
subunit of bacterial RNA polymerase. Further research, using anybodies 
specific to the largest subunits, has implied these may be functionally 
equivalent to the' f t and >8 subunits from prokaryote RNA polymerase. Anti­
bodies against the largest subunits of RNA polymerase I and II, from rat 
hepatoma, inhibit binding of DNA to these subunits (3121. Monoclonal 
antibodies against the 190,000 M.W. subunit inhibit chain elongation by RNA 
polymerases I and III from the same species. A monoclonal antibody, specific 
against the 135,000 M.W. subunit of RNA polymerase I, inhibits . RNA 
synthesis by this enzyme. This inhibition may be prevented by pre­
incubation of the enzyme with DNA, which appears to confirm earlier 
indications that this subunit is involved in DNA binding.
Transcription of the DNA template is concluded when the RNA polymerase 
dissociates from the DNA and releases the newly synthesised RNA chain. 
Termination of RNA synthesis has been studied in E. coli. Several lines of 
investigation have implicated a protein - termed the rho (yo ) factor - 
in transcription termination in vitro (50). It is now established that 
there is an A-rich region of the DNA that directs a transcript with 6 to 8 
terminal uridines. In addition, there are hairpin loops prior to this 
region (124-.313). It is thought that the instability of the rU-dA duplex 
is a major force in prokaryotic termination (242). There appear to be few 
consensus sequences for termination. Some workers (e.g. 378) believe a 
"TACA"•sequence at position -33 from the 3' end and a "CGGG" sequence at -12, 
from the same relative position, may be important in directing prokaryote 
termination. Trifonov remarked that the distance between these two sequences
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was similar to that of the promoter sequences TTGACA and TATAAT (378).
Termination by eukaryotic RNA polymerases - like so many other -aspects of 
transcription - is not as well documented as it is for prokaryotes.
Bogenhagen and Brown have reported that RNA polymerase III recognised a short 
sequence at the end of the X. laevis 5 S rRNA gene, that signalled the end of 
transcription ( 34 ). Studies have been made on transcription termination 
with ENA polymerase I using cloned rDNA injected into frog oocytes (18 ). The 
results from these studies have revealed that, in addition to a specific DNA 
sequence, other factors are required for accurate termination. The length 
of RNA transcribed by RNA polymerase II may be modified,by heat stable protein 
factors (341,342). A protein of M.W. 3C,000, purified from rat liver cells, 
increases the average product size of RNA transcribed from ds DNA. This 
factor is species specific and has no effect on RNA polymerases I and III. 
Other protein factors, from lamb and calf thymus (305,359) have been found 
to specifically stimulate the elongation reaction of RNA polymerases from 
these species. In order to avoid repetition, further discussions on the 
modifying influence of some proteins on RNA synthesis, will be deferred 
until 7.4. 1
1.4 RNA synthesis in C. albicans - aims of this thesis
It was noted in 1.2.2 that in contrast to the huge amount of inform­
ation available on RNA synthesis in brewer's and baker's yeast (Saccharomyces) 
there was a paucity of information on this process in C. albicans. Although 
C. albicans shares some characteristics with S. cerevislae. it would be 
unwise to believe that all aspects of their metabolism are similar. This 
thesis will examine some aspects of RNA synthesis in C. albicans and how 
comparable it is to eukaryotes in general and S, cerevislae in particular.
The initial research was concerned with the preparation and character­
isation of two in vitro systems (protoplasts and nuclei). These were chosen 
as they would then allow Investigations to be made on the mode of action 
of potential novel inhibitors of C. albicans. The ability of these two
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systems to actively synthesise RNA was monitored at each stage of prep­
aration by the incorporation of a labelled substrate into RNA. The methods 
used to prepare both ¿n_^ritro systems were based on those described for the 
preparation of protoplasts and nuclei from S. cerevisiae. How comparable 
the RNA species synthesised by nuclei and protoplasts were with that reported 
by other groups, using different organisms will be discussed.
The three RNA polymerases from eukaryotes are distinguishable by a 
variety of criteria (see 4.4.2 ). Those of S_i__cerevi£iae> have been
extensively characterised (see 1.3.3). They differ from the RNA polymerases 
of higher eukaryotes in at least one important respect - the <x amanitin 
sensitivity of class X and III enzymes. How comparable the RNA polymerases 
from C. albicans were to those from other organisms will be discussed in 
chapter 4. Methods used to purify, to electrophoretic homogeneity, the 
RNA polymerases from the yeast form of C. albicans, and part purify those 
from the mycelial form, were based on those described for other fungi.
The action of lomofungin - a known inhibitor of RNA synthesis - on 
C. albicans growth and RNA synthesis was investigated. It was hoped that these 
studies would eventually lead to novel inhibitors of this organism. Chapter 
5 will show the results obtained from such investigation. Included in 
this chapter are results showing the effects of several potential novel 
inhibitors of transcription against in vivo and in vitro RNA synthesis in 
C. albicans. These compounds were chosen from a collection of more than
190,000 available from Imperial Chemical Industries, Pharmaceuticals Division 
(ICI).
Although there are a number of studies on the changes in the cell wall 
and membrane of C. albicans during the yeast-mycelial transformation, there 
are few investigations into RNA synthesis during this process. Both denovo 
RNA synthesis and changes in the total levels of RNA during the dimorphic 
change were monitored for C. albicans in buffered media that induced this 
morphological transition. These findings were compared to studies made by 
other workers. Studies were also made into the classes of RNA synthesised
- 41
by C. albicans in different media that could induce germ tube formation. 
Results for such investigations would suggest which RNA polymerase enzymes 
were most active during the transformation.
The final chapter of this thesis (chapter 7 ) will be concerned with 
evaluating the results presented in chapters 3 to 6 and suggest 
further avenues for future research-on RNA synthesis in C, albicans.
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CHAPTER 2 MATERIALS AND METHODS
2.1 Introduction
This chapter deals with the biochemical methods and microbiological 
techniques used during the course of this research. It outlines the general 
techniques used when growing and using a pathogen such as C. albicans. In 
addition, the various procedures used to investigate RNA synthesis in this 
organism are described. Some experimental techniques developed in the course 
of research will be discussed in the relevant chapters.
2.2 Chemicals, enzymes, radiochemicals, scintillation fluids, buffers and media
Calf thymus DNA (type I), Candida utllls RNA (type II), protamine sulphate 
°<-amanitin, unlabelled nucleotides, bovine serum albumin (BSA), phenylmethyl 
sulphonyl fluoride (PMSF), agarose (type V), dithiothreitol (dTT) and 
N-acetyl glucosamine (NAG), penicillin streptomycin, Ficoll, actinomycin D 
DNase A, Blue dextran 2,000, and poly Cd(A-T)l were all obtained from the 
Sigma chemical Co. Tetramethyl ethylenediamine (TEMED), RNase free sucrose, 
Cellex 410 cellulose powder and Biogel Agarose A-5M (pre-swollen) were
i
obtained from Biorad. Acrylamide, N,N -methylene-bis-acrylamide and Amberlite 
MB3 ion exchange resin were obtained from BDH. Diethylamino ethyl (DEAE)- 
Sephadex A-25 was obtained from Pharmacia Fine Chemicals. E coli 16 S and 
23 S rRNA markers, for gel electrophoresis of RNA, were purchased from 
Boehringer Mannheim. Human serum was obtained from Flow Laboratories. 
Rifamycin AF/021, lomofungin and rapamycin were kindly donated by Nuevo 
Petrone, Upjohn Chemical Co. and Ayerst Chemical Co. respectively. All other 
chemicals used were purchased from commercial sources and were of the highest 
analytical grade.
Zymolyase 60,000 was obtained from the Kirin brewery, Japan. This 
enzyme - supplied as a lyophilised powder - contained 60,000 units of lytic 
activlty/g dry weight. 1 unit was defined as the amount of enzyme that gave a 
decrease of Jj in optical density, at 630 nm, when an aliquot of treated cells 
was diluted in 1.30 in water, compared to that of cells before treatment.
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All the radiochemicals used in this research were obtained from Amersham
International, i.e. [5,6-^h J uridine (specific activity 47.5 - 52 Ci/mmol, 1758
- 1924 GBq/mmol), [5- H} uridine (specific activity 23 Ci/mmol, 851 GBq/mmol),
[4-^c|uridine (speclfc activity 488 mCi/mmol, 18 GBq/mmol), [5-^H] uridine 5*
triphosphate, ammonium salt (specific activity 23 - 26 Ci/mmol, 851 - 962 GBq/
mmol), [4-^^cJ uridine 5' triphosphate, ammonium salt (specific activty 48 mCi/ 
32mmol), £ P] sodium orthophosphate in aqueous solution, carrier free (activity 
10 mCi/ml, 0.37 GBq/ml).
A toluene-based scintillation fluid was used for all liquid scintillation 
counting. The scintillation "cocktail" consisted of 0.2 g 2,2 - (1,4-phenylene) 
bis-5-phenyloxazole and 5 g 2,5-diphenyloxazole per L toluene. Solubilizing gpl 
slices, containing either [^Hj or , involved incubation of the slice in
0.7 ml N.C.S. (Nuclear Chicago solubilizer) solution (1 vol N.C.S.:6 vol 
scintillation fluid) for 12 hr at 40° C. .
All buffers and solutions used throughout the research were made up in 
glass double-distilled water. The protoplast buffer consisted of 1.0 M D ( ■ ) 
sorbitol, 10 mM MgCl2 in 50 mM Tris HC1 pH 7.2, as described by Harrington and 
Douglas(152) • Buffers A, B and C, as described by Schultz (331), were used 
in the isolation of nuclei. Buffer A consisted of 187. (w/v) Ficoll, 1 mM 
MgCl2 in 20 mM potassium phosphate buffer pH 6’b. Buffer B consisted of 77.
(w/v) Ficoll, 1 M D ( - ) sorbitol, 1 mM MgCl2> 207. (w/v) glycerol in 20 mM 
potassium phosphate buffer pH 6.6. Buffer C consisted of 0.6 M sucrose, 1 mM 
MgCl2 1 mM dithothreitol in 50 mM Tris HC1 pH 7.5. The purification of RNA 
polymerases from C. albicans involved the use of buffers described by Hager 
et al (H1). The buffer used to suspend the yeast cells (buffer i) consisted 
of 857. (w/v) glycerol, 107. (w/v) DMS0, 50 mM MgCl2, 1 mM Na^DTA, 5 mM PMSF 
and 5 mM dTT in 100 mM Tris HC1 pH 7.9 (4° C.). Buffer A of Hager et al 
(141) contained 107. (v/v) glycerol, 5 mM MgCl2, 0.1 ntt Na3EDTA, 0.2 mM 
dithisthreltol in 50 mM Tris HC1 pH 7.9 (4° C.). Buffer B of Hager et al ( 141) 
was identical with buffer A except that the glycerol concentration was 257.
(v/v).
All media used to grow C. albicans yeast and mycelial phases and
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S. cerevisiae were made up in glass double distilled water. Sabourauds. dextrose 
broth (S.S.B.) contained 47. (w/v) D ( + ) glucose and 17. (w/v) mycological 
peptone (oxoid). The pH was adjusted to 5.5 by the addition of 1 M NaOH, 
prior to autoclaving. Sabourauds dextrose agar (S.D.A.) was identical 
to S.D.B.^ except that 1.57. (w/v) agar (oxoid) was added. Yeast extract 
-peptone (YEP) broth consisted of 17. (w/v) yeast extract (Difco), 17. (w/v)
Bacto peptone 37. (w/v) glycerol, 0.17. (w /v ), adenine sulphate in 50 mM 
potassium phosphate buffer pH 6.25. Glucose-beef extract (G.B.E.) media contained 
0.17. (w/v) D ( + ) glucose and 2.67. (w/v) beef extract (Lab Lemco). The pH 
was adjusted to 7with NaOH. The growth media of Shepherd and Sullivan (S. and £ 
medium ) contained 0.0057. ( N H ^ S O ^ ,  0.27. KH2 PO^, 0.057. CaCl2.2H20 , 0.00 57. 
MgSO^ .7H20 and 1.57. glucose. Biotin was added to a final concentration of 
25 ¿ig/L and the pH adjusted to 5.2 (34$).
2.3.1 C. albicans - Use of a pathogen in biochemical research
Research on any aspect of a pathogen - such as C. albicans - should be 
conducted with caution. In addition to the standard aseptic techniques 
used in microbiology, extra care had to be taken when handling the organism.
All solutions, media and buffer used for growing and harvesting the organism 
were autoclaved at 120° C. for 18 minutes. Glassware, pipettes and plastic 
tips were sterilised by overnight (17 hours) incubation in an oven at 140° C.. 
Glassware and equipment which had been in contact with C, albicans were 
decontaminated by immersion in 257. sodium hypochlorite solution in water.
2.3.2 C. albicans - Strains used
Several strains of C, albicans were used in studies on the inhibitor 
lomofungin. These were strains of A and B serotypes, i.e. NCPF3153 and NCPF3156 
and also strains AB2, B2630, Leeds and 6406/8. All strains were maintained 
on slopes of Sabaurauds dextrose agar at 25° C. In addition, reference 
colonies of the strains of C. albicans were kept in sterile double distilled
water.
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The A serotype - NCPF3153 - was most frequently used in this research for 
two main reasons. As a wild type strain any results pertaining to its mode of 
RNA synthesis would be applicable to the species as a whole. In addition, the 
A serotype readily formed mycelia in suitable media. (There have been 
reports that some clinical isolated strains, particularly the drug resistant 
strains, did not readily produce mycelia (11, 147)).
2.3.3 C. albicans - Growth conditions
It was indicated in 1.2.1 that the morphological form of C. albicans may 
be influenced by the media and growth conditions used for cultivation. In 
order to obtain large quantities of the yeast phase, the organism was grown 
in Sabourauds dextrose broth at 37° C., in an orbital shaker operating 
at 150 r.p.m.. Under these conditions all the strains of C. albicans studied 
had doubling times of 71 + 3 min during the expoential phase of growth. The 
cells were grown to the required cell density and harvested. The cells were 
collected by centrifugation at 3,000 r.p.m. for 15 min in a M.S.E. Mistral 
centrifuge (4 x 1L). The cells were washed twice with double distilled water 
and the pellet suspended in buffer consistent with the yeast cells eventual 
use.
Cultivation of the mycelial phase C. albicans involved growing a small 
inoculum (typically 1 x 10^ - 2 x 10^ yeast cells/ml media) in glucose - beef 
extract (G.B.E.) medium. The suspension was incubated for seven days at 
37° C. without shaking. This method resulted in a culture consisting of 
both mycelial and unicellular forms of C. albicans. The mycelia were easily 
identifiable as large "clumps" floating in the media. Separation of the two 
forms was achieved by pouring the suspension into a 1L measuring cylinder and 
allowing the mycelia to precipitate under gravity. The media was siphoned off 
from the top of the cylinder by vacuum aspiration as the mycelial clumps 
precipitated. The mycelia were collected on a sintered glass funnel by 
filtration. They were then resuspended In double distilled water, transferred 
to a measuring cylinder and the process repeated. A further repetition of
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this washing process resulted in preparations which contained predominantly 
the mycelial form of C. albicans (85 - 957. mycelia as judged by observation 
of diluted samples under the light microscope (x 200 magnification) ).
The cultivation of cells for studies on the yeast to mycelial trans­
formation involved preparing yeast cells of C. albicans A serotype as des­
cribed by Shepherd and Sullivan (346)- The cells were grown in shake 
cultures in S. and S. medium. After incubation for at least 
50 hr the cells were harvested by centrifugation at 3,000 g^for 10 min in a 
G.S.A. rotor, using a Sorvall RC5B centrifuge. They were then washed three 
times with double distilled water and finally resuspended in 50 mM potassium 
phosphate buffer pH 5.6 as a thick slurry (typically 10*^ - lO1'*’ cells/ml 
buffer). Germ tubes were induced when the cells were diluted in water and 
treated as described in 6.2.1.
Cell growth of C. albicans was occasionally measured by the absorbance of 
a cell suspension. Measurements of the O.D., at 650 nm, were made using a 
Pye-Unicam SP500 spectrophotometer
2.3.4 C. albicans - Identification
Research on any microorganism demands methods for the identification of 
that species. Apart from the ability of C. albicans to ferment certain 
sugars and assimilate certain compounds as sole carbon and nitrogen source, 
there are two widely used methods for identification of C. albicans. These 
are based on the organisms ability to form chlamydospores and formation of 
germ tubes in suitable media.
C. albicans forms chlamydospores when inoculated in nutritionally 
impoverished media containing surfactants. A small inocolum was streaked 
across a microscope slide embedded in cornmeal-Tween 80 agar, enclosed within 
a sterile plastic tray. The slides were then incubated for four days at 
25° C.. When C. albicans NCPF3153 was applied as an inoculum, observation 
under the light microscope (x 200 magnification) revealed the presence of 
chlamydospores. In addition, it was noticed that this strain produced clumps
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of blastospores at regular intervals along the pseudo-hyphal shoot. In 
contrast, it was found NCPF3156 and 6406/8 strains of C. albicans grew as 
unicellular blastospores in this media. The ability of all the strains to 
form chlamydospores is not a universal characteristic of this 
species. In addition, "ritualised" inoculation techniques have been 
described by many groups attempting to produce this phenomenon (190,329).
The standard procedure used throughout the course of this research to 
identify C. albicans was the germ tube test. A standard test involved the 
addition of a very small inoculum (typically 10"* yeast cells) to 1 ml human 
serum. The suspension was incubated at 37° C. for 3 hr. A sample of the 
suspension was removed after this time and observed under the light microscope 
(x 200 magnification). The presence of mycelia (germ tubes) growing from 
the yeast cell was judged to be positive presumptive evidence for C. albicans.
2.3.5 C. albicans - Recovery from oral flora
The incidence of C. albicans in the oral flora of university staff, 
working in the vicinity of the research was measured, as described by Clayton 
and Noble (76). Mouthwashes were taken from sixteen individuals in the 
following manner. Participants were asked to swill their mouths with 10 ml 
of 0.97. NaCl solution. 1 ml of this solution was pipetted over 10 ml of 
Sabourauds dextrose agar. The agar had been supplemented with a 57. solution 
of penicillin/streptomycin(20,000 units penicillin and 5 mg streptomycin/ml 
H20). The plates were then left for 48 hr at 30° C. to allow any yeast 
colonies to develop. The incidence of C. albicans was determined using the 
germ tube test on sample yeast colonies, as described in the preceding section. 
It was found that C. albicans colonies were recovered from four of the sixteen 
individuals working in the department prior to commencement of this research. 
(Repetition of this experiment six months later revealed that C. albicans was 
recovered from mouthwashings of only three different individuals out of 
sixteen).
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2.3.6 C. albicans - Preparation of protoplasts
Enzymatic degradation of the cell wall of C. albicans resulted in the 
formation of protoplasts. The method used to prepare protoplasts was based 
on that described by Harrington and Douglas (152). A commercially available 
enzyme preparation (Zymolyase 60,000) was used to remove the cell wall. The 
protoplasts were identifiable as spherical bodies under the light microscope. 
In addition, protoplasts are osmotically sensitive. This property provided 
a useful tool to monitor the formation of protoplasts. The optical density, 
at 650 nm, of a sample of cells, diluted thirty times in distilled water was 
greater before enzymatic digestion than after.
Protoplasts were prepared from yeast phase C. albicans growing at 37° C.. 
The cells were harvested when the cell density corresponded to mid-exponential 
phase (1 - 5 x 10^ cells/ml Sabourauds dextrose broth). The yeast cells were 
then suspended, at 8 mg dry weight cells/ml protoplast buffer and incubated 
at 37° C.. (It was found that the dry weight was approximately 107. of the 
wet weight of a sample of cells dried in an oven at 85° C.). A suspension 
of cells of 8 mg/ml, diluted 30 fold in ^ 0  was sufficient to give an 
optical density at 650 nm of approximately 1 O.D. Unit. Protoplast formation 
commenced on addition of the enzyme. 1 mg of enzyme was used to prepare 
protoplasts from 100 mg dry weight of mid-exponential phase C. albicans. This 
ratio of enzyme to dry weight of cells resulted in a good yield of proto­
plasts after 45 min incubation at 37° C., in an orbital shaker operating at 
150 r.p.m. Protoplast formation was monitored by the susceptibility to 
lysis of 100 /j1 aliquots, removed at various time intervals, diluted into 
2.9 ml water. The optical density at 650 nm was measured using a Pye-Unicam 
SP600 spectrophotometer. Protoplast formation was judged to be complete when 
the optical density had fallen to % of the original value.
The protoplasts were decanted from the suspension of digested cell walls 
and collected by centrifugation at 3,000 g for 5 min, using a Sorvall S534 
rotor in a Sorvall RCB5 centrifuge. The protoplasts were washed twice in
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protoplast buffer and stored at -70° C. until required. Typically between 
307. to 507. of the original yeast cells of C. albicans were converted into 
protoplasts, as judged by observation under the light microscope (x 200 
magnification).
The viability of the protoplasts - as defined by the ability of the 
cells to regenerate new cell walls - was found to be between 50 and 707.. 
Protoplast viability was determined by serial dilution of samples of the 
cells, in protoplast buffer, to an expected protoplast density of 100 - 200 
cells/ml. 1 ml of this suspension was then plated onto 10 ml modified 
Sabourauds dextrose agar (made up in protoplast buffer, not water) and 
incubated for three days at 28° C. The percentage viability was found by 
counting the number of colonies growing on the plate and comparing this 
value with the expected number.
2.3.7 C. albicans - Preparation of nuclei
Nuclei were prepared from protoplasts by hypotonic stock using a method 
based on that described by Schultz (331) to prepare nuclei from S. cerevisiae. 
Protoplasts were first prepared as described in 2.3.6. These were lysed by 
dilution 1 s 5 in Schultz's buffer A - modified by the exclusion of Ficoll 
and inclusion of 0.5 mM CaC^. This procedure lysed the protoplasts, but 
left nuclei intact. The nuclei, cell debris, contaminating whole cells and 
any unlysed protoplasts were precipitated by centrifugation at 10,000 g for 
10 min, using a Sorvall S534 rotor in a Sorvall RC5B centrifuge,pre-cooled 
to 4° C.
Several procedures were used to try and achieve an uncontaminated nuclear 
preparation. The first method was based on that used by Coles to prepare 
Tetrahvmena pvrlformis macronuclei (78). This involved resuspending the 
crude nuclear pellet in Schultz's buffer A, modified by exclusion of Ficoll 
and by the inclusion of 0.5 nH CaCl^. The suspension was then layered on 
top of 20 mM potassium phosphate buffer pH 6.6 containing 1 mM MgCl^t 0.5 mM 
CaCl2 and 2.1 M RNase free sucrose. The nuclei were collected by
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centrifugation at 59,000 g for 60 min using a Beckman type 30 rotor in a 
Spinco L2 centrifuge, pre-cooled to 4° C. An alternative method involved 
layering the protoplast lysate on 20 mM potassium phosphate buffer pH 6.6 
containing 1 mM MgC^, 0.5 mM CaC^ and 2.2 M RNase free sucrose. Centri­
fugation of 30,000 g for 90 min using a Beckman type 40 rotor in a Spinco 
L2 centrifuge, pre-cooled to 4° C. resulted in precipitating the nuclei.
This method was based on that described by Busch and Daskal (53).
The procedure described by Schultz (3 3 1 /  was also used to attempt to séparai 
nuclei from cellular contaminants. This involved lysis of protoplasts by 
1 : 5 dilution in Schultz's buffer A, modified by the inclusion of 0.5 mM 
CaCl^. Whole cells and protoplasts were removed by low speed centrifugation 
(2,000 g for 5 min, in a Sorvall S534 rotor in a Sorvall RC5B centrifuge, pre- 
cooled to 4° C.) The nuclei remaining in the supernatant were collected by 
centrifugation at 30,000 g for 30 min, using a Beckman type 30 rotor in a 
Spinco L2 centrifuge, pre-cooled to 4° C. Any membranous material at the 
top of the supernatant was removed by vacuum aspiration and the remaining 
supernatant decanted. The nuclear pellet was then resuspended in Schultz’s 
buffer B, modified by the inclusion of 0.5 mM CaC^. A further low speed 
centrifugation was tried to remove contaminating unlysed protoplasts or 
whole cells. Centrifugation at 20,000 g,for 25 min in a Beckman type 30 
rotor in a Spinco L2 centrifuge,resulted in the precipitation of the nuclei.
The nuclear pellet collected from any of the high speed centrifugation 
was resuspended in Schultz's buffer C. The integrity of the nuclei was 
assessed by light microscopy (x 1,000 magnification) and in vitro RNA poly­
merase activity. The DNA and protein content of the nuclear preparation 
were determined. The most successful method for preparation of nuclei was 
judged to be that which had in vitro RNA polymerase activity and was 
uncontaminated by whole cells or unlysed protoplasts.
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2.3.8 C. albicans - Purification of RNA polymerases
The methods used to purify the RNA polymerases from the two morphological 
forms were based on those described by Hager et al (141) and Kumar et al (2 0 }). 
In order to avoid repetition, the experimental details developed to purify 
the RNA polymerases from C, albicans will be fully discussed in 4.2.1 - 4.2.7.
2-4 S. cerevisiae - Strain and growth conditions used
Studies on the inhibitor lomofungin involved the use of S. cerevisiae 
CD40 strain (a wild type strain). This organism was maintained and grown in 
YEP broth at 28° C., in an orbital shaker operating at 150 r.p.m. Under these 
conditions this strain of S. cerevisiae had a doubling time , during 
exponential phase, of approximately 130 min.
2.5 Enzyme assays
2.5.1 Measurement of RNA synthesis by protoplasts and yeast cells
Incorporation of £^C] or [^H ] uridine into TCA insoluble material was 
used as an index of RNA synthesis. The precursor was added to a suspension 
of whole cells or protoplasts in protoplast buffer, supplemented with 50 mM 
fructose (see 3.3.1, 5.3.3, 5.3.6 and 6.4.4). The cell suspensions had been 
pre-incubated for the length of times and temperatures as subsequently des­
cribed in these sections. After specified times duplicate or triplicate 
0.5 ml aliquots were removed. The reaction was terminated by addition of the 
aliquot to 2 ml ice cold 107. TCA. The insoluble precipitate was collected 
by filtration onto a Whatman GF/C 25 mm disk over a sintered funnel. The 
disk was washed three times with 10 ml ice cold 57. TCA containing 10 p g /m l  
uridine, once with 10 ml ethanol and once with diethyl ether. The disks 
were dried and the radioactivity incorporated measured by liquid scintillation 
counting, using a Packard Tricarb scintillation counter. The assay to 
measure RNA synthesis in vivo by yeast cells or in vitro by protoplasts 
was based on that described by Kuo et al (205).
- 52 -
2.5,2 Measurement of RNA synthesis in vitro
Incorporation of f 3 or £^Cj UTP into TGA insoluble material was used 
as an index of RNA synthesis, in cell free extracts, nuclei, purified and 
partially purified RNA polymerases. Two incubation media were assessed for 
their ability to support RNA synthesis by the aforementioned in vitro 
systems. These were based on the assay ‘'cocktails'* described by Higashinakagawc 
et al (163) (to support RNA synthesis by Tetrahymena pyriformis macronuclei) 
and Schultz ( 331) (to support RNA synthesis by S. cerevisiae nuclei). The 
assay media of Higashinakagawa et al contained, at final concentrations:
50 mM Tris HC1 pH 7.9 (22° C. ), 2.25 mM MnCl2, 0.25 tiM dTT, 2 it« ATP,
0.5 mM GTP and CTP, 150 raM KC1, 50 nCi (1.85 KBq) of [ i t 14C] UTP and 0.1 mM 
"cold" UTP. The "cocktail" based on that described by Schultz contained, 
at final concentrations: 50 raM Tris HC1 pH 7.9 (22° C.), 1 ttM dithiothreitol,
0.5 mM each of GTP, CTP and ATP. The concentration and specific activity of 
[3H] or C^Cj UTP and concentration of KC1, and either MgCl2 or MnCl2 in 
the "cocktail" were varied during the course of the research, depending upon 
the aim of the experiment. In appropriate cases, exogenous DNA 
was added. The DNA was heat denatured according to the method of Aposhian 
and Kornberg (9). This involved heating a solution of DNA (2 mg DNA/m l in 
20 mM Tris HC1 (containing 20 mM NaCl)#at 100° C. for 10 min.
The reaction was started by the addition of the test suspension (i.e. 
nuclei, cell free extract, partial purified RNA polymerase) to the assay 
"cocktail", and in appropriate cases the exogenous DNA. The reaction was 
allowed to proceed for a given length of time. The reaction was terminated 
by spotting aliquots (typically 100 /ul) onto Whatman GF/C disks and 
immersing the disks into ice cold 57. TCA containing 17. sodium pyrophosphate 
In total, the disks were washed three times in ice cold 57. TCA containing 17. 
Sodium pyrophosphate, once in ethanol and once in diethyl ether. The disks 
were dried and counted by liquid scintillation counting as described in 2.5.1.
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2.5.3 Assay for RNase activity
The RNase activity of a solution was estimated by the ability to degrade 
RNA substrate. The method of McDonald (249) was used to measure the 
release of acid soluble oligonucleotides from the exogenous RNA substrate.
An appropriate amount of the test sample was suspended in 50 nM Tris HC1 
pH 7.3 and 0.1 M KC1 to 1.5 ml. This was mixed with 1 ml of 17. (w/v)
C. utllls RNA and incubated at 30° C. After 10 min 1 ml of 0.757. (w/v) 
uranylacetate in 257. (v/v) perchloric acid was added to precipitate, the 
intact RNA. The mixture was cooled in ice for 15 min and centrifuged at 
maximum speed for 5 min, at 4° C. in a B & T microangle bench centrifuge. 
Aliquots of the supernatant were diluted with 3.0 ml double distilled 
water and increased absorbance of 260 nm over a control, which lacked a 
RNase sample was measured.
2.5.4 DNase treatment of nucleic acids extracted from C. albicans *34
Section 2.7.1 and 2.7.2 will deal with the procedures that were used to 
extract RNA synthesised both in vivo and in vitro. Contaminating DNA was 
degraded using the method of Zaug and Cech (415). The precipitate of 
nucleic acids was collected, by centrifugation at 3,000 r.p.m., for 10 min 
in a M.S.E. Mistral centrifuge (12 x 150 ml rotor) cooled to 4° C. The 
nucleic acid precipitate was then suspended in 1 ml of 50 mM Tris acetate 
buffer pH 7.5. Sodium acetate and MgCl^, in aqueous stock solutions of
3 M, were added to final concentrations of 0.25 M and 0.01 M respectively.
A sufficient volume of 50 mM Tris acetate buffer pH 7.5 was added to give a 
final volume of 4 ml.
The nucleic acid/Tris acetate suspension was incubated with DNase for
4 min at 25° C. (10 p i  of a 10 mg/ml solution of the enzyme was added to 
the nucleic acid suspension). DNase A is an endonuclease (molecular weight 
65,000) which cleaves both double and single stranded DNA. It is not active 
against RNA (219). The action of the DNase was terminated by cooling in ice 
for 10 min.
Lactate dehydrogenase (LDH) assay
One of the criteria used for successful homogenisation of C. albicans 
was L DH activity before and after the two methods for cell suspension had been 
attempted. The activity of this enzyme was measured using a method based on tha 
described by Williamson and Corkey 099). LDH activity was measured in terms 
of the decrease in concentration of NADH (substrate), followed by measuring 
changes in absorbance at 366 nm.
An appropriate amount of sample (typically 100 ¿il) was added to a 
cuvette containing 1 ml 0.2 M sodium phosphate buffer pH 7.2, 0.1 ml 4.0 mM 
sodium cyanide, 0.1 ml NADH (5.2 mM in 10 tiM Tris HC1 pH 8.5) and 1.6 ml 
double distilled water. The solutions were carefully mixed and the reaction 
started by the addition of 100 /il 60 mM sodium pyruvate solution. The 
change in O.D., at 366 nm, over a 3 min period, was measured using a 
Pye-Unicam SP1800 spectrophotometer and compared with a blank (i.e. 0.1 ml 
H^O added instead of sodium pyruvate).
Estimation of protein and nucleic acid content 
Determination of DNA content *&
The isolated DNA was quantitated by a colorimetric reaction involving 
the deoxyribose residues and diphenylanine as described by Burton ( 52 ).
9The nucleic acid, from a suspension of at least 10 nuclei/cells in 
0.5 ml water, was precipitated by the addition of 0.5 ml ice cold 107. TCA.
The samples were centrifuged, at maximum speed for 5 min at 4° C., in a B
& T microangle centrifuge and the supernatant discarded. The pellet was 
then resuspended in 0.5 ml 0.5 M HC10^, treated for 15 min at 70° C. and 
centrifuged as previously described. The supernatant from this centrifugation 
was removed and kept in ice. A further 0.5 ml of 0.5 M HCIO^ was added to 
the pellet and treated as previously described. The supernatants from the 
first and second centrifugation of 0.5 ml of 0.5 M HC10^ were combined with 
2 ml of diphenylamine reagent ( 1.5 g diphenylamine in 100 ml glacial acetic 
acid and 1.5 ml 8 M H^SO, , and just prior to use, 0.5 ml 1.67. aqueous
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acetaldehyde was added to the diphenylamine solution). This assay mixture 
(total volume 3ml) was mixed and incubated for 17 hr at 28° C.
The optical density at 600 nm of the solution was recorded using a Pye-Unicam 
SP1800 spectrophotometer. Calf thymus DNA was used to construct a linear 
standard plot from 10 - 100 /jg DNA.
2.6.2 Determination of RNA content
The RNA content of a sample was estimated using the method of Schnieder 
(330). This utilised the reaction of orcinol with pentose sugars.
Samples were diluted to 1.5 ml in H^O, mixed with 6 ml of ice cold 107.
TCA and incubated for 5 min at 4° C. The tubes were centrifuged, at 
maximum speed for 5 min at 4° C., using a B & T microangle centrifuge. The 
pellet was resuspended in 5 ml ice cold 57. TCA and centrifuged as previously 
described. The pellet was resuspended in 5 ml ice cold 57. TCA, extracted 
at 90° C. for 20 min, cooled and centrifuged as previously described. 1.5 ml 
of this solution was then added to 1.5 ml orcinol reagent and heated for 
15 min at 90° C. (The orcinol reagent consisted of 1 g purified orcinol 
dissolved immediately prior to use in 100 ml 12 M HC1 containing 0.5 g FeCl^. 
The orcinol was purified from commercial sources by recrystalliaing from 
boiling hexane). The optical density of the solution at 660 nm was recorded. 
C. utilis RNA was used to construct a linear standard plot from 10 - 100 /ig 
RNA.
2.6.3 Estimation of protein content
The method used to estimate the protein content of C. albicans was based 
on that of Lowry et al (224). A colorimetric assay was based on the biuret 
reaction between protein and copper ion in alkali and the reduction of 
a phosphomolybdic-phosphotungstic reagent by the tyrosine and tryptophan 
present in the treated protein.
A test sample (up to 0.6 ml) of C, albicans homogenate was mixed with 3 ml 
alkaline copper solution for 10 min at 25° c. (The alkaline copper solution
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consisted of 50 ml 2% Na^CO^ in 0.1 M NaOH combined with 1 ml of an aqueous 
solution of 0.57. Cu50^. 51^0 and 1 ml of an aqueous solution of 17. sodium 
potassium tartrate). 0.3 ml of Folins reagent was then added to the homo­
genate-alkaline copper solution and immediately mixed. After 30 min, the 
optical density at 600 run of the solution was then recorded using a Pye- 
Unicam SP600 spectrophotometer. A linear standard plot, using 10 - 100 ^ ig 
bovine serum albumin (BSA), was prepared in a similar manner to the test 
sample.
Estimates of the protein content of nuclei and during the various stages 
of RNA polymerase purification were performed on untreated samples. However, 
prior to estimating the protein content of whole cells the samples were 
homogenised using a Potter-ElvejV\ft«\ homogeniser.
2.7.1 Extraction of RNA synthesised in vivo
In vivo synthesised RNA was extracted by the hot phenol— SDS method 
described by Hermolinand Zimmerman (162). The extraction was performed on 
a cell suspension (typically 10 yeast cells) in 5 ml of extraction buffer. 
(The extraction buffer consisted of 10 mM EDTA in 10 mM sodium acetate buffer 
pH 5.0, containing 20 y g polyvinylsulphate/ml buffer. The cells were 
disrupted by the addition of a 107. solution of SDS to a final concentration 
of 0.57. and 10 ml of phenol reagent added. (The phenol reagent consisted of 
a water-saturated solution of 50 ml phenol, and 7 ml m-cresol, containing 
50 mg 8-hydroxyquinoline. Both the m-cresol and phenol were purified by 
re-distillation of the commercially available product).
The disrupted cell and phenol suspension was then incubated for 5 min 
in a 50° C. water bath. The mixture was then cooled in ice for 10 min. The 
aqueous and organic layers were separated by centrifugation at 3,000 r.p.m. 
for 5 min in an M.S.E. centrifuge pre-cooled to 4° C. The nucleic acids, in 
the aqueous top layer and in the Interface, were removed and subjected to an 
additional extraction with 10 ml of organic phase phenol reagent. After this 
second extraction with the phenol reagent the nucleic acids in the aqueous
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layer and interface with the organic layer were removed.
The nucleic acid solution was subjected to an extraction in 10 ml 
chloroform reagent. (The chloroform reagent consisted of a solution of 24 
volumes chloroform : 1 volume isoamylalcohol. The solvents 
were redistilled from the commercially available material) The aqueous 
phase was removed and the nucleic acid precipitated by the addition of 10 ml 
957. ethanol containing 0.2 M sodium acetate. A precipitate of nucleic acids 
was obtained after cooling to -20° C. for 12 hr.
In order to avoid contamination of the extracted RNA, rubber gloves were 
worn throughout this operation.
2.7.2 Extraction of RNA synthesised in vitro *15
RNA synthesised in vitro by protoplasts was extracted by the hot phenol/ 
SDS method ofHermolin and Zimmerman (162) as described in the preceding 
section. RNA labelled and synthesised in vitro by nuclei was extracted by 
the method of Davies and Walker (86 ).
A suspension of nuclei (450 ^ ul of nuclei and assay "cocktail") was 
incubated at 25° C. for the length of time indicated in the figures (typically
15 min). 450 ^ 1 of 0.27. SDS solution was added to the nuclear suspension.
The 900 ¿il SDS/nuclear suspension was cooled in ice and 900 jul of organic 
phase of phenol reagent added. The 1800 ¿il suspension was mixed for 3 min 
at 0° C. The aqueous and organic phases were separated by centrifugation 
at 3,000 r.p.m. for 5 min in a M.S.E. centrifuge cooled to 4° C. The 
aqueous layer was removed and stored in ice. The interface between organic 
and aqueous phases was removed and resuspended in 3 ml of 1 mM Tris HC1 
pH 8.0 buffer. The 3 ml solution was combined with an equal volume of 
organic phase phenol reagent and heated at 70° C. for 10 min. The aqueous 
layer was separated by centrifugation of 3,000 r.p.m. for 5 min in a M.S.E. 
centrifuge cooled to 4° C. and combined with the 900 ¿il aqueous layer from 
the previous phenol extraction. RNA in the combined aqueous layers was 
repeatedly extracted with organic phase phenol reagent until the ratio of
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optical densities at 260 and 280 nm of the aqueous layer was between 1 and 2. 
Two extractions, with organic phase phenol reagent, were usually required to 
achieve this. The RNA was then precipitated by the addition of 8 ml 957. 
ethanol containing 0.2 M sodium acetate and cooling to -20° C. for 12 hr.
All glassware used in the extraction of both in vivo and in vitro 
synthesised RNA was chromic acid cleaned and sterilised by heating in a 40° C. 
oven for 17 hr. The solutions used for the extraction of RNA were assayed 
for RNase activity. RNase activity in all solutions was found to be 
negligible.
2.8 Analytical techniques
2.8.1 Electrophoretic analysis of RNA
RNA extracted, as described in 2.7.1 and 2.7.2 was analysed by electro­
phoresis using polacrylamide tube gels and agarose slab gels. The 107. 
polyacrylamide and 2.57. polyacrylamide/0.57. agarose composite tube gels were 
prepared as described by Ringborg et al (30P). The 1.37. agarose slab gel 
was prepared as described by Lehrach et al ( 2 1 3 ) *
The 2.57. polyacrylamide/0.57. agarose composite tube gels were prepared in 
the following manner: 75 mg of agarose was refluxed in 9.5 ml of water, in a 
water bath at 90° C., for 20 min. The refluxed agarose solution was cooled 
to 35° C. and added to 2.5 ml of acrylamide solution (157. acrylamide, 0.757. 
methylene-bis-acrylamide) and 3 ml gel buffer (180 mM Tris HC1 pH 7.8, 
containing 150 mM NaH2P02 and 5 mM EDTA). The gel buffer and acrylamide 
solution had been previously "de-gassed" by vacuum aspiration : 25 jil of 
TEMED solution and 150 jil fresh 107. ammonium persulphate solution were then 
added to the 15 ml acrylamide/agarose solution. Approximately 3 ml of this 
solution was quickly pipetted into a 10 cm glass tube (100 mm x 6 mm) and 
allowed to set.
107. polyacrylamide tube gels were prepared in a similar manner to the 
2.57. polyacrylamide/0.57. agarose gels. 10 ml of the acrylamide solution,
2 ml of H^0 and 3 ml of gel buffer were "de-gassed" by vacuum aspiration.
/50 /il of TEMED and 150 j^l of fresh 107. ammonium persulphate solution were 
then added to the 15 ml polyacrylamide solution. Approximately 3 ml of this 
solution was quickly pipetted into a 10 cm glass tube (100 mm x 6mm) and 
allowed to set.
Extracted RNA to be analysed was layered onto the top of the gel in 25 yul 
sample buffer. (The sample buffer consisted of 30 mM Tris HC1 pH 7.8, 
containing 30 mM NaH2P03, 5 mM EDTA, 0.27. SDS, 107. sucrose (RNase free) and 
0.0027. Bromophenol blue) Unlabelled RNA to be analysed was added as a sus­
pension containing 2.5 O.D. units of RNA. One O.D. unit of RNA was defined 
as the amount of RNA which had an optical density of 1 at 260 nm. In vitro 
synthesised RNA, either T. or labelled, was suspended in 25 ^ jl sample
buffer and layered onto the gel. After 3 hr electrophoresis, at 5 nA/gel, 
the gels were removed from the glass tubes. Gels containing unlabelled RNA 
were scanned using a Gilson gel scanner, operating at 260 nm wavelength.
Gels containing labelled RNA were cut into 2 mm slices using a gel slicer.
The polyacrylamide gel slice was solubilized using 0.7 ml of N.C.S./toluene, 
solution. (1 volume N.C.S. : 6 volumes toluene) The radioactivity of each 
slice was measured by liquid scintillation counting - with 20 ml toluene 
scintillant added to each slice.
Agarose gel electrophoresis was performed using slab gels containing 1.37. 
agarose. Formamide was used as the denaturing agent for the RNA. The gels 
were prepared by dissolving 1.3 g of agarose in 10 ml Tris acetate buffer 
(40 mM Tris acetate pH 7.8 containing 20 mM sodium acetate and 2 mM EDTA)
40 ml H20 and 50 ml formamide. The formamide was de-ionised by the addition 
of 5 g amberlite MB 3 resin to 50 ml formamide. The suspension was stirred 
for 3 hr, the resin removed by filtration and the deionised formanide stored 
at -20° C.) The agarose was dissolved by heating the agarose - Tris acetate - 
formamide suspension for 20 min at 90° C. This suspension was cooled to 40° C. 
and poured, whilst still liquid, to form slabs 5 mm x 100 mm x 200 mm.
RNA.was extracted as described in 2.7.1 and suspended in 10 ;ul H20 
(typically 10 yug/sample). 26 /il de-ionised formamide and 4 j u l Tris acetate
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buffer were added to the RNA suspension. The 40 p i RNA suspension was 
denatured by heating for 4 min at 60° C. After cooling in ice, 5 jil of 
0.047. bromophenol blue marker in 507. glycerol was added. The test samples 
of RNA were loaded into the wells in the agarose gels. The RNA suspension 
was layered on top of 20 p i  solution of 2 pi Tris acetate buffer and 607. 
de-ionised formamide. Electrophoresis was carried out at 180 mA for 5 hr.
The buffer used in electrophoresis consisted of 4 mM Tris acetate buffer 
pH 7.8 containing 2 mM sodium acetate and 0.2 mm EDTA.
2.8.2 Polyethyleneimine (PEI) thinlayer chromatography
The nucleotides used in the in vitro RNA polymerase assay, described 
in 2.5.Ztwere stored in aqueous solutions at -20^ C.. However, in aqueous 
solution hydrolysis of the NTP can occur and as a consequence nucleoside di- 
and monoephosphates may be formed as breakdown products. Thinlayer chroma­
tography (TLC) was used as an analytical technique for estimating the extent 
of hydrolysis. The method was based on that described by Randerath and 
Randerath (297) using commercially available PEI cellulose plates (Whatman)
The plates were prepared for use by developing in 107. NaCl to 5 cm above 
the origin and then transferred to double distilled H2O until the "solvent 
front" ran off the edge. The plates were air dried for 2 hr and immersed in 
double distilled H^O and developed until the "solvent front" ran off the edge. 
After the plates had been thoroughly dried, 5 p i  aliquots of test nucleotides 
(15 mM in aqueous solutions) were applied. The plates were then run in double 
distilled water for the first 5 cm and then immediately transferred and 
developed in a 1:1 mixture of 2 M LiCl and 2 M HCOOH for the next 5 cm. The 
plates were then air dried and the position the nucleotides had migrated was 
marked, after observation under a UV lamp (254 nm). Both radioactively 
labelled and unlabelled nucleotides were chromatographed in this way. The 
unlabelled nucleotides ATP, UTP, GTP and CTP migrated as single spots visible 
under the UV light. These nucleotides were found to have rf values of 0.37, 
0.24, 0.29 and 0.40 for each NTP respectively. These rf values are
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comparable to those reported by Randerath and Randerath of 0.33 for ATP, 0.20 
for UTP, 0.24 for GTP and 0.32 for CTP (297).
The radiochemical purity of the labelled UTP was assessed by a similar 
method, using 2 yul 15 mM UTP and 2 /il 15 mM UDP as carrier material for 
radioactive UTP. The position of the carrier was visualised under UV light 
and the radioactivity of the spot counted by liquid scintillation counting. 
Typically between 97 and 997. of the radioactivity migrated with the UTP.
2.8.3 Gel filtration
Pre-swollen Biogel A-5 M agarose was used for the gel filtration step in 
the purification of RNA polymerase purification. This agarose gel (wet bead 
diameter 60 - 200 /jm) had an exlusion limit of molecular weight 5 x 10 . The 
gel was de-gassed, packed into a 45 cm x 2.5 cm column and eluted with buffer 
A of Hager et ai (141) at 4° C.. The elution volume was calculated by 
exclusion of Blue dextran 2,000 (a high molecular weight polysaccharide). 
Samples were applied as between 1 and 57. of the bed volume onto a drained 
bed surface. A flow rate of 5 -8 cm hr ^enabled rapid separation of high 
molecular weight RNA polymerase from the lower molecular weight components 
of the cell. The flow rate was controlled using a peristaltic pump. The 
eluent was monitored at 280 nm using a Uvicord scanner connected to a chart 
recorder.
2.8.4 Ion exchange chromatography
This method was used to resolve the three classes of RNA polymerase from 
C. albicans. DEAE-SephadexA-25 was swollen in buffer B of Hager et al (14-1) 
containing 0.02 M KC1. The swollen ion exchange material was mixed with the sai 
buffer and packed into a column 30 cm x 1.5 cm. The column was eluted with 
at least two bed volumes prior to applying the sample. The sample was 
applied onto a drained bed surface and eluted with the starting buffer.
Elution by a continuous gradient of changing ionic strength was used to 
desorb the bound RNA polymerases. A flow rate of 2 cm hr“  ^was controlled
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using a peristaltic pump. The eluent was monitored at 280 nm using a Uvicord 
scanner connected to a chart recorder.
2.8.5. Affinity chromatography
Denatured calf thymus DNA-cellulose was used to retain RNA polymerases 
as a stage in the enzyme's purification. A DNA-cellulose column was prepared 
as described by Alberts and Herrick ( 5 ). A 2 mg/ml solution of calf thymus 
DNA,in 10 mM Tris HC1 pH 7.9 containing 1 mM Na^EDTA was added to Cellex 410 
cellulose powder (approximately 160 ml of DNA solution was added to 50 g of 
Cellex). The paste was left in a petri dish and thoroughly dried for five 
days at 70° C.. The dried powder was suspended in 20 volumes of 10 mM 
Tris HC1 pH 7.9 containing 1 mM Na^EDTA, and left at 4° C. for one day. After 
two quick washes to remove free DNA the DNA cellulose was stored as a frozen 
slurry at -20° C.. The amount of DNA bound was determined by heating at 100° C. 
for 20 min. Typically 507. of the original DNA was normally bound to the 
cellulose.
The sample was applied to the column (10 cm x 1.5 cm) and extensively 
washed with buffer B of Hager et al (1411 containing 20 mM KC1 to remove 
unbound proteins. The DNA binding RNA polymerases were recovered by elution 
with buffer containing a linear salt gradient of 2 - 3 bed volumes. A low 
flow rate of 0.5 cm hr"^ was maintained using a peristaltic pump. The eluent 
was monitored at 280 nm using a Uvicord scanner connected to a chart recorder.
2.8.6 Glycerol gradient centrifugation
The final stage in the purification of RNA polymerases was a glycerol 
gradient centrifugation using a method based on that of Kumar et al (20*4)
The sample was layered onto 11 ml linear gradients of 15 - 307. glycerol in 
buffer B of Hager et al (141) . The gradients were then centrifuged in the
rotors for the lengths of time stated in 4.2.6
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2.8.7 Non-denaturing polyacrylamide gel electrophoresis
Analytical polacrylamide gel electrophoresis, under non-denaturing 
conditions, was performed on the purified yeast phase RNA polymerases 
according to the method of Sklar and Roeder (352). A 57. polyacrylamide 
tube gel was prepared essentially as described in 2.8.1. However, 7.5 ml 
of gel buffer (containing 507. v/v, 0.75 M Tris HC1 pH 8.9, 0.3 mM dithiothreitol 
was added to 7.5 ml solution of 107. acrylamide/0.267. methylene-bis-acrylamide 
and de-gassed prior to polymerisation with 60 ^ jl TEMED and 120 jul fresh 107.
(w/v) ammonium persulphate.
Typically 1 - 2 Jig of protein was applied to the gel in 25 >il buffer B 
of Hager et al ( 141) containing 0.0057. bromophenol blue. The gels were 
subjected to electrophoresis at 1.5 mA/gel until the dye front reached the 
bottom of the gel ( 5 mM Tris 38 mM glycine was used as the electrode buffer).
2.8.8 Protein staining
The protein in the gels subjected to non-denaturing electrophoresis, as 
described in 2.8.1, was visualised using the sensitive protein staining 
technique described by Merril et al (258). The protein in the tube gels was 
fixed by suspension for 30 min in 507. methanol/127. acetic acid. The gels 
were re-expanded by storing in 107. ethanol/57. acetic acid for 2 hr. This 
was followed by three 5 min washes in 107. ethanol. The gels were soaked in 
a solution of 47. (w/v) paraformaldehyde/1.437. (w/v) sodium cacodylate - the 
pH adjusted to 7.3 with HC1 - for 30 min. After three further washes in 107. 
ethanol, the gels were gently agitated for 30 min in CuNO^/AgNO^ solution.
(This solution contained 3.5 g AgNO^ in 100 ml H^O with 1.5 ml of 0.57. CuNO^. 
Immediately prior to use 4 ml pyridine and 8 ml ethanol were added to the 
solution). The gels were then soaked for 5 min in fresh diamine solution.
(The diamine solution was made up 5 min prior to use and contained 30 ml of 
19.47. (w/v) AgNOj solution and 22.2 ml of NaOH/NH^OH stock solution. The 
NaOH/NH^OH stock solution contained 0.367. NaOH, 45 ml concentrated NH^OH and 
55 ml 207. (v/v) ethanol). The diamine solution was discarded immediately after
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use. The gels were washed twice for 1 min in reducing solution A and then 
washed several times in reducing solution B until the brown/black lines 
appeared marking the position of the protein band. Reducing solution 
A contained 2.5 ml of 107. formaldehyde, 6 ml of 17. citric acid and 107. (v/v) 
ethanol per L l^O. Reducing solution B was identical to reducing solution A 
except 5 ml of 107. formaldehyde and 5 ml of 17. citric acid solutions were 
used instead . The gels containing the protein bands were stored in water.
2.8.9 Preparation of autoradiographs
The method used to prepare autoradiographs of 1.37. agarose slab gels,
32 i
containing [ PJ labelled RNA, was based on that described by Maniatis et al 
(233). After electrophoresis, the gel was covered with Kodak X-omat X-ray 
sensitive film. The plate was exposed for between one and fourteen days at 
-70° C. , depending upon the level of radioactivity in the gel. The photo­
graphic plates were developed, in a dark room, by soaking in Kodak liquid 
X-ray developer for 5 min. This was followed by 1 min in 37. acetic acid bath, 
to stop development, and 10 min in Kodak rapid fixer. The plates were 
washed in running water for 15 min and dried at room termperature.
2.9 Data analysis
Correct interpretation of any result demands methods for its statistical 
analysis, which will enable a conclusion to be drawn. The results obtained 
from most experiments were usually presented as a mean value + the standard 
deviation of that sample. A line of best fit for two variables (e.g. see 2.6.1 
standard plot of DNA concentration vs O.D. at 600 nra) was made using 
a regression line. In calculating the regression line the estimated variable 
was regressed against the given variable. The Pearson product-moment 
coefficient of correlation was used as an estimate of the closeness of the 
relationship between two variables.
Significance tests may be useful in determining whether differences in 
sample data were significant. In order to test if an observed series of 
values were statistically significant from expected a test was performed.
CHAPTER 3 A COMPARISON OF SYSTEMS USED TO STUDY in vivo AND in vitro RNA
SYNTHESIS BY C. albicans
3.1 Introduction
RNA synthesis is a complex process that requires multiple approaches in 
the elucidation of its mechanism and control. Ever since the ability of 
eukaryotes to synthesise RNA was demonstrated (398)» it has been necessary 
to prepare suitable in vitro and in vivo systems for studying this process.
In vitro studies, with isolated enzymes, have been important in defining the 
characteristics and kinetics of the individual components (e.g. 5 1 ) .  Other 
groups have isolated mutant organisms, defective in some aspect of RNA 
synthesis, and used this method to demonstrate which in vivo function is 
blocked (e.g.317). The rationale behind many studies has been to try and 
recreate the events that occur in vivo using in vitro systems of increasing 
complexity. These systems vary from isolated RNA polymerases (e.g. 310) to 
protoplasts (e.g. 81 ) .
This chapter will deal with the preparation of two in vitro systems used 
to study RNA synthesis in C. albicans, namely protoplasts and nuclei. The 
ability of protoplasts and nuclei to synthesise RNA and the RNA species formed 
by these two systems were investigated. The suitability of these systems, as 
models to investigate in vivo RNA synthesis, will also be discussed.
Protoplasts are bacterial or plant cells, from which the cell wall has 
been removed. Removal of the constraints imposed by the cell wall confers 
osmotic sensitivity on the protoplasts. As a consequencejthe protoplasts 
ought to be prepared in isotonic buffer or lysis of the cell results. A 
variety of methods have been used to prepare these osmotically sensitive cells. 
Pre-treatment of the cells with a solution of mercaptoethanol and EDTA (to 
reduce surface protein disulphide bands) followed by incubation with Helix 
pomatia digestive juice is a commonly used procedure ( 6 ,  1 9 5 ) .  Lytic enzymes 
from Cvtophaga ( 2 3 9 ) ,  Streptomvces spp (10 7 )  and Arthobacter luteus (191) have 
also been successfully employed for protoplast preparation. In this project 
protoplasts were prepared using Zymolyase 60 ,000 .  This enzyme
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had been successful in the preparation of protoplasts from S. cerevisiae 
(iS6). The formation of protoplasts from C. albicans blastospores used a 
method based on that described by this group.
Experiments dependent upon protoplasts, or indeed whole cells, to 
investigate RNA synthesis are likely to suffer several disadvantages. The 
cell membrane is impermeable to the immediate substrates for RNA synthesis, 
i.e. nucleoside triphosphates. Monitoring nucleic acid synthesis in these 
systems, therefore, requires the use of labelled nucleosides. There is a 
complicating aspect to such studies as pools of precursors are present in 
cell cytoplasm. In addition, any molecules introduced into the cell, via the 
incubation media, would effectively be diluted by the bulk of the cytoplasm. 
This would reduce the number of molecules reaching their target sites in the 
nucleus. The RNA products synthesised in the nucleus may be similarly 
diluted on entering the cytoplasm. The cytoplasm contains a variety of 
proteins and enzymes that may modify or degrade any molecules exported from 
the nucleus (251). Some of these problems may be overcome by the use of 
nuclei.
Nuclei contain the main genomic information of eukaryotic cells (see 
1.3.1). The methods employed to isolate the nuclei from C. albicans were 
based on those used to prepare nuclei from the yeast S. cerevisiae. It was 
hoped that techniques which had proved suitable for this latter organism 
would be applicable to C. albicans, as both systems are similar in many 
respects (see 1.2.2 ). Published methods for the isolation of S. cerevisiae 
nuclei are of two major types. One method is through lysis of yeast
cells by various pressure methods (e.g. 32). This has the advantage that 
nuclei are prepared from physiological "normal" cells. However, yields are 
often low and microscopic appearance indicates damage during preparation.
The second method to prepare nuclei is by osmotic shock or detergent lysis 
of protoplasts (e.g.221 ,401). This method apparently results in high yields 
of nuclei, although their nutritional state is questionable. In addition, 
the relatively long isolation procedures may adversely affect the physiological
state of the nuclei
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Nuclei may be separated from whole cells, unlysed protoplasts and cell 
debris by a variety of techniques. The procéderai step most frequently used 
is differential centrifugation. The methods described by Coles (78), to 
prepare T. pyrlformis macronuclei and Busch and Daskal (53) for mammalian 
nuclei were used to try and recover C. albicans nuclei. These procedures 
involved centrifugation of the disrupted cells in hyperosmotic sucrose 
solutions. Although such high concentrations of sucrose may shrink the 
nuclei, these methods may be used to rapidly prepare nuclei. Another 
differential centrifugation technique, described by Schultz (331 was also 
tried for the recovery of C. albicans nuclei. This method - used to isolate 
nuclei from S. cerevisiae - had the advantage that the nuclei could be 
recovered under isotonic conditions by the use of Ficoll containing solutions. 
Although an uncontaminated nuclear preparation may result, many time consuming 
centrifugation steps were required. The criteria for a successful preparation 
of nuclei from C. albicans was freedom of the preparation from contamination 
by cell debris, whole cells or unlysed protoplasts and whether these nuclei 
showed the ability to synthesise RNA.
The ability of protoplasts and nuclei to synthesise RNA was investigated. 
RNA synthesis was measured by the ability of the system, incubated in 
suitable media, to incorporate a labelled precursor into TCA insoluble 
material. Radioactively labelled UTP was used to measure RNA synthesis by 
nuclei in vitro. The nuclear membrane is freely permeable to nucleotides.
In contrast, as noted earlier in this section, the cell membrane is only 
permeable to nucleosides. As a consequence, radioactively labelled uridine 
was used as an index for measuring RNA synthesis in protoplasts. RNA 
synthesis in vivo by blastospores was measured by the same method.
This chapter will also describe the conditions required for optimal nuclear 
RNA synthesis. The labelled RNA species synthesised under these conditions 
by nuclei and also by protoplasts were extracted and analysed, by polyacry­
lamide gel electrophoresis. These were compared to the RNA species extracted 
from protoplasts.
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3.2 Materials and Methods
Chapter 2 outlines the general methods and techniques used to conduct 
investigations into RNA synthesis by whole cells, protoplasts and nuclei. 
Specific experimental details are given in the legends of figures and tables.
3.3 Results
3.3.1 RNA synthesis by protoplasts
The ability of protoplasts, prepared from yeast form C. albicans, to 
synthesise RNA was investigated. A time course of l H ) uridine incorporation 
into TCA insoluble material by protoplasts is shown in Fig. 3.1. There was 
a lag period of 20 min, after the addition of the label to the incubation 
medium,before its appearance in TCA insoluble material. The regression line 
of [ H] uridine incorporation with time was estimated over the next 60 min 
period since uridine incorporation was approximately linear. During
this period f 3 uridine was incorporated into RNA at a rate of 11 fmoles 
min  ^for 10^ protoplasts.
The effect of protoplast density on [ HJ uridine incorporation into TCA 
insoluble material is shown in Fig. 3.2. Incorporation of [^h ] uridine per 
unit time increased linearly with protoplast density. If one assumed a 20 
min lag period, with no measurable incorporation of (^H J into RNA, the rate 
of incorporation over the next 40 min, of a 60 min incubation period, may be 
found. This was estimated as 13 fmoles ("*H] uridine min 1 by 10^ protoplasts.
The incorporation of label into RNA was expressed in terms of 10^ viable 
protoplasts. Typically 50 - 70% of the protoplasts in the incubation medium 
were viable. Viability was defined as the ability to regenerate cell walls 
and grow as colonies on S.D.B. as described in 2.3.6.
3.3.2 RNA synthesis by C. albicans blastospores
The incorporation of uridine into RNA was measured for two different
growth phases of yeast form C. albicans, using the same incubation conditions 
used for protoplasts. Blastospores were harvested and washed when cell
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TIME OF INCUBATION AT ¿5 C. (min) 
Tim« course of RNA synthesis by C. albicans protoplasts
the exponential phaseProtoplasts were prepared from C. albicans yeast cells 
of growth, as described in 2.3.6. The protoplasts were suspended in protoplast 
buffer to a cell density of <* x 10' viable cells/ml. The suspension was 
incubated for 80 min at 37° C. and 10/jCi of f.3H } uridine (specific activity 
<*7.5 Ci/itmol) was added per ml suspension. Triplicate 0.5 ml aliquots were 
removed at the times shown in the figure. The reaction was terminated and 
radioactivity incorporated into RNA was reasured as described in 2.5.1. The
pla albicans veast cells, in the exponential phase
of growth, as described In 2.3.6. The protoplasts were suspended in protoplast 
buffer to a cell density of 126 x 10* viable cells/ml. This protoplast suspension 
was diluted, in the same buffer, to give protoplast suspensions with final cell 
densities shown in the figure. The diluted protoplast suspensions were 
pre-incubated for 80 min at 37° C.. 10 >iCl of f 3h ) uridine (specific activity 
<•7.5 Cl/mmoi) was added per ml protoplast suspension. Triplicate 0.5 ml aliquots 
were removed after 60 min Incubation. The reaction was terminated end 
radioactivity Incorporated Into RNA was measured as described In 2.5.1. The error 
bars refer to the standard devlatlona of the three values.
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densities corresponding to mid-exponential (5 x 107/ml) and stationary 
(5 x 10 /ml) phases were reached. Their ability to synthesise RNA is shown 
in Fig. 3.3. This time course revealed that, onaddltionof [ 3H ] uridine to 
buffer containing mid-exponential phase yeast cells, there was immediate 
incorporation of label into RNA. A regression line of C H] uridine incorp-
3oration with time was estimated for a 30 min period, when [ H] uridine 
incorporation was approximately linear with respect to time. Incorporation 
of f H] uridine into RNA proceeded at a rate of 49 fmoles min- by 10' yeast 
cells over this period. Blastospores in the stationary phase of growth had a 
much slower rate of incorporation of just 0.1 fmoles min-1 by 107 yeast cells.
3.3.3 Extraction and analysis of RNA synthesised by protoplasts in vitro
RNA synthesised by the protoplasts, during a 60 min incubation period, 
was extracted and analysed by polyacrylamide gel electophorasis. The high 
and low molecular weight RNA species were analysed by 2.57. polyacrylamide/
0.57. agarose and 107. polyacrylamide tube gels respectively (Figs. 3.5 and
3
3.4 respectively). Most of the £ Hj uridine was incorporated into RNA 
species larger than 4S. The amount of low molecular weight RNA species 
(i.e. smaller than 4 S) represented approximately 10 - 157. of the labelled 
total RNA (based on c.p.m. of gel slices). T. pyriformis 25 S, 17 S, 5.8 S and 
5 S RNA, E. coll 23 S and 16 S RNA and bromophenol blue were the markers used.
3.3.4 Extraction and analysis of RNA synthesised in vivo by C. albicans yeast cells
RNA synthesised by C. albicans yeast form cells was extracted and analysed 
using 107. polyacrylamide and 2.57. polyacrylamide/0.57. agarose composite tube 
gels. Unlabelled RNA was extracted from blastospores at a cell density 
corresponding to the exponential phase of growth (i.e. 5 x 107 cells/ml). It 
can be seen, from traces made of UV scans of gels containing RNA, that there 
were slight peaks corresponding to 4 S RNA and 25 S, 17 S and 5 S rRNA (Figs.
3.6 and 3.7). In addition, some RNA species that were smaller than 4 S 
were found. As a comparison, T. pvrlformls RNA was analysed using the
3.3 Time count of RNA synthesis by C. albicans. blastospores
= ans y>lost cells were grown to cell densities corresponding i
10 cells/ml) phese. Theexponential (5 x 10 cells/ml) or stationary (3 : 
blastospores were harvested and re-suspended in protoplast buffer. The 
suspensions of exponential ( - W -  > end stationary ( -•—  ) phase yeast cells 
were pre-incubated for 3c min at 37° C.. 10>iCi of fVj uridine (specific 
activity *7.5 Ci/mmol) was added per ml suspension. Duplicate 0.5 ml aliquots 
were removed at the times shown in the figure. The reaction was terminated and 
radioactivity incorporated into RNA measured as described in 2.5.1. The error 
bars refer to the standard deviations of the two values.
3.» and 3.3 PACE of labelled RNA svnthesised bv C . i! t: c in.s protoplasts 
Protoplasts were prepared from exponential phase, C. altican« veait cells 
as described in 2.3.6. The protoplasts were suspended in protoplast buffer 
to a final cell density of 2 x 10 viable cells/ml. The suspension was 
pre-incubated for SO min at 37° C.. 10/iCi of f Vj uridine (specific 
activity 47.5 Ci/mmol) was added per ml suspension. After 60 min 
Incubation the RNA from yeast cells, in a total volume of 3 ml suspension, 
was extracted as described in 2.7.1. The labelled RNA was analysed by 
PACE on 107. polyacrylamide (Tif. 3.4) and 2.3?. polyacrylamide/0.37. agarose 
(Tig. 3.3) tube gels as described in 2.8.1. The position of the 
bromophenol blue (4 S), T. pvrtfcr-is 23 S. 17 s, 3.S S and 3 S rRNA and 
t- coll 23 S and 16 S rRNA marker species are indicated in the figure.
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Fig. 3.6
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3.6 and 3.7 PACE of RNA svnthaslsad bv C. albicans and 1
RNA was extracted from C. albicans yaast calls, in tha exponential phasa 
of growth, as dascribad In 2.7.1. Contaminating DNA was dagradad by 
traatmant with DNase I as dascribed in 2.5.4. Tha RNA from C. albicans 
yaast calls (corrasponding to 2.5 O.D. units at 260 nm) was analvsad by 
PAGE on 107, polyacrylamida (Fig. 3.6) and 2.5% polyacrylamide/C. 5% 
agarosa (Fig. 3.7) tuba gals as dascribad in 2.6.1. Tha figure shows 
traces of O.D. scans at 260 nm of RNA from T. pvriformis ( —  — ) -(kindly 
donated by A.M. Colas) and C. albicans ( - ). The position of tha
bromophenol blue (4 S), E. coil 23 S and 16 S rRNA markers is as snown.
DNA content Protein content
(stationary phase)
« * 1  fg/cell 7.6 ♦ 4.3 pg/cell
C. albicans yeast cell 
(ald*axponentlal phase)
50 ♦ 2 fg/cell 8.6 ♦ 1.0 pg/cell
C. albicans nuclei *0 * 5 fg/nucleus 0.3 pg/nucleus
(stationary phase)
47 fg/cell N/D
Tabla 3.1 Protein and ON A content of C. ilblcans yeest cells and nuclei
The DNA and protein content of homogenised C. albicans yeast cells and nuclei 
was estimated as described In 2.6.1 and 2.6.3 respectively. The DNA content of 
S. cerevlsiae CD40 strain yeast cells was also estimated for s comparison to be 
made. (N/D • not determined)
3.3.5
/
same conditions. The traces revealed small peaks due to the 25 S and 
5.8 S rRNA and also a high proportion of 4 S tRNA and 5 S rRNA. The distance 
migrated by these species, and the internal marker (bromophenol blue) and 
E. coli 23 S and 16 S rRNA is as shown.
Isolation of nuclei
Nuclei were prepared by lysis of protoplasts prepared from exponential 
phase C. albicans blastospores. The protoplasts were prepared and analysed 
as cited in 3.2.2. If was found that centrifugation of the protoplast lysate 
in buffer containing 2.1 M sucrose resulted in a nuclear preparation highly 
contaminated with unlysed protoplasts and whole cells. This method was 
based on that described by Coles ( 78) to successfully prepare T. pyriformis 
macronuclei. The differential centrifugation technique - described by 
Schultz 031 ) - was similarly unsuccessful. Both these methods resulted in 
nuclear preparations that were contaminated (25 - 507.) by whole cells and 
protoplasts, as judged by observations under the light microscope (x 1000 
magnification). A satisfactory procedure for the separation of nuclei from 
contaminants was achieved by layering the protoplast lysate onto 20 mM 
potassium phosphate buffer containing 2.2 M RNase free sucrose and 0.5 mM 
CaC^. This was centrifuged, at 4° C. for 90 min at 30,000 g as described 
in 2.3.7. The resulting nuclear pellet was resuspended in Schultz's buffer C
9(typically 10 nuclei per ml buffer). Nuclei prepared in this manner were 
approximately 1 ^ im in diameter when examined using a light microscope 
(x 1000 magnification). Yields of nuclei from whole cells were estimated to 
be 5 - 107. based on counts made using an improved Neubauer haemocytometer.
The protein and DNA content of the nuclei were estimated (Table 3.1). For 
comparison, the DNA and protein content of yeast form C. albicans, harvested 
in the mid-exponential and stationary phases of growth, were also determined.
It was found that the nucleus contained 60 fg of DNA and 0.5 pg of protein. 
The protein content of stationary and exponential phase C. albicans yeast cells 
were estimated respectively as 7.6 and 8.6 pg per cell. The DNA
-  7 3  -
4
A
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content of C. albicans yeast cells in these two growth phases was determined 
as 45 fg and 50 . fg for stationary and exponential phase cells respect­
ively. As a comparison the DNA content of S. cerevisiae was measured and 
estimated at 47 fg per cell.
3.3.6 RNA Synthesis in vitro by nuclei
Two incubation media were assessed for their suitability in supporting 
in vitro RNA synthesis. A protoplast suspension was completely lysed, as 
described in the legend of Fig. 3.8, and incubated in assay conditions based 
on those described by Schultz (.331) or Higashinakagawa et al (163). RNA 
synthesis was measured by the incorporation of [ ]  UTP into TCA insoluble 
material. A time course (Fig. 3.8) revealed that the conditions described 
by Higashinakagawa et al (163) did not support measurable in vitro RNA 
synthesis by lysed protoplasts. By contrast, there was marked incorporation 
of label when assay conditions based on those described by Schultz (331) were 
used. The amount of label incorporated into RNA was rapid for the first 5 min 
period and then decreased slightly over the next 5 min. After 10 min 
incubation the level of [ CJ incorporated into the RNA decreased rapidly.
These assay conditions were also capable of supporting nuclear RNA synthesis.
A time course (Fig. 3.9) for C. albicans nuclei showed a non-linear increase 
over the 25 min incubation period. The rate of incorporation of C^cJ UTP 
into RNA decreased the longer the period of incubation. Increasing the 
number of nuclei, per unit volume, in the assay incubation medium resulted in 
an increase in UTP incorporation into RNA (Fig. 3.10). The incorporation
r ••of 1, CJ UTP into RNA was measured over a 10 min incubation period using 
freshly isolated nuclei. The assay conditions, which supported nuclear RNA 
synthesis in C. albicans, were also capable of supporting the same process in 
T. pyrlformls nuclei (results not shown).
3.3.7 Effect of Magnesium and salt concentration on nuclear RNA synthesis
The effect of KC1 and MgCl, concentration, in the assay "cocktail", on
Fig. 3.S RSA svnthes1 s bv Ivs'A protoplasts
Protplasts w«n prepared from C. albicans yeast cells as described in 2.3.0. A 
protoplast lysate was prepared from 2 x 13‘° cells by dilution 1 : 3C in 20 mM 
potassium phosphate buffer pH O.b, containing 0.5 rr* CaCl, ar.d 1 -ft MgCl,. A 
precipitate was collected by centrifugation at 3000 g for 5 min at 4s C. The 
precipitate was resuspended in Schultz's buffer C to 5 ml. Two assav "cocktails" 
were tested fer the ability to support RNA polymerase activity in 1.1 ml protc- 
plast lysate. The first was based on the medium described by Higasninakagawa 
e l  (— ♦ — ), and the second was based on the medium described by Schultz 
The components of these media are described in 2.5.2. The reaction was started 
by the addition of protoplast lysate to assay "cocktail". Triplicate 100 /j1 
aliquots were removed after the times of incubation at 25° C. snown in tne 
figure. The reaction was terminated and the radioactivity incorporated into 
TCA insoluble material reasured as described in 2.5.2. The error bars refer to 
the standard deviations of the three values.
Fig. 3.9 Time course of ANA svnthesis by C. albicans nuclei
Nuclei were prepared from C. albicans protoplasts and separated from cellular 
contaminants by the centrifugation method of Busch, as described in 2.3.7. The 
nuclei were suspended in Schultz's buffer C to a final density of 5 x 10' 
nuclei/ml. 0.7 ml of nuclear suspension was incubated, at 25° C., in total 
volume 1.4 ml of assay medium. The components of the "cocktail" were based on 
those described by Schultz in 2.5.2. Duplicate 100 >ji aliquots were removed at 
the times indicated in the figure. The reaction was terminated and the radio* 
activity Incorporated into RNA measured as described in 2.5.2. The error bars 
refer to the standard deviations of the two values.
Fig. 3.10 Effect of number of nuclei in assay medium on RNA synthesis
Nuclei was prepared fro«- C. e.ticar.i protoplasts and separated from cellular 
contaminants by the centrifugation method of Busch, as described in 2.3.7. The 
nuclei were suspended in Schultz’s buffer C to a final density of l x 109 
nuclei/ml. This nucieer suspension was diluted, in the same buffer, to give 
nuclear suspension with the final densities snown in the figure. 200>ul of the 
diluted suspensions were incubated in total volume of <.00 >il of assay medium. 
The components of the "cocktail" were bated on tnose described by Schultz in 
2.5.2. Duplicate 109 pi aliquots were removed after 0 and 10 min incubation at 
25 C.. The reaction was laminated and radioactivity Incorporated into RNA 
measured at described in 2.5.2. The error bars refer to the standard davit
of the two values.
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nuclear RNA synthesis is shown in Figs. 3.11 and 3.12 respectively. KC1 and 
MgC^, each at concentrations of 100 mM, supported the highest level of
C\ l \ 1CJ UTP into RNA by nuclei over a 10 min incubation period. 
It was found that 39 p moles [^C] UTP were incorporated by 100 f i l nuclear 
suspension in buffer containing 100 mM KC1 and 100 mM MgCl^ (see Fig. 3.12).
3.3.8 Analysis of RNA synthesised in vitro by nuclei
The RNA species synthesised by C, albicans nuclei were analysed by 
polacrylamide gel electrophoresis. The effect of high (100 mM) and low 
(10 mM) MgCl^ concentrations, in the assay medium, on the RNA species 
synthesised by nuclei were investigated. The low and high molecular weight 
species, synthesised over a 15 min incubation period, were analysed by 10% 
polyacrylamide and 2.57. polacrylamide/0.57. agarose tube gels respectively 
(Figs. 3.13 and 3.14). In the assay "cocktail" containing a low concen­
tration of MgCl^, the newly synthesised RNA was smaller than 4 S. Approx­
imately 85 - 907. of the total labelled RNA - based on c.p.m. of gel 
slices - was found migrating with RNA species smaller than the bromophenol 
blue marker. A high proportion of labelled RNA, from nuclei incubated in a
"cocktail" containing a high MgC^ concentration, also migrated with RNA
r 14 ispecies smaller than 4 S. Between 607. and 807. of the [ CJ radioactivity - 
based on c.p.m. of gel slices - was found associated with RNA species smaller 
than the bromophenol blue marker. Small peaks of [ ]  radioactivity were 
found associated with RNA species that migrated as 2 5 S and 17 S rRNA.
3.4 Discussion
3.4.1 RNA synthesis in C. albicans blastospores and protoplasts
As mentioned in the introduction of this chapter, one approach for 
elucidating the mechanisms used by a cell to control RNA synthesis is to 
study this process in models of increasing complexity. It almost appears 
axiomatic to state that such models should in some way, resemble the in vivo
system for any applicable conclusions to be made. Protoplasts of C. albicans
fi«. 3.11 Effect of KCl concentration on RNA synthesis bv C. Lblcans nuclei
Nuclei were prepared from C. albicans protoplasts and separated from cellular 
contaminants by the centrifugation method of Busch, as described in 2.3.7. The 
nuclei were suspended in Schultz's buffer C to a final density of 3.4 x 10 
nuclei/ml. 200 >jI aliquots of the nuclear suspension were incubated in 400 pi 
total volume assay medium. The components of the "cocktail" were based on those 
described by Schultz in 2.5.2. However, KCl was present in the "cocktail" at the 
final concentrations indicated In the figure. Duplicate 100 pl aliquots were 
removed after 0 and 10 min incubation at 25° C.. The reaction was stopped and 
the radioactivity incorporated into RNA measured as described in 2.5.2. The 
error bars refer to the standard deviations of the two values.
Fig. 3.11 Effect of MgCl? concentration on RNA synthesis by C. albicans nuclei
Nuclei were prepared from C. lloicans protoplasts and separated from cellular 
contaminants, by the centrifugation method of Busch, as described in 2.3.7. Nuclei 
were suspended in Schultz's buffer C to a final density of 3.4 x 103 nuclei/ml. 
200 >ul aliquots of the nuclear suspension were incubated in 400 pi total volume 
assay medium. The components of the "cocktail" were based on those described by 
Schultz in 2.5.2. However, the KCl concentration of the "cocktail" was 100 nM 
and MgCl, was present at the final concentrations indicated in che figure. 
Duplicate 100 jul aliquots were removed after 0 and 10 min incubation at 25° C.
The reaction was stopped i-l the radioactivity incorporated into RNA measured 
as described in 2 . 5 . 2 .  The error bars refer to the standard deviations of the 
two values.
Flgs. 3.t) and 3. IV PACE of RNA syntheslsed bv C■ 1 1blcar.s nuclel in media contalnlng hlgh 
and low MgCl, concentratlons
Nuclel were prepared from C. ilbicans protoplasts and sepereted frote 
cellular contaminante by the centrifugación method of Busch, as 
descrlbed In 2.3.7. The nuclel were suspended In Schultz's buffer C 
to a final denslty of l x 10* nuclel/ml. 400 pi allquocs were 
Incubaced In 300 pl total volume assay médium. The componente of 
the "cocktail" were based on those descrlbed by Schultz in 2.3.2. 
However the KCl concentratlon of the "cocktail" was 100 ti* and ¡igClj 
was present at a final concentratlon of 10 mH or 100 t i * .  After 
13 mln Incubatlon at 25° C. the RNA was extractad from the nuclel as 
descrlbed In 2.7.2. The RNA syntheslsed by nuclel In the presence
of 10 tT* ( . . . )  and 100 nM ( ---  ). MgClj was analysad by PACE as
descrlbed in 2.3.1. The figures show PACE of the RNA on 10% 
polyscry lamida (fig. J.J ' *nd 23% polyecrylamlde/0. 5t ageróse 
(Plg. 3. IV) tuba gels. The dlstence mlgreted by the bromophenol blua 
(4 S), t, 23 S and 16 S tRNA and T. nvrlformis 23 S, 17 S 33 S
and 3 S rRNA spacies is show«.
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yeast form cells were prepared for two main reasons: 1) protoplasts represent 
a hightly organised in vitro system and so RNA synthesis proceeds in an 
authentic manner, 2) they may be used as the first stage in the preparation 
of nuclei. It is the first reason which will be discussed first.
Protoplasts prepared here were shown to be capable of synthesising RNA 
under suitable conditions (Figs. 3.1 and 3.2). The conditions which supported 
this process (i.e. incubation in buffer containing sorbitol at 25° C.) also 
maintained the protoplasts as viable entities. The protoplasts were micro­
scopically distinguishable as spherical bodies, approximately 8 in 
diameter. This indicated successful cell wall removal, since the cell wall 
maintains the characteristic ovoid shape of C. albicans blastospores. However, 
the susceptibility of the cells to lysis, when diluted in water, was used as 
the major indicator of protoplast formation. Protoplasts have been prepared 
by other workers using time consuming methods (e.g. 24 hr incubation period) 
with highly impure enzyme preparations (e.g. snail digestive juices)
( 6 ,195). Protoplast preparation, in this project, involved a short (45 min) 
incubation of a buffered suspension of blastospores with Zymolyase 60,000 
enzyme, as described in 2.3.6. It is interesting to note that protoplast 
formation was more readily achieved from cells harvested during the exponential 
growth phase rather than the stationary phase. It is thought the older a 
cell becomes the greater the degree of cross linking of cell wall components. 
Some workers believe that this may account for the greater difficulty found 
when preparing protoplasts from blastospores in the stationary phase of growth 
(278).
RNA synthesis by protoplasts and blastospores was measured by incor- 
3
poration of [ H) uridine into TCA insoluble material. The time course (Fig. 3.1 
reveals that, after a lag period of 15 - 20 min, linear incorporation of label 
into RNA ensured, at a rate of 11 fmoles min * by 10^ viable protoplasts. In 
contrast, no such lag period was found when blastospores were incubated under 
identical conditions (Fig. 3.3). There are a variety of explanations to 
account for this difference. One reason may be that there was no RNA synthesis
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during the first 95 - 100 min after protoplast preparation (i.e. 15 - 20 min
3
after the addition of the f Hj uridine label and 80 min pre-incubation of 
the protoplasts). This seems unlikely as the protoplasts were prepared from 
rapidly growing yeast form cells - a growth phase accompanied by a high level 
of RNA synthesis (see Fig. 3.3). Another possibility could be that the
315 - 20 min lag period was an indication of the time taker for the C H]
3
uridine to be incorporated into the cell, phosphorylated into t H] UTP and 
incorporated into RNA. As protoplasts are perturbed systems, some workers 
believe they will show different properties from the cells they were prepared 
from. Burgess ( 46) has suggested that protoplasts (of plants) do not simply 
behave as plant cells without walls, but as a stressed system, requiring a 
recovery period. The lag period found when label was added to protoplasts 
and the higher rates of incorporation of [3h3 uridine shown by blastospores 
indicates that C. albicans protoplasts behaved as similar stressed systems.
Increasing the number of protoplasts, per unit volume of buffer, resulted 
in a linear increase in the amount of C H] incorporated into RNA over a 60 min
incubation (Fig. 3.2). Assuming an initial lag period of 20 min when no
3 3[ H] was incorporated into RNA, [ H] uridine was incorporated at a rate of
13 fmoles min  ^by 107 viable protoplasts over the next 40 min. This value
was comparable to that obtained from the rate calculated from the time course
of Fig. 3.1 (i.e. 11 fmoles min * by 107 viable protoplasts). Incubation of
yeast cells - in the exponential phase of growth - under identical conditions
resulted in the immediate incorporation of [3h ] uridine into RNA at a rate of
49 fmoles min * by 107 yeast cells. In contrast, yeast cells harvested at the
3 "1stationary phase of growth, incorporated 0.1 fmoles of [JH] uridine min by 
107 yeast cells.
Although the latter values are expressed in terms of 107 yeast cells, it
should be noted that the cell densities of the blastospore suspensions were
7 8different (i.e. 5 x 10 exponential phase yeast cells/ml and 5 x 10
stationary phase yeast cells/ml). If yeast cells from both growth phases
were diluted to the same cell density, and pre-lncubated for 80 min,
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comparable rates of incorporation of label into RNA were found. This 
indicates that the cell density of the yeast suspension - usually associated 
with its growth phase - affects the general level of RNA synthesis per unit 
cell. Such a result should not be unexpected as it is known that periods 
of rapid growth are associated with high levels of RNA synthesis (139).
Over the past ten to fifteen years protoplasts, from a variety of species, 
have been used to study RNA synthesis. Protoplasts have been prepared from 
S. cerevisiae (380), tobacco (17‘t) and cucumber (81) and all these systems 
have yielded some information about RNA synthesis. The overall picture from 
these reports is that there are similarities between RNA synthesis in vitro 
by protoplasts and in vivo by whole cells. In contrast to the results reported 
here, it has been found that the kinetics of incorporation of label into RNA 
by Centaurea cvanus protoplasts were similar to whole cells (202). However, 
this same group reported differences in the metabolism of the 40 S pre-rRNA 
precursor and also the levels of poly A containing RNA molecules between 
protoplasts and whole cells. Results obtained using protoplasts prepared 
from higher plants are not strictly comparable with a lower eukaryote such as 
C. albicans. Nevertheless, groups using such diverse organisms as cucumber ( 81 ) 
and S. cerevisiae (205) have reported that protoplasts from these species 
synthesised a high proportion of the high molecular weight rRNA species. A 
similar result was found when the RNA species synthesised by C. albicans, over 
a 60 min incubation period, were analysed as described in Figs. 3.4 and 3.5.
O
The results shown in these figures show slight peaks of [ H ] associated 
with 25 S, 17 S, 5.8 S and 5 S rRNA species. Indeed, most (807.) of the 
label was found associated with RNA species having a higher M.W. than the 4 S 
marker species . (It is believed that the rRNA species of Candida spp resemble 
those of S. cerevisiae (408). However, whilst rRNA of C. albicans shows about 
807. homology with nucleic acids from other Candida spp. Saccharomvces spp 
showed a homology of about 257. (339). There are some similarities in the 
RNA species synthesised by protoplasts from C. albicans and other species.
It is possible that these may be required by the cell for cell wall repair.
- 81 -
Analysis of unlabelled RNA extracted from C. albicans blastospores, in 
the exponential phase of growth, is shown in Figs. 3.6 and 3.7. (These 
Figures also showed traces made of UV scans of RNA extracted from T. pyriformis 
as a comparison) The gel scans revealed slight peaks corresponding to 
25 S, 5.8 S and 5 S rRNA and 4 S tRNA. It has been reported that a high 
proportion of RNA synthesised by S. cerevisiae is directed by RNA poly­
merase I during periods of rapid growth (335). It is, thus, not surprising 
that peaks are found in RNA,extracted from exponential phase C. albicans 
corresponding to the mature RNA species that are directed by this 
isozyme . Presumably, such high quantities of these RNA species are required 
to form extra ribosomes and amino acid-tRNA molecules for rapid cellular 
growth. Although mRNA molecules can direct translation of many copies of a 
protein, rRNA and tRNA molecules, as the final gene products, are required 
in large amounts. Thus,during any period of growth the levels of abundant 
rRNA and tRNA rises (262).
The results discussed above indicate that RNA synthesis does occur in 
C, albicans protoplasts. However, there do appear to be some differences in 
the kinetics of RNA synthesis between protoplasts and yeast cells, i.e. there
3
is a lag period before C HJ is incorporated into RNA by protoplasts which is 
then incorporated at a lower rate compared to blastospores. Thus, preparation 
of nuclei from protoplasts would involve the preparation of a system that 
was not physiological "normal" compared to the original blastospore. As 
protoplasts do synthesise RNA and other methods used to prepare nuclei from 
physiological "normal" cells require techniques which disrupt the 
cell, and destroy the nuclear membrane, the preparation of nuclei 
necessitated protoplast formation.
3.4.2 Preparation of C. albicans nuclei
Several methods were used to try and separate nuclei, prepared by lysis 
of protoplasts, from contaminants. Two criteria were used to evaluate the 
success of a preparation were 1) the ability of the nuclei to synthesise RNA
8 2  -
and 2) lack of contamination by cellular debris and whole cells. The former 
criterion is, of course, of paramount importance when preparing nuclei as 
a system to study RNA synthesis. Section 3.4.3 will discuss the results 
obtained from investigations into in vitro nuclear RNA synthesis. This 
section will consider the techniques and rationale for preparation of nuclei 
from C, albicans.
It was found that nuclei could be prepared by dilution of a protoplast 
suspension 1 : 5 in phosphate buffer, as described in 2.3.7. The nuclei 
could then be collected by a low speed centrifugation. Separation from 
cellular contaminants and whole cells could be achieved by high speed 
centrifugation over 20 mM phosphate buffer containing 1 mM MgCl^, 0.5 mM 
CaC^ and 2.2 M sucrose. Nuclei prepared by this method had a diameter of 
1 - 2  pm,as judged by light microscopy. As a comparison, nuclei isolated 
from S. cerevlsiae are 2 pm in diameter ( 32 ). Electron microscopy has shown 
that the nucleus of C. albicans has a similar dimension in situ (36).
Any medium used in the isolation of nuclei should maintain this organelle, 
and its components, in, as near as possible, its in vivo condition.
C. albicans nuclei were stored in the medium described by Schultz (331) as 
"buffer C" (see 2.2). This medium was used to successfully store S. cerevisiae 
nuclei. The basis of any medium is the buffer. Phosphate,HEPES NaOH and 
Tris HCl are the most commonly used buffers. Nuclei have been maintained in 
buffer within a pH range of between 6 and 8.5 (251). The osmolality and 
ionic composition of the medium should be such that nuclear integrity is 
maintained. The osmolality of the medium is usually determined by the amount 
of glycerol or sucrose present. The sucrose concentration in "buffer C" was 
0.6 M, which is similar to that used by other workers for the storage of 
nuclei from other organisms ( 2 5 1 ) .  Although during the nuclear preparation 
stages the sucrose concentration was 2.2 M, the effects of this component 
do appear to be reversible ( 2 5 1 ) .  (The ionic conditions employed in the 
preparation and assaying nuclear activity will be discussed in 3.4.3),
The hypertonic conditions described for the preparation of C. albicans
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nuclei did appear to shrink the nuclei. Although the conditions described 
by Schultz (331) used essentially isotonic conditions (using Ficoll contain­
ing buffer) for the centrifugation steps, they had the disadvantage that 
the nuclear preparation had a high level of yeast cell contaminants. Schultz 
maintained an uncontaminated nuclear preparation could be achieved by many 
Ficoll centrifugation steps. However, time consuming methodologies do have 
a disadvantage in that nuclei need to be rapidly isolated, as a lot of RNA 
polymerase activity is essentially elongation activity (see 3.4.3). Recently, 
Ide and Saunders (171) described a technique using polyvinylpyrollidone coated 
silicia (Percoll) gradients to separate S. cerevisiae nuclei. This method 
had the advantage that nuclei were prepared rapidly under isotonic conditions, 
with minimal cytoplasmic contamination. This seems an ideal technique to be 
used for future nuclear preparations from C. albicans.
The DNA content of C. albicans nuclei was estimated using a colorimetric 
reaction by the deoxyribose residues and diphenylamine as described in 2.6.1. 
It was found that the DNA content of C. albicans nuclei, prepared in this 
thesis, was 60 fg (see Table 3.1). In contrast, the DNA content of 
S. cerevisiae has been measured as 40 - 46 fg per nucleus (32 ,279). This 
difference could arise as a consequence of contamination, in the storage 
medium, of DNA from broken nuclei. Some authors have suggested 
using bovine serum albumin in the isolating and storage media to preserve 
nuclear integrity and minimise lysis. However, many commercial preparations 
have been shown to be contaminated with a high level of protease and nuclease 
activity (251).
The DNA content of stationary phase C. albicans yeast cells reported 
here is 45 fg, which is comparable to the literature value of approximately 
40 fg/cell (depending upon the strain used) (32T). The DNA content of
C. albicans, harvested when the cell density corresponded to the exponential
2phase of growth, was estimated at 50 fg/cell (see Table 3.1) A H. test 
revealed that, at the 957. confidence level, any differences in estimated DNA 
content per cell between stationary and exponential phase cells were not
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significant. The DNA content of S. cerevlsiae yest cells (wild type CD 40 
strain) was measured in order to compare this estimate with published data.
The value of 47 fg per cell was comparable to that reported elsewhere (32 ).
The protein content of the C. albicans nucleus was estimated as 1.3 pg.
This value was approximately twice that reported for S. cerevisiae nuclei of 
0.7 pg per nucleus (32 ). The higher protein content of C. albicans nuclei 
may be due to cytoplasmic contamination or by lysis of nuclei during storage. 
The protein content of C. albicans yeast cells in the stationary and exponen­
tial phases of growth was estimated at 7.6 and 8.6 pg per cell respectively. 
This value is similar to that reported by other groups working with C. albicans 
(e.g.405;. However, it is approximately twice the value reported by Bharghava 
et al of 3.9 pg protein/S. cerevisiae yeast cell (32).
Ideally the preparation of in vitro systems, such as nuclei, should be 
accompanied by stringent precautions to guard against cytoplasmic contam­
ination. The cytoplasm contains many components which interfere with measure­
ment of RNA synthesis, e.g. proteases and nucleases. An illustration of the 
effect of such cytoplasmic components, on RNA synthesis, is shown in Fig. 3.8. 
The results shown in this figure indicate that labelled RNA, synthesised by 
RNA polymerases on endogenous DNA,in an assay "cocktail" based on that 
described by Schultz ( 331 ), was rapidly degraded within 10 min of the start 
of the assay. However, the need to prepare nuclei completely free from 
cytoplasmic contamination must be tempered with achieving this aim rapidly 
and with minimal perturbation of the nuclear membrane.
Nuclear RNA synthesis in vitro
RNA synthesis in vitro by C. albicans nuclei was the most important 
parameter considered during their preparation. The ability of the nuclear 
preparation to incorporate a labelled precursor (i.e. UTP) into TCA
insoluble material was used as a measure of RNA synthesis. Two assay 
"cocktails", which were capable of supporting RNA synthesis by T, pyrlformis
(1 6 3 )  and S. cerevisiae ( 3 3 1 )  nuclei, were tried to show measurable RNA
synthesis by C. albicans in vitro (see Fig. 3.8). It should be realised
that the conditions, described in the legend of this figure, lysed both proto­
plasts and nuclei. The precipitate from the low speed centrifugation was 
capable of incorporating £ Cj UTP into RNA in an assay "cocktail" based on 
that described by Schultz (331). Those assay conditions described by 
Higashinakagawa et al (163), which supported nuclear RNA synthesis in 
T. pyriformis. did not support measurable RNA synthesis by lysed protoplasts 
and nuclei of C. albicans. As a consequence, the assay conditions based on 
those described by Schultz (331) were used to monitor RNA synthesis by 
C, albicans nuclei.
There are almost as many assay conditions described to support in vitro 
RNA synthesis as there are groups working in the field. However, all assay 
media described do seem to have common factors in the components that make 
up the assay "cocktail". Most studies on transcription have used a buffer 
having a pH in the range 7 - 8 . 5  (251). The buffers used in the preparation 
and storage of nuclei are usually adequate for studies on nuclear RNA 
synthesis (see 3.4.2). Tris HC1 was used as the buffer for the assay 
"cocktail" in this research to maintain a pH of 7.9. The osmolality in the 
assay "cocktail", in addition to the media used to prepare and store 
(see 3.4.2), is usually determined by the amount of sucrose or glycerol 
present. Glycerol is more often used than sucrose to maintain the osmolality 
of the assay "cocktail", as the latter often contains RNase impurities, when 
obtained from commercially available sources. However, glycerol has been 
found to affect the rate of RNA synthesis in vitro (251). RNase free sucrose, 
at a final concentration of 0.25 M, was used to maintain the osmolality of 
the assay "cocktail" in this research. Such a sucrose concentration - lower 
than that in the storage buffer - is believed to retain "normal" chromatin 
conformation during the assay to measure RNA synthesis (21(7).
Vital components of any assay "cocktail" are the four ribonucleoside 
triphosphates necessary for transcription. It was found that omission of one, 
or more, of the ribonucleotides resulted in negligible incorporation of C ]
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UTP into RNA. This indicated that the pool sizes of nucleotides in the 
nucleus were negligible and all RNA synthesis was DNA directed and not due 
to polynucleotide phosphorylase. The concentrations of ATP, GTP and CTP, at 
0.5 mM, in the assay "cocktail" was well above the expected Km of 10  ^M for 
RNA polymerases (I8r) (Estimations of the Km for CTP of the three RNA poly­
merases are given in 4.3.13). The concentration of C^C] UTP of 5 nmoles/100 p  
assay "cocktail" (50 yuM) was only slightly above the expected Km. It
was found that the addition of 0.1 mM "cold" UTP resulted in dilution of
f14 nthe l CJ UTP to such an extent that there was no measurable incorporation 
of [ *^C J into RNA. This may account for the negligible incorporation of 
t^C] UTP into RNA}which resulted when lysed nuclei were incubated in the 
assay "cocktail" of Higashinakagawa et al (163). This assay medium contained 
0.1 mM "cold" UTP. The assay "cocktail" of Higashinakagawa et al (163) also 
contained lower concentrations of dithiothreitol (dTT) than that of Schultz 
(331) (see 2.5.2). This component is often added to media to protect thiol 
residues on the RNA polymerase enzyme (251).
Long term (i.e. longer than 30 min) nuclear RNA polymerase assays 
require an energy-conserving system. Transcription is an active process and 
utilization of ATP in this way leaves less available for incorporation into 
RNA itself. The assay "cocktail" described by Schultz (331) contained 
phosphoenolpyruvate/pyruvate kinase as S. cerevisiae nuclei were incu­
bated for periods of 60 min to analyse the RNA polymerase III directed 
transcripts. As C. albicans nuclei were incubated for relatively short 
periods of time (i.e. less than 15 min) and as ATP concentration was not 
limiting,phosphoenolpyruvate and pyruvate kinase were omitted. Other energy 
conserving systems which have been used include creating phosphate and 
creatine phosphokinase (e.g. 232).
The unrestricted action by nucleases and proteases in a nuclear preparation 
is a problem for which there is no easy answer. Although RNases have an 
important role to play in the nucleus (e.g. processing (106) ), many workers 
have tried to minimise the otherwise destructive effects of these enzymes.
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Most of the direct inhibitors of nuclease or protease activity (e.g. SDS, 
diethylpyrocarbonate and PMSF)have been found to have a direct effect 
on the template activity of the nucleus ^251). Heparin has been employed as 
an RNase inhibitor in vitro, but has been found to cause gross structural 
modification of the chromatin (90). In addition, RNA polymerase initiation 
is inhibited (381). NaF has been added to assay "cocktail" as a potential 
RNase inhibitor (251). The presence of fluoride will inhibit other enzymes
| -j- | |
which require the divalent cations Mg and Mn such as RNA polymerase. The 
use of NaF in an in vitro system which is measuring the activity of this 
enzyme is thus questionable.
Potentially the most successful method for inhibiting RNase activity is 
that of end product inhibition. Crampton and Woodland (83 ) found that the 
addition of 1 mM CMP to Xenopus cell culture nuclei resulted in an increase 
in the higher molecular weight rRNA species this system synthesises (i.e.
40 S, 28 S and 18 S). There was a corresponding decrease in the amount of 
low molecular weight degradation products. However, it was found that the 
addition of 2 rrM CMP, CDP, AMP or ADP to C. albicans nuclei resulted in 
negligible incorporation of Q^Cj UTP into RNA over a 10 min incubation 
period in the assay "cocktail" described in the legend of Fig. 3.10. This 
appears to be a contradictory finding to that described by Crampton and 
Woodland ( 93) - inhibition of RNase action ought to be accompanied by an 
increase in [ CJ UMP incorporation into RNA. However, the ratio of rNTP to 
rNDP has been found to be an important controlling mediator for RNA synthesis 
(134-). The levels of nucleotides have been found to be important in regulat­
ing RNA synthesis in vitro in nucleoli (270) and RNA polymerases (135). One 
further measure, taken to reduce the action of nucleases, was incubation of 
the nuclei from C. albicans in an assay medium at a temperature of 25° C.. 
Incubation at a higher temperature (i.e. 37° C.) has been shown to result in 
a higher level of RNase activity (381).
A time course for RNA synthesis by C, albicans nuclei incubating at 25° C. 
in the assay "cocktail" based on Schultz (3313 was as shown in Fig. 3.9. The
- 88 -
rate of reaction decreased as time progressed with no increase in the 
incorporation of £ UTP into RNA after 20 min. This "levelling off" in 
the incorporation of [ CJ UTP could have arisen as a consequence of protease 
and RNase action on the proteins involved in RNA synthesis and degradation 
of the product synthesised. Alternatively, the decrease in the rate of 
incorporation may have been due to disengagement of the RNA polymerase 
enzymes from the DNA template. It is unlikely that the decrease in rate of 
incorporation of label into RNA was due solely to the former factors (i.e. 
protease and RNase activity). Although these enzymes do cause problems in 
nuclear- preparations, disengagement of the RNA polymerase from the template, 
without re-initiation, has been commented upon by other workers (e.g. 381).
Endogenous RNA polymerases can exist in two distinct states - the so 
called "template engaged" and "free" forms (414). In many of the organisms, 
from which nuclei have been isolated, the majority of template engaged RNA 
polymerases appear to be retained ( 82 ). After transcribing a section of 
DNA the RNA polymerase will disengage. Although re-initiation of an RNA 
polymerase can occur in certain circumstances, such as in mouse myeloma 
nuclei, it is not readily accomplished (356). However, RNA polymerase III - 
responsible for 5 S rRNA and 4 S tRNA synthesis - does appear to have a greater 
ability to re-initiate, than either RNA polymerases I and II (251). (It is 
thought that the factors responsible for accurate transcription initiations 
may be lost, through the nuclear pores during isolation (251) ).
The inability of RNA polymerases to re-initiate successfully in C. albicans 
nuclei may account for the non-linearity found between incorporation of C ^ C ]  
into RNA, over a 10 min incubation period, and the number of nuclei in an 
assay aliquot (Fig. 3.10). When the nuclei were prepared they were suspended 
in Schultz's buffer C to the density indicated in the legend of Fig. 3.10. 
Samples of nuclei were taken from this suspension, diluted to the required 
nuclear density and incubated in the assay "cocktail". If the RNA polymerases 
in the nuclei in the original suspension did not remain attached to the DNA, 
and disengaged,the proportion of template engaged enzyme would decrease. This
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would be accompanied by a corresponding decrease in the level of L CJ UTP 
incorporated into RNA by a nucleus. Thu^ although increasing the number of 
nuclei per unit volume assay "cocktail" would be accompanied by increasing [^C ] 
incorporation,the increase in this value would be non-linear when "older" 
nuclei were used. Changes in the levels of bound and free RNA polymerases in 
a nucleus over the period they were stored in suspension, could be determined 
by measurement of template activity with exogenous polyCd(A-T)] as described 
by Yu (414) and in 4.4.1.
The assay "cocktail" used to support RNA synthesis by C. albicans nuclei 
was also capable of supporting RNA synthesis by T. pyriformis nuclei. This 
suggests that assay media, which contain components in common, may direct 
in vitro RNA synthesis in other systems. The assay "cocktail" described by 
Higashinakagawa et al ( 1 6 3 )  did not support measurable RNA synthesis in lysed 
nuclei of C. albicans (see Fig. 3.8). However, this was probably due to 
excess "cold" UTP in the assay "cocktail" (see earlier in this section).
Another major difference between the assay media described by Higashinakagawa 
et al ( 1 6 3 )  and that used in this research,was the ionic composition. This is 
the most variable component of any of the various media described which support 
in vitro RNA synthesis.
Inorganic ions have a dramatic effect on gross nuclear morphology 
( 3P ) and on chromatin structure (1 ). The ionic strength of the assay
"cocktail" used in this research was maintained by the KC1 concentration.
(NH^ ) 2 SO^ may also be used to maintain the ionic strength (e.g. 251) ). At
higher ionic strength (i.e. 100 mM KC1) C. albicans nuclei synthesised a 
greater level of RNA over a 10 min incubation period, compared to lower ionic 
strength (Fig. 3.11). It is believed that higher KC1 concentrations "opens up" 
the chromatin allowing easier transcription to occur ( 1,210). Alteration of 
these ionic conditions has been found to modify in vitro transcription. Laval 
et al (210) found that, using Mn*"*" as the divalent cation and 0.28 M (NH^^SO^, 
the RNA synthesised had a A:U/GiC ratio of approximately 1. In comparison, 
at lower ionic strengths the A:U/G:C ratio of the product RNA decreased to 0.47.
14 ,
_____________________________A
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Most preparations of nuclei show slower rates of RNA synthesis in vitro
than are found in vivo (251). As a consequence, many studies have attempted
to optimise conditions for in vitro transcription by nuclei. The divalent
ion present, and the concentration in the media, have been found to markedly
| |
affect the general level of RNA synthesis by nuclei. Mn has been found to 
generally result in higher rates of RNA synthesis than Mg in nuclei prepared 
from various organisms (210). The concentrations of Mn which have been 
reported to give highest rates of RNA synthesis (approximately 1 mM) are not 
normally found in physiological systems (251). The addition of Mn to an
assay "cocktail" has been reported as resulting in aberrant transcription and
| |
is incapable of maintaining nuclear morphology (387). As a consequence. Mg
was the divalent cation used to stimulate in vitro RNA synthesis by C, albicans
nuclei.
The effect of Mg concentration, in the assay medium, on nuclear RNA
synthesis over 10 min, is shown in Fig. 3.12. Possibly the most interesting
result of the research on C. albicans nuclei was that the highest level of
incorporation of into RNA was found when the M g ^  concentration was
( |
100 mM. This finding seems in complete contrast to Mg optima reported by
other workers for in vitro nuclear RNA polymerase activity. These are
generally in the range 3 - 20 mM (251). Indeed, such high Mg concentrations
have been found to affect nuclear conformation ( 1 ). A change in the
molecular environment may have far reaching effects on the ability of RNA
-14 -polymerase to bind to the DNA template. The higher level of L CJ incorporatior
into RNA may arise as a consequence of such nuclear changes. However, it
seems unusual that this phenomenon is observed solely in C. albicans nuclei.
The higher level of [^C) UTP incorporation into TCA insoluble material
may have arisen as an experimental artefact. Divalent cations, such as Mg t
bind to nucleotides (and as such are the substrates for RNA polymerase - see
♦ ♦
1.3.A) and at higher concentrations of Mg could bind non-specifically to 
GF/C filter disks used to collect the TCA insoluble precipitate. The 
addition of MgC^, to a final concentration of 100 mM, after a 10 min
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incubation of nuclei in media containing 10 mM MgCl^, did not result in an
rl4 -iincrease in the level of L Cj incorporated into TCA insoluble material. Thus, 
the higher level of [^C] incorporation, found when nuclei were incubated in 
media containing 100 mM MgCl^, did not arise as an artefact of non-specific 
binding.
RNases present a problem when investigations into in vitro RNA synthesis
are made. Some RNases do show a requirement for a divalent cation, such as Mg 
| |
However, high Mg concentrations can inhibit these enzymes. For example
RNase H from a basidiomycete (Ustilago mavdis ( 19 ) ) and RNase from
S. cerevlsiae (.211) are both inhibited by Mg concentrations greater than
| |10 trM. It was thus possible that an increase in Mg concentration, from 
10 mM to 100 nil, would inhibit C. albicans RNases, and a corresponding 
increase in the level of recoverable [“ cl would be found. The effects of 
low and high Mg concentration on the RNA species synthesised by C. albicans 
nuclei would give an insight into the effects of RNases during an incubation 
period.
3.4.4 RNA species synthesised in vitro by C. albicans nuclei
The effect of MgCl^, at a concentration of 10 mM or 100 mM, on the classes
of RNA synthesised by C. albicans nuclei is shown in Figs. 3.13 and 3.14.
The RNA was extracted from nuclei after a 15 min incubation period at 25° C..
r 14 tA 15 min period was chosen as the rate of incorporation of [ CJ into RNA was 
slowing - indicating possible disengagement of the RNA polymerase from DNA 
after finishing transcription (see 3.4.3). The figures showed the low (i.e. 
Fig. 3.13) and high (i.e. Fig. 3.14) molecular weight RNA species synthesised 
when the MgC^ concentration of the assay "cocktail" was either 10 mM or 
100 mM. These figures showed that the majority of the newly synthesised RNA 
migrated as a species smaller than 4 S. RNA extracted from nuclei in assay 
"cocktail" containing 10 mM MgC^ was 85 - 907. smaller than the 4 S marker 
species (bromophenol blue). In contrast, only 60 - 807. of the RNA from nuclei 
incubated in a "cocktail" containing 10 mM MgCl^ was smaller than the
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bromophenol blue marker. This may indicate endonuclease activity was 
responsible for the higher percentage of low molecular weight RNA species 
found in RNA extracted from nuclei incubated when the MgCl^ concentration 
was 10 mM.
r 14 .Fig. 3.14 shows small, but distinct peaks due to t Cj UTP incorporated 
into 25 S, 17 S and 5.8 S rRNA species. These probably arose from processing 
of the 37 S precursor rRNA. The 37 S pre-rRNA transcript is synthesised by 
RNA polymerase I in S. cerevisiae (288'). As the ribosanes of Candida spp 
resemble those of S. cerevisiae (4C8), C. albicans also presumably synthesised 
a similar sized RNA. Polyacrylamide gel electrophoresis is not usually a 
sensitive enough technique to monitor the synthesis of RNA polymerase XX 
directed transcripts - assays for the activity of specific genes often require 
other techniques (see 7.4.2).
It has been found that in media with high ionic strength, using Mn as 
the divalent cation, a greater amount of the RNA synthesised in vitro is
| fRNA polymerase II directed. In contrast, lower ionic strength, plus Mg as
the RNA arising due to RNA polymerase I directed transcription (310). RNA
| |polymerase III is apparently equally active in vitro in nuclei when Mg or 
| |
Mn is used as the divalent cation. These ionic strength optima and divalent 
cation preferences are two criteria used by Reeder (310) to discriminate 
between the different RNA polymerase isozymes. Whether the RNA polymerases 
from C. albicans exhibited similar preferences will be discussed in 4.4.2.
Most of the RNA synthesised in vitro by C. albicans nuclei was RNA poly­
merase III directed. In contrast, a high proportion of RNA synthesised 
in_vi_tro by protoplasts, from which the nuclei were isolated, was the higher 
molecular weight species. Thus,during the preparation of nuclei the level of 
RNA polymerase I directed synthesis falls. Nuclei and protoplasts from 
C. albicans share some similarities with these systems from other lower 
eukaryotes (see 3.4.1 and earlier in this section). However, the nuclei do
_l_i.show unusual Mg optima for RNA synthesis. This is probably the most unusual 
result in this chapter.
C H A P T E R  U P U R I F I C A T I O N  OF R N A  P O L Y M E R A S E S  F R O M  Y E A S T  A N D  P A R T I A L  P U R I F I C A T I O N  OF
MYCELIAL FORM C. ALBICANS
4.1 Introduction
It was established in the late 1960's that eukaryotes possessed three 
distinct classes of nuclear DNA-dependent RNA polymerases (311). Since then, 
there has been intensive research into their involvement in the regulation of 
gene transcription. The sub-cellular localisation^subunit composition and 
reaction properties of these complex enzymes has been elucidated over the 
past decade. Numerous reviews have appeared describing the general properties 
of eukaryotic RNA polymerases (63»100, 310) Some facets of current knowledge 
on this subject were outlined in 1.3.3. In this chapter the techniques, and 
reasons, for the purification of yeast and the partial purification of 
mycelial forms of C. albicans RNA polymerases will be discussed. Some proper­
ties of the yeast RNA polymerases will also be discussed.
It was reported in 3.4.3 that nuclei showed a higher level of incorpor- 
i> 14 iation of l C J when incubated in media containing 100 mM rather than 10 mM 
MgC^. In order to investigate whether this finding was due to activation of 
one or more forms of RNA polymerase, at higher MgC^ concentrations, or to 
other factors, the three RNA polymerases were purified. In addition, puri­
fication or at least partial purification, would be the first step in allowing 
studies to be made on the action of specific inhibitors directly on isolated 
RNA polymerases from C. albicans. The main reason for purification of the 
RNA polymerases was to ascertain whether the three classes of RNA polymerases, 
from the two morphological forms possessed distinctly different properties.
It has been known for some time that the major classes of cellular RNA 
(i.e. ribosomal (r)RNA, transfer (t)RNA and messenger (m)RNA are synthesised 
at different rates during the many growth and developmental transitions of 
eukaryotes (310. For instance, during the cell cycle of S, cerevlslae. it 
has been reported that the relative levels of RNA polymerases I and II - as 
judged by DEAE-Sephadex profiles from whole cell extracts - differ during G^, 
S, early G, and late G, stages of the cell cycle (58, 336). In addition,
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it has been reported that there seems to be a correlation between growth 
rate, cellular RNA content and the levels of RNA polymerase I activity. It 
was suggested that RNA polymerases I and II are independently regulated in 
S. cerevlsiae - the level of RNA polymerase I regulating rRNA synthesis 
(335). RNA polymerase activities has been monitored during developmental 
transitions in several fungi. Changes in the specific activities and amounts 
of RNA polymerases I and II>but not Ill^of the phyeomycete Mucor rouxli have 
been observed (413). RNA polymerases I, II and III from yeast and mycelial 
phases of the dimorphic fungus Histoplasma capsulatum are reported to differ in 
their sensitivities to <x-amanitin, mono and divalent cations and temperature 
(203).
Several reviews have dealt with quantitative and qualitative changes in 
RNA polymerases during various growth and developmental transitions. The 
general impression, given by these reviews of plant and lower eukaryote (138) 
and animal ( 310) RNA polymerases may be summarised as follows. Firstly, there 
is not necessarily a correlation between the level of activity for a particular 
class of RNA polymerase and the total amount of that particular isozyme in 
the cell. In addition, RNA polymerases I, II and III are almost undoubtedly 
present in both quiescent and dividing cells. Thus other factors, i.e. 
proteins or chromatin structure, will play a role in regulation of the overall 
rates of transcription by the individual RNA polymerases. Thirdly, it has 
been suggested that the evidence for qualitative changes in subunits may be 
explained by purification artefacts such as proteolysis of susceptible sub­
units (138). However, some workers believe that there are differences between 
the RNA polymerases from distinct growth and developmental forms of the same 
organism. Kumar et al (204-) havereported that antisera to RNA polymerase III, 
from yeast form H. capsulatum. did not completely cross-react with the same 
isozyme from the mycelial form. These differences in the antigenic determin­
ants suggest there could be differences between the RNA polymerases of the two 
morphological forms.
The initial breakthrough in eukaryotic RNA polymerase purification resulted
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from the efficient solubilization of the enzymes from the DNA template. This 
was achieved by employing high salt sonication procedures with isolated nuclei 
or whole cell extracts. The high salt concentration (i.e. greater than 0.3 M 
(NH^^SO^) disrupts the nuclear chromatin and sonication reduces the viscosity 
of the high salt extract. This procedure has been generally applicable to 
the purification of nuclear RNA polymerases from animals, plants and lower 
eukaryotes. After solubilization of the RNA polymerases, purification of the 
enzymes may be achieved by conventional techniques. These include ammonium 
sulphate fractionation, chromatography on cationic (e.g. carboxymethyl- 
sephadex) or anionic (e.g. diethylaminoethyl-sephadex) exchange columns and 
sedimentation through glycerol or sucrose density gradients. In addition, 
as eukaryotic nuclear RNA polymerases are large proteins (approximate molecular 
weight 500,000) gel filtration may also be used as a step in the purification 
of these enzymes.
Two common procedures now employed in the purification of enzymes are 
nucleic acid precipitation and affinity chromatography. Jendrisak and 
Burgess originally suggested the use of polymin P (polyethylenimine) to 
precipitate nucleic acids in cell free extracts (178). Another polyamine - 
protamine sulphate - has also been used to achieve the same end (293)• Methods 
such as these are now widely employed in the purification of RNA polymerases. 
Affinity chromatography on DNA sepharose or DNA cellulose has also been applied 
to RNA polymerase purification (127,412). In addition to the use of DNA as 
an affinity ligand, heparin - as heparin sepharose - has also been successfully 
used to achieve this aim (e.g.137,143). RNA polymerases bind very tightly to 
their affinity ligands whilst most contaminating proteins do not. The enzymes 
may be eluted from the column by buffer containing high salt concentrations.
In order to achieve purification of C, albicans yeast form RNA polymerases 
to homogeneity, and the partial purification of mycelial form RNA polymerases, 
some of the above described techniques were employed. The procedures used to 
achieve this were based on those used by Hager et al (141 ) and Kumar et al
(203) to purify RNA polymerases from S. cerevislae and H, capsulatum
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respectively. In addition, the three RNA polymerases from the yeast form of 
of C. albicans were characterised with reference to their divalent metal ion 
preferences and salt optima, Kms for the substrate CTP and cx-amanitin
sensitivities. These results will be discussed with reference to RNA 
polymerases from other eukaryotes in general and-S. cerevisiae in particular.
4.2. Materials and Methods
4.2.1 Preparation of c.ell free extracts
C. albicans A serotype (NCPF3153) yeast and mycelial forms were cultivated 
in Sabouraud's dextrose broth and glucose beef extract medium respectively, 
as described in 2.3.3. Yeast cells, growing to the cell density required, 
and mycelia were harvested, washed and resuspended /^q (w/v) in buffer i.
Two methods of cell breakage were tried. The first was based on that
used by Hager et al (141) using a press to disrupt the cells. 10 ml of the
_2C. albicans suspension in buffer i were compressed at 100 Nmm (15,000 p.s.i. 
in a press at 4° C. The second method, as described by Kumar et al (203), 
involved homogenisation with balotini. The suspension of either yeast or 
mycelial cells was mixed with twice their weight of ballotini (0.45 - 0.55 mra 
diameter) and homogenised in a Braun homogeniser. The suspension was kept 
cool (0 - 5° C.) using CO2 gas. The criteria for disruption were based on the 
appearance of lactate dehydrogenase (LDH) and RNA polymerase activity and on 
cell counts before and after treatment.
After successful disruption of the cells, the homogenate was diluted 
with an equal volume of buffer A of Hager et al(1411, which contained 1.0 M 
(NH^^SO^, 17. (w/v) DMS0, 0.5 mM dTT, 0.5 mM PMSF and 1 mg bovine serum 
albumin/ml buffer. The viscous homogenate was sonicated with six 10 sec 
bursts at maximum power on an M.S.E. sonicator using a 1.3 cm probe. The 
sonicate was then centrifuged for 20 min at 10,000g, using a SorvallS.S.34 
rotor in a SorvallRC5B centrifuge, cooled to 4° C.. The resulting supernatant 
(fraction F^) was diluted with buffer A of Hager et al (141) to give a sus­
pension with a final (NH^^SO^ concentration of 0.15 M.
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4.2.2 Protamine sulphate precipitation of nucleic acids
A 2.57. (w/v) solution of protamine sulphate in buffer A of Hager et al 
(141), containing 0.15 M (NH^)2S04, was prepared by stirring at 3° C. for 17 hr 
21.8 ml of this solutionwas added to every 100 ml of diluted at 4° C..
The resulting suspension was then stirred for 30 min at 4° C., followed by 
centrifugation at 8,000g for 20 min, in a Sorvall" GSA rotor in a Sorvall RC5B 
centrifuge, cooled to 4° C.. The supernatant from this centrifugation (F^) 
was adjusted to 827. saturation with ammonium sulphate. After stirring for 
30 min at 4 ° C. the F2/(NH^)2SO^ suspension was centrifuged at 8,000g for
re
1 hr, in a Sorvall GSA rotor in a Sorvall RC5B centrifuge, cooled to 4 C.
The precipitate from this centrifugation (F2ASppt) was resuspended in buffer 
A of Hager et al (141) to give a protein concentration of 30 mg/ml.
4.2.3 Gel filtration
The F^ASppt suspension was applied, in a total volume of not more than 
7 ml, to an agarose A-5 M column (45 cm x 2 cm), which had been previously 
equilibrated with buffer A containing 0.1 M (NH^)2S0^,’ as described in 2.8.3.
The column was then eluted with the same buffer. Fractions which contained 
significant RNA polymerase activity were pooled, concentrated by (NH^)2SO^ 
salt precipitation (as F^) and dialysed three times against buffer B of Hager 
et al (141). The resulting dialysate was termed F^.
4.2.4 Ion exchange chromatography
The F^ fraction was layered onto a DEAE-sephadex A-25 column (30 x 1. cm), 
which had been previously equilibrated with buffer B of Hager et al (141 ) 
containing 20 mM KC1, as described in 2.8.4. The bound protein was eluted 
with a linear gradient, as described in the legends of Figs. 4.4 and 4.20 
The fractions were collected and assayed for RNA polymerase activity. The 
resulting peaks of activity from the yeast or mycelial form that were found 
were each separately combined. The three separate pools from the yeast form
were concentrated by (NH^J^SO^ precipitation (as F^) and dialysed three times 
against buffer B of Hager et al (141). The three fractions were termed
fractions F. , F_ and F^  .4 5 6
Affinity chromatography
Dialysed fractions F^ and F^ were applied to two DNA cellulose columns, 
which had been equilibrated with buffer B of Hager et al (141) containing 
20 mM KC1. (The DNA cellulose was prepared as described in 2.8.5). The 
columns were washed with the same buffer and the proteins eluted as described 
in the legends of Figs. 4.5 and 4.6. The fractions were collected and 
assayed for RNA polymerase activity. The resulting peaks of activity - 
termed F_ and F arising from fractions F, and F. respectively - were con- 
centrated by (NH^^SO^ precipitation (as F ^ ) .
Glycerol gradient centrifugation
The ammonium sulphate precipitates of fractions F^, Fg and F^ were applied 
onto 11 ml linear 15 - 307. glycerol gradients, as described in 2.8.6. The 
gradients were then centrifuged in the rotors and for the lengths of time 
stated in the legends of Figs. 4.7, 4.8 and 4.9.
Polyacrylamide gel electrophoresis
Analytical PAGE, under non-denaturing conditions, was performed on the 
purified yeast phase RNA polymerases according to the method of Sklar and 
Roeder (352), as described in 2.8.7. Fractions from the glycerol gradient, 
showing RNA polymerase activity, were separately pooled. Aliquots of these 
pooled fractions were analysed on 57. tube gels (0.8 x 10 cm). The gels were 
stained for protein using the silver staining technique of Merril et al 
(258), as described in 2.8.8.
RNA synthesised by yeast, in the presence of of-amanitin, was labelled with 
C 32Pj sodium orthophosphate, as described in the legend of Fig. 4.15. The
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C P] labelled RNA was extracted, as described in 2.7.1, and analysed by
agarose gel electrophoresis, as described in 2.8.1.
4.3 Results
4.3.1 Purification of RNA polymerases from C. albicans
An outline of the procedure used to purify the RNA polymerases from 
yeast and mycelial forms of C. albicans is shown in Tables 4.1 and 4.2. The 
total RNA polymerase activities, protein, specific activities and class of 
isozyme present at each stage of the purification of the enzymes, from both 
morphological forms, are shown. One unit of RNA polymerase activity was
3
defined as the incorporation of 1 pmole C Hi UMP into TCA insoluble material, 
per 5 min incubation at 25° C..
The specific activities of RNA polymerases, from the yeast form,
increased from 0.18 to 1.5 units mg protein-  ^ from the preparation of
homogenate to after the gel filtration step. The ion exchange step resolved
the yeast RNA polymerases into three peaks, with specific activities of 3.57,3.8
and 0.32 units mg protein . DNA cellulose chromatography resulted in further
-1
purification, to 7.52 and 15.61 units mg protein for RNA polymerases I and II.
Glycerol gradient centrifugation resulted in a decrease in the specific
activities of RNA polymerase I and II, to 0.68 and 1.17. Although RNA poly-
-1
merase III showed an increase in specific activity, to 0.75 units mg protein, thf 
total activities of this and the other isozymyes- fell markedly. This may be 
illustrated by 110 total units of activity, for the three RNA polymerases prior 
to glycerol gradient centrifugation, decreasing to 0.32 after this step.
The specific activity of RNA polymerases from the mycelial form increased 
from 0.22 units mg protein^in homogenate to 1.3 units mg protein after gel 
filtration.
4.3.2 Initial stages in the purification of RNA polymerases from yeast C. albicans; 
preparation of homogenate
32
The suitability of the two methods, i.e. compression and the use of
1 0 0
F r a ction RNA Total Total Speci fic
Polymerases Po l y m e r a s e Protein activity
present activity c o n c e n t r a t i o n
(uni ts) (mg) ( uni ts/mg)
H o m o g e n a t e I.II.Ill 473 256 0 0.18
S o n icate I.II.Ill 296 2 7 2 0 0.11
F i I.II.Ill 216 1450 0.15
F [ ppt I.II.Ill 97 518 0 .19
F 2 I.II.Ill 31 1260 0.02
F 2 ppt I.II.Ill 14 144 0.10
F 3 I.II.Ill 427 372 1.15
CSI«X
F4 I 50 14 3.57
4S Í  
2 F S II 93 24 3.88
a» —  v> 3 
uj 5 <c -
=> vj
F6 III 2.2 6.9 0.32
O  T3 
3  zr
—  o
f 7 I 18.8 2.5 7.52
5  i F 8
II 89 5.7 15.61
«X
o  u
ca*—  c T3 3
F 9 I 0.19 0.2 8 0.68
F 10 II 0.07 0.06 1.17
Oi- — <U l-<_l *->
F U III 0.06 0.0 8 0.75
o  O
T«bl« 4.1 Sunary oí purification oí M A  polyaaraaaa iron yaast ioni C. albicano
C. albican« yaast fron calla vara grow in S.O.B. at 37° C. to a coll density 
corresponding to lata exponential phaaa. Tha colla wnra homogenised and 
fractions praparad as dascrlbad In 4.2.1 to 4.2.4. RNA polynarasa activity 
was measured using tha assay conditions dascribad In 2 Vi. Tha tabla shows 
results obtained iron 60 g (wat weight) of C. albicans. Protein was naasured 
as dascrlbad 2.6.3.
Fraction
Total
RNA
Polymerase
activity
Total
Protein
concentration
(mg)
Specific
activity
(units/mg)
Homogenate 94 422 0.22
Sonicate 73 427 0.17
Fi 70 238 0.29
^PPt 7 125 0.06
F2 10 184 0.05
FjPPt 3 46 0.06
F3 13 10 1.3
Tabi« 4.2 Sunary of partial purification of M A  polynarasa iron mycelial fora C. albicans 
C. albicans nycallal fora calls wara grown in O.8.K. medium at 37° C.. Tha 
nycelia wars collected after 7 days growth as dascribad in 2.3.3. Tha calls 
wara homogenised and fractions preparad aa dascrlbad In 4.2.1 ta 4.2.V. M A  
polynarasa activity at each stage was naaaurad using tha assay condìtlana 
dascrlbad In Tha value shews tha results obtained from 12 g (wet weight)
of C. albicans. Protein was measured aa described in 2.4.3.
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balotini to homogenise the cell suspension, is shown in Table 4.3. There 
was no decrease in the cell density of samples of cell suspension before or 
after compression. In addition, the negligible RNA polymerase activity and 
the low LDH activity (i.e. 0.8 - 1.0 yumoles NADH oxidised min * mg protein *) did 
not change markedly on compression. There was a marked decrease in cell 
count of samples of cell suspension removed after 1 min homogenisation with 
ballotini. After 3 min homogenisation the cell count of a sample fell 
to approximately 0.57. of that prior to treatment. In addition, the measur­
able activity of RNA polymerase of a sample, increased from 0 to 0.33 pmoles 
of [14C) UMP incorporated min * mg protein * after 3 min homogensation with 
balotini. The LDH activity of samples removed after treatment with balotini 
was greater than that prior to homogenisation (i.e. rising from 0.8 to 12 - 14
jimoles NADH oxidised min * mg protein *). RNA polymerase activity of samples 
before and after the two methods of cell disruption attempted, was measured in the 
assay "cocktail", described in 3.3.7. This resulted in optimal RNA synthesis 
in vitro in nuclei. The components of the "cocktail" were the same as des­
cribed in 2..5.Z, with the exception that 250 nCi of UTP was added and
I Ithe MgCl2 concentration was 100 mM. The effect of altering the Mg concen­
tration, in the "cocktail", of homogenates prepared from yeast and mycelia, 
is shown in Fig. 4.1. Optimal RNA polymerase activity occurred in an assay 
"cocktail" containing 10 mM MgCl_. Optimal specific activity (i.e. 0.2 units mg 
Protein ) was found in RNA polymerases from yeast, harvested in the exponen­
tial phase of growth.
Table 4.4 shows the specific activity (units mg protein *) for RNA poly­
merases in crude homogenate prepared from C. albicans harvested at different 
cell densities. Similar specific activities (of between 0.178 - 0.219 units mg 
protein”*) were found for RNA polymerases in homogenates prepared from early 
(2 x 107 yeast cells/ml), mid (5 x 107 yeast cells/ml) and late (1 x 10® 
yeast cells/ml) exponential phase cells. (ATC value of 0.057, with five 
degrees of freedom, for the specific activity of RNA polymerases in crude 
homogenates prepared from yeast cells in any period of growth, indicated 
that there were no significant differences between these values). RNA poly­
merases in a crude homogenate prepared from stationary phase yeast cells
/Table <».3 C«ll break«;« of C. albican«
C. albican» yaast form cells w«r« grown In S.D.B. to a cell density correspondió; 
to late exponential phase. The cells were harvested and washed as described In 
2.3.3. and resuspended 1/10 (w/v) in buffer l. Two methods were then used to 
try and disrupt the cells: a) compression at 90 - 100 in a press, cooled
to 4° C., b) homogenisation of 10 ml yeast suspension with twice the weight of 
balotini added (0.45 • 0.35 »  diameter), at low temperature, for the lenghs of 
time indicated in the table. RNA polymerase activity was measured as described 
in 3.4.2. L.D.H. activity was measured as described in 2.5.5. Protein was 
measured as described in 2.6.3. Cell counts were made using an improved Neubauer 
haemocytometer, on samples removed before and after treatment, and diluted 1/20 
in buffer 1.
Fig. 4.1 Effect of MgCl, concentration in assay "cocktail" on UNA poly-.«rase activity tn 
homogenates prepared from yeast and r.vcellal fora C. ilbicsns 
Yeast fora C. ilblcans was grown in S.D.B. at 37° C. to cell densities corres­
ponding to the stationary (5 x 10* cells/al media) and late exponential 
(10* cells/ml media) phases of growth. Mycelial form cells were grown in G.B.E. 
medium at 37° C.. The cells from both growth forms were harvested and washed as 
described In 2.3.3. and homogenates prepared as described In 4.2.1. The RNA 
polymerase activities of 200>tl homogenate, prepared from stationary ( —  )
and late exponential ( W  ) phases of growth, of yeast and mycelial ( #■ ■■ )
forms of C. albicans were measured using the conditions described In The
error bars refer to the standard deviations of duplicate measurmants. Protein 
was measured as described in 2.6.3.
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Table 4.3
Method of 
cell disruption
Duretlon of 
treatment
RNA polymerase activity 
(petóles [ C) W P  Incorporated 
into RNA/mln/mg protein)
L.D.H. activity 
(/jmoles NACH oxidised/ 
mln/mg protein)
Cell count of sample 
(number of cells .
(x 10"°)/ml)
Homosenlsatlon 0 min 0 0.8 215
with balotlnl
1 min 0.03 5 64
2 min 0.12 7 28
3 min 0.33 12 1
4 min 0.31 11 1
5 min 0.27 14 1
Compression before 0 0.8 220
In press compresi ioti
after 0 1.0 210
coagtresslon
Fig. 4.1
MfClj CaMCENTCATIGN
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table 4.3 Call breakage of C. albican;
C. albican» yeast fora cells were grown In S.D.B. to a cell density corresponding 
to late exponential phase. The cells were harvested and washed as described in 
2.3.3. and resuspended 1/10 (w/v) in buffer l. Two methods were then used to 
try and disrupt the cells: a) compression at 90 - 100 in a press, cooled
to 4° C., b) homogenisation of 10 ml yeast suspension with twice the weight of 
balotinl added (0.45 - 0.55 inn diameter), at low temperature, for the lenghs of 
time indicated in the table. RNA polymerase activity was measured as described 
in 3.4.2. L.D.H. activity was measured as described in 2.5.5. Protein was 
measured as described in 2.6.3. Cell counts were made using an improved Neubauer 
haemocytometer, on samples removed before and after treatment, and diluted 1/20 
in buffer 1.
Pig. 4.1 Effect of MgCl, concentration In assay "cocktail" on RNA polymerase activity in 
homogenates prepared from yeast and mycelial fora 0. ilbitans 
Yeast fora C. slbicsni was grown in S.D.B. at 37° C. to cell densities corres­
ponding to the stationary (5 * 10 calls/ml media) and late exponential 
(103 cells/ml media) phases of growth. Mycelial fora cells were grown in C.B.E. 
medium at 37° C.. The cells from both growth forms were harvested and washed as 
described In 2.3.3. and homogenates prepared as described in 4.2.1. The RNA 
polymerase activities of 2 0 0 >il homogenate, prepared from stationary ( 1 )
and Lata exponential ( *  " ) phases of growth, of yeast and mycelial ( #  )
forms of C. albicans were measured using the conditions described in Z-B.JL The 
error bars refer to the standard deviations of duplicate maasurments. Protein 
was measured as described In 2.6.3.
1 0 2
Table 4.3
Method of 
cell disruption
Duration of 
treatment
RNA polymerase activity 
(pewles l* Cl t*1P Incorporated 
into RNA/mln/mg protein)
L.D.H. activity 
(¿anoles NADH oxidised/ 
mln/mg protein)
Cell count of sample 
(number of cells .
(x 10*”)/ml)
Homogenisation 
with balotinl
0 min 0 0.8 215
1 min 0.03 5 64
2 min 0.12 7 28
3 min 0.33 12 1
4 min 0.31 11 1
5 min 0.27 14 1
Compression 
In press
before
compression
0 0.8 220
after
compression
0 1.0 210
Fig. 4.1
*|CI, CONCnTHATXON (*(>
//
- 103 -
Q
(5 x 10 /ml) had a much lower specific activity of 0.035 units/mg protein.
Initial stages of RNA polymerase purification: preparation of sonicate
The effect of sonication on the percentage of bound and free RNA poly­
merase in homogenates, prepared from yeast in the exponential phase of growth, 
is shown in Table 4.5. The addition of exogenous DNA template to the homo-
O
genate, prepared from yeast harvested at 1 x 10 cells/ml, resulted in an 
increase in the amount of [ H] UMP incorporated (i.e. from 4 1.3 to 70.6 fmoles) 
Sonication, of the same homogenate, resulted in a decrease of RNA polymerase
activity, on endogenous DNA, to 11.6 fmoles. The addition of exogenous DNA,
to the sonicate, resulted in an increase in incorporation of C3h1 UMP into 
RNA to 24.6 fmoles. The RNA polymerase activity, using endogenous DNA, of 
homogenate and sonicate corresponds approximately to the amount of "bound"
RNA polymerase in the sample. The activity of the enzyme in the presence of 
exogenous DNA approximates to the level of "bound" plus "free" RNA polymerase 
activity. The level of "free" RNA polymerase may be estimated by measurement 
of the activity in the presence of actinomycin D and exogenous poly fd(A-T)] 
template. It was found that the addition of both these components to the
"cocktail" resulted in 28.3 and 17.3 fmoles [3h J UMP incorporated into RNA
by homogenate and sonicate respectively. A low level of [ H] UMP incorporation 
into RNA by homogenate and sonicate, with endogenous DNA plus actinomycin D, 
of 5.3 and 1.7 fmoles respectively, indicated the residual amount of RNA 
polymerase activity.
The percentage of "bound" and "free" RNA polymerases in homogenates, 
prepared from yeast at two different cell densities, before and after soni­
cation, may be estimated as described above. The percentage of "bound" RNA
Q
polymerase in the homogenate of yeast grown to 1 x 10 cells/ml was 587..
3
The level of "bound" enzyme in the homogenate prepared from 3 x 10 yeast/ml 
was less (447.). Sonication slightly reduced the percentage of "bound"
3 3
enzymes in homogenates from 1 x 10 and 3 x 10 yeast/ml (i.e. to 47 and 337. 
respectively).
Table 4.4 RNA polymerase activity of homogenst«* prepared from yeast form C. albicans
harvested at various cell densities
C. albicans yeast cells were grown in 1 L S.D.B. to the cell densities shown 
In the table. Cell densities, of aliquots removed from suspension, were-measurec 
using an improved Neubauer haemocytometer. The cells were harvested and 
homogenates prepared with balotlnl as described in 4.2.1. The RNA polymerase 
activity of 200 >il homogenate over a 5 min period was estimated as described 
in M X .
Tabl« 4.3 Template free and engaged forma of M U  polymerase in homogenates of 
before and after sonicatioe
Homogenates were prepared from yeaat form C. albicans - grown to the cell 
densities indicated in the table - as described in 4.2.1. The RNA polymerase 
activity of 200 >il homogenate, before and after the sonication step of 4.2.1, 
was estimated over a 3 min period. The activities were measured as described 
in A.S.X with the exception that no calf thymus ENA was added. When required 
120 ;ug of Act.nomycln D and 13 xS poly C <*<*-*>) «"»• •<*<»•«* 400 •••«*
n!.<cwe. (The asterisks refer to homogenate before • and aftar sonication •*).
Flg. 4.2 RNA polyraerase actlvlty ln homogenstes left for 90 min at 03 C. and 25° C.
A homogenste was prepared fron yeast form C. albicans - grown to «xponentlal 
Phase ln S.0.1. - as descrlbed ln 4.2.1. Aliquot« of homogenste wer« kept on 
lee at 0° C. or ln a water bath at 23° C. Th« RNA polyraeras« actlvlty, after 
the langths of tim« lndlcatad ln th« flgure, was measured uslng th« asaay 
conditlons descrlbed ln 3.4.2. Th« flgura shows actlvlty ln th« homogenste 
left at 0° C. ( m  ), 23° C. < •  ) and at 0# C. wlth th« addltlon of 
bovine serum albumln (1 mg/ml) to the homogenst« ( ■ ■■ ). th« error bars 
refer te the Standard daviations of dupllcate msasuremants.
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Table 4.4
Cell density of 
yeast on 
harvesting
Dry weight of 
yeast from 1L 
S.D.B.
RNA polymerase activity 
of homogenate 
(units/mg)
2 x 107/ml 0.82 g 0.178 ♦ 0.04
5 x 107/ml 1.23 g 0.193 + 0.04
1  « 10^/ml 3 . 7 5  s 0.219 + 0.04
5 x 10^/ml
(stationary phase)
17. g«; g 0.035
Table 4.5
RNA polymerase activity of cell free extract
(fmoles [3h 3 UMP incorporated into RNA/50 ¿il aliquot/5 min,
Cell density 
of yeast on 
harvesting
Cell free
extract
only
Ceil free 
extract +■ 
actinomycin D
Cell free 
extract +■ 
poly [d(A-T))
Cell free 
extract + 
actinomycin D 
•+• poly (d(A-T)]
Percentage
"bound
enzyme
41.3* 5.3 70.6 28.3 537.
1 x 103/ml
11.6** 1.7 24.6 17.3 477.
34.2* 6.3 78.6 48.3 447.
3 x 108/mt
15.8** 3.0 47.8 25.7 337.
Fig. 4.2
TDtt AFTER miFAMTiai 0F HauCOIATR (•!•>
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4*3-4 RNA polymerase activity at various times after preparation of homogenate
The decrease in activity of RNA polymerases in freshly prepared homogenate, 
over a period of time, is shown in Fig. 4.2. Samples of the homogenate were 
kept at 0 C. and at 25 C.. Using the conditions that resulted in optimal 
nuclear RNA synthesis, aliquots of the homogenate were assayed for RNA poly­
merase activity after various periods of time. The figure also shows the 
effect of adding bovine serum albumin to the "cocktail". RNA polymerase 
activity, of a 50 ^ il aliquot of homogenate was negligible after 90 min at 
25 C., whilst at 0 C. approximately 507. of initial activity was detectable. 
The addition of BSA increased the level of detectable RNA polymerase activity.
4.3.5 Gel filtration of yeast form RNA p olymerases
The fraction F^ASppt suspension was applied to an agarose A-5 M column, 
as described in 2.8.3. Fig. 4.3 shows a typical result obtained with gel 
filtration of this fraction. The RNA polymerase activity of selected 
fractions, assayed as described in 2.5.2, was found to be optimal in 
fractions eluting from the column just behind the void volume (i.e. having 
a M.W. smaller than the exclusion M.W. of 5 x 106). The fractions containing 
significant activity were pooled and concentrated by ammonium sulphate 
precipitation.
4.3.6 Ion exchange chromatography of yeast RNA polymerase
The ammonium sulphate precipitate derived from fraction F3 was dialysed, 
as described in 4.2.4. Fig. 4.4 shows a typical result obtained when the F^ 
fraction was chromatographed on DEAE-sephadex. Three peaks of RNA polymerase 
activity were found when fractions eluted from the column were assayed for 
RNA polymerase activity. The activities were eluted when the salt concen­
tration of the buffer B was 0.06 - 0.09 M KC1, 0.09 - 0.2 M KC1, and 0.24 - 
0.29 M. The three enzyme activities were named RNA polymerases I, II and III 
respectively according to the procedure of Roeder and Rutter (311).
rig. 4.1 CeL filtration of fraction f; fro« yooat form C,
The ammonium sulphate precipitate of fraction 2, containing 30 mg protain/al, was 
applied to an agarosa A-5 N column. Tha coluon was «luted with Hager*s buffer A 
containing 0 . 1  M (NH^)^SO^. The transmittance» at 290 na, of tha eluant ( —  • “  ) 
was recorded using a Uvlcord scanner. Twenty two 3 ml fractions wera collected 
and alternate fractions were assayed for M U  polyaarase activity In a "cocktail" 
containing 10 aM HgCl2 and salt to a final concentration of 100 oM as described 
In 2.3.2. Tha activity of duplicate 30 >»l aliquots was measured by tha 
Incorporation of C JhJ IMP into TCA Insoluble material over a 3 min Incubation 
period at 23 C. ( “  ) Tha error bars refer to the standard deviations of
duplicate measurements.
/lg. A.4 Ion axchanga chromatography of fractlon P^ from yeast fotm C. alblcans
The anmtonlua sulphate precipítate of fractlon 3, contalning 63 mg proteln 
(dlalysed as descrlbed ln 4.2.1» ), vas applled to a DEA£-5ephadex 
A-25 coluam. Tha column was washed with Hager's buffer B contalning 0.02 M KCl» 
followed by elutlon wlth a 100 mi gradlent of 0.02 H - 0.42 N KCl ( *» • — ). 
Elghty 1 mi fractlons were collected and selectcd fractlons aasayed for RNA 
polymerase actlvlty ln a "cocktail" contalning 10 mM NgCl^ and 100 (MI KCl, 
as descrlbed ln 2.3.2. The actlvlty of duplícate 50 ¿il allquots was mensurad 
by the lncorporatlon of C*h1 CMP lnto TCA Insoluble material over a 13 mln 
incubación perlod at 23° C. ( ■ ) Tha error bars refer to the standard
davlatlons of duplícate measurements. The transaittanca at 260 na of the 
eluent (—  • — ) was recordad uslng a Uvlcord scanner.
Tabla 4.6 Adsorptlon and elutlon of RNA polvmerases I» IX and III froa DNA callulosa
Tha 3 RNA polymarasas íron yeast foca C. alblcans were separated as dascrlbed 
ln 4.2.4, by Ion exchenge chromatography. 100>ul allquots of fractlons P. , fj 
and P6 were mlxed wlth 0.3 mi (bed voluae) DNA callulosa slurry. The slurry 
was washed wlth 100 pil of buffer B contalning the lncraaslng concentratlons of 
KCl shotm ln the tabla. Tha 0NA callulosa was separated froa the "elutlng" 
buffer by centrlfugatlon at 0*4° C, ln a I and T micro-angla banch centrifuga, 
for 10 mln at máximum speed. The RNA polymerase actlvlty ln tha aupamatant 
was measurad ovar a 10 mln incubetlon perlod uslng the condltlons descrlbed ln 
R.9-X.(n/d • not determinad)
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4.3.7 Affinity chromatography of RNA polymerases from yeast form C. albicans
The next stage of enzyme purification was affinity chromatography, 
using DNA as the ligand. However, before this stage was performed, aliquots 
of the three enzymes were titrated against DNA cellulose (Table 4.6). This 
was done in order to determine whether any of the enzymes had too strong or 
too weak an affinity for the ligand. Aliquots of each class of enzyme were 
mixed with 0.5 ml (bed volume) of DNA cellulose slurry and "washed" with 
buffer B containing increasing amounts of KC1. After each "washing" the 
RNA polymerase activity in the buffer was measured. The buffer was separated 
from the cellulose by centrifugation. It was found that RNA polymerases I 
and II were "eluted" from the DNA cellulose when the KC1 concentration was 
0.1 M. RNA polymerase III activity was eluted from the DNA 
cellulose slurry when the salt concentration of the buffer was 2.0 M. As a 
consequence^only fractions and F,. were chromatographed on DNA cellulose.
Figs. 4.5 and 4.6 show typical results obtained when fractions F^ and F^ 
were chromatographed on DNA cellulose. Peaks of RNA polymerase activity were 
eluted when the buffer contained 0.1 - 0.2 M and 0.05 - 0.1 M KC1, when 
fractions F^ and Fg respectively were chromatographed. To avoid cross contam- 
ination,only the leading fractions showing activity of RNA polymerase II and the 
latter of RNA polymerase I were pooled and concentrated by (NH^J^SO^ precipit­
ation as described in the methods section. These two fractions were termed 
fraction F^ (RNA polymerase I) and fraction Fg (RNA polymerase II).
4.3.8 Glycerol gradient centrifugation of yeast RNA polymerases
Fractions F^, Fg and F& were centrifuged on 15 - 307. glycerol gradients 
at the speeds and for the lengths of time indicated in Figs. 4.7, 4.8 and 4.9 
respectively. Three peaks of low activity were observed.
4.3.9 Non-denaturing PAGE of purified yeast RNA polymerases
Analysis, by n o n - d e n a t u r i n g  PAGE of the purified enzymes was performed.
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•5 ONA cellulose cnroni’sgrapny of fraction P
Tha dialysed umonurn sulphate precipitate of fraction F , containing ’ mg 
protein was applied to a DMA cellulose column. The column was washed with 
5 -nl of Hager's buffer B containing 3.02 M KCl, and eluted with a Id -nl 
gradient of 0.02 * 0.4 M KCl ( — — — ). Twenty five 0.’5 ml fractions were 
collected and selected fractions assayed for RNA polymerase activity in a 
"cocktail" containing 10 rti MgCl, and KCl to a final concentration of 100 
as described in 2.5.2. The activity of 25 >jl aliquots was -.easured by the 
incorporation of ] CMP into TCA insoluble material over i 13 min incubation 
period at 25 C. ( ). The error oars refer to the standard deviations of
duplicate measurements. The transmittance, at 230 run, of t.-.e eluent was recorded 
using a Uvicord scanner ( — e — ).
nucrion
rig. 4.* DMA cellulose chroaatography of fraction
Tha dlalysad aosonlun sulphate precipttaca of fraetlon P)( containing 11 mg 
protein, was applied to e DNA cellulose colun. The column was washed with 
5 ml of Hager's buffer ■ containing 0.02 N KCl, end eluted with e 20 ml linear 
gradient of 0.02 - 0.5 N KCl (- — ). Twenty five 0.7 ml fractions were collected an 
selected fractions essayed for KNA polymerase activity la e "cocktail” containing 
10 n* MgClj and KCl to a final concentration of 100 nM, as described in 2.5.2.
The activity of 2S/il aliquots was measured by the incorporation of f JHj UMP into 
TCA Insoluble materiel over a 15 min incubation period at 25° C. ( ). The
error bars refer to'the standard deviations of duplicate measuronenta. The 
transmittance, el 110 nm, of the eluant wee recorded using e Uvicord scanner
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DISTANCE FROH BOTTOM OF TUBE (coi)
Fl«s. 4.7 • 4.9 Clycarol «radiane cantrlfuqatlon of fracciona f,, F, and F.
Tha armonium sulphaca precipitata of fractlona F,, F^  and F  ^wara layarad 
oneo 11 mi 15% - 30'. «lycarol «radianes In Hagar's buffar B, concainln« 0.1 M 
(NlOjSO^. Tha «radianes -ara chan canertfu«ad for 19 hr In althar a 
Backman 50 Tl roeor, at 100,000 « (Fi«, u.7), or Bacwnan -0 rocor, at 95,000 « 
(Fl«s. 4.9 and 4.9). Fracciona of 0.5 mi (FI«. 4.7), 0.4 mi (FI«. «.9) or 
0.45 mi (FI«. 4.9) wara collacead. Duplicata 50 *il aliquota wara assayad for 
RNA polymaraaa aceIviey in cha aasay "cocktail" dascribad in 2.5.Ì. Tha 
acelviey was maaaurad by tha Incorporatton of C*«} UHP into TCA insolubla
maearlal ovar a 15 min Incubación partod ac 15° C. ( --- ). Tha arror bara
rafar co tha seandard daviaciona of duplicata maaauraoianca.
4.3.10
4.3.11
4.3.12
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Fractions from the glycerol gradient centrifugation, having the highest 
activity for each of the three RNA polymerases, were analysed as described in 
2.8.7. Each of the purified enzymes showed only one band when stained using 
the technique based on that of Merril et al (258), as described in 2.8.8.
Divalent cation optima for partially purified RNA p olymerases
The effect of MgCl2 concentration in an assay "cocktail" on the three 
RNA polymerases from yeast form C. albicans is shown in Fig. 4.10. Optimal 
activity, for all three classes of enzyme, was found when the assay medium 
contained MgCl2 at a concentration of 10 mM.
The effect of MnCl2 concentration on partially purified RNA polymerases 
in "cocktails" containing either 10 or 100 mM KC1 is shown in Figs. 4.11 and 
4.12. In a "cocktail" containing 10 mM KC1, optimal RNA polymerase IX and III 
activities were found using a MnCl2 concentration of 1 mM. Optimal RNA poly­
merase I activity resulted using 0.5 mM MnCl2. Activity of RNA polymerases 
II and III in an assay "cocktail" containing 100 mM KC1 (Fig. 4.12) was optimal 
for RNA polymerase III at 0.5 mM MnCl2 and optimal for RNA polymerase II at 
0.75 mM. In addition, a smaller peak of activity was observed for RNA poly­
merase II incubating in a "cocktail" containing 1.5 mM MnCl2 and 100 mM KC1.
Salt optima for partially purified RNA polymerases
The effect of KC1 concentration on the partially purified RNA polymerases 
from yeast phase C. albicans, in a "cocktail" containing 10 mM MgCl2, is 
shown in Fig. 4.13. Optimal activity for RNA polymerases I and II occurred 
when the KC1 concentration was 40 mM and 100 mM respectively. Two peaks of 
optimal RNA polymerase III activity were found when the assay "cocktail” 
contained 100 and 240 mM KC1.
«-Amanitin sensitivities of partially purified RNA polymerases
The effect of addition of ot-amanitin on the activity of partially purified
A
3
Fl*. 4.10 Effect of MgCl, concentration on partially purified RNA polraerases from veast 
fora C. albicans
Th« 3 classes of RNA polymerase from yeast fora C. albicans wer« separated by 
DEAE-Sephadex chromatography, as described In 4.2. . 50 >»1 aliquots of
partially purified RNA polymerase I (containing approximately 6 >jg protein 
-«* —  ), RNA polymerase II (containing approximately 10 >ig protein ) and
RNA polymerase III (containing approximately 70 ¿ig protein —Ä —  ) were Incubated 
in 100 >il total volume of assay "cocktail" containing MgC^ to the final 
concentrations shown in the figure. The other components of the "cocktail" 
were as described in 2.5.2. The activity was measured by the incorporation of 
C 3H 3 IMP into TCA insoluble material over a 15 min incubation period at 25 C.
The error bars refer to the standard deviations of duplicate measurements.
Figs. 4.11 and 4.12 Effect of MnClg concentration on partially purified RNA polymerases 
from yeast fora C. albicans
The 3 classes of RNA polymerase from yeast fora of C. ilbicani were 
separated by DEAE-Sephadex chromatography, as described in 4.2. .
50 Ml aliquots of partially purified RNA polymerase I (containing 
approximately b >ig protein — a*— ), RNA polymerase II (containing 
approximately 10 >ig protein - ® —  ) and RNA polymerase III (containing 
approximately 70 >ig protein - O —  ) were Incubated In total volume of 
100 * l "cocktail" containing MnClj at the final concentration
shown in the figure. The components of the "cocktail" were as 
described in 2-. S.'S. section, except KC1 was present at final 
concentrations of 10 iM (rig. 4.11) or 100 <* (rig. -.12). Incorp­
oration of C n] (■‘W  Into TCA Insoluble material over a 15 min 
incub.cion p.cloC .t ¡!a C. ... ...4 .. .
activity. The error bars refer to the standard deviations of duplicate 
measurements.
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Fig. 4.13 Effect of KCL concentration on perdali/ purified RMA polymerases fro« yeast fora
The 3 classes of RMA polymerase from yeast form C, albicans were separated by 
DEAS-Sephadex chromatotraphy, *• described In Fig. 4.4. SO >il aliquots of 
Partially purified RMA polymerase I (containing approximately 6 /ig protein 
"* )t RMA polymerase 1Z (containing approximately 10 ¿ig protein—m ) and
RMA polymerase IZZ (containing approximately 70 jug protein —A —  ) were Incubated 
In total volume s>t 100 >il assay "cocktail" containing 10 oM MgCl2 and KC1 to the 
final concentrations shown. The other components of the "cocktail" were as 
described In • 5' a. section. RMA polymerase activity was measured by the 
Incorporation of IMF Into TCA Insoluble material over a IS min Incubation
period of 25° C. The error bars refer to the standard deviations for duplicate 
measurements.
Fig. 4.14 Effect of m-arnaaltln concentration on partially purified RMA polymerases from
yeast form fUlSIBl
The 3 classes of RMA polymerase from yeast form C. albicans were separated by 
DEAE'Sephadex chromatography, as described in 4.2.4. Duplicate S >il aliquots 
of partially purified RMA polymerase I (containing 17 >ig protein '<*—  ), RMA 
polymerase ZZ (containing 23 protein — O —  ) and RMA polymerase IZZ (containing
180 protein —  ) were Incubated la a total volume 20 jil assay "cocktail" 
as described laX.9.Z. atamani tie was present In the "cocktail" at the final 
concentrations Indicated la the figure. RMA polymerase activity was measured by 
the incorporation of UM» late TCA Insoluble material over a 10 mia
Incubation period at 23° C. 1*71 activity of partially purified RMA polymerases 
Z, ZZ and IZZ was 127, 1 8 1  «ad 118 f moles [*Hl UMF Incorporated/ 10 >il aliquots/ 
10 min Incubation at 23° C.
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KC1 CONCENTRATION (rSS)
Fig. 4.14
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28 S
18 S
5.8 S 
5 S
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Analysis of RNA synthesised by C. albicans ycasc calls, by agarose gel 
electrophoresis, showing eha affacts of « -amanicin at 20 and 200>ug/ml 
Yaasc calls of C. albicans wara grown eo a call density corrasponding eo tha 
stationary phasa of growth, harvested and re>suspended in protoplast buffar.
Tha calls wara incubatad for 10 min at 25° C. prior to tha addition of 10 >iCi 
and aithar 20 >ig or 200 >ig of x«amanltin par ml yaast suspension.
No ««aiunitin was added to a control yeast suspension. The three yeast call 
suspensions wara than incubatad at 29° C. for 90 min. Tha RNA was extracted and 
DNase traatad as described in 2.7.1. and 2.5.4. raspactivaly. Tha extracted,
C32pJ labelled RNA was suspended in sample buffar for agarose gal electrophoresis, 
as described in 2.8.1, to a final volme at 50>il. Tha different lanes contained: 
a) 10 >il and b) 20 />1 of C32P] labelled RNA extracted from controls, c) 10 ,«1 and 
d) 20>ul of f32P] labelled RNA extracted from yaast in tha presence of 20 >jg 
« -amanltin/ml, a) 90 >il of f l a b e l l e d  RNA extracted from yaast in tha 
presence of 200 /ig «-amanitln/ml. The position migrated by tha CJ2p] labelled 
RNA was visualised as described in 2.8.9. The position migrated by the 4 S . 
(bromophenol blue) 28 S, 18 S, 5.8 S and 9 S Plsf satirist marker RNA species 
are shown.
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Fie- ¿.15 Analysis of RNA svnthesised by C. albicans yeast ceils, by agarose < ei 
elec cropnore sis, showing the effects of« -amanitin at ¿0 and 200 >ig/ml 
Yeast cells of C. albicans were grown to a cell density corresponding to Che 
stationary phase of growth, harvested and re-suspended in protoplast buffer.
The cells were incubated for 10 min at 25° C. prior to che addition of 10 >iCi 
SaH2t32R]04 and either 20 pg or 200 >ig of s-ananitin per ml yeast suspension.
No m-ananitln was added to a control yeast suspension. The three yeast cell 
suspensions were then incubated at 25° C. for 90 min. The RNA was extracted and 
DNase treated as described in 2.7.1. and 2.5.A. respectively. The extracted,
C Pj labelled RNA was suspended in sample buffer for agarose gel eleccropnoresis. 
as described In 2.8.1, to a final volume at 50 >il. The different lanes contained: 
a) 1C ¿tl and b) 20 ¿il of [32Pj labelled RNA extracted from controls, c) 10 ,ul and 
d) 20>ul of f32Pj labelled RNA extracted from yeast in the presence of 20 >jg 
* -amanitln/al, e) 50 ¿jI of f32P] labelled RNA extracted from yeast in the 
presence of 200 ;ig «• amanitln/al. The position migrated by the C32p] labelled 
RNA was visualised as described In 2.8.9. The position migrated by the 4 S 
(bromophenol blue) 28 S, 18 S, 5.3 S and 5 S Ptsum satirum marker RNA species 
are shown.
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Fij. ...i Analysis of RNA svnthesised by C. albicans yeast cells, by agarose gel 
electrophoresis, showing the effects of <x-amanttin at 20 and 200 >jg/ml 
Yeast cells of C. albicans were grown to a cell density corresponding to the 
stationary phase of growth, harvested and re-suspended in protoplast buffer.
The cells were incubated for 10 min at 25° C. prior to the addition of 10 >iCl 
and either 20 pg or 200 >jg of s-ananltin per ml yeast suspension.
No «-amanitln was added to a control yeast suspension. The three yeast celL 
suspensions ware then Incubated at 25° C. for 90 min. The RNA was extracted and 
DNase treated as described In 2.7.1. and 2.5.4. respectively. The extracted,
C Pj labelled RNA was suspended in sample buffer for agarose gel electropnoresis. 
as described in 2.8.1, to a final volume at 50 >il. The different lanes contained: 
a) 1C >il and b) 20 jtl of t32P] labelled RNA extracted from controls, c) 10 >il and 
d) 20>ul of (32Pj labelled RNA extracted from yeast In the presence of 20 >ig 
* -amanltln/ml, a) 50 >il of f32P] labelled RNA extracted from yeast in the 
presence of 200 ¿ig ot-amanltln/ml. The position migrated by the C32p ] labelled 
RNA was visualised as described In 2.3.9. The position migrated by the 4 S 
(bromopnenol blue) 28 S, 18 S, 5.3 S and 5 S PI sum satiric marker RNA species 
are shown.
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RNA polymerases is shown in Fig. 4.14. At a concentration of 2 mg of-amanitin/ 
ml RNA polymerase I was completely inhibited, whereas RNA polymerase II was 
inhibited 407, by o<-amanitin at this concentration. RNA polymerase III activity 
was almost completely inhibited at concentrations of 200 jig/ml.
The effect of <x-amanitin, at a concentration of 20 and 200 p g/ml, on the
RNA species synthesised in vivo by C. albicans, is shown in Fig. 4.15. The 
32[ Pj labelled RNA, extracted from yeast cell suspensions containing no ©< — 
amanitin, has bands migrating to the same positions as the 5 S and 4 S marker 
species (lanes a and b). Bands due to the presence of [32P] labelled RNA 
migrating with the mobility of 5 S and 4 S species are evident in lanes c and 
d. These lanes contained RNA extracted from yeast cells incubated in a sus­
pension containing 20 pg et-amanitin/ml. The wells of lanes a and c, and b 
and d, contained 10 ^ il and 20 pil of extracted RNA solution respectively. This 
represented 207. and 407. of the labelled RNA that was extracted from C. albicans 
incubating in a suspension containing none or 20 ¿ig «-amanitin/ml. The well 
of lane e contained all the RNA that was extracted from yeast cells incubating 
with 200 p g <x-amanitin/ml suspension. There are no bands of £32p J labelled 
RNA migrating with the mobility of 5 S and 4 S species.
4.3.13 Apparent Km for CTP for yeast form partially purified RNA polymerases
The affinity of the partially purified RNA polymerases for one of the 
nucleotide substrates was investigated. The apparent Km values for the three 
classes of enzyme was estimated using the Eadie-Hofstee method (Figs. 4.16,
4.17 and 4.18 for RNA polymerases I, II and III respectively). The Km values 
were estimated using regression lines of "enzyme activity/CTP concentration" on 
"enzyme activity". These revealed Km values for 0.01 mM, 0.02 mM and 0.06 mM 
for RNA polymerases I, II and III respectively. The Pearson coefficient of 
correlation values for these three regression lines of -0.68, -0.73 and -0.84 
for RNA polymerases I, II and III, Indicated that there was high negative 
correlation between "enzyme activity" and "enzyme activity/CTP concentration".
(">• 
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QIZYMI ACTIVITT/SUBSTRATE CONCENTRATION (fMlu[1H] UHF Incorporated into RMA/SO p\ allquot/15 ■ln)/(nM)
fit». 4.16 - 4.18 Apparent Ka values for CTP of partially purified RNA polymerases from 
yaasc form C. albicans
The 3 classes of RNA polymerase from yeast form C. alblcana were 
partially purified, as described la 4.2.%. Duplicate 23 jul aliquots 
of RNA polymerase I (containing approximately 6 protein) (Pig. 4.16), 
RNA polymerase 1Z (containing approximately 10 ¿jg protein) (Pig. 4.17) 
and RNA polymerase IZZ (containing approximately 70 ¿jg protein) (Pig. 4.19. 
ware Incubated la 1 0 0  >il total volume of assay "cocktail" were as 
described In Z 9  1. section, with the exception that "cold" UTP 
was present at a concentration of 0.01 <m and CTP at final concentration 
of 1 m . 0.3 rn. 0.1 rn, 0.03 rn and O.Ol m . RNA polymnraae activity 
was measured by the Incorporation of [3h ) UMP into TCA insoluble 
material over a 13 min incubation period at 23® C.. The figures show 
the Radio Hofstae plot method used to determine the Km. Regression 
lines were determined using the statistical methods described In 2.R.1 .
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ENZYME ACTIVITY/SUBSTRATE CONCENTRATION 
(fsolas C M  IMP Incorporated Into RNA/50 pi allquot/15 aln)/(aM)
ENZYME ACTIVITY/SUBSTRATE CONCENTRATION (faoles(3H) IMP Incorporated into RNA/30 pi allquot/15 nln)/(s«)
/4.3.14
4.3.15
4.3.16
4.4
4.4.1
Partial purification of mycelial form. RNA polymerase
Essentially similar procedures were used to partially purify RNA poly­
merase from mycelial form C. albicans. As noted in section 4.3.1, Table 4.2 
shows the total activity, protein and specific activity of the RNA polymerase 
to the stage after gel filtration.
Gel filtration of mycelial form RNA polymerase
The fraction F^AS precipitate was layered onto an agarose A-5 M column 
as described in 2.8.3. Fig. 4.19 shows a typical result obtained of gel 
filtration of the F^AS precipitate fraction. Optimal RNA polymerase 
activity, assayed as described in the legend of Fig. 4.19, was found in 
fractions eluting after the void volume. This implied the polymerase had a 
slightly smaller molecular weight than the exclusion molecular weight of 
5 x 106.
Ion exchange Chromatography of mycelial form RNA polymerase
The ammoniun sulphate precipitate, derived from Fraction F^, was dialysed 
as described in 2.8.4. Fig. 4.20 shows the result obtained when this fraction 
was chromatographed on DEAE-sephadex. One peak, of low activity, was found 
eluting from the column when the salt concentration of the buffer was 0.225 - 
0.25 M KC1.
Discussion
Purification of RNA polymerases from yeast form C. albicans
The three RNA polymerases from yeast form C. albicans were purified to 
electrophoretic homogeneity for the first time. The combination of techniques 
used to achieve this had previously been successfully employed to purify RNA 
polymerases from S. cerevlslae and H. capsulatum (see 4.1). The 
enzyme activity at each stage of the purification (see Tables 4.1 and 4.2).
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Fig. 4.19 Cal filtración c
5 5
The anmonium sulphate praclpltata of fraction F^ , containing 30 mg proteln/ral, 
was applied to an agarosa a-5 M column. Tha column was than alutad with Hagar's 
buffar A containing 0.1 M (NH^J^SO^. Tha transmit tanca, at 240 no, of tha aluant 
( —  • —  ) was racordad using a Uvlcord scannar. Twenty two 5 ml fractions wara 
collected. Salactad fractions wara assayad for RNA polymerase activity la a 
"cocktail" containing 10 tt* MgCl2 and 100 oM KC1, as described In 2.5.2. Tha 
activity of duplicate 50 ul aliquots was measured by incorporation of [3h } UMP 
into TCA insoluble material over a 5 rain incubation period at 25° C. ( ),
Tha error bars refer to tha standard deviations of duplicate measurements.
KCI CONCFNIRAfl«N (H)
Fig. 4.20 Ion aachanga chro
FRACTION
tatograpny of fraction F. from mycelial for
Tha amonlua sulphate praclpltata of fraction Fj, containing 40 mg protein 
(dialysed as described la 4.2.3,), was appllad to a DtAX-Sephade« A-25 coluan.
Tha column was washed with Hagar's buffar I, containing 0.02 N KCI, followed by 
olutloa with a 100 ml gradient of 0.02 • 0.4 M KCI ( - - ->. one hundred and 
fifty 0.5 ml fractions wara collected. Selected fractions ware assayad for RNA 
polymerase activity In a "cocktail" containing 10 and KCI at a
concentration of 100 t«, as described in 2.5.2. The activity of duplicate 50 >U 
aliquots was measured by tha incorporation of into TCA insoluble material
over a 15 min Incubation period at 23° C. ( —  ). The error bars refer to
the standard deviations of duplicate measurements. Tha transmittance of the 
eluant was recordad using a Uvlcord scanner < —  a — ).
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was measured using different assay conditions to those found to give optimal 
activity in vitro in nuclei (3.3.7). Higher levels of C14C] UMP incorporation 
into RNA were found when nuclei were incubated in a "cocktail" containing 
100 mM compared to 10 mM MgClj. Cell—free extracts, prepared from either mor­
phological form of C^_a_lbicaiis, showed optimal JLn_^^tr^ RNA polymerase activity 
at a MgCl2 concen*:ration of 10 mM (Fig. 4.1). This finding is in agreement 
with other workers, with MgCl2 concentrations of 3 - 20 mM required for optimal 
in vitro activity in RNA polymerases, from a wide range of prokaryotic and 
eukaryotic sources (310).
It is almost axiomatic to state that the first step in the purification
of any nuclear protein from such an organism as C. albicans requires methods
to disrupt the fungal cell wall and membrane. The results shown in Table 4.3
indicate that the most suitable method for disruption of C. albicans cells
was that described by Kumar et al (203) i.e. homogenisation with ballotini.
_  ?Although compression by 90 - 100 Nmm is believed to result in disruption of 
S. cerevisiae (105), it is evident that greater pressure than that used was 
required to disrupt C. albicans cells. Thus, cell-free homogenates of 
C. albicans were prepared by 3 min treatment with ballotini. Homogenisation 
for longer lengths of time resulted in less recoverable RNA polymerase activity. 
This presumably arose as a consequence of heating the homogenate by 
friction of the ballotini on shaking and the disruptive influence of proteases. 
(Although a jet of CO^ was used to cool the apparatus, some skill was required 
to prevent the homogenate freezing or overheating).
Proteases and RNases are two enzymes which interfere, in the initial 
stages, with the RNA polymerase and hence the measurement of enzyme 
activity. The action of proteases should be minimised by the addition of PMSF 
to the buffer (PMSF is a potent inhibitor of serine proteases, but it is 
believed to interfere with transcription - see 3.4.3). The addition of calf 
thymus RNA to the "cocktail" used to measure RNA polymerase activity, resulted 
in an increase in the amount of label incorporated into RNA^over an incubation
- 119 -
period of 5 min (results not shown). However, this practice was abandoned 
when it was realised that, especially in cruder preparations of commercially 
available RNA, other ill-defined contaminants would be present. A probable 
example of the destructive effects of the proteases on the enzyme activity 
is illustrated in Fig. 4.2. This figure revealed that RNA polymerase activity 
in the homogenate, kept at 25° C. for 90 min, was negligible, and reduced by 
half when kept at 0 - 4° C. for the same period. The addition of bovine serum 
albumin to the homogenate also appeared to enhance the stability of RNA poly­
merase activity. Gel filtration presumably removed the destructive protease 
and RNase enzymes. Generally these proteins have much lower molecular
weights than the RNA polymerase containing fractions - typical molecular 
weights of RNases and serine proteases are 15,000 to 30,000 (219,245 )» Thus, 
the initial steps in the purification, i.e. from the preparation of homogenate 
to gel filtration, needed to be carried out as quickly as possible.
RNA polymerases represent a small percentage of the total protein of a 
cell. Approximately 8 - 15 mg of RNA polymerase I, 20 mg of RNA polymerase II 
and 3 - 10 mg of RNA polymerase III may be purified from 1 Kg of yeast cells cf 
S. cerevisiae (see 1.3.3). As a comparison^the results shown in Table 4.1 
indicate 3.5 mg, 0.75 mg and 1.0 mg of RNA polymerases I, II and III respect­
ively would be purified from 1 Kg (wet weight) of C. albicans yeast cells.
Thus, obtaining sufficient quantities of RNA polymerase for characterisation 
experiments, and other studies, on the enzyme required cultivation of large 
amounts of the organism.
An attempt was made to optimise the yield of total RNA polymerase activity 
available from C, albicans growing in a given volume of growth media. Homo­
genates prepared from yeast cells in the late exponential phase of growth
g
(1 x 10 cells/ml medium) had the greatest amount of total RNA polymerase 
activity of cells harvested from 1 L of medium (Table 4.4). Measurement of 
the specific activity of the RNA polymerases present in crude homogenate 
prepared from the early (2 x 107 cells/ml), mid (5 x 107 cells/ml) and late
g
(1 x 10 cells/ml) exponential phase cells were not significantly different
from one another. This could indicate that there were similar levels of 
total (i.e. "bound" and "free") RNA polymerase activity, per unit cell, 
during the growth period. In contrast, the specific activity of RNA polymerase 
in crude homogenate prepared from yeast cells in the stationary phase of
g
growth.(i.e. 5 x 10 cells/ml) was much lower. This finding indicates that, 
during the stationary phase of growth, RNA polymerase activity per unit cell, 
was lower than that of growing cells. This confirms the results shown 
earlier in this thesis (see 3.3.2). It was reported that, in vivo, a greater 
level of RNA synthesis, per unit cell, was found in exponential phase cells, 
compared to those in the stationary phase of growth.
The lower specific activity in homogenate prepared from yeast cells in 
the stationary phase of growth could be accounted for by three factors. The 
lower specific activity may reflect lower levels of RNA polymerase enzymes 
per cell. Another possibility was that the assay conditions used to measure 
RNA synthesis did not measure optimal RNA polymerase activity in homogenates 
prepared from stationary phase cells. The third reason could be that in the 
stationary phase of growth specific classes of RNA polymerase could be inac­
tivated (such a phenomenon is not unknown and was briefly commented on in the 
introduction of this chapter).
An interesting finding reported in this chapter was that the specific 
activities of RNA polymerases in crude homogenate, prepared from mycelia and 
exponential phase yeast cells^were comparable (i.e. 0.22 units/mg protein 
and 0.18 units/mg protein for mycelia and exponential phase yeast cells 
respectively - see Tables 4.1 and 4.2 and Fig. 4.1). This indicates that the 
activity of the enzyme, as a proportion of total protein, was similar in 
mycelia to that in yeast cells growing in exponential phase. This statement, 
of course, assumes that in the homogenate a given quantity of RNA polymerase 
directs the synthesis of a given quantity of labelled RNA. (It should be 
noted that levels of proteases and RNases which may interfere with the 
perceived levels of RNA polymerase activity, may be different in homogenates 
prepared from exponential phase yeast cells and mycelial cells)
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Sonication of homogenate, in a high salt environment is now a favoured 
technique for the large scale purification of RNA polymerases. This is 
believed to result in dissociation of the RNA polymerase(s) from the DNA 
template. Measurement of the extent of "bound" and "free" enzyme, before and 
after this treatment, was measured as described by Yu (414). The rationale 
behind the assay was that the RNA polymerase activity that could be 
measured in the homogenate and/or sonicate using endogenous DNA template, 
represents the bound form of the enzyme. The activity in the presence of a 
defined template (i.e. poly [d(A-T)] ) represented the combined activity of 
both "bound" and "free" forms of the enzyme.. A measure of only the'free" form of 
the enzyme in the homogenate/sonicate was provided by inhibition of the "bound" 
RNA polymerase using actinomycin D. This compound intercalates with the DNA 
in G-C rich regions (284). RNA polymerase activity, which was poly fd(A-T)] 
template directed, would thus be unaffected. Table 4.5 shows that the 
addition of the drug to homogenate/sonicate transcribing endogenous DNA 
resulted in 75 - 807. inhibition compared to that untreated control.
C. albicans has a G-C content of the DNA of 357. (362). The low level of 
activity found when actinomycin D was added to either homogenate or sonicate 
probably represented transcription of A-T rich regions of DNA.
The proportion of "bound" enzyme did not markedly change after sonication 
(Table 4.5). However, "bound" RNA polymerase activity was much lower after 
high salt sonication than prior to treatment. This finding could be accounted 
for by two explanations. Firstly, loss of RNA polymerase activity could arise 
as either protease activity or through heating as a direct consequence of 
sonication. Secondly, there could be less affinity for the exogenous template 
shown by the previously "bound" enzyme. One of the assumptions made for the 
"bound" and "free" assay was that both forms of the RNA polymerase had equal 
affinity for endogenous template and poly [ d(A-T)]. The high salt conditions 
employed to dissociate the RNA polymerase from the endogenous DNA may not have 
allowed the enzyme to bind to the artificial template. Thus, the RNA 
polymerase dissociated from the endogenous DNA by high salt sonication
/may not be measured in an assay due to failure to bind and re-initiate to the 
same extent on the polytd(A-T)].
After sonication the homogenate was centrifuged to precipitate cell debris 
and unlysed cells. Although the bulk of RNA polymerase activity was found in 
the supernatant (i.e. fraction F.^ ), a small amount of activity was found in 
association with the precipitate (i.e. ppt). This probably represented 
mitaochondrial RNA polymerase and chromatin associated RNA polymerase that had 
not been dissociated by high salt sonication. Mitochondrial RNA polymerases 
are very tightly associated with membrane bound DNA. (Solubilisation of 
these complexes often requires treatment of the homogenate with a detergent 
(e.g. Triton X-100) with metal chelators(e.g. EDTA), high salt concentrations 
and, in some cases, DNase (215,333). As a consequence, one may expect the 
centrifugation step to remove most of the mitoc.hondrial RNA polymerases.
Nucleic acid was precipitated by the addition of the polyamine^ protamine 
sulphate. It has been reported that (NH^^SO^ concentration is critical in 
this stage of the purification for efficient recovery of the RNA polymerases. 
Below a concentration of 0.15 M Hager et al (14)) reported that RNA polymerase 
and DNA re-associated. This reduced the RNA polymerase recoverable after the 
protamine sulphate precipitation step. At concentrations greater than 0.16 M, 
the insolubility of the protamine sulphate led to entrapment of RNA polymerase 
molecules (141). After this stage only template-directed RNA synthesis could 
be measured, i.e. the assay "cocktail" required the addition of exogenous DNA 
for measurable incorporation of label into TCA insoluble material.
The gel filtration step (see 4.3.4 ) resulted in the separation of the
high molecular weight RNA polymerases from other components of the cell with 
different molecular weights. An analysis of scans made of UV transmittance 
indicated that most RNA polymerase activity was associated with those relatively 
few proteins of high molecular weights - slightly smaller than the exclusion 
molecular weight. This stage resulted in a fifty five fold increase in the 
specific activity of the RNA polymerase (i.e. from 0.02 to 1.15 units/mg 
protein). A small amount of RNA polymerase activity was associated with
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fractions eluting in the void volume. This may have represented small amounts 
of enzyme re-associating with the residual level of nucleic acid. After this 
stage the RNA polymerases were a good deal more stable than in the earlier 
stages of purification. Evidence for this is shown in the stability of the 
enzymes during long periods of dialysis when little loss of activity was 
observed.
Resolution of multiple nuclear RNA polymerases into three classes was 
achieved by ion exchange chromatography (see Fig. 4.4). The three peaks of 
RNA polymerase activity eluted from DEAE-sephadex were termed RNA polymerases 
I, II and III according to the procedure of Roeder and Rutter (311) and 
Blatti et al (33 ). The three peaks of activity were eluted when the buffer 
contained KC1 concentrations of 60 - 90, 90 - 200 and 240 - 290 mM for RNA 
polymerases I, II and III respectively. These values are similar to those 
reported for RNA polymerases from a wide variety of plants, animals and lower 
eukaryotes. If DEAE-sephadex is used to resolve RNA polymerases I, II and 
III from other eukaryotes, they are eluted from the column when the KC1 
concentration is 0.1 - 0.15 M, 0.17 to 0.25 M and 0.2 - 0.35 M respectively 
(138). Although three peaks of RNA polymerase activity were found, complete 
resolution was not achieved using the methods described in the legend of 
Fig. 4.5. Re-chromatographing fractions showing activity, after dialysis, on 
DEAE-sephadex, using a less steep KC1 gradient, resulted in negligible RNA 
polymerase activity eluting from the column. After ion exchange chromat­
ography most (647.) of the activity was RNA polymerase II associated with 
smaller amounts (347. and 27.) due to RNA polymerases I and III respectively 
(based on proportion of total activity after ion exchange chromatography).
Affinity chromatography was the next stage in the purification of RNA 
polymerases. This involved further purification of the RNA polymerases based 
on their affinity for DNA. The affinity shown by each isozyme was established 
as described in Table 4.6. Washing the bound RNA polymerase with buffer 
containing increasing KC1 concentration resulted in the "elution" of poly­
merases I and II at fairly low KC1 concentrations. In contrast, RNA polymerase
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III was very tightly bound, eluting only when the buffer contained a KC1 
concentration of 2.0 M. Hager et al (1411 reported that S. cerevisiae RNA 
polymerase III also appeared to bind very tightly to DNA cellulose. However, 
this group reported that this isozyme was eluted at a much lower KC1 concen­
tration of 0.45 M. This tight binding is thought to be a characteristic of 
the class III isozyme that is reflected in the resistance of the enzyme to 
high salt inhibition of activity>measured on native DNA (1 3Q).
When RNA polymerases I and II (Fractions and F^) were chromatographed 
on DNA cellulose, the relative position of elution for the enzymes was con­
firmed by ot-amanitin sensitivity of fractions. It was found that oc-amanitin 
resistance - at a concentration of 1 mg/ml - was associated with lead 
fractions (results not shown). (Surprisingly - see 4.4.2.-«-amanitin insen­
sitivity to this concentration of amatoxin was associated with RNA polymerase 
II). This indicated that RNA polymerase II was eluted from the DNA cellulose 
prior to RNA polymerase I. Figs. 4.5 and 4.6 show RNA polymerases I and II 
were eluted from DNA cellulose when the buffer contained 0.1 - 0.2 and 0.05 - 
0.1 M KC1 respectively. Hager et al have also commented upon a similar finding 
for RNA polymerases from S. cerevisiae (141). This group reported that DNA 
cellulose chromatography resulted in two peaks of RNA polymerase activity.
The second peak - as earlier mentioned - consisted of RNA polymerase III. The 
leading fractions of the first peak were enriched with RNA polymerase II, whilst 
the latter were mostly RNA polymerase I. RNA polymerases I and II from 
C. albicans seen to resemble those of S. cerevisiae in their elution from DNA 
cellulose.
The final stage in the purification of the three RNA polymerases from yeast 
form C. albicans, to electrophoretic homogeneity, was glycerol gradient cen­
trifugation (see Figs. 4.7, 4.8 and 4.9). As noted in 4.3.1, the specific 
activities of RNA polymerases I and II fell drastically after this step (i.e. 
from 7.52 to 0.68 units mg protein 1 and 15.61 to 1.17 units mg protein"1 for 
specific activities of RNA polymerases I and II respectively). Although the 
specific activity of RNA polymerase III did increase slightly (i.e. from 0.32 to
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0.75 units mg protein-1) measurable total activity had fallen dramatically 
after this purification step (i.e. from 110 units to 0.32 units). Kumar et al 
(203) reported that the RNA polymerases from H. capsulatum were very labile 
after the last step of purification, RNA polymerase I being the most labile.
In addition, the low specific activities reported may have occurred on account 
of the high glycerol concentrations in the incubation medium. High glycerol 
concentrations (as much as 307. (w/v) in some assays shown in Figs. 4.7, 4.8 
and 4.9) have been found to affect in vitro RNA polymerase activity (251). 
However, this stage resulted in the purification of the three RNA polymerases 
to electrophoretic homogeneity as judged by single bands migrating by non­
denaturing polacrylamide gel electrophoresis. The protein bands were stained 
using the very sensitive technique of Merril et al as only between 1 and 2 
i^g of protein were applied to each tube gel. In addition, fractions either 
side of the peaks of RNA polymerase activity, after the glycerol gradient 
centrifugation step, had similar specific activities - indicating that the peaks 
of activity corresponded to single proteins.
4.4.2 Characterisation of RNA polymerases from yeast form C. albicans
In order to catalyse the in vitro synthesis of RNA,eukaryotic RNA poly­
merases show absolute requirement for a DNA template, the four ribonucleoside
| | | |
triphosphates and a divalent cation. Most reports use Mg or Mn salt as 
the divalent cation source. (The requirement for these metals is believed to 
reflect binding of the cation to /& and & phosphates of the nucleotide during 
the initiation and elongation reaction (25) and see 1.3.4) The choice of 
divalent cation has been shown to affect the fidelity of RNA synthesis by all 
three classes of RNA polymerase. Sony and Hunt reported that the length of 
RNA transcribed by RNA polymerases I and II, from rabbit bone marrow erythroid 
cells, was shorter when Mg was used in preference to Mn (357). It has 
also been reported that RNA polymerase III directed synthesis of 5 S rRNA 
in vitro results in different lengths of transcript,depending upon the choice 
of divalent cation ( 2 ). The divalent cation may also Influence the structure
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of the DNA. It has been reported (306) that the conversion of B' DNA to Z DNA
| | I I
may be influenced by the concentrations of divalent cations Mn and Mg in 
the buffer. Other groups have also noted that the stability of nucleic 
acids and the stacking of the bases may be affected by these divalent cations 
(e.g. 57,226 ). In addition to binding Mn at the elongation site, it has 
been reported (198) that prokaryotic RNA polymerases have binding sites for 
divalent cations. These may play a role in stabilising the protein. As such, 
eukaryotic RNA polymerases almost certainly would have similar binding sites.
There have been some reports that other divalent cations may be used in 
the assay "cocktail" to support RNA synthesis by RNA polymerases. Vaisius 
and Horgen (382) found that RNA polymerase II from calf thymus and the
| t | |
mushroom Agaricus blsporus may use Co as well as Mn and Mg as activating
divalent cations. In an in vitro system such as T. pvrlformls nucleoli it
was recently reported that Co may support transcription of chromatin (181).
| | | |These divalent cations, in addition with Cd and Zn ( 10 ), have also been 
reported to be capable of supporting transcription of poly [d(A-T)J by E. coll 
RNA polymerase.
The optimum divalent cation concentrations for eukaryotic RNA polymerases
| |are generally in the range of 5 - 10 mM for Mg and 1.0 - 2.0 mM for 
| |
Mn (138). The partially purified RNA polymerases from yeast form 
C. albicans all had optima of 10 mM for MgCl_ (see Fig. 4.10). In "cocktails"
j |
containing 10 mM KC1, optimal concentrations of Mn of 0.5, 0.75 and 
0.75 mM were found for RNA polymerases I, II and III respectively (see Fig. 
4.11). At higher KC1 concentrations (100 mM) RNA polymerases II and III had 
optima for Mr^of 0.75 and 0.5 irM respectively (see Fig. 4.12). It should be 
noted that higher rates of in vitro activity - as measured by levels of f H 1 
UMP incorporated into RNA over 15 min at 25® C. - were found when the RNA poly- 
merases were incubated in "cocktails" containing Mn compared to Mg . This 
result is similar to that reported by Adman et al for RNA polymerases from 
S. cerevlslae (3 ). The divalent cation present, and the ionic strength, are
thus important factors in determining the activity of the RNA polymerase isozyme
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It has been suggested that the higher levels of RNA polymerase activity in 
the presence of Mn compared to Mg are due to Mn stimulating initiation
to a greater extent than Mg (269), This group reported that Mn preferen­
tially activated the initiation step of RNA polymerase I from Ehrlich ascites
I j | |
tumour cells whilst Mn or Mg was necessary for the elongation step. The
I |
inhibition by hi^i concentrations of Mn is thought to be due to inhibition 
of chain elongation.
In the presence of a divalent cation such as MgC^, purified RNA poly­
merase II from eukaryotic sources initiates non-specific RNA synthesis with 
low efficiency (1C4). The purified enzyme lacks one or more factors required 
for promoter recognition and efficient formation of an "open" complex with 
the DNA (see 1.3.4). In the absence of these factors, RNA polymerase, 
initiation of RNA synthesis may occur preferentially at "nicks" (216) and at 
single stranded regions (217). Supercoiled DNA may also provide a good sub­
strate for RNA polymerase II (214-) (Torsional strain in the molecule is
believed to facilitate "open complex" formation by the enzyme). As earlier
| |
noted, the presence of Mn enables non-specific initiation to occur. This 
may be enhanced by the presence of a salt such as (NH^^SO^ (231).
In addition to the requirement for a divalent cation, RNA polymerase 
activity is stimulated by inclusion of a monovalent ion. This is supplied in 
the form of salts such as (NH^^SO^, KC1 and NaCl. The effect of inclusion of 
KC1 in the assay "cocktail" on activity of RNA polymerases I, II and III from 
yeast form C. albicans is shown in Fig. 4.13. RNA polymerases I and II 
showed optimal activity when the KC1 concentration was 40 mM and 100 mM 
respectively. In contrast, RNA polymerase III showed a biphasic 
optima at 100 mM and 240 mM. The RNA polymerases were assayed using heat 
denatured calf thymus DNA as a template. RNA polymerases I, II and III, 
purified from S. cerevlsiae displayed optimal activity at 0.03 - 0.05 M,
0.05 - 0.1 M and a biphasic optima of 0.04 - 0.1 and 0.18 • 0.3 M salt con­
centration for the three enzymes respectively, when assayed using native DNA 
templates. The effects of ionic composition on RNA polymerase activity on
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naked DNAis markedly different from that on chromatin or in nuclei. The 
latter cases require higher salt concentrations to achieve optimum RNA poly­
merase activity. This is believed to be a property of the protein associated 
with the DNA template - possibly as a consequence of the chromatin "opening 
up" at such high salt concentrations (210) (see also 3.4.3).
The salt concentration of the assay "cocktail", like that of the divalent 
cation present, has been shown to modify transcription (411). The salt con­
centration and choice of template for RNA polymerase has been used as a method
• t <<
for quantitating the levels of the three classes of free polymerase enzyme 
(316). This group reported an assay specific for RNA polymerase II from 
S. cerevisiae based on that enzyme's ability, in the presence of MnCl^, to 
transcribe the ribohomopolymer polyfr(C)] . The levels of RNA polymerases I 
and II could be distinguished by transcription of poly fd(l-C)], using Mg"*-*" 
as the divalent cation. RNA polymerase III directed transcription of poly 
fd(l-C)] occurs solely at high ionic strength (0.1 M (NH^^SO^). This assay 
is thus able to discriminate between, and measure, the relative levels of 
each class of "free" RNA polymerases. Possibly the most well known method for 
discrimination between total activities of each class of RNA polymerase is by 
each isozyme's sensitivity to the fungal toxin 0(-amanitin.
It is accepted that, usually, the three classes of eukaryotic RNA poly­
merase exhibit differential sensitivities to oc-amanitin. This bicyclic 
octapeptide interacts directly with the RNA polymerase, inhibiting elongation 
of the RNA chain (397.)« In general^ animal, plant and lower eukaryotes show 
similar sensitivities to inhibition. RNA polymerase II from sources such as 
mice (3*0), wheat (179) and Dlctvostellum dlscoldlum (292) are inhibited by 
very low concentrations of ot-amanltin (i.e. in the range 0.01 - 0.1 /tg/ml).
It has been found that the site of very strong binding is the large subunit of 
RNA polymerase II - an analogue of which is present in all the isozymes found 
(397)* RNA polymerase I is usually not inhibited even by oc-amanitin concen­
trations as high as 1 mg/ml, certainly when isolated from X. laevls (310), Rye 
(179) and Bombyx morl (silkworm) (310). Eukaryote RNA polymerase III is usuall;
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inhibited by "intermediate" concentrations of «C-amanitin. Typical concen­
trations for total inhibition of this class of enzyme from calf thymus (395). 
Triticum aestivum (wheatgerm) (179) and Acanthamoeba castellani ( 91 ) all lie 
within the range of 5 - 20 /ig/ml.
In contrast to the general patterns of «.-amanitin sensitivities found for 
animal, plant and most lower eukaryotes, fungal RNA polymerases I, II and III 
display a number of uncharacteristic sensitivities to the toxin. For example, 
concentrations required for complete inhibition of S. cerevisiae RNA polymerase 
II of 1 jug/ml are ten fold higher than those for this isozyme from other 
eukaryotes (332). However, the main difference lies in the sensitivity of 
RNA polymerases I and III, from this organism, to «-amanitin. These isozymes 
are respectively inhibited by "intermediary" (i.e. 100 - 300 ^ ig/ml) and "high" 
(i.e. greater than 1 mg/ml) concentration of the fungal toxin (331). Such 
unusual findings are common in fungi. Unsurprisingly, RNA polymerases from 
basidiomycetes that are able to synthesise «<-amanitin (e.g. Amanita suballiacea 
and A. hygroscopica) are inhibited only by very high concentrations of the 
drug. The RNA polymerase activities are 190 - 340 fold more resistant than 
those of S. cerevisiae (182).
The oc-amanitin sensitivities of RNA polymerases purified from fungi 
appear to be the most unusual so far studied. RNA polymerases I and II from 
Aspergillus nidulans were not inhibited by oc-amanitin concentrations of 
400 jug/ml (366,367) RNA polymerases from both phases of H, capsulatum. 
another dimorphic funqus > have been reported to have unusual et-amanitin 
sensitivities (203). Yeast form RNA polymerase III was the most sensitive 
isozyme to the drug, requiring 1 ¿ig/ml for 507. inhibition. In contrast, RNA 
polymerase II was the most insensitive class requiring 1 mg/ml for 507. 
inhibition. RNA polymerase I required "intermediary" concentrations (i.e.
16 ^ig/ml) for 507. inhibition. It was found that the mycelial phase RNA poly­
merases were ten fold less sensitive to ot-amanitin than the corresponding 
yeast form enzymes. The «t-amanitin sensitivities of RNA polymerases from 
yeast form C. albicans reported here are similar to the "unusual" findings for
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other deuteromycetes (i.e. RNA polymerases I and II requiring 1 and 2 mg 
«.-amanitin/ml respectively for 507. inhibition with RNA polymerase III 
inhibited at concentrations of 200 ¿ig/ml) (see Fig. 4.14).
Evidence that o f-amanitin, at a concentration of 200 j j g / m l, affects RNA 
polymerase III directed transcription, in vivo.was provided in Fig. 4.15. It 
is apparent that, at the highest concentration of ot-amanitin tested, no 5 S 
and 4 S RNA species were synthesised by C. albicans. These are the transcripts 
synthesised by RNA polymerase III in eukaryote cells. Stationary phase yeast 
form C. albicans were chosen for this experiment as it is believed most RNA, 
synthesised by quiescent S. cerevisiae, is mostly 5 S rRNA and tRNA (see 273) •
The overall level of RNA synthesis is very low in stationary phase C. albicans.
32Thus, in order to obtain adequate amounts of C PJ labelled RNA, for agarose 
gel electrophoresis, the yeast cells were incubated for a long period of time 
(90' min) at 25° C.
A measure of the affinity of any enzyme for it's substrate may be given 
by the apparent Michaelis constant for that substrate (Km). The apparent Km 
for CTP of yeast form RNA polymerases I, II and III were found using the 
Eadie-Hofstee method (see Figs. 4.16, 4.17 and 4.18). Enzyme activity of the 
RNA polymerase was measured in a "cocktail" containing the substrates 0.5 mM 
ATP and GTP, 0.9 ^ uM UTP and 0.01 mM "cold" UTP. It has been reported
(187) that RNA polymerases have Km for substrate nucleotides in the range of 
0.01 - 0.08 mM. The levels of UTP in the assay "cocktail" were thus limiting. 
Low concentrations of UTP were used as dilution of the radio-labelled UTP with 
"cold" UTP resulted in a decrease in the level of incorporation of C n] into 
RNA, thus the "measurable" RNA polymerase activity appeared to decrease.
The Km for CTP of RNA polymerases I, II and III from yeast form C. albicans 
were estimated as 0.01, 0.02 and 0.06 mM respectively. The values reported 
here for RNA polymerases I and II were comparable to values of 0.015 mM 
reported for RNA polymerases from other eukaryotes (167). The value of Km for 
CTP of RNA polymerase III was slightly greater. It should be noted that very 
low c.p.m. were recorded when RNA polymerase III was incubated in the assay
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"cocktail" with limiting concentrations of CTP. The values for the Pearson 
coefficient of correlation for the Eadie-Hofstee plots indicated that there 
was quite high negative correlation between "enzyme activity" and "enzyme 
activity/substrate concentration" (i.e. values of -0.68, -0.73 and -0.84 for 
plots of RNA polymerases I, II and III respectively). Kes hgegian (187) 
reported that higher concentrations of purine nucleoside triphosphates (i.e. 
ATP and GTP) were required for half maximal RNA polymerase activity compared 
to the pyrimidine nucleoside triphosphates (i.e. CTP and UTP). (Values for 
Km of ATP and GTP of approximately 0.08 mM and for CTP and UTP of approximately 
0.015 mM were reported by this author) It has been found that the Km for 
initiating nucleotides is higher than the Km for nucleotides involved in 
elongation ( 8 ). The higher apparent Kms observed for purine nucleoside 
triphosphates may thus be related to their roles in initiation (188).
4.4.3 Preparation of RNA polymerase from mycelial form C. albicans
Only a partial purification of mycelial form RNA polymerase was achieved. 
Table 4.2 showed the total RNA polymerase activity t protein content and 
specific activities of the fractions from cell disruption to gel filtration.
Aji interesting result from the initial stages in the purification (i.e. homo­
genisation with balotini) was that only 94 units of RNA polymerase activity 
were recovered. This probably arose as a consequence of the low yields of 
mycelia when C. albicans was grown in G.B.E. medium. A measure of the low 
yields may be illustrated by the fact that 7.9 g of mycelia were harvested 
from 8 L of media.
It was noted that the specific activity of the RNA polymerases in the 
homogenate prepared from mycelia was similar to that of homogenate prepared 
from yeast cells in the exponential phase of growth (see 4.4.1). As puri­
fication of the RNA polymerases proceeded through high salt sonication, centri­
fugation and protamine sulphate precipitation, the measurable total RNA poly­
merase activity decreased. This result was similar to that achieved during 
the initial stages of purification of yeast form RNA polymerases (see Table 4.1)
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Gel filtration of the ammonium sulphate precipitate of revealed a peak of 
low activity was eluted from the column just after the void volume (see Fig. 
4.19). This indicated that mycelial RNA polymerase(s) had a similar M.W. 
to those from the yeast form. The specific activity of the RNA polymerase 
after this step, i.e. 1.3 units/mg, was similar to that of RNA polymerase.
It was found that omission of the protamine sulphate-nucleic acid precipitation 
step with the cell-free extract (i.e. gel filtration of fraction F^) resulted 
in approximately 30% of total activity eluting in the void volume. This could 
indicate that the conditions for precipitation of the nucleic acid resulted in 
entrapment of the mycelial RNA polymerase molecules. Hence, a large amount of 
RNA polymerase activity could be lost if the conditions for nucleic acid 
precipitation were not ideal. An alternative explanation may be that the enzyme 
could re-associate with nucleic acid as fraction F^ was eluted through the ag­
arose column. The buffer contained a (NH^^SO^ concentration of 0.1 M.
Hager et al (141) noted that at concentrations below 0.15 M (NH^^SO^ RNA poly­
merases and DNA were able to re-associate (see page 122).
Possibly the most surprising result obtained from the partial purification 
of mycelial form RNA polymerases was that only one peak, of very low activity, 
was found after ion exchange chromatography (see 4.3.16). This seems to be in 
complete contrast with assertions made earlier in this thesis (see 1.3.3) i.e. 
that eukaryotes possess three different classes of RNA polymerase. Boguslawskl 
et al (35), working with H. capsulatum yeast,reported that only one class of 
RNA polymerase - of low activity - was eluted from DEAE-Sephadex. In contrast, 
three classes of RNA polymerase were resolved by ion exchange chromatography of 
the mycelial form. Kumar et al (203) later reported that treatment of cell 
extracts from yeast H. capsulatum with Polymin P enabled three classes of RNA 
polymerase to be resolved. This group presumed that Polymin P precipitated the 
"factor(s)" responsible for concealing RNA polymerase activity. The presence 
of such "factors" in mycelial form C. albicans could explain the low RNA poly­
merase activity eluted. It should be noted that scans of fractions eluted 
from the DEAE-sephadex contained UV absorbing material. However, these 
fractions contained no activity significantly different from the background.
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Alternatively, the low total activity eluting from the DEAE-sephadex could 
arise as a consequence of the lability of the RNA polymerases.
It was noted at the beginning of this section that low yields of mycelia 
were obtained when C. albicans was grown in G.B.E. medium. This illustrates 
one of the major limiting factors on research with C. albicans mycelial form. 
Large volumes of media, with low cell densities are required, in order to 
cultivate mycelia. To obtain large quantities of mycelia - sufficient for 
further studies on RNA polymerases - a method for the large scale cultivation 
is needed. However, such large scale preparations must entail stringent 
safety precautions to guard against the much greater risk of contamination 
with the pathogen.
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CHAPTER 5 SOME STUDIES ON INHIBITORS OF RNA SYNTHESIS IN C. albicans
5.1 Introduction
The eventual aim of the investigations into RNA synthesis in C. albicans 
was to develop ideas for novel potential inhibitors of this fungus that had no 
effect on mammalian cells. Originally, these studies were to investigate 
the effect of a putative inhibitor on RNA synthesis by C. albicans 
in vitro (in nuclei and protoplasts) and in vivo (in whole cells). This com­
pound - lomofungin - has been shown to affect RNA synthesis in S. cerevisiae 
(205), probably by direct interaction with the RNA polymerase (55'). Studies 
were made on the effect of this drug against exponential phase growth of 
C. albicans yeast against RNA synthesis by protoplasts. The results and 
conclusions of this investigation are described in this chapter.
The effects of several novel potential inhibitors, from the ICI collection, 
against RNA synthesis in vivo and in vitro were investigated. RNA synthesis 
is a complex process that may be inhibited at several sites or stages. Indeed, 
the known inhibitors of RNA synthesis can, and do, act by a variety of mechan­
isms (e.g. intercalation by actinomycin D with G-C rich regions of the DNA 
( 31 ) or interaction with the RNA polymerase by various rifanycin derivatives 
(255)). One possible method for inhibition is by the use of substrate analogues. 
There are four nucleotides which are used as substrates by RNA polymerase (i.e. 
ATP, GTP, CTP and UTP). It has been noted that some substrate analogues are 
effective inhibitors of in vitro RNA synthesis (e.g. Seibert et al reported 
that Tubercidin triphosphate inhibited RNA polymerases I, II and III from mouse 
cells (340) ). However, nucleoside triphosphate analogues would be unable to 
cross the cell wall and membrane. In order to overcome this difficulty 
nucleoside analogues, which can cross the cell membrane via specific permeases^ 
(291 ) were chosen. The effic acy of 25 of these derivatives against in vitro 
and in vivo RNA synthesis was compared with other, known RNA synthesis
inhibitors.
/5.2 Materials and Methods
C. albicans A and B serotype (strains NCPF3153 and NCPF3156 respectively) 
and strains AB2, Leeds B2630 and 6406/8 were maintained and grown on 
Sabourauds dextrose broth as described in 2.3.3. S. cerevisiae strain CD40 
was grown and maintained on yeast extract peptone (YEP) broth; as previously 
described (2.4.1).
Protoplasts of yeast form C. albicans were prepared as described in 2.3.6, 
using Zymolyase 60,000 enzyme to remove the cell wall. RNA synthesis by 
protoplasts was measured by incorporation of [ H] uridine into TCA insoluble 
material, as described in 2.5.1. When required, lomofungin was added from a 
stock solution of 10 mg/ml (32 mM) in 5 mM NaOH. Measurement of RNA synthesis 
in vivo, using yeast form C. albicans was measured in the same manner as 
described for protoplasts. The effect of some known transcription inhibitors o 
nucleoside analogues on RNA synthesis by yeast cells in the exponential phase 
of growth, was investigated. When required, the test compound was added 
to the suspension of yeast cells from a stock solution of 12 mM in DMSO. RNA 
synthesis in vitro was measured in cell free homogenates of C. albicans 
NCPF3153. Homogenates were prepared, from yeast cells in the exponential 
phase of growth, using ballotini, as described in 4.2.1. RNA synthesis in vitro 
was measured as described in 2.5.2. When required the test compound was added, 
from a stock solution of 12 mM in DMSO, to the homogenate.
5.3 Results
5.3.1 Effect of lomofungin on C. albicans exponential phase growth
The effect of lomofungin, at various concentrations, on cellular growth 
by C. albicans is shown in Fig. 5.1. Lomofungin, at final concentrations of 
15 /ug (48 jiM), 30 yug (96 yum) or 100 yjg (320 yaM)/ml media, had no effect on the 
rate of exponential phase growth in Sabourauds dextrose broth at 37° C..
Under these conditions the yeast cells had a doubling time of 71 min as judged 
by the regression line of Log1Q (cell density)against time of incubation at 37° C 
The Pearson coefficient of correlation (r) was estimated at 0.95, indicating
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very high positive correlation between Log1Q(cell density) and time of incubation 
at 37 C.. The Log^Q(cell density) of aliquots of cell suspensions in the 
presence of the drug was not significantly different from that of the controls.
5.3.2 Effect of lomofungin on growth by several strains of C. albicans
The effect of lomofungin, at a concentration of 100 ^ ig/ml media, on growth 
of several strains of C. albicans is shown in Fig. 5.2. Under these conditions, 
all the strains of C, albicans exhibited doubling times of 71 + 3 min, as 
estimated by the regression line of Log^gtcell density) against time of incubat­
ion at 37° C.. The values for r, estimated at approximately 0.9 for all 
6 strains, indicated very high positive correlation between Log^fcell density
and time of incubation at 37° C. . The error bars refer to the standard
deviations for the six strains. Lomofungin, at a concentration of 100 ¿ig/ml
media, did not have an effect on exponential phase growth by C. albicans NCPF
3153, AB2, Leeds B2630, 6406/8 and NCPF3156 strains.
5.3.3 Effect of various concentrations of lomofungin on RNA synthesis by protoplasts 
of C. albicans
The effect of lomofungin, at various concentrations, on RNA synthesis by 
C. albicans protoplasts is shown in Fig. 5.3. RNA synthesis over an 80 min 
period was monitored by incorporation of C H] uridine into TCA insoluble 
material. Incorporation of label into RNA was linear over the 60 min period 
of 20 - 80 min after the addition of C H} uridine to the pre-incubated proto­
plast suspension. The rate of incorporation of 11 fmoles C^Hj uridine min * 
by 10^ viable protoplasts was estimated using the regression line of "pmoles 
of {3H] uridine incorporated by 10^ viable protoplasts" against "time of 
Incubation" over the period incorporation of label into RNA was linear The 
value for r, of 0.85, indicated there was high positive correlation between the 
two variables. The addition of lomofungin at concentrations of 
25 f ig (80/*M) on 100 ^ jg (320 jjM) per ml suspension did not have any effect on
Fig. 3.1 Efface of lonofungln at various concentrations on e^ O'p/.tlal phase growth by
c-
Inocula of C. alblcans NCFF3133 wara grown ln 3 al of S.D.B., aa descrlbed la 
2.3.3. At cha cali denslty lndlcatad ( 4° ), loaofunglo, aa a aolutlon ln 
3 =* NaOH, waa addad to final concantratlona of 13 ^ ig (44 yH O  ), 30 pg 
(46/uM A  ) and 100 >jg (320 ^ 1 9 ) par al aadla. Tha cali danalty of dupllcata 
allquots waa aaaaurad at varloua tlaaa bafora and aftar tha addlClon of eha 
drug uslng aa lmprovad Naubauar hamaocytoneter. Tha arror bara rafar to cha 
standard davlatlons for cha control (no drug addad * ).
Fig. 3.2 Effact of lomofungln at a concentration of 100 >ig/al on various strains of 
C. albicans growing la tha exponential phase of growth
Inocula of C. albicans strains NCPP3133, NCPT3156, AB2, Laads. B2630 and 6406/8 
strains «fare grown ln 3 al of S.D.B.. as described la 2.3.3. At tha call 
densities indicated ( 4» ). lomofungln, aa a solution Id 3 A  NaflM, was added 
to a final concentration of 100 >ig/nl madia (0-32 ott) to C. albicans strains 
NCPF3133 ( A  ). NCPF3136 ( Q  ), AB2 ( O ), B2630 < ♦ >, 6406/8 ( 9 ) and Usds 
( Jr ). Tha call densities of duplicate aliquots, bafora and after tha addition 
of tha drug, was measured using an improved Naubauar haaaocytonatar. Tha arror 
bars rafar to tha standard deviations of tha controls (no drug added).
5 *  [ft,ct °f 11 » « « ! » “ ■  cenc.ntr.ttop» on M *  m i M i l ,  b y  c. . i b l r . n .
protoplasts.
•' * » » «  >»r. pr.p.r.d .. d..c«b.d 1» 2.3.6. Th.
luap.o.lon ... ,..-l.a.6...d 1» protopl.at buff.r (toa.l velum. 8 « 1 with 
proa.pl.,. d.nalty of 7 . 10 vl.bl. proaopl..../.!) .. 3 7° c. for 60 mle. 
Lomofundln, .. . a.l„tlo„ ln j *, ... ..... t.
*"d 100 «'*» or dlr.r.l, a. , (J.i ^  .0 .,
40 >»Ci t H) uridine (specific activty 47.3 Cl/rmol) was added to each 
protoplast suspension and triplicate 0.3 nl aliquots removed aftar tha times of 
incubation shown. Radioactivity incorporated into TCA Insoluble material wa, 
measured as described in 2.5.1. Tha arror bars rafar to tha standard davlatlons 
of tha control (no loowfungin added).
TIM E or INCUBATION AT 23 C . ( m i n )
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incorporation of C H] uridine into RNA, compared to the control. Lomofungin, 
at a concentration of 1 mg/ml suspension (3.2 mM), had some effect on 
the rate of RNA synthesis by the protoplasts as 7 fmoles t h ] uridine were 
incorporated by 10^ viable protoplasts min 1.
5.3.4 Effect of lomofungin at a concentration of 20 ^ g/ml on growth of S. cerevislae
The effect of lomofungin at a concentration of 20 ^ jg/ml YEP medium 
(64 /jM) on growth of S. cerevisiae CD40 strain - as measured by increase in Log 
(cell density) - is shown in Fig. 5.4. The figure shows regression lines of
Logfo (cell density) against time of incubation for control cultures of 
S. cerevisiae. with a doubling time of 134 min. The value for r of
0.95 indicated high positive correlation between the two variables . Lomo­
fungin, at a concentration of 20 /jg/ml media, completely inhibited cell growth 
by S. cerevisiae.
3
5.3.5 Effect of some known inhibitors of transcription and nucleoside analogues on 
in vitro RNA synthesis by C. albicans
The effect of some known RNA synthesis inhibitors and nucleoside aralogues o 
in vitro RNA synthesis is shown in Table 5.1. The test compound was added, 
in a solution of DMSO, to the assay "cocktail" so that the final concentration 
of the drug would be 1 mM. RNA synthesis by homogenates of C. albicans, in the 
presence or absence of the test compounds, was measured over a 5 min incubation 
period. The addition of DMSO to the homogenate affected measurable RNA 
synthesis. It was found that without DMSO, 52 fmoles [3h ] UMP were incorporated 
by 50 /ul homogenate over a 5 min incubation period at 25° Cv compared to 28 
fmoles by homogenate when this solvent was added. Thus, the percentage 
inhibition of the test compound compared to control refers to controls contain­
ing the same volume of DMSO. It should be realised that only those compounds 
which showed inhibitory activity against RNA synthesis are included in this 
table. The structure of the nucleoside analogues showing inhibitory activity
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Fig. 5 . n Effect of iomofungin at a concentration of 20 >ig/ml on growth of Scerevl <:ae
Inocula of Scerevisiae CD40 strain was grown in 5 ml Y.E.P. brotn, as described 
in 2.4.1. At the ceil density indicated ( 4> ), iomofungin, as a so.uticn in 5  
SaOH was aaded to a final concentration of 20 ^ig/ml media (0- >_M ■ O  ). The 
cell density of duplicate aliquots at various tl=«s, both before and after tne 
addition of the drug, was estimated using an improved Seubauer naeaocytoneter. 
The error bars refer to the standard deviations of the duplicate aliouots. The 
figure also snows the increase in cell density of control cell cultures, with 
no lemofungin acded (- Pd —1 .
RNA polymerase activity Percentage
Test compound in homogenate inhibition
(IC1 compound (fmoles [3h] UTP incorporated/ compared to
number in brackets) 5 min/50 /il homogenate) control (“.)
(69619) IS F 6 11 + 1 55+10
(79053) 10 * 6 12-*-35
- % (79192) 13 + 2 1 5 + 3
3 U (92939) 2 * 1  3 + 3
(113796) 5 + 3 7 * 5 79 * 5
2 (113797) 2 + 4 9 + 4 91 + 17
(154391) 1 2 + 2  6 + 4 t>9 + 14
aphldlcolin lo9653) 9 + 2 13 + 2 ■>- r ~
cyclizldine derivatives
(95154) 0 + 3  0 + 3 ICO + 2
i , cycllzldlne derivatives
(95404) 7 + 1 5 + 3 -9 + 5
i  z zlncophorin (144235) 9 + 1  10 + 4 6 9 + 3
1 ! loraofungin
2 4 + 6  1 9 + 3 26 + 12
I » rifamycln AF/013 26 + 6 23 + 3
12 + 2
A rapamycln 1 0 + 7  7 + 3 71 + 7
control 29 + 2
Table 3.1 Effect of some known transcription Inhibitors t-m.\ analogues on
RNA synthesis ir. if?
Homogenates were prepared from C, albicans NCPF3153 yeast cells growing in 
exponential phase, as described In 4.2.1. 2C0/sl aliquots of homogenate were 
Incubated in 200 >il "cocktail", the components of which were present at the 
final concentrations described in <*.2.9. Test compounds. In OMSO, were added 
to a final concentration of 1 mM. Duplicate 100 pil aliquots ware removed after 
0 and 3 min incubation at 23° C. The radioactivity Incorporated Into TCA 
insoluble material was measured, as described In 2.3.1. The results of 2 
separate experiments are shown (Sstandard deviations) complete with the 
average percentage Inhibition compared to control (CMSO only added).
/\
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Test compound Radioactivity incorporated inhibition
(1CZ compound Into RNA (pmoles uridine compered to
ouaber in brackets) incorporated 0.3 «1 allquots/40 ein) control (l)
(69613) 0.15 ♦ 0.08 97
f
: % (73033) 0.09 ♦ 0.01 92
i i
H (79191) 0.31 +  0.01 74
(78192) 0.94 ♦ 0.10 29
(113797) 0.17 ♦ 0.01 36
(154391) 0.21 ♦ 0.03 92
aphldicolin (69633) 0.92 ♦ 0.04 22
eye 1 1 s idlne derivative
5 (93464) 0.60 ♦ 0.04 -9
ni ? zlncophorin (144255) 0.12 ♦ 0.03 90
H
lomofungin 0.02 ♦ 0 99
P
ri famycin Af/013 oo 91
rapamyc in 0.92 ♦ 0.08 30
control 1.19 ♦ 0.03
Table 5.2 iffscc of some <nowo transcription inhibitors an d.^ u W analogues er.
RNA synthesis in vivo
Yeast ceils of C. albicans NCPF3133 were grown to aid exponential phese of 
growth in S.D.B. (3 x 10' cells/nl media), harvested and washed as described 
in 2.3.3 . the yeast cells were then resuspended, to c.ne same ceil density, 
in 2 ml protoplast buffer and pre-incubated for 10 min at 37° C. The test 
compound was added in a solution of 31SO to a final concentration of 1 mM prior 
to the addition of 10 >iCl C^tOurtdlne (specific activity 52 Cl/maol). Duplicate 
0.3 ml aliquots were removed after 0 and «0 tin incubation at 37s C.. Radio­
activity incorporated was measured as described in 2.5.1. The error bars refer 
to the standard deviation of evo separata expenaents. The cable shows the 
average percentage inhibition cohered to control cultures (CMSO only added).
11378« 113787 138181
Fig. 3.3 Structure of analogues showing Inhibitory activity against In vitro or In vivo 8NA synthesis
c^
CYCLIZIDINE DERIVATIVE 
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F i g .  Ç . 6  Son* known I n h i b i t o r s  o f  RNA s y n t h e s i s
- ¡42 -
against in vitro RNA synthesis by C. albicans and also the structure of the 
known inhibitors of transcription are as shown in Figs. 5.5 and 5.6.
5.3.6 Effect of some known inhibitors of transcription and nucleoside analogues on 
RNA synthesis by C. albicans in vivo
The effect of some nucleoside analogues from the ICI collection and some 
known inhibitors of transcription on in vivo RNA synthesis by C. albicans is 
shown in Table 5.2. The test compound was added in a solution of DMSO to a 
suspension of yeast cells (harvested and washed whilst growing in the expon­
ential phase of growth) in protoplast buffer . The Table shows the effect 
of some of the test compounds on RNA synthesis - as measured by incorporation 
of [ H] uridine into RNA over a 40 min incubation period at 25° C. - compared
to controls (DMSO only added). DMSO, at concentrations of 107,, did not inhibit 
3incorporation of C H] uridine into RNA bv C. albicans yeast cells in vivo.
The structure of the nucleoside analogues showing inhibitory activity against 
RNA synthesis in vivo by C. albicans is shown in Fig. 5.5. The structure of 
the known inhibitors of transcription used in this research is shown in 
Fig. 5.6.
5.4 Discussion
5.4.1 Studies using the inhibitor lomofungin
Lomofungin has a broad antifungal and antibacterial spectrum, active 
against yeasts and other fungi and both gram positive and gram negative 
bacteria (184). Kuo et al reported that, at a concentration of 5 pg/ml, 
lomofungin markedly and rapidly inhibited RNA synthesis by S. cerevisiae proto­
plasts (2Ci). In a later paper the same group reported that the antibiotic 
prevented RNA synthesis by direct interaction with the RNA polymerase and not 
with the template or substrate ( 55). (It has been postulated that lomofungin 
inhibits this enzyme by coordination with a divalent metal ion to the zinc 
at the RNA polymerases active site (282) ). Thus, it did not seem
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unreasonable to expect that this drug would have affected growth of 
C. albicans by inhibition of RNA synthesis. However, as shown in Figs. 5.1,
5.2 and 5. 3, lomofungin at concentrations as high as 100 jjg/ml did not affect 
either cellular growth by the six strains of C. albicans used or RNA synthesis 
by protoplasts. In contrast, growth of S. cerevlsiae was completly inhibited 
by 20 _/ug lomofungin/ml YEP media (Fig. 5.4). Thus, lomofungin was active 
against S. cerevisiae but not C. albicans. This is in agreement with Johnson 
and Dietz (184), who reported that growth of C. albicans A and B serotypes 
were only inhibited by concentrations of lomofungin of 1 mg/ml.
It is possible that different species of fungi will show differ­
ential sensitivities to a drug. However, when examining experimental approaches 
to fungal chemotherapy and drug discovery and evaluation, a few pertinent 
points should be borne in mind.
Any method for testing the efficacy of a compound requires a method 
for measuring its inhibition against the test organism. Attempts to find the 
lowest concentration of the test drug - in this case lomofungin - which resultec 
in inhibition were made initially by adding increasing concentrations of the 
drug to growing cultures of C, albicans. Cell growth was estimated by direct 
observations of aliquots of cells under the light microscope using an improved 
Neubauer haemocytometer. Obviously a method for large scale screening of test 
drugs would require a less time consuming approach. Such an end is usually 
achieved by a program such as broth or agar dilution (i.e. dilution of the test 
compound in liquid or solid growth) media or agar diffusion (i.e. diffusion 
of the test compound from a reservoir). Inhibition of growth is measured by 
the absence of colonies of the organism growing in/on the media.
An important consideration when investigating potential inhibitors and/or 
their mode of action is that the test compound will be soluble in the media 
chosen for growth. The initial studies on the inhibitor lomofungin used a 
stock solution of lomofungin in 5 mM NaOH. It was reputed that the drug was 
soluble under such conditions ( 30 )• Many antifungal agents are 
soluble in organic solvents. Indeed, when examining the effects of nucleoside
/ >•
analogues, and other known inhibitors of transcription on in vitro and in vivo 
RNA synthesis, the test compounds were dissolved in DMSO. Other solvents 
commonly employed are dimethylformamide, acetone, ethanol and polyethylene­
glycol (318). The growth media for cultivating the organism should allow free 
growth, but should not possess constituents which could antagonise the anti­
fungal activity of the compound (see 1.2.5). It has been reported that fungi-
|_ | |cidal action of lomofungin may be affected by Cu and Zn (262). Thus, the 
content of these metal ions in an undefined media, such as peptone broth, 
could have an effect on the inhibitory action of lomofungin. However, as 
growth by S. cerevisiae in a similarly ill-defined peptone broth was completely 
inhibited by lomofungin at 20 jug/ml, another mechanism must account for the 
differential sensitivity of these two yeast species.
When lomofungin was added, to a concentration of 3.2 mM, to C. albicans 
protoplasts, the rate of in vitro RNA synthesis was inhibited 367., compared 
to controls (see 5.3.3). In contrast, RNA synthesis in vivo was inhibited 
997. by lomofungin at a lower concentration of 1 mM (Table 5.2). One factor 
that may account for this differential sensitivity may be the solvent the drug 
was dissolved in. This can have an important bearing on the inhibitory 
action of the drug. DMSO does enhance the susceptibility of some organisms 
to antifungal drugs by increasing the permeability of the cell membrane to 
certain molecules (322). Other factors, such as the size of fungal inoculum 
and also the morphological form are important when trying to evaluate the 
effects of potential inhibitors. In addition, the incubation conditions can 
affect the susceptibility of an organism to inhibition. As fungi are aerobes, 
the conditions for cultivation should allow adequate aeration. This was prov­
ided by the use of an orbital shaker.
5.4.2 Inhibitors of in vivo and in vitro RNA synthesis
Investigations into the efficacy of several known inhibitors of RNA synth­
esis and nucleoside analogues from the ICI collection against in vivo and
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in vitro RNA synthesis are contained in this chapter. The test compounds were
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added, in DMSO,to the assay mixture to a final concentration of 1 mM. Such a 
high concentration was chosen as this would establish whether the test compound 
did inhibit RNA synthesis and warrant further investigation.
One of the problems in using DMSO as a solvent for the test compounds was 
that it was found to inhibit in vitro RNA synthesis by C. albicans homogenates. 
Other groups have commented on this phenomenon (268), believing that the 
solvent decreases the RNA polymerase - DNA interaction. However, contradictory 
findings have been reported which suggest that DMSO has no effect, or even 
stimulates RNA polymerase activity (228). In contrast to in vitro RNA 
synthesis, the addition of DMSO had no effect on RNA synthesis in vivo by 
yeast C. albicans in the exponential phase of growth (see 5.3.6).
The results of the efficacy of test compounds against in vitro and in vivo 
RNA synthesis was as shown in Tables 5.1 and 5.2. In many cases there was a 
discrepancy between the effectiveness of the test inhibitor in vitro and 
in vivo. For example, nucleoside analogues 78192, 82939 and 113786 and 
aphidicolin, the cyclizidine derivatives 95154 and 95464 and rapamycin all 
had a greater inhibitory effect on in vitro RNA synthesis than in vivo. One 
reason for this may have been that these inhibitors had difficulty crossing 
the cell wall and membrane. Nucleoside analogues 113787 and 154391 had 
similar efficacies against in vitro and in vivo RNA synthesis by C. albicans. 
This indicates that these two compounds were not affected by the cell wall and 
membrane in their ability to inhibit RNA synthesis. It was found that some 
nucleoside analogues had greater inhibitory activity against in vivo RNA 
synthesis compared to in vitro (i.e. 69619, 78053 and 78191). In addition, 
lomofungin, rifamycin AF/013 and 144255 showed greater efficacy against RNA 
synthesis in vivo than in vitro. These results show that, for greater percent­
age inhibitory effect against RNA synthesis in C, albicans, the undamaged whole 
organism was required. There could be several explanations to account for 
these findings. Firstly, particularly in the case of the nucleoside analogues, 
the compound could be metabolised to more potent inhibitors such as direct 
substrate analogues (c.f. 5-fluorocytosine, see 1.2.5). Secondly, if the
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inhibitor affected a particular stage of RNA synthesis, such as initiation, 
then in vitro RNA synthesis - often cited as mostly elongation of in vivo 
initiated chains (see 3.4.3) - would not be affected. This would explain 
the preferential activity of rifamycin AF/013 against in vivo RNA synthesis 
compared to in vitro. Thirdly, the test compound may affect RNA synthesis 
as a consequence of inhibition of other metabolic process. The action of a 
compound such as 144255, an ionophore, may account for such a phenomenon.
It should be noted that this compound also affects in vitro RNA synthesis. 
Thus, other mechanisms must account for the ability of 144255 to inhibit 
RNA synthesis. The finding that lomofungin was more effective against 
in vivo RNA synthesis by C. albicans than in vitro, seems somewhat surprising. 
This compound, as noted in 5.4.1, is purported to inhibit RNA synthesis by 
direct action with the RNA polymerase. This finding could possibly be 
explained by the action of the drug against other proteins or components 
involved in transcription as well as the RNA polymerase.
One of the problems encountered, when "screening" such compounds as 
uridine analogues for their efficacies against in vitro RNA synthesis, was 
that there was low measurable radioactivity incorporated into TCA insoluble 
material. Unfortunately, such a phenomenon was an integral part of the 
assay as DMSO has an affect on RNA polymerase activity. (The DMSO was 
necessary as a solvent for the test compound). In addition, the crude homo­
genate does contain enzymes such as proteases and RNases, which have a 
destructive effect on measurement of RNA polymerases (see 4.4.1). Thus, a 
more accurate assessment of test compounds in vitro efficacy could be gauged 
using partially purified RNA polymerases. This would indicate whether the 
test drug had any effect against RNA polymerase action. However, inhibition 
of RNA synthesis in vitro is no guarantee of inhibition of this process 
in vivo. This ought to be borne in mind when attempting to design drugs 
that inhibit this biochemical process.
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CHAPTER
6.1
6 THE INVOLVEMENT OF RNA SYNTHESIS IN THE YEAST - MYCELIAL TRANSFORMATION 
OF C. albicans 
Introduction
Investigations in the 19th century revealed that, microscopically,
C. albicans sometimes appeared as ovoid budding yeast cells, sometimes as 
mould-like hyphae. Audrey established that these forms arose from the same 
organism and the predominant form observed was dependent on the growth medium 
(12 ). Rarely has such a simple observation caused such a confused and contra­
dictory literature as dimorphism in C. albicans. Dimorphism may be defined as 
the reversible interconversion between the yeast-like and filamentous forms.
The phenomenon of dimorphism is of interest for two reasons. Firstly, there 
is the view that mycelium formation may be correlated with the pathogenicity 
of C. albicans. However, conflicting evidence implicating yeast (301), mycel­
ial (2e9) or indeed both forms (372), as the virulent entity has tended to 
confuse rather than clarify the situation. Secondly, the regulation of cell 
divergence remains a basic and poorly understood problem in development biology. 
As a dimorphic fungus, C. albicans presents a suitable model to study this 
problem.
Extensive research has been undertaken by many groups over the past 100 
years to achieve a greater understanding of dimorphism. Research into the 
environmental factors that have been considered to affect C. albicans 
morphogenesis has resulted in many stimulants being advocated. These may 
promote either yeast-like or mycelial growth (e.g. see 278 ). The 
importance of temperature ( 6 6 ), inoculum density ( 8 9-), media compo­
sition (''0) and strain variation (248) have been widely reported. Also, 
several specific stimulants have been reported as being capable of inducing 
the formation of mycelia. These include low Znconcentrations (406 ), C o 4”4- 
(275) and Fe4 "4 (207) salts, amino acids such as proline (84) and the
hexosamine N-acetyl glucosamine (NAG) (349). However, attempts to define a 
single, universal environmental stimulus have foundered as many of the results 
have often been confused and contradictory.
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In contrast to those reports on environmental factors, biochemical studies 
of the differences between the yeast and mycelial forms have been more fruit­
ful. These have contributed much to the understanding of dimorphism. Initial 
biochemical studies were carried out by Nickerson's iroup (274). These workers 
believed that the morphology arose from an interplay between cellular growth 
and cellular division and how this affected the cell wall — the principal 
determinant of cell shape . Biochemical comparisons have generally revealed 
quantitative differences between the two forms (e.g. in content of membrane 
(20) and cell wall ( 23) ). In addition, some enzymes concerned with the 
relative levels of these components have been found to differ markedly in the 
two forms (e.g. Chitin synthetase ( 7 2 ) ).
More recent studies on C. albicans dimorphism have been focussed upon 
germ tube formation. Germ tubes are the initial morphological form observed 
during the yeast-mycelial transformation and may be identified as cylindrical 
outgrowths of new cellular material from any point on the yeast's surface 
(see 1. 2.2). A variety of complex media may induce germ tube formation.
Germ tubes may also be induced from starved or stationary phase cells when 
incubated in buffer containing NAG (349) or glucose plus glutamine (glu plus 
gin) (345) at temperatures above 35° C.. Under these conditions it has 
been reported that there is extensive RNA and protein synthesis (345).
Strain variation is an important parameter in the ability of C. albicans 
to form germ tubes. It was with this point in mind that studies on germ tube 
formation were made, using a wild type strain, i.e. NCPF3153. This 
strain was obtained from a clinical isolate. As such^ it is probable that 
this strain is similar, in many respects, to wild type strains used by other 
groups working in this field. How valid such a prediction was in the light 
of the results presented in this chapter will be discussed.
Initial studies examined the effects of a buffered solution containing 
"complex" (l.e. serum) or "simple" (i.e. NAG) stimulating agents on germ tube 
formation by C. albicans NCPF3153. The effect of other "simple" stimulating 
agents, such as glucose plus glutamine (glu plus gin), on germ tube formation
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by this strain of C. albicans was also examined. A range of concentrations of 
these different stimulating agents were examined for their effects on germ 
tube formation and cell growth by buffered yeast suspensions.
The total RNA and protein content of the yeast, incubating in germ tube 
inducing conditions, was monitored. This was done to investigate whether the 
levels of these macromolecules changed during germ tube formation. De novo 
RNA synthesis was monitored by incorporation of labelled uridine into TCA 
insoluble material. The effect of altering the concentration of the different 
stimulating agents on RNA synthesis was investigated. This would indicate 
whether there was any correlation between the level of stimulating agent, in 
the buffer, and RNA synthesis by the yeast. The effects of several RNA and 
protein synthesis inhibitors on both germ tube formation and RNA synthesis were 
investigated. This would confirm that RNA synthesis was necessary for germ 
tube formation and not merely accompanying this phenomenon. The RNA species 
synthesised could give an insight into the RNA polymerase isozymes involved in 
germ tube formation. It was with this in mind that RNA synthesised during 
this process, either or [.^C1 labelled, was analysed by standard electro­
phoretic techniques.
The conclusions that were drawn from the results shown in this chapter 
will be compared with those found by other workers. Also, this chapter will 
discuss how valid such a comparison is.
6.2 Materials and Methods
6.2.1 Organism and growth conditions used
C. Albicans A serotype (strain NCPF3153) was used in all experiments 
reported in this chapter. The yeast cells were cultivated in S. and S medium 
and stored in phosphate buffer, as described in 2.3.3. The thick cell sus­
pension was kept at 0 - 4° C. , for at least 24 hr, in order to starve the cells 
prior to induction of germ tubes.
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6.2.2 Germ tube formation by C. albicans
The method used for inducing germ tubes from the strain of C. albicans 
used in this chapter was based on that described by Shepherd and Sullivan 
(346). The thick cell suspension, prepared as described in 2.3.3, was diluted 
in 20 mM imidazole HC1 buffer pH 6 . 6  containing 0.2 mM M n C ^  (imidazole buffer) 
to give a cell suspension with a final cell density of 1 x 10^ - 5 x 10^ cells/ 
ml buffer. When required,human serum, N-acetyl glucosamine (NAG), glucose 
(glu) or glucose plus glutamine (glu plus gin) were present in the cell sus­
pension at final concentrations indicated in the legends of the figures in the 
results section of this chapter. The cell suspensions were then incubated at 
37° C. for the lengths of time indicated in the legends. The formation of 
germ tubes was assessed by light microscopy (x 400 magnification) of samples 
of the cell suspension removed at various times during the incubation. Cell 
growth during germ tube formation was monitored by changes in O.D. of cell 
suspension. Measurements were made of the O.D. using a Pye-Unicam SP500 
spectrophotometer.
Protein and RNA content of the cells were estimated using methods based 
on those described by Lowry et al (224) and Schnieder (330) as cited in 2.6.3 
and 2.6 .2 respectively.
6.2.3 Measurement of RNA synthesis during germ tibe formation
RNA synthesis by C. albicans during the yeast-mycelial transformation was 
measured by incorporation of H^H] or uridine into RNA. The precursor
was added to cell suspensions of C. albicans incubating at 37° C., as sub­
sequently described in the legends of the figures. Incorporation of label 
into TCA insoluble material by duplicate aliquots of cell suspension was 
measured as described in 2.5.1.
6.2.4 Extraction and analysis of RNA synthesised during germ tub« formation
The RNA synthesised by C. albicans during germ tube formation
-  1 5 1
was radioactively labelled with either uridine or c 32o  (as sodium
orthophosphate). Typically 10 jiCi of £ 41^ - c] uridine or 5 - 25 yuCi of 
sodium C 32p 3 orthophosphate were added per ml of C. albicans yeast cell sus­
pension incubating as described in 6.2.3. The labelled RNA was extracted 
as described in 2.7.1. The extraction buffer contained 0.5 mg C. utllis 
RNA/ml solution in order to obtain a visible nucleic acid precipitate after
.14 .the ethanol cooling step. RNA containing £ Cj uridine was analysed by poly­
acrylamide gel electrophoresis without a DNase treatment step. The RNA
was analysed on 2.57. polyacrylamide/0.57. agarose composite tube gels, as
32described in 2.8.1. [ P] labelled RNA was extracted as described for the
,14 .[. CJ labelled RNA, with the exception that the nucleic acid was DNAse treated, 
as described in 2.5.4. The RNA was then precipitated as described in 2.7.1 
and analysed by agarose gel electrophoresis, using 1.37. agarose slab gels as 
described in 2.8.1. The position of the labelled migrating RNA was visualised 
by autoradiography using 8- sensitive photographic plates. These were devel­
oped as described in 2.8.9.
6.3 Results
6.3.1 Pretreatment of C. albicans for germ tube formation
Table 6.1 shows the effect of the growth medium used, and the cell density 
of inocula, on the ability of yeast to form germ tubes. In order to obtain 
reproducibly high percentages of cells with germ tubes, it was necessary to 
grow the cells for at least 50 hr in S. and S. medium. The yeast cells were 
then starved for at least 24 hr at 0 - 4° C.. In addition, it was necessary 
to use small inocula of cells - i.e. l x  10^- 5 x 10^ cells per ml buffer. It 
was found that imidazole buffer containing 27. serum enabled all the cells to 
possess germ tubes after 6 hr incubation at 37° C. when these preconditions 
were met. (If the C. albicans strain used in this research was grown in S. and 
medium for only 20 * 30 hr - followed by starvation at 0 - 4°C. - then the 
cells did not form germ tubes).
-  1 5 2  -
Media used to 
cultivate cells
Cell density of inocula on dilution in buffer containing sérias
5 x IO7 cells/ml 5 x 106 cells/ml 5 x 105 cells/ml
S.O.B.
S. and S. medium 10X ibi 100X
Table 6.1 Growth media and Inoculum density on ability of C. albicans to form zerm tubes 
Yeast cells of C. albicans were grown in either S.D.B. or S. and S. medium 
and stored as described in 2.3.3. Aliquots of the cell suspension were 
diluted in imidazole buffer containing 2?. serum, to the final cell densities
Indicated in the table, 
cells with germ tubes wa
After b hr incubation at 37 C., the percentage of
i estimated by light microscopy ( x ¿00 magnification).
Fig. 6.1 effect of varying serum content of imidazole buffer on ger*a tube formation by
1-. lumai
Yeast cells of C. albicans were grown in S. and 3. medium as described in 2.3.3. 
After starvation for lU hr, samples of the cells were diluted, in imidazole buffer, 
to final call densities of 2 x 105 yeast cells/ml. ôerura was present in the buffer 
at final concentrations of 5", (— ), 2". ( -• ), 0.5?. ( m  ) or 0. 257. ( ♦ — )
The percentage of cells with gem tubes, in these buffered media at the times 
indicated in the figure, was estimated by light microscopy ( x ¿00 magnification). 
The error bars refer to the standard deviations of estimates of percentage numbers 
of cells with germ tubes, when duplicate aliquots were removed from the suspension 
incubating at 37°C.. The absorbance at o50 nm, of yeast cells Incubating in 
buffer containing 57. (- ^ -), 2% ( - O  —  ), o.57. ( - O —  ) or 0.257. ( - O  - ) serum 
was monitored over a 22 hr incubation at 3;°C.. The error bars refer to the 
standard deviations of duplicate measuraaents of the O.D., after the times of 
incubation indicated in the figure.
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6.3.2 Germ tube formation by C. albicans in various buffered systems and the 
effect of varying the concentration of the stimulant
Pre treatment of C. albicans NCPF3153. as described in 6.3.1, allowed 
this strain to reproducibly form germ tubes when incubated in imidazole buffer 
containing a suitable stimulating agent. These were human serum, NAG, glu 
plus gin and glu only. (It was found that cells incubating in imidazole buffer 
only, at 37° C., did not, at any time, form germ tubes). The effect of 
varying the concentration of these four inducing agents in the imidazole 
buffer is shown in Figs. 6.1 - 6.4. The figures also show the absorbance, at 
650 nm, of the cell suspensions over a 22 hr incubation period at 37° C..
This parameter was used as a measure of cell growth.
Fig. 6.1 shows the effect of varying the concentration of human serum in 
the buffer on the yeast's ability to form germ tubes. Increasing the concen­
tration of serum in the buffer decreased the time taken for all the yeast cells 
to possess germ tubes. In buffer containing 57. serum all yeast cells possessed 
germ tubes within 3^ hr from the start of incubation. In buffer containing 27.,
0. 57. or 0.257. serum, the time taken for all yeasts to produce germ tubes was 
longer (i.e. 4^, and 12*s hr respectively). The absorbance of the cell sus­
pensions in buffer containing 57., 27., 0.57. or 0.257. serum increased only 
slightly over the 22 hr incubation period (i.e. by 0.038 O.D. units). This 
indicated that there was only a small amount of cellular growth by C. albicans 
in these buffered systems over the incubation period.
Fig. 6.2 shows the time course for the yeast cells to possess germ tubes 
in NAG-containing buffer. All the cells possessed germ tubes after 10 hr 
incubation at 37° C. when viewed under the light microscope. Varying the 
concentration of NAG in the buffer did not have any effect on the time course 
for germ tube formation. The optical density of the cell suspensions in NAG 
containing buffer increased only slightly over the 22 hr incubation period,
1. e. by 0.028 O.D. units. Thus, under these conditions there was only a small 
amount of cellular growth shown by C. albicans.
The effect of varying the concentration of both glu plus gin on the ability
Fig. 6.2 C a m  tub« f ornât ion by C . albicans ia NAG containing buffer
C. albican« yeast calls wara grown in S. and S. medium as dascribad in 2.3.3. 
Aftar starvation for 24 hr, samples of the calls wars diluted, ia imidazole 
buffer containing 1.23 dl SAC, to a final call density of 2 x 10* yeast cells/ml. 
The call suspension was incubated at 37° C ., and samples removed at the times 
indicated in the figure. The percentage of yeast cells with gens tubes was 
estimated by light microscopy ( x 400 magnification) ( ■  ~  ). The error bars
refer to the standard deviations of duplicate aliquots, removed from the cell 
suspension at the appropriate times. The absorbance at 630 run, of yeast cells 
incubating in buffer containing 1.23 cM SAC, was monitored over a 22 hr 
incubation ( •••). The error bars refer to the standard deviations of 
duplicate measurements of the 0.0., after the times indicated in the figure.
Tig. 6.3 Effect of varying concentration of glu plus gin, in imldazole^buffer^on 
germ tube formation by C. albicans
C. albicans yeast cells were grown in S. and S. medium and stored as described 
in 2.3.3. After starvation for 24 hr, samples of the cells were diluted, in 
imidazole buffer to final cell densities of 2 x 10* yeast cells/ml. The 
buffer contained glu plus gin, both at final coresntrations of 25 mH ( -* r" >. 
5 (-♦—  ), 1.25 n* ( ) or 0.25 it« ( ). The cell suspensions
were Incubated at 37° C., and samples removed at the times indicated in the 
figure. The percentage of yeast cells with germ tubes was estimated by light 
microscopy ( x 400 magnification). The error bars refer to the standard 
deviations of estimates of percentage numbers of cells with germ tubes at the 
times shown. The absorbance at 650 nm, of yeast cells incubating in buffer 
-c.ntalnlng 25 it« ( ), 5 d l ( - « - ) ,  1.25 a« ( - O - ) or 0.25 n* ( - O * )
glu plus gin, was monitored over a 22 hr incubation at 37 C. The error bars 
refer to the standard deviations of duplicate measurements of the O.D., after 
the times of Incubation indicated in the figure.
Fig. 6.6 Cerm tube formation by C, albicans in glu containing buffer
C. albicans yeast calls were grown in S. and S. medium and stored as described 
in 2.3.3. After starvation for 24 hr, samples of the cells were diluted, in 
imidazole buffer containing 1.23 r* glu, to a final cell density of 2 x 10* 
yeast cells/ml. The cell suspension was incubated at 37° c. and samples 
removed at the times Indicated in the figure. The percentage of yeast cells 
with germ Cubes wes estimated by light microscopy ( x 400 magnification) <— -). 
The error bars refer to the standard deviations of estimates of percentage 
numbers of cells with germ cubes at the times shown. The ebsorbance at 630 nm, 
of yeast cells Incubating in buffer containing 1.23 ntt glu, was monitored 
over a 22 hr incubation at 37° C. The error bars refer to the standard 
deviations of dupllcat* measurements of the O.D., after the times indicated 
in the figure • •).
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of C. albicans to form germ tubes was shown in Fig. 6.3. Yeast cells 
incubated in buffer containing equal amounts of glu plus gin, at concentrations 
of 0.25 mM and 1.25 mM,all produced germ tubes within 10 hr at 37° C.. Cells 
incubating in buffer containing both compounds at final concentrations of 
25 mM did not form germ tubes at any time over the 22 hr incubation period 
at 37° C.. In buffer containing both glu plus gin at final concentrations of 
5 mM 507, of the yeast cells possessed germ tubes after 7^ hr incubation at 
37° C.. After 16 hr incubation no cells possessed germ tubes, when viewed by 
light microscopy.
Over the first 10 hr incubation at 37° C. the absorbance of the cell sus­
pension did not change markedly - whatever the concentration of glu 
plus gin . Over the next 12 hr the absorbance of the cell suspension con­
taining 25 mM glu plus gin increased (i.e. by 0.136 O.D. units). This indicates 
almost a twofold increase in cellular material by C. albicans yeast cells in 
this medium. In buffer containing 5 mM glu plus gin the absorbance increased 
(i.e. by 0.088 O.D. units) over a similar 12 hr incubation period at 37° C..
This indicates an increase in cellular material by C. albicans yeast cells in 
this buffer. Cells incubating in buffer containing glu plus gin, at concen­
trations of 1.25 mM or 0.25 mM, showed a slight increase in absorbance over 
the same period of 0.04 O.D. units. This indicated that there was only a 
small increase in cellular material under these conditions.
Fig. 6.4 shows the time course for germ tube formation by yeast cells in 
buffer containing glu only. All the cells possessed germ tubes after 10 hr 
incubation at 37° C., when viewed under the light microscope. Varying the 
concentration of glu in the buffer did not effect the time course of germ tube 
formation. The optical density of the cell suspension in glu containing buffer 
increased only slightly over the 22 hr incubation period (i.e. by 0.022 O.D, 
units). This indicated that there was only a slight increase in cellular 
material shown by C. albicans over the 22 hr incubation period in glu contain­
ing buffer.
In media that promoted germ tube formation by C. albicans yeast cells this
— 156 —
phenomenon was always accompanied by flocculation of cells. Germ tubes 
were approximately 10 - 30 /am before growth stopped.
6.3.3 RNA and protein content of C. albicans during germ tube formation
Fig. 6.5 shows the RNA content of C. albicans yeast cells before, and 
during, the formation of germ tubes in buffer containing 27. serum or 1.25 mM 
NAG. In serum-containing buffer the RNA content per yeast cell increased more 
than three fold over a 6 hr incubation period at 37° C.. In buffer containing 
NAG the RNA content per yeast cell increased more than two fold over the same 
period.
The protein content of yeast cells incubating in buffer containing serum 
over a 6 hr incubation period at 37° C. was as shown in Fig. 6.6. The protein 
content of individual yeast cells did not change markedly over the incubation 
period. It was found that the protein content per unit yeast cell increased 
by only five percent over 6 hr.
6.3.4 RNA synthesis by C. albicans during germ tube formation
RNA synthesis by C. albicans, during the yeast-mycelial transformation 
was measured by incorporation of t^C.l uridine into TCA insoluble material.
In the absence of a suitable stimulating agent in the buffer, there was 
negligible C ^ C ]  incorporation into RNA.
The effect of varying the concentration of serum, in the imidazole buffer, 
r 14 ion incorporation of l. CJ uridine into RNA by C. albicans is shown in Fig. 6.7.
Increasing the concentration of serum in the buffer increased the amount of
t U Cj uridine incorporated into RNA for the first 16 hr incubation. The
, 1 4  .highest level of L C J incorporation by C. albicans was found when the yeast
cells were incubated in buffer containing 57. serum. Decreasing the serum
r 14 ^content decreased the level of L CJ incorporated into RNA by the yeast. Over 
the next 6 hr incubation the level of [^CJ incorporated into RNA fell.
14A time course of incorporation of [ C] into RNA by yeast incubating in 
NAG-containing buffer is shown in Fig. 6.8. The amount of [ ^C ] incorporated
P i * .  6 . 5  C h a n « « «  l a  RNA c o n c t n t  o f  C . a l b i c a n «  d u r i n g  * « n a  C u b «  f o r m a c l o a
C. a l b i c a n s  y e a s t  c a l l «  w a r «  g ro w n  l a  S .  a n d  S .  m e d iu m  a n d  s c o r e d  a s  d e s c r i b e d  
l a  2 . 3 . 3 .  A f C e r  i c a r v a d o n  f o r  2 6  h r ,  s a m p l e s  o f  C he c e l l s  w e r e  d l l u c e d ,  l a  
l a l d a z o l e  b u f f e r  c o n c a l n l n g  e i c h e r  1 . 2 5  a d  NAG o r  2 1  s e r u m ,  c o  c e l l  d e n s l C y  o f  
2  x  1 0 5 m l .  T h e  c e l l  s u s p e n s i o n  w a s  I n c u b a c e d  a t  3 7 °  C . a n d  1 0 0  m l a l l q u o c s  
re m o v e d  a c  C h e  C l a e s  sh o w n  I n  C he f i g u r e .  T h e  c e l l s  w a r e  c o l l e c c e d  b y  f l l c r a c l o a  
u s i n g  G F /C  g l a s s  f i b r a  d i s k s .  T h e  RNA c o n c e n c  o f  c a l l s  l n c u b a c l n g  I n  b u f f e r  
c o n e a i n l n g  e i c h e r  NAG ( — *•—  )  o r  s e r u m  (  •  ■ )  w a s  e s d m a c e d  a s  d e s c r i b e d  I n
2 . 6 . 2 .  T h e  e r r o r  b a r s  r e f e r  Co c h e  s c a n d a r d  d e v l a c l o n s  o f  d u p l i c a t e  e s t i m a t e s  
o f  RNA c o n c e n c .  A s s a y  b l a n k s  c o n s i s C e d  o f  s e r u m  -  c o n c a l n l n g  b u f f e r  o n l y .
F i g .  6 . 6  C h a n g e s  I n  p r o t e i n  c o n t e n c  o f  C. a l b i c a n s  d u r i n g  g e r m  c u b e  f o r m a t i o n
C. s i b i c a n s  v e a s t  c e l l s  w e r e  g r o w n  I n  S .  a n d  S .  m e d iu m  a n d  s c o r e d  a s  d e s c r i b e d  
i n  2 . 3 . 3 .  A f c e r  s t a r v a t i o n  f o r  2 6  h r ,  s a m p l e s  o f  c h e  c e l l s  w e r e  d l l u c e d .  I n  
i m i d a z o l e  b u f f e r  c o n c a l n l n g  27. s e r u m  t o  a  f i n a l  c e l l  d e n s i t y  o f  6  x  1 0 5  c e l l s /  
m l .  A f t e r  t h e  t i m e s  o f  i n c u b a t i o n  a c  3 7 °  C . ,  I n d i c a t e d  I n  c h e  f i g u r e ,  t h e  
c e l l s  I n  5 m l s u s p e n s i o n  w e r e  c o l l e c t e d  b y  c e n t r i f u g a t i o n .  T h e  p r o t e i n  c o n t e n t  
o f  t h e  c e l l s  w a s  e s t i m a t e d  a s  d e s c r i b e d  i n  2 . 6 . 3 .  T h e  e r r o r  b a r s  r e f e r  t o  t h e  
s t a n d a r d  d e v i a t i o n s  o f  d u p l i c a t e  e s t i m a t e s  o f  p r o t e i n  c o n t e n t .  A s s a y  b l a n k s  
c o n s i s t e d  o f  s e r u m  c o n t a i n i n g  b u f f e r  o n l y .  T h e  r e g r e s s i o n  l i n e  o f  " p r o t e i n  
c o n c e n t "  a g a i n s t  " t i m e  o f  i n c u b a t i o n "  w a s  e s t i m a t e d  a s  d e s c r i b e d  i n  2 . 9 . 1 .
■-J uridineE f f e c t  o f  v a r y i n g  s e ru m  c o n t e n t  o f  b u f f e r  o n  i n c o r p o r a t i o n  ,
I n t o  RNA b y  C . a l b i c a n  d u r i n g  g e rm  t u b e  f o rm a t i o n
» • • • t  c a l l .  o f  i i H i m  w . r .  i r o w r .  I n  S .  a n ,  S .  - . a l u m  a n d  . t o , a d  a .  d a t c r l b a d  
i n  l . J . l .  A l t . ,  a t a r v a t l o n  t o ,  24 h r .  . a n , ! . ,  0 (  t h .  c a l l ,  . . . .  d i l u t e d .  l a  
l a u d a t o ! ,  b u f f . ,  c o n t . l n l n ,  . . r u m ,  t o  f i n a l  c a l l  d . n . l t l . a  o f  J  «  1 0 S c l l a / o l .  
S . r ia n  w aa  p r . a . n t  I n  t h .  b u f f . ,  a t  t o n c . n t r a t l o n a  o f  i\  (  —. —  ) ,
^  * *  * 0T ( 50 uCl of urldln. (ip.clflo activity
*“  "•» .«•< P.f cl .u.p.n.lon, Du,11,.,. 0.1 ml
r.mov.d aft.t th. dm.. of Incubation a, 11» C., ahown In ch. fljur., Th. 
radioactivity Incorporated Into TCA In.olubl. mat.rial m...ur.d a. d.acrlb.d 
in l.J.l. Th. .„or bar. ,.f„ to th. ...nd.rd d.vl.tlon. of dupllc.t. .U,uot. 
removed at the times shown.
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into RNA increased over the first 8% hr of incubation at 37° C.. Over the 
next 14 hr the level of C 3 incorporated into RNA did not increase or 
decrease. Varying the concentration of NAG in the buffer did not affect the 
rate of incorporation of [ ^ C ]  uridine into RNA by the yeast.
Fig. 6.9 shows a time course of incorporation of C ^ c }  into RNA by 
C. albicans over a 22 hr incubation and the effect of altering the glu con-
,14 .centration in the buffer. The level of £ Cj incorporated into RNA increased 
with time over this period. Altering the concentration of glucose did not 
affect the rate of £ ]  incorporation.
The effect of varying the concentration of glu plus gin, in the buffer,
,14 _on incorporation of [ CJ into RNA by C. albicans is shown in Fig. 6.10. The 
level of [ C J uridine incorporated increased with time when yeast cells were 
incubated at 37° C. . Over the first 12*5 hr incubation, increasing the con­
centration of glu plus gin in the buffer, increased the rate of incorporation 
of £ ^ C  } into RNA by C. albicans. After this period, the level of f ^ C  J 
uridine incorporated into RNA by yeast, in buffer containing 25 mM glu plus gin 
gin, decreased. A similar result was found after 16 hr incubation for yeast 
incubating in buffer containing 5 mM glu plus gin. The level of £ ] incorp­
orated into RNA by yeast, in buffer containing 1.25 mM or 0.25 mM glu plus gin, 
increased over the 22 hr incubation period.
The effect of adding the labelled precursor to cell suspensions of 
C, albicans in 27. serum, 1.25 mM NAG, 1.25 mM glu or 1.25 mM glu plus gin at
differing times during germ tube formation is shown in Figs. 6.11 to 6.14.
3The addition of £ H] uridine to cells incubating in buffer containing 27. serum 
after 0, 2, 4 and 6 hr incubation at 37° C. is shown in Fig. 6.11. When label
was added to the cell suspensions after these times, there was linear incor-
3 3poration of £ Hj into RNA at rates of 0.31, 0.30, 0.33 and 0.27 pmoles £
hr  ^by 1.5 x 10 yeasts. The rates were calculated from regression lines of
"■ j 5 >• ii
pmoles £ Hj incorporated into RNA by 1.5 x 10 cells against time of incubation
M
at 37° C.. When label was added after 0, 2, 4 and 6 hr respectively, values 
for r of 0.80, 0.81, 0.77 and 0.65 were found. These values indicated high
Eff«cc of varytng NAC conaanttatlon of buffar on incorporatlon of Z  cl urldlno 
loco AMA by C. albicane durlng germ tub« fomclon
Yaaic calla of C. albicane «ara grown la S. and S. medita and atorad as daa- 
crlbad in 2.3.3. Aitar starvatlon for 24 hr, samples of tha calla «ere 
dlluted, In lmidazola buffar contatolo» NAC, to floal cali danaitlaa of 
5 x 10^  calls/ol. NAC waa present In tha buffar at coocantratlona of 25 odi
(_*»_), 5 «tt (— • — >, 1.25 s* ( m -  ) or 0.25 a* (---- - 50 >»Cl of
u c} uri dina (spaclflc actlvlty 438 mCl/tnnol) waa addad par mi suspenslon. 
Duplicata 0.1 mi aliquota wara removad aftar tha timaa of lncubatlon at 37 C-,
shown in tha figura. Tha radloactlvlty locorporatad into TCA loaolubla 
material waa meaaurad aa deacrlbad in 2.5.1. Tha arror bara rafar to tha 
atandard davtatlona of duplicata aliquota removad at tha timaa ahown.
Fig. 6.9 Effect of varying glu concentration of buffer on incorporation of CU C} uridine 
into ANA by C. albicans during germ tuba formation *5
Yaaat calls of C. aibicana wara grown in 3. and S. medium and stored aa 
described in 2.3.3. After starvation for 24 hr, temples of the cells waro 
dllutad. In imidazole buffer containing glu, to final call dansitlas of
5 x 10 cells/ml. Glu was present In tha buffer at concentrations of 23 m 
< ), 5 ( » -), 1.23 sM ( ) or 0.23 nM ( — — ). 50 pCl of
&, uridine (specific activity 438 mCl/mul) was added par ml suspension.
Duplicate 0.1 ml aliquots wara removed aftar tha times of Incubation at 37° C., 
shown in tha figure. Tha radioactivity incorporated into TCA insoluble material 
waa measured as described in 2.5.1. Tha arror bars refer to the standard 
deviations of duplicate aliquots removad at tha times shown.
/ h
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Fig. 6.9
Fig. 6.10 Effect of varying glu plus gin concantratlon of buffer on Incorporation of 
CU C1 uridine Into RNA by C. albicans during germ cube fonnetlon
Yeast cells of C. albican» were grown in S. and S. medium and stored as 
described In 2.3.3. After starvation for 24 hr, samples of the cells were 
diluted, In imldasole buffer containing glu plus gin, to final cell densities 
of 3 x 10* cells/ral. Clu plus gin was present In the buffer at concentrations
of 23 rH ( +  ), 5 sM ( ■ ♦  - ), 1.25 mM (— • — ) or 0.23 rM (---- ). 50 >jCl
of (4, u <3 uridine (specific activity 483 -rrCl/Rinol) was added per ml suspension. 
Duplicate 0.1 ml aliquots were removed after the times of Incubation at 373 C., 
shown in the figure. The radioactivity incorporated Into TCA Insoluble material 
was measured as described In 2.5.1. The error bars refer to the standard 
deviations of duplicate aliquots removed at the times shown.
Fig. 6.11 Effect of addition of C uridine at different times on incorporation cf label  
Into RNA by C. alb leans ir. buffer containing serum
least cells of were grown in S. and S. medium and starved for
2- hr, as described in 2.3.3. Samples of the cells were diluted, in i-.idasole 
buffer containing 2X serum, to final cell densities of 3 x 105 celle/ml. 
i: *Cl at C>. *0 uridine (specific activity 23 Ci/mnol) was added per ml of 
suspension, incubating at 3*J C., at the times indicated In the figure (4 ). 
Duplicate 0.5 ml aliquots were removed at the times shown in the figure. The 
radioactivity Incorporated Into TCA Insoluble material was measured as described 
In 2.5.1. The error bars refer to the standard deviations of duplicate aliquots.
fl«. Effect of addition of C M  uridine at different times on Incorporation of label
into RNA ts sit leans in buffer containing NAG
Yeast cells of (¡, AlfcaJUM «town In S. and S. medium and starved for 24 hr, 
as described In 2.3.3. Samples of the cells were diluted. In imidazole buffer 
containing 1.25 rM NAG, to final cell densities of 3 x 105 cells/ml. lO^Cl 
of D.HJ uridine (specific activity 23 CI/rsaoI) was added per ml of suspension 
incubating at 37° C., at the times indicated In the figure ( 1 ). Duplicate 
0.3 «1 aliquots were removed at the times shown in the figure. The radioactivity 
incorporated into TCA insoluble material was measured as described in 2.5.1.
The error bars refer to the standard deviations of duplicate aliquots.
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3 5correlation between "pmoles f Hj uridine incorporated into RNA by 1.5 x 10
cells" and "time of incubation at 37° C.".
Fig. 6.12 shows a time course for incorporation of £ Hj uridine into RNA
by cells incubating in buffer containing 1.25 mM NAG. The label was added
to the suspension after 0, 2, 4 and 6 hr incubation. Addition of label at
the start of incubation revealed a non-linear increase in amount of J
incorporated into RNA by yeast cells. A non-linear increase in incorporation
3
of [ H] into RNA, for the first 6 hr incubation, was found when the label was 
added to the suspension after 2 hr. After 8 hr incubation there was no change 
in the level of [ ^ Hj incorporated into RNA. Addition of the label after 4 and 
6 hr incubation also revealed that between 8 and 10 hr there was no change in 
level of f ] incorporated into RNA by the yeast.
3
The addition of [ H} uridine to yeast cells, in buffer containing 1.25 mM 
glu only, after 0, 2, 4 and 6 hr incubation at 37° C., is shown in Fig. 6.13. 
When label was added to the cell suspensions after these times of incubation,
3incorporation of [ H] uridine into RNA was found at rates of 0.07, 0.08, 0.06
and 0.06 pmoles hr  ^ by 1.5 x 10^ yeast cells. These values were calculated
" 3 5 '*by regression lines of pmoles of [ H] incorporated into RNA by 1.5 xlO cells
against time of incubation of cell suspension at 37° C.. Values for r of 0.80,
0.85, 0.79 and 0.63 for the two variables were found, when label was added to
the cell suspensions after 0, 2, 4 and 6 hr incubation respectively. These
values indicate high positive correlation between "pmoles of [ H) incorporated
into RNA by 1.5 x 10^ cells" and "time of incubation of the cell suspension
at 37° C.".
The effect of the addition of labelled uridine at different times of
incubation at 37° C. of cells suspended in buffer containing both 1.25 mM glu
/.
plus gin is shown in Fig. 6.14. Regression lines were calculated for incorp- 
oration of f h J into RNA by 1.5 x 10 cells against time of incubation" from time 
courses when the label was added after 0, 2, 4 and 6 hr incubation. These 
revealed rates of incorporation of label into RNA of 0.18, 0.17, 0.16 and 0.12 
pmoles hr * by 1.5 x 10^ cells respectively. Values for r of 0.86, 0.85, 0.79 
and 0.61(when label was added after 0, 2, 4 and 6 hr incubation^ indicated high
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FI*. 6.13 Effect of addition of £Jh1 uridine at different tines on Incorporation of label 
into RNA by C. albicans in buffer containing glu
Yeast cells of C. albicans were grown in S. and S. medium and starved for 26 hr, 
as described In 2.3.3. Samples of the cells were diluted, in imidazole buffer 
containing 1.23 nM glu, to final cell densities of 3 i 105 cells/nl. 10 >iCi 
of L5.3hJ uridine (specific activity 23 CI/t ooI) was added per »1 of suspension, 
incubating at 37° C., at the tines indicated in the figure ( V ). Duplicate 
0.5 ml aliquots were removed at the tines shown in the figure. The radioactivity 
incorporated into TCA insoluble material was measured as described in 2.5.1.
The error bars refer to the standard deviations of duplicate aliquots.
Fig. 6.16 Effect of addition of uridine at different times on Incorporation of label
into RNA by C. albicans in buffer containing glu plus gin
Teast cells of C. albicans were grown in S. and S. medium and starved for 26 hr, 
as described In 2.3.3. Samples of the cells were diluted, in imidazole buffer 
containing 1.25 -rM glu plus gin, to final cell densities of 3 x 105 cells/ml.
10 jiCi [5, V )  uridine (specific activity 23 Ci/rmnol) was added per ml of 
suspension. Incubating at 37° C., at the times indicated in the figure ( i ). 
Duplicate 0.5 ml aliquots were removed at the tines shown in the figure. The 
radioactivity incorporated into TCA insoluble material was measured as described 
in 2.5.1. The error bars refer to the standard deviations of duplicate aliquots.
Fig. 6.13 Effects of addition of Inhibitors of RNA and protein synthesis on g e m  tube 
formation by C. «11 lean
C. albicans yeast cells were grown ln S. and S. medium, and starved for 26 hr, 
as described in 2.3.3. Samples of the cells were diluted to final cell 
densities of 3 x 103 cells/ml in Imidazole buffer containing 1.23 rM SAC, 
Actlnomycln D ( — rlfamycln AF/013 ( - « —  ), lomofungin ( - ♦ —  ) end 
rapamycln ( ) were added, as a solution ln CMSO to final concentrations
of 0.2 «M, to cell suspensions. Cyclohexlmlde ( ■ •  ) and chloramphenicol
( ^  * w#r# •dd,d' • • * solution in M^O, ce final concentration* of 0.1 «M,
to cell suspensions. Control cultures had CMSO only added to a final 
concentration of 1*. The cell suspensions were incubated at 37° C. and samplaa 
removed at the times Indicated In the figure. The percentage of cells with 
gars tubes was estimated by light microscopy ( x 600 magnification). The error 
bars refer to the standard deviations of duplicate samples removed from the 
suspension at the appropriate times.
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6.3.5 Inhibitors of transcription and translation on germ tube formation by 
C. albicans
The effect of some inhibitors of RNA and protein synthesis on germ tube 
formation by C. albicans is shown in Fig. 6.15. The drugs were added in or
DMSO to the final concentrations indicated in the legend of the figure. The 
figure shows the effect of the drugs on germ tube formation by C. albicans in 
buffer containing 1.25 mM NAG. In this buffer all cells possessed germ tubes 
after 10 hr incubation. Actinomycin D, chloramphenicol or cycloheximide, at 
the concentrations tested, did not have an affect on the time course for germ 
tube formation by C. albicans. In the presence of lomofungin, rifamycin 
AF/013 and rapamycin only a small percentage (approximately 107.) of cells had 
produced germ tubes after 16 hr incubation. After 22 hr incubation in buffer 
containing 1.25 mM NAG and 0.2<nM rifamycin AF/013 the percentage of cells with 
germ tubes increased to 307.« Similar results to these found by C. albicans 
incubating in 1.25 mM NAG containing buffer were found when cells were incubatec 
in buffer containing 1.25 mM glu, 1.25 mM glu plus gin and 27. serum. However, 
cells incubating in buffer containing 27. serum formed germ tubes after hr 
incubation at 37° C..
The effect of inhibitors of transcription RNA synthesis, over a 6 hr 
period, by C. albicans in suitable buffer for germ tube formation is shown in 
Table 6.2. Actinomycin D, rifamycin AF/013 and lomofungin all inhibited RNA 
synthesis by 477. - 997.. These inhibitors had an affect on RNA synthesis by 
yeast incubating in buffer containing serum, NAG or glu plus gin. It was 
found that incorporation of C H J into RNA was inhibited when cells were 
incubated in buffer containing 27. serum and 0.2 mM rapamycin. Cells incubat­
ing in buffer containing 1.25 mM glu plus gin and 1.25 mM NAG showed an 
increase in incorporation of [ H] uridine into RNA when rapamycin was added 
to the suspensions. All the drugs, added from stock solutions in DMS0,vere addec 
to the suspensions, so the final concentration of the solvent was 17.» Increasing
Tabic e.2 Effect of inhibitors of RNA synthesis on incorporation of tVj uridine into 
RNA by C. albicans during germ tube formation
Yeast cells of C. albicans were grown in S. and S. medium and stored as 
described in 2.3.3. After 24 hr, aliquots were diluted. In imidazole buffer, 
to final cell densities of 1 x 10* yeasts/ml. The cells were incubated at 
37° C., in buffer containing either 2* serum, 1.23 nM NAG, 1.23 nil glu or 
1.23 nM glu plus gin. The inhibitors were added to a final concentration 
of 0.2 nil in CMSO, to the suspensions. 10 /iCl oft,3«] uridine (specific 
activity 23 Cl/mnol ) was added per ml yeast suspension. After a hr at 
37°C., the radioactivity incorporated into duplicate 0.3 ml aliquots was 
measured as described in 2.3.1. The table includes the standard 
deviation*of radioactivity Incorporated by the duplicate aliquots. The 
figures in brackets refer to the percentage inhibition compared to controls 
(CHSO only added to the suspension).
Figs, 6.16 - 6.20 PACE of labelled RNA extracted from C. alblears during germ tub*
formation in buffer containing serum
C. albicans yeast cells were grown in S. and S. medium and starved for 24 hr 
as described in 2.3.3. Samples of the cells were diluted, to final cell 
densities of 3 x 10* yeast tslli/nl, in imidazole buffer containing 2X 
serum. 10 ¿iCl of Q4, *¿1 uridine (specific activity 4*6 mCi/nmol) was
added per ml suspension. The RNA from yeast cells in a volume of 3 ml 
of suspension, was extracted as described in 2.7.1. The RNA extracted 
after 1 (Fig. 6.1b), 2 (Fig. 6.17), j (Fig. 6.18), 4 (Fig. 6.19) and 3 
(Fig. 6.20) hr incubation was analysed by PACE as described in 2.9.1. The 
distance migrated by the bromophenol blue (a $), T. ovrifor-is 23 S, 17 S, 
3.9 S and 5 S rRNA and E. c~li 23 S and 16 S rRNA species are shown.
Flgs. 6.21 - 6.23 PACE of labelied RNA extracted from durlng gora tube
formatlon in buffer cantalr.ing NAC
C. alticans yeast cells w*r* grown in S. and S. medium and starved for 
24 hr, as described in 2.3.3. Samples of th* cells wer* dlluted, to 
final celi denslties of 3 x 10* yeast calls/ml, in lmidazole buffer 
containlng 2« NAC. 12 ¿iCi of[*. U cJ uridlne (spedile aetivlty
mCl/*r»ol) was added per mi suspenslon. Th* RNA from yeast cells in 
a volume of 3 mi of suspension was extracted as described in 2.7.1. The 
RNA extracted after 1 (Fig. 6.21), 2 (Flg. 6.22) 3 (Flg. 6.23), 4 (Flg. 
6.2*),and 3 (Flg. e.23) hr lncubation was analvsed by PACE ss described 
in 2.9.1. The distane* migratad by thè bromophenol blu* (4 8),
T. avrifar-lt 23 S, 17 S, 3.9 S and 3 S rRNA and E. coll 23 S and 16 S 
rRNA specie* are »ho***.
RA
DI
OA
CT
IV
IT
Y 
IN
OX
 PO
UT
ED
 
(c
.*
.■
./
! 
mm
 «
«1
 »
li
e«
)
— 1 6 6  —
Fig. 6.21 Fig. 6.22
25 3 17 3 5 .8  3 4 3
23 S 16 3 5 3
DISTANCE MICRATED BY RNA (on)
c
25 S 17 3 
23 S 16 3
5.8 3 43
5 S
20 40 60 80 100
DISTANCE MICRATED BY RNA (on)
Fig. 6.23
25 3  17 3  5 .8  3  4 3
23 3  16 3 5 3
i iA i i AJ l
P  200
J
w
V
20 40
DXSTAMCB NXCUATtS BY M U ( a )
«A
M
Ot
óT
ivm
 m
eo
»f
om
iti
 u
.,.
,.n
 _
- 168 -
the DMSO content of the suspension to 57. or 107. resulted in an inhibition in 
the ability of cells to form germ tubes in suitable media.
6.3.6 Analysis of RNA synthesised by C. albicans during germ tube formation
RNA synthesised by C. albicans yeast cells incubating in buffer contain­
ing 27. serum or 1.25 mM NAG was extracted at various times during the formation 
of germ tubes. Figs. 6.15 - 6.25 show analysis by PAGE, RNA extracted after 
1, 2, 3, 4 and 5 hr incubation at 37° C. of yeast in buffer containing 1.25 mM 
NAG or 27. serum. The Figs, show peaks of corresponding to the high M.W. ,
25 S and 17 S rRNA species and also the lower M.W. (5.8 S and 5 S rRNA and 
4 S tRNA) species. The position of these species was estimated from the 
position marker RNA species migrated (i.e. T. pyriformis 25 S, 17 S, 5.8 S 
and 5 S rRNA, E, coll 23 and 16 S rRNA and bromophenol blue 4 S). A high 
proportion of was associated with the small 5 S and 4 S RNA
species. This qualitative observation was confirmed by autoradiography of
32agarose slab gels containing £ P] labelled RNA. The RNA was extracted during
the yeast-mycelial transformation of C. albicans in buffer containing 27. serum
32or 1.25 mM NAG. Most [ Pj labelled RNA migrated as low M.W. species (results 
not shown).
The proportions of RNA greater or smaller than 5 S rRNA species during
the yeast-mycelial transformation of cells in buffer containing 27. serum or
1.25 mM NAG was estimated as described in the legend of Fig. 6.26. The ratio
of in RNA larger than 5 S to that smaller than 5 S fell from 0.95 in
that extracted from cells in buffer containing 27. serum after 1 hr incubation
«-14to 0.3 after 5 hr. The ratio of L CJ in RNA larger than 5 S to that 
smaller than 5 S did not change markedly over the 5 hr period the yeast 
cells were incubating in buffer containing 1.25 mM NAG (i.e. approximately
0.85).
- 169 -
6.4 Discussion
6.4.1 Pretreatment of C. albicans for germ tube formation
In order to achieve reproducible germ tube formation by C. albicans 
NCPF3153, pre»treatment of the yeast inoculum was necessary. The cells had 
to be grown in nutritionally impoverished media, starved for at least 24 hr 
and inoculated in suitable germ tube inducing media. The methodology used 
was based on that described by Shepherd et al (345). This group 
reported reproducible germ tube formation, by C. albicans ATCC10261, when 
grown for 20 hr, in glucose-salts-biotin medium, and starved for 24 hr, prior 
to inoculation in suitable media. The choice of growth medium for C. albicans 
NCPF3153 was an important parameter for reproducible germ tube formation. It 
was found that if the yeast was grown in peptone broth (S.D.B.), the cells 
were unable to form germ tubes, even when starved for 24 hr prior to inocul­
ation in suitable media (Table 6.1).
It was necessary to grow C. albicans NCPF3153 for 50 - 70 hr in glucose- 
salts-biotin medium. Lower yields, and slower growth rates are found, when 
C. albicans is grown in defined media compared to complex media. A greater 
yield of yeast, per unit volume growth media, was obtained when C. albicans 
NCPF3153 was grown for 50 - 70 hr, compared to 20 - 40 hr growth. The yeast 
cells were then presumably in the stationary phase of growth as the yield of 
cells did not change between 50 and 70 hr incubation. It was found that if 
this strain of C. albicans was grown for 20 - 40 hr, the yeast did not form 
germ tubes. These results indicate that the growth phase is an important 
parameter for germ tube formation by this strain of C. albicans. It has been 
suggested that C. albicans must accumulate in stationary phase - of the Gi 
phase of the cell cycle - before germ tube formation, in suitable media, can 
occur (248,345). However, by no means all groups working on the yeast-mycelial 
transformation of C. albicans are in agreement. Ahrens et al reported that 
the strain of C, albicans used in their experiments was able to form germ tubes
in the exponential phase of growth. Synchronous germ tube formation occurred 
when the yeast cells were diluted into suitable media at 37° c .  ( 4 ). Thus,
/no hard and fast rule can be made concerning the growth phase of C. albicans, 
as a species, for germ tube formation to occur.
A further prerequisite for reproducible germ tube formation by C. albicans 
NCPF3153 was that the yeast had to be starved, for at least 24 hr, after 
harvesting. This was achieved by storing the yeast in 20 mM phosphate buffer 
pH 5.6. Shepherd et al (345) stressed that starvation was a necessary 
precondition for reproducible germ tube formation by C. albicans ATCC10261. 
Starvation of the yeast may be reflected by changes in cellular metabolism 
that are requirements for C . albicans to form germ tubes. An analysis of the 
levels of metabolites in C. albicans ATCC10261, during the exponential and 
stationary growth phases and during starvation has recently been made (368).
It was found that, during starvation, the levels of hexose phosphates 
decreased, whilst the levels of storage polysaccharide (e.g. glycogen) and 
the size of the free amino acid pools increased. Such changes should be 
found whenever a strain of C. albicans undergoes germ tube formation for 
these criteria to be applicable to the species as a whole.
It has long been recognised that inoculum density plays an important 
role in the ability of C. albicans to form germ tubes. In order to obtain 
a high percentage of cells with germ tubes a small inoculum was required 
(see Table 6.1). These results are in agreement with the general findings 
reported in the literature. Typically, a low inoculum ( l x  105 - 5 x 105 
yeast/ml media) is required for C. albicans to form germ tubes (HO). It is
thus somewhat unusual that Shepherd et al (345) found that high inocula (0.8
8 8x 10 to 1.2 x 10 yeast/ml media) were able to form germ tubes. It has 
recently been found that yeast C. albicans, at high cell densities, produced 
a substance Hazen and Cutler termed "morphogenic auto-regulatory substance" 
("MARS") (15^) • This compound was found in the growth media of yeast at
Q
high cell densities (1 x 10 /ml). MARS was capable of suppressing germ tube 
formation by yeast in media that normally promoted this phenomenon. Hazen and 
Cutler later reported that this compound is probably a proline analogue (160).
The important preconditions required for reproducible germ tube formation
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by C. albicans NCPF3153 may thus be summarised: Firstly, the yeast must be 
grown to stationary phase in nutritionally impoverished media. Secondly, the 
yeast must be starved before a small inoculum may be added to suitable 
buffered media.
6.4.2 Media used to induce germ tube formation by C. albicans
Several stimulating agents could be added to C. albicans NCPF3153 which 
resulted in the buffered suspensions forming germ tubes. Two important 
requirements for formation of germ tubes were the presence of a suitable 
inducing agent in the buffer and an incubation temperature of 37° C..
It is now firmly established that the temperature for incubation of the 
yeast is a very important parameter in the formation of mycelia. However, 
this is not the single environmental stimulus that triggers morphogenetic 
conversion as it does for other dimorphic fungi,(e.g. H. capsulatum (203^).
The existence of strain variation argues against such a single, universal 
stimulus . The requirement for high temperatures (typically greater than 35° C. 
(66)) may reflect a need for membrane fluidity by yeast C. albicans before 
germ tubes may be initiated - the first visible sign of the yeast-mycelial 
transformation. It was found that if C, albicans NCPF3153 was incubated at 
temperatures below 35° C. (i.e. 30° C.) the yeast did not form germ tubes.
Germ tube formation could be induced by incubation of C. albicans NCPF3153 
in imidazole HC1 buffer pH 6.6 containing 0.2 mM MnCl^ and either serum, NAG, 
glu plus gin or glu only. Shepherd et al also reported that the same buffer 
containing NAG or glu plus gin could stimulate starved C. albicans yeast to 
produce germ tubes. However, this group reported that C. albicans was unable 
to form germ tubes in the presence of glu only (345). Hrmova et al (167) 
recently reported that low concentrations of glu - in the presence of monorden 
(an antibiotic) - stimulated germ tube formation by C. albicans. This same 
group reported that higher (100 mM) concentrations favoured unicellular yeast 
growth. The result that low (i.e.less than 25 mM) glu concentrations stimulated 
germ tube formation by C. albicans was similar to the results reported in this
/thesis (see Fig. 6.3). The addition of other hexoses, such as fructose or 
galactose, to the buffered yeast suspension did not induce germ tubes by 
C. albicans NCPF3153.
Observation under the light microscope revealed that floculation of the 
cells occurred at the same time as germ tube initiation. This was found 
whatever system was used to induce germ tubes by C. albicans. This made 
estimation of cell numbers difficult - thus growth had to be monitored by 
other means. Other groups have commented on this phenomenon during germ tube 
formation and have tried various methods to disrupt the clumps of cells.
These have included the addition of inositol, bovine serum albumin, Tween 80 
or Triton X-100 to yeast suspensions (345). Unfortunately, these attempts 
proved unsuccessful. Sonication did successfully disrupt the cell clumps. 
However, it also resulted in the shearing of the germ tube from the cell.
Clumps of cells are seen during mycelial formation by growth of daughter 
blastospores along the hyphal shoot (see 1.2.1 and 2.3.4). The aggregation 
of yeasts, reported in this thesis, probably reflected flocculation of single 
blastospores rather than growth of daughter cells. An apparent decrease in cell 
numbers, per unit volume, was found when cells were observed by light 
microscopy, using a haemocytometer,during germ tube formation. In addition, 
measurement of the absorbance of the cell suspensions during germ tube form­
ation did not show any marked increase in the optical density. This contra­
diction, i.e. an increase in cellular material - germ tubes - not reflected 
in an increase in absorbance of the cell suspension - will be discussed below.
Methods for measuring increases in cellular growth include dry weight 
estimations, cell counts, DNA estimations and optical density. Measurement of 
dry weight and DNA content of the yeasts would have proved difficult. Assuming 
a dry weight of 40 pg for a yeast cell (see results in 4-. 3 • 1 ) it was
Q
necessary to obtain 2.5 x 10 cells for measurable (10 mg) quantities. This 
represents all the cells in a total volume of 500 ml (assuming a cell density 
of 5 x 10^ cells/ml - as low cell densities are required to successfully 
obtain a high proportion of cells with germ tubes). Practical problems arise
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when attempting to harvest such low cell densities from such large volumes
of media. These practical problems are applicable to DNA estimates; in order
to obtain measurable - i.e. more than 10 jug DNA - it was necessary to extract 
8 9the DNA from 10 - 10 cells (see 2.6.1). Cell aggregation makes estimates 
of cell numbers by haemocytometry difficult - as described in the preceeding 
paragraph. Thu^ measurement of the optical density appeared to offer a quick 
and reliable estimation of cell growth.
A variety of stimulating agents could induce germ tube formation by 
C. albicans. Yeast incubated in imidazole buffer containing 57. serum showed 
the most rapid ability to produce germ tubes. In this buffer all yeast cells 
had germ tubes within 3^ hr incubation at 37° C.. As a comparison, a small 
inoculum of yeast, incubated in 1007. serum, all produced germ tubes within 
3 hr incubation at 37° C. (see 2.3.4). Fig. 6.1 showed that a decrease in 
the serum content of the buffer resulted in an increase in the time taken for 
all the cells to produce germ tubes. These results indicated that serum 
possessed component(s) which stimulated the production of germ tubes by 
starved yeast cells in a dose-response manner. Serum - from both human and 
animal sources - has long been recognised as a medium capable of inducing 
germ tube formation (227). Barlow et al (21 ) reported a protein isolated 
from seminal plasma and serum of low molecular weight (2,000 - 3,000) which 
would induce germination in low concentrations ( 67). It is this component 
of serum which may be responsible for inducing germ tubes by the yeast cells.
The results of Fig. 6.1 showed that the absorbance of the cell suspension 
increased only slightly over the 22 hr incubation period. Varying the con­
centration of serum in the medium did not affect the slight increase in optical 
density over the 22 hr incubation period. The absorbance of the cell suspen­
sion did not change markedly over the period the cells were forming germ tubes. 
This seems to be a contradictory finding to that expected, i.e. an increase 
in cellular material - germ tubes - not reflected by an increase in absorbance.
Formation of a germ tube from a yeast cell will only reflect a small per­
centage Increase in total cellular material of the yeast. A small increase
/of cellular material would be compounded by the low absorbance of the cell sus­
pension at the start of the incubation. This may be illustrated by the obser­
vation that a cell suspension of 2 x 10^ cells/ml had an absorbance of 0.15 O.D. 
units at 650 nm. As the absorbance of the cell suspension only increased 
slightly over the 22 hr period of incubation, this indicates that there was 
no full development to the mycelial state. This was confirmed by observation 
of the cells after 22 hr incubation by light microscopy. This revealed the 
yeast produced germ tubes, with a length of 15 - 30 /um. Altering the concen­
tration of serum in the buffer did not affect the length of the germ tubes.
These results seem to be in contrast to those of Chiew et al ( 70). This group 
reported that development of C. albicans in complex media, such as serum, 
continues to the multicellular mycelial state. However, it should be borne in 
mind this group used 1007. serum as the medium used to induce germ tubes. In 
this research fairly low concentrations (less than 57.) of serum were added to 
buffer to induce germ tube formation. It is possible that development to the 
multicellular hyphal form requires a medium containing components for growth, 
in addition to stimulating agents.
Possibly the simplest media to date that has been described for the 
successful induction of germ tubes is a buffered solution containing the 
hexosamine NAG. More than 907. of the cells had formed germ tubes when an 
inoculum was incubated for 10 hr, at 37° C., in NAG-containing buffer (Fig.
6.2). Altering the concentration of NAG in the buffer did not have any 
effect on the time course for germ tube formation. It has been hypothesised 
that the capability of NAG to trigger germ tube formation is related to an 
activation of the synthesis of chitin ( 3 9 t 3 4 9 ) .  Chitin is a biopolymer 
consisting of (1 - 4 ) linked NAG subunits. In addition to glucans and 
mannarns, the cell wall of C. albicans has a small amount of chitin. About 17. 
in the yeast and 57. in the mycelia form of total cell wall polysaccharide is 
chitin (23 ). This polymer appears to be important to the growth process as 
the bud ring and septum are predominantly chitin (54) and it is an important 
component in the growth of hyphal tips ( 22 ).
- 175 -
The formation of germ tubes has been accompanied by an increase in activity 
of such enzymes as chitin synthetase (22) and other enzymes of NAG metabolism, 
e.g. glutamine fructose-6-phosphate amino transferase (71), N-acetylglucosa- 
mine-6-phosphate deacetylase (296). Recent studies have shown that other 
N-acetyl hexosamines, such as N-acetyl mannosamine, may gratuitously induce 
germ tube formation with glucose (369). Indeed, it has been found that NAG 
need not enter a cell to induce germ tube formation (347) and the subsequent 
increase in the activities of the enzymes associated with NAG metabolism. 
However, these enzymes are probably not control points for germ tube formation 
as the increases in activity may be induced by NAG whether or not C. albicans 
yeast undergoes dimorphic change (126). Also, the activities of enzymes 
concerned with cell wall "re-modelling" (chitin synthetase and chitinase) have 
been found to increase during the exponential phase of growth (22).
The time taken for all the yeast cells of C. albicans strain NCPF3153 to 
produce germ tubes was much longer than that found by Shepherd et al 
(345). This group used a different strain of C. albicans to that used here.
In addition, this group reported that the time course for germ tube formation 
was the same whether the yeast was incubated in buffer containing NAG, serum or 
glu plus gin. This group reported buffer containing gin and other hexoses 
(such as D fructose, D galactose and D mannose) was also capable of inducing 
germ tubes by C. albicans (345). However, a lower percentage of yeast had 
germ tubes when incubated in these buffers compared to the NAG or glu plus gin 
systems.
Low concentrations of glu plus gin (both at 0.25 or 1.25 mM) could induce 
germ tube formation by C. albicans NCPF3153 (Fig. 6.3). The time course for 
all cells to form germ tubes was similar to that buffer containing NAG.
However, at higher (25 nM) glucose and glutamine concentrations no germ tube 
formation was observed by the yeast. The reversible nature of the yeast 
mycelial transformation was illustrated by incubating cells in buffer containing 
5 mM glucose and glutamine. In this buffer approximately 50% of cells had 
developed germ tubes after 7>j hr Incubation at 37° C.. 8*i hr later no yeast
/cells were visible which had germ tubes.
A two fold increase in optical density at 650 nm over a 22 hr incubation 
period of cells suspended in buffer containing 25 mM glu plus gin was found 
(Fig. 6.3). This indicated an increase in the amount of cellular material of 
yeasts in this buffer. The absorbance of cells suspended in buffer containing 
5 mM glucose and glutamine also increased over the same period. However, the 
increase in O.D. was not as great as for cells in buffer containing the higher 
(i.e. 25 mM) concentrations of glu plus gin. The absorbance of yeast incubat­
ing in buffer containing serum, NAG, glu or glu plus gin (at a concentration 
of 0.25 mM and 1.25 mM) did not increase over 22 hr. This indicated that 
there was no marked increase in cellular material in these buffers. Hence, 
germ tube formation by C. albicans, in these systems, was not accompanied by 
development to a multicellular state. Shepherd et al (345) also reported that 
incubation of cells in buffer containing NAG or glu plus gin was not accompan­
ied to full mycelial development. However, this group did report that develop­
ment to the multicellular hyphal state did occur when yeast cells were incubated 
in buffer containing serum.
The time course for all yeast to form germ tubes was similar in buffer 
containing NAG, low concentrations of both glu plus gin and glu only. All 
cells had germ tubes within 10 hr of inoculation. This suggests that similar 
mechanisms were responsible for germ tube formation by C. albicans NCPF3153 
when incubated in these "simple" media.
It is apparent that some of the results reported here, in this thesis, 
are different from those found by other groups. Johnson et al (183) have found 
that the formation of germ tubes in suitable buffer (i.e. glucose plus gluta­
mine) was strain dependent. This group used small inocula to achieve germin­
ation of the susceptible strains at 37° C.. As noted in 6.1, almost as 
many strains of C. albicans, and conditions described "suitable" for the 
induction of germ tubes, have been reported as there are groups working in 
the field. Thus, it is not surprising that many apparently conflicting results 
have been found. As the formation of germ tubes is the first indication of
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morphogenesis many studies on the phenomenon have investigated the cell wall 
and membrane and any changes therein. Unfortunately, there does seem to be 
a paucity of information regarding the involvement of RNA synthesis. The next 
section discusses the results obtained when this process was investigated 
during germ tube formation.
6.4.3 Protein and RNA Content during the Yeast-Mycelial Transformation of C. albicans
It was hoped that studying RNA synthesis before, during and after the 
formation of germ tubes would add to the knowledge of this phenomenon. In 
order to confirm that RNA content was increasing - as found by Shepherd et al 
(345) - the levels of total RNA in the cell were measured before and during 
germ tube formation (Fig. 6.5). The orclnol method was used to estimate the 
levels of RNA in yeast cells in buffer containing 27. serum and 1.25 mM NAG.
It should be noted that serum contained components that would react with the 
orcinol reagent. This problem was easily overcome by the use of "blanks" in 
the assay for the RNA content, containing buffer and 27. serum treated as the 
samples as cited in the legend of Fig. 6.5.
The RNA content of the yeast cell was estimated as 0.64 pg at the start 
of incubation. In buffer containing 27. serum all cells possessed germ tubes 
after 4*i hr incubation at 37° C. . After 6 hr Incubation the RNA content had 
increased over three fold to 2.10 pg/cell. The RNA content of yeast 
cells in 1.25 mM NAG containing buffer increased to 1.56 pg/cell over the 
same period. Yeast cells in this buffer all produced germ tubes after 10 hr 
incubation at 37° C. . Thus, two firm conclusions are that RNA content/cell 
increased during the formation of germ tubes and, in buffer containing serum, 
the RNA content still increased after all the cells possessed germ tubes.
It is worth commenting on the qualitative and quantitative levels of RNA 
per yeast cell during the yeast mycelial transformation. Qualitatively, the 
results shown in Fig. 6.5 for yeast in serum containing buffer are similar to 
those found by Shepherd et al (34Ç), i.e. a trebling in the RNA content 
per cell over a 6 hr Incubation period at 37° C.. However, quantitatively the
/RNA content per yeast cell reported by this group of 50 fg was much lower 
than that reported in this thesis. In complete contrast the RNA content of 
C. albicans has been estimated elsewhere at 8 pg/yeast cell 1389). Such high 
values for total cellular RNA seem typical for Candida s p p  as a whole, with 
RNA accounting for approximately 157. of the dry weight of the cell ( 123, 185, 
246) (Assuming a dry weight of 40 pg per cell, the average RNA content of 
Candida s p p . in these reports, was approximately 6pg/cell). The value of
0. 64 pg/yeast reported here is rather lower than that found in the reports 
cited. It has been found that the RNA content of yeast cells has been found 
to decrease on "ageing" from 157. to 57. of the dry weight ( 7 ). Thus, 
starvation may have accounted for the apparently "low" RNA content of
C. albicans yeast reported here. As a further comparison, the RNA content of 
S. cerevisiae - an organism often compared with C. albicans (e.g. 345) - was 
estimated as 3.9 pg/cell (32).
In contrast to the finding that RNA content increased markedly during 
germ tube formation by C. albicans, the protein content per cell only increased 
slightly (Fig. 6.6). Thus, it would appear that RNA synthesis was not 
followed by an increase in protein content. The method used for estimation of 
protein content - i.e. that of Lowry et al (see 2.6.3) - was based on the 
quantitative colorimetric measurement of tyrosine and tryptophan and the 
peptide bonds in a protein. This would only measure the total protein con­
tent of the cell; no increase in protein content would be apparent if there 
was also an increase in protein degradation. In addition, this technique may 
only be sufficiently sensitive to monitor marked changes in protein content,
1. e. a greater than 307. increase in newly synthesised protein.
Previous data on protein content on yeast form cells, germ tubes and 
hyphae of C. albicans reported by other groups has been somewhat conflicting 
and contradictory. Some workers have reported that there is a decrease 
in protein content of yeat during germ tube formation (-6 4 ), whilst‘others 
maintain there is an increase (345)* It should be emphasised that the data 
cannot be readily compared due to the different conditions and times by which
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germ tubes of different strains of C. albicans are formed.
Undoubtedly, de novo synthesis of proteins does occur in C. albicans 
during germ tube formation. It has been found by several groups of workers 
that high levels of labelled precursor amino acids are rapidly incorporated 
into protein over this period (4, 42, 43, 234). In addition, germ tube 
formation by C. albicans, in suitable media, may be prevented by the addition 
of protein synthesis inhibitors, such as trichodermin and cycloheximide (345).
Alterations that occur during morphogenesis in protein synthesis have 
prompted several workers to try and identify and quantitate any phase specific 
proteins. Manning and Mitchell (234) used two dimensional (2 D) gel electro­
phoresis to analyse labelled proteins, synthesised during germ tube formation. 
The proteins were extracted from two different strains of C. albicans, growing 
at two different temperatures, which resulted in germ tube formation in the 
susceptible strain. This group found that there did not appear to be any 
major differences between the major protein components of the cell. However, 
they did report the existence of 33 yeast and 10 mycelial specific proteins.
The mycelial proteins were found to have similar antigenic determinants to 
those in the yeast form (235). This indicated that the 10 proteins apparently 
specific to the mycelial form may have been modified from proteins also found 
in the yeast form. Brown and Chaffin ( 42 ) also reported the existence of 
yeast form specific proteins, on analysis of approximately 230 proteins, by 
2 D gel electrophoresis. This group used a temperature shift to induce germ 
tube formation by C. albicans from which only 5 proteins, specific to the yeast, 
were observed. The high number of apparent specific yeast form proteins found 
by Manning and Mitchell (234) almost certainly includes some proteins specific 
to the different strains.
The existence of yeast phase specific proteins is in contrast to the 
results of Brummd and Soil ( 43). These workers reported there appeared to be 
no major differences between proteins synthesised during "germ tube formation" 
and blastospore development. However, examination of this report reveals that 
these workers may have been studying pseudo-mycelial development, rather than 
germ tube formation. Work recently published has complicated rather than
A
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clarified the position over form-specific proteins. Ahrens et al reported
both yeast and mycelial specific proteins ( 4 ). This group used a pulse/
chase method of protein labelling and temperature induced germ tube formation
of yeast cells growing in exponential phase. This group also analysed proteins
precipitated by a low speed centrifugation, in addition to those in cell free
extract which the other groups (42, 43, 2343 discarded. These groups had
35 3labelled proteins with either C S ] or [ H ] precursors and induced germ tube 
formation from cells in the stationary phase of growth. The major problem 
with the attempts to identify phase specific proteins is that differences in 
environmental conditions and strain variation have been used as a basis for 
the induction of germ tubes. Thus, one should be aware of this problem when 
trying to draw any firm conclusions from these workers research.
It seems reasonable to suggest that proteins newly synthesised during the 
formation of germ tubes will include those associated with NAG metabolism.
As noted in 6.4.2 polymerised NAG subunits form the important cell wall com­
ponent chitin. It was mentioned on page 179 that the increase in activity of 
these enzymes was sensitive to protein synthesis inhibitors. In addition, the 
development of suitable systems for the uptake of inducing agents, like NAG, 
has also been found to be sensitive to protein synthesis inhibitors (126).
One may expect, as germ tube formation is a cell wall morphogenesis, the 
synthesis of cell wall and membrane associated proteins.(e.g. chitin synthetase 
(73) and f i  1.1 - 3) glucan synthetase (125) )■ Recent work (60 ) has indicated 
that these cell wall proteins are the same in both phases of C. albicans.
As the majority of proteins from both phases of the fungus are similar, 
it is possible that any different less abundant proteins may serve a regulatory 
function. Brown and Chaffin ( 42 ) noted that the total proteins observed in 
their analysis represented a small proportion of the total genetic coding 
capacity of C. albicans - only those relatively abundant were visualised.
Thus, the dimorphism of C. albicans may be regulated by hyphal or yeast phase 
specific proteins or proteins that modify proteins already present.
Knowledge that protein synthesis may be regulated by cyclic nucleotide
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levels, has led several groups to Investigate possible roles for these 
compounds in dimorphic transformations. Larsen and Sypherd (208) first 
remarked on a correlation between intracellular cAMP levels and the morpho­
logical form of the fungus Mucor racemus. (Later research by the same group 
indicated that cAMP levels were not the sole factor for controlling mycelial 
to yeast development (283) )• The dimorphic fungus H. capsulatum is 
reported to have five times the cAMP concentration in the mycelial compared 
to the yeast form (237).
It has recently been found (68, 276) that cAMP levels increased to at 
least twice those of yeast C. albicans prior to germ tube formation. In 
addition, cAMP may induce the germination of 607. yeast cells under conditions 
that normally did not result in germ tube formation. However, evidence 
implicating cAMP in the phenomenon of germ tube formation is by no means 
unequivocal. Sullivan and Shepherd (369) reported that the cAMP levels did 
not change over the period of germ tube formation in buffer containing serum. 
This group believed that the conflicting results were due to the cellular 
metabolism adjusting to the effect of the nitrogen rich sources, used by Nimii 
et al (276) and Chattaway et al (68), for inducing the yeast-mycelial trans­
formation. Thus, the precise aetiologlcal relationship between cAMP levels 
and the yeast-mycelial transformation remains unclear.
6.4.4 RNA synthesis by C. albicans during the yeast-mycelial transformation
De novo RNA synthesis by C. albicans during and after germ tube formation 
was measured by the incorporation of labelled uridine into TCA insoluble 
material. Essentially similar conditions to those described in 3.3.2 were used 
to measure this process in yeast cells and protoplasts.
An interesting result was found when exponential phase yeast cells were 
incubated in protoplast buffer (containing 50 mM fructose) at 37° C. and 
1 nmole of uridine. It was found that 29 pmoles of C ^ c j  uridine were
incorporated by 2.5 x 10^ yeast cells over 40 min incubation at 37° C.. If 
one assumed a linear rate of incorporation, over the 40 min, 2.9 x 10 ^  moles
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of were incorporated min  ^per exponential phase yeast cell. As a
comparison, the level of [ ]  incorporated into C. albicans in germ tube
1 Ainducing media was measured. It was found 71, 23 and 12 pmoles of £ CJwere 
incorporated by 2.5 x 10^ cells in buffer containing 27. serum, 1.25 nil glu 
plus gin and 1.25 mM NAG respectively. Assuming linear incorporation of label 
into RNA over the assay period, the rate of incorporation may be found. 1.6 
x 10 5.1 x 10 ^  and 3.2 x 10 pmoles of were incorporated min *
by yeast in buffer containing serum, glu plus gin and NAG. These values 
represent levels of incorporation of C ^ C j  into RNA 55, 17 and 11 times that 
of cells harvested in the exponential phase of growth. It should be borne in 
mind that any attempt at comparing relative rates of RNA synthesis, based on
incorporation of label into RNA, should take into account any effects due to
' 14dilution of the label in the precursor pools. Thus, the higher rates of [ C J
incoporation into RNA by yeast during germ tube formation, compared to expo­
nential phase^may reflect less dilution of the label in the pools rather than 
greater levels of RNA synthesis.
The effect of altering the serum content in the imidazole buffer and the 
concomitant effect on labelled uridine incorporation by yeast cells, during 
the yeast-mycelial transformation, was as shown in Fig. 6.7. Increasing the 
concentration of serum in the buffer increased the rate for all the cells to 
possess germ tubes (see Fig. 6.1). In addition, increasing the serum content 
increased the rate, and maximum amount, of C ^ C j  uridine incorporated into 
RNA. Thus, higher levels of RNA synthesis were associated with conditions 
that promoted the most rapid germ tube formation. RNA synthesis continued 
after all the cells had formed germ tubes. This may reflect RNA synthesis 
required for elongation of the hyphal shoot until development ceased.
It was found that the level of C ^ C ]  incorporated by the yeast into RNA 
decreased after 16 hr incubation in buffer containing any of the concentrations 
of serum tested. Two explanations could account for this decrease in the 
level of [U C] incorporation. Firstly, degradation of the labelled RNA 
(synthesised by the yeast cell since the start of Incubation) could occur as
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part of the natural turnover of RNA. If unlabelled uridine, synthesised by 
the yeast itself was used as the precursor for new RNA the level
of L C] incorporated would decrease. Alternatively,RNA synthesis by 
the yeast cell may have slowed, or terminated, with no replacement of RNA 
that had been degraded by RNases. The former point would imply that exogenous 
label was diluted to a greater and greater extent as the incubation progressed. 
(This ought to be reflected by a non-linear increase in incorporation of label 
into RNA).
A pertinent question concerns the- extent the label was diluted by the
pool of "cold" precursor uridine. Labelled uridine was added, at different
times during germ tube formation, to investigate if the precursor was diluted
3to the same extent over this period. When C H] uridine was added to the sus­
pension, after 0, 2, 4 and 6 hr incubation, the label was immediately incor­
porated into RNA at similar linear rates (Fig. 6.11). One may tentatively 
conclude that there was little change in the rate of incorporation of label 
into the intracellular pool and thence into RNA.
The effect of different concentrations of NAG, in the imidazole HC1 
buffer, on RNA synthesis by C. albicans incubating at 37° C. is shown in Fig. 
6.8. It was found that altering the concentration of NAG did not markedly
alter the time course for incorporation of labelled uridine into RNA. Incor- 
r 14poration of [ CJ uridine into RNA of cells incubating in buffer containing 
NAG increased with time for 6 hr incubation at 37° C.. After this period the 
level of C14Cl incorporated into RNA remained at a similar level 
for the next 14 hr. A time course for germ tube formation, in NAG containing 
buffer, showed all yeast had produced germ tubes after 10 hr incubation (Fig. 
6.2). Thus, RNA synthesis, by yeast in NAG-containing buffer, was associated
with germ tube formation by the cells.
3
Addition of [ H ] uridine to yeast in buffer containing NAG, after 0 and 2 
hr Incubation at 37° C., revealed non-linear incorporation of C^h J uridine 
for 6 hr (Fig. 6.12). After 6 hr there was no change in the level of ( H J 
uridine incorporated into RNA. When labelled uridine was added to the cell
/suspensions, after 4 and 6 hr incubation, little or no incorporation of label 
into RNA after 6 hr, was found. These findings could be explained by the 
level of RNA synthesis, by yeast, decreasing as the incubation - and germ 
tube formation - progressed. These findings suggest RNA synthesis, by 
C. albicans during germ tube formation in NAG-containing buffer, was linear 
for the first 6 hr. Label was incorporated from the medium into RNA, without 
dilution by the precursor pools. However, after this period there was a 
decreasing rate of incorporation of label into RNA and an increasing dilution 
effect of the pyrimidine pools.
The effect of varying the concentration of glu in the imidazole buffer on
RNA synthesis by yeast cells is shown in Fig. 6.9. A time course showed that 
#■14 iL Cj incorporation into RNA increased with time over the 22 hr period of 
incubation at 37° C.. Varying the concentration of glucose, in the buffer, 
did not alter the rate of incorporation of C^ C j  uridine into RNA by yeast. 
Uridine incorporation into RNA proceeded at a similar rate to that found by 
cells in NAG containing buffer for the first 8 hr incubation. However, over 
the next 12. hr incubation, the amount of C 14c] incorporated into RNA by cells 
in glu-containing buffer increased. In this buffer, yeast C. albicans formed 
germ tubes after 10 hr incubation at 37° C. (Fig. 6.4). Thus, RNA synthesis 
was associated with germ tube formation and continued after all the cells had 
produced germ tubes. If C H ] uridine was Ridded to yeast at different times 
of incubation in glu-containing buffer, the label was immediately incorporated 
at a similar linear rate (see Fig. 6.13). Thus, incorporation of the radio- 
actively labelled precursor into the pyridine pool, and then into RNA, 
proceeded at a linear rate for the first 10 hr incubation.
Yeast incubating in buffer containing NAG or glu all produced germ tubes 
with a length of 15 - 30 >im, Incubation in these buffered media was not 
accompanied by development of the yeast to the multicellular hyphal state. 
Hence, the initial stages of the yeast-mycelial transformation by C. albicans 
in buffer containing NAG or glucose were similar in these respects.
However, in the latter buffer C. albicans continued the synthesis of RNA long
A
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after this process had slowed/stopped on incubation in NAG containing buffer.
r 14 ,The effect on incorporation of [ CJ uridine into RNA by C. albicans in 
buffer containing different concentrations of giu plus gin is shown in Fig. 6.10. 
Increasing the concentration of glu plus gin in the buffer increased the rate of
incorporation of label into RNA for the first 12% hr of incubation. After this 
r 14 nperiod, the level of L C J incorporated into RNA by yeast in buffer containing
»14 -i25 mM glu plus gin decreased over the following 10 hr. The level of L C J
incorporated into RNA by yeast in buffer containing 5 mM glu plus gin decreased
after 16 hr incubation at 37° C.. It was found cellular growth (as measured by
absorbance - see Fig. 6.3) increased after 16 - 22 hr incubation of C. albicans
•» 1 4  *iin buffer containing 25 mM and 5 mM glu plus gin. Thus, the decrease in L C J
incorporation into RNA appeared to be associated with a period of growth by the
yeast. This contradiction could possibly be explained by natural turnover of
the RNA synthesised (and hence labelled) since the start of the incubation. If
this RNA was replaced with RNA containing unlabelled nucleotides, synthesised by
_ 14 ,the yeast using unlabelled precursors, the level of [ C J incorporation would
_ 14 -decrease. The level of [ CJ uridine incorporated into yeast, in buffer containing
either 1.25 mM or 0.25 mM glu plus gin, increased over the 22 hr incubation
period. Qualitatively, this result is similar to that found for yeast incubating
in buffer containing low concentrations of glu. RNA synthesis by C. albicans in
buffer containing low concentrations of glu plus gin was associated with germ
tube formation. Incorporation continued after all the cells possessed germ tubes.
»14 _Quantitatively, higher rates of L CJ incorporation were found, when yeast cells 
were incubated in buffer containing 1.25 mM glu plus gin compared to yeast in 
buffer containing glucose only. When labelled uridine was added to yeast, after 
various times of incubation in buffer containing 1.25 mM glu plus gin, it was 
incorporated immediately into RNA at similar rates (see Fig. 6.14). Thus, the 
[3H] uridine was incorporated into the precursor pool and then into the RNA at a 
similar rate when added to the suspension.
Perhaps the overall conclusions from the results shown in this section, is 
that RNA synthesis is associated with germ tube formation by C, albicans NCPF3153.
//
In contrast to the findings of Shepherd et_al_ ( 345), it was found that the presence 
of different inducing agents, at various concentrations, resulted in different 
rates of incorporation of labelled uridine into RNA. Shepherd et al (345) reported 
that incorporation of label into RNA by cells incubating in "simple" (i.e. NAG or 
glu plus gin) buffered media ceased when 607, of the cells possessed germ tubes.
It was reported here that only cells in buffer containing NAG showed a similar 
qualitative result. In more "complex" tissue culture media (e.g. serum), Shepherd 
et al reported a continuation of RNA synthesis until the yeast developed to the 
hyphal state. RNA synthesis continued after germ tube formation, when C. albicans 
NCPF3153 was incubated in buffer containing serum, glu plus gin and glu only. 
However, full development to the multicellular state did not occur after the 
cells formed germ tubes. Thus, the level, and rate, of labelled uridine incor­
poration into RNA was dependent upon the buffered medium, in which the yeast cells 
were incubating, to a greater extent than the cells ability (or otherwise) to 
form germ tubes.
6.4.5 The effect of inhibitors of transcription and translation on germ tube formation 
by C. albicans
In order to further examine the involvement of RNA synthesis in the yeast- 
mycelial transformation, the effect of several inhibitors of transcription on 
germ tube formation was investigated. The results obtained in Fig. 6.15 show the 
effect of some inhibitors of transcription and translation on germ tube formation 
by yeast cells incubating in buffer containing 1.25 mM NAG. A similar result 
for time course and sensitivity of germ tube formation to the drugs was found 
for cells in 1.25 mM glu plus gin and 1.25 mM glu only. Cells in buffer contain­
ing 27. serum exhibited similar sensitivities to the drugs, although the time 
course for germ tube formation was more rapid. It should be noted that the 
figure shows the effects of the drugs on germ tube formation and not on elon­
gation.
Inhibitors of RNA synthesis were added to the cell suspension, at the cornn- 
encement of incubation, to final concentrations of 0.2 mM. The drugs were added
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in DMSO, so the final concentration of the solvent was not greater than 1%, It 
was found that DMSO concentrations higher than this had a deleterious effect on 
the ability of cells to form germ tubes. This was reflected in the lower 
percentage numbers of cells (i.e. 507.) having germ tubes, after 10 hr incubation 
in buffer containing higher (i.e. 57.) concentrations of DMSO compared to control 
cultures. It is well known that DMSO is a solvent that can alter the integrity 
of the cell membrane (see 5.4.2 and also 322). It is this property that is 
presumably responsible for the effect on germ tube formation, when concentrations 
of DMSO greater than 17., were added to cell suspensions. The yeast-mycelial 
transformation manifests itself visually as an outgrowth from the membrane. In 
addition, RNA synthesis by cells was inhibited by concentrations of DMSO as low 
as 107. when incubated in buffer containing components which promoted germ tube 
formation.
It has been noted in the literature that inhibitors of RNA synthesis can 
inhibit germ tube formation (126,280,345). Indeed, it was found (Fig. 6.15) 
that lomofungin, rifamycin AF/013 and rapamycin all had an effect on germ tube 
formation by C. albicans. Both lomofungin and rifamycin AF/013 inhibited RNA 
synthesis by yeast, in suitable germ tube inducing media, by approximately 90 - 
1007. and 80 - 957. respectively (see Table 6.2). These results suggest RNA 
synthesis is necessary for germ tube formation.
The addition of rapamycin to yeast in serum-containing buffer inhibited RNA syn­
thesis. Rapamycin is a strong inhibitor of growth of C. albicans (16), with
concentrations as low as 0.005 pg/ml ( 5 n.M) showing some effect on growth 051)-
32Concentrations of 0.02 ;ug/ml (0.02jiM) inhibited incorporation of Hj [ Pi 0^ 
into RNA by C. albicans by 497.. Thus, it seems surprising that 0.1 mM (100/ig/ml). 
rapamycin actually stimulated incorporation of C^H] uridine into RNA during germ 
tube formation in imidazole buffer containing NAG or glu plus gin. Singh et al 
commented that rapid growth, in a "complete" medium, seemed to be essential for 
the inhibitory effect of rapamycin. It was found when C. albicans was suspended 
in Tris HC1 buffer containing glucose, rapamycin did not have any effect on RNA 
synthesis (351). The increase in incorporation of C Hi uridine into RNA, found
/when C. albicans was incubated in buffer containing NAG or glu, may have arisen 
as a consequence of the drug affecting other metabolic processes.
It was established, in the previous section, that the level of RNA synthesis 
by C. albicans NCPF3153 depended upon the medium in which the cells were incubated. 
Thus, the activity of those many enzymes and components which control RNA syn­
thesis may vary according to the incubation conditions. Any compound which 
affected the control of gene expression would exhibit an effect on RNA synthesis 
which was apparently dependent upon the media. Thus, rapamycin may have had a 
direct effect on expression of DNA. Whatever method accounted for the effects of 
rapamycin against C. albicans, it was clear that this compound inhibited germ tube 
formation.
Actinomycin D did not inhibit germ tube formation. This was a surprising 
result in view of the result found using other RNA synthesis inhibitors. Neither 
the time course nor the percentage of cells possessing germ tubes was affected by
the presence of actinomycin D. It was found (Table 6.2) that, at the same con­
centration, RNA synthesis by yeast cells in suitable buffer was 26 - 54% that of
controls. This presumably represents synthesis of A-U rich RNA by C. albicans in
media that promoted germ tube formation. (Actinomycin D inhibits RNA synthesis 
by intercalation with G-C rich regions of the DNA (31) ). This germ tube form­
ation may be associated with the synthesis of A-U rich RNA. It is possible that 
translation of such an RNA transcript would result in a protein containing hydro- 
phobic amino acids as part of the sequence (394). Such a protein would be an 
ideal candidate for a membrane associated component. Since germ tube formation 
is initially distinguishable as a membrane associated event, it is possible the 
synthesis of such a protein may be required for this process.
It was noted earlier, in this section, that the addition of lomofungin and 
rifamycin AF/013 to the yeast suspension inhibited germ tube formation. These 
compounds greatly inhibited RNA synthesis, by inhibition of initiation by KIW. 
polymerases (see 5. 1 ). The germ tubes formed by yeasts in suitable buffer
containing actinomycin D were 5 - 10 /im in length. In contrast, the germ tubes 
of yeast from control cultures were longer than 15 ¿an. It is possible that the
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synthesis of G-C containing RNA molecules was required for this step. Alternat­
ively, the mRNA species that coded for proteins necessary for elongation may 
have been present, prior to the induction of the germ tube and the addition of 
actinomycin D.
The effects of rifamycin AF/021, lomofungin and rapamycin on germ tube 
formation were reversible. It was found that inocula, kept for 12 hr in buffer 
containing the drugs, were able to form germ tubes when resuspended in suitable 
media. In. contrast to the effects of inhibitors of RNA synthesis, it was found 
that cycloheximide and chloramphenicol did not have any effect on germ tube for­
mation. This would appear to indicate that protein synthesis was not required 
for successful germ tube formation by the yeast. Cycloheximide concentrations of 
10”6 - 10^ M strongly inhibit eukaryotic protein synthesis in systems as diverse 
as Chlorella and rats (392). However, it is probable that the concentrations 
of cycloheximide used in the buffer (i.e. 10 ^ M) were insufficient to inhibit 
protein synthesis by C. albicans. It has been found by other workers (e.g. 345, 
409) that other protein synthesis inhibitors such as trichodermin or puromycin 
prevented germ tube formation by the yeast. Mitochondrial protein synthesis was 
not required for germ tube formation as chloramphenicol - an inhibitor of prokar­
yotic and mitochondrial protein synthesis - was not effective.
It was reported that RNA polymerase III from C. albicans yeast was sensitive 
to 2.00 ^ jg oe-amanitin/ml (see 4.4.'l), It was found that concentrations of 200 ¿ig/ 
ml completely inhibited germ tube formation by C. albicans in serum-containing 
buffer. At a concentration of 20 ¿ig/ml the amatoxin did not have any effect on 
germ tube formation by yeast in conditions that promoted this phenomenon (results 
not shown). This result indicated that at least RNA polymerase III directed syn­
thesis was required for successful germ tube formation.
6.4.6 RNA species synthesised by C. albicans during germ tube formation
It is now firmly established that the ultimate control of cell differen­
tiation resides in gene activation and repression. Regulation at the transcrip - 
ional level received its original impetus from the studies of Monod, Jacob
/et al on inducible and repressible enzymes in bacteria (175,265}. Since then, 
attempts to unravel the mechanisms involved in the regulation of this process, 
in both prokaryotes and eukaryotes, have continued unabated. Many investigations 
into the regulation of specific genes have been conducted in organisms that 
produce abundant quantities of the desired gene product (e.g. the vitellogenin 
gene from X. laevls oocytes (1 1 4-) ). Attempts have also been made to correlate 
the levels of abundant RNA species (i.e. rRNA and tRNA) with changes in cellular 
growth or differentiation. This section will investigate whether the levels of 
these RNA species changed over the initial 5 hr period of yeast in media that 
promoted germ tube formation.
RNA synthesised by C. albicans, incubating in buffer containing either 1.25 mM
NAG or 27. serum, was labelled with either C ] uridine or [ ^ P  ] sodium ortho-
32phosphate. Qualitative information was provided by electrophoresis of C P ]
32labelled RNA on 1.37. agarose slab gels. These revealed that the [ P] labelled
RNA was associated with the more abundant rRNA and tRNA species. The nature of
slab gel electrophoresis is such that it is difficult to discern quantitative
levels of the higher and lower M.W. RNA species. As a consequence, the changes
in the relative levels of these RNA molecules was monitored using methods that
allowed a quantitative interpretation to be made.
The L CJ labelled RNA was extracted from yeast in the two buffered media
used to promote germ tube formation. The RNA was extracted after 1, 2, 3, 4 and
5 hr incubation in buffer containing NAG or serum. This RNA was analysed, by
PAGE, on 2.57. polyacrylamide/0.57. agarose tube gels. Figs. 6.16 - 6.25 show the 
p 14 iposition the L CJ labelled RNA migrated under electrophoresis in denaturing
a \L\ •conditions. These figures show the peaks of I. CJ label incorporated into the 
25 S, 17 S and 5 S rRNA and 4 S tRNA. The position of the 5.8 S rRNA was infered 
from the mobility of T. pvriformis RNA under the same conditions (see 3.3 3).
Several eukaryotic organisms have been studied to obtain information on the 
quantitative and qualitative activies of the RNA polymerase isozymes. However, 
the results have not led to any definitive conclusions in correlating the synthetic 
rates, or the quality and quantity of RNA present in the cells, with the level of
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in vitro RNA polymerase activity. It was reported in 6.4.3 and 6.4.4 that the
quantitative levels of RNA synthesised (measured by incorporation of labelled
uridine into RNA and by the orcinol method for levels of total RNA) depended
upon the media in which the yeast cells were suspended. It was found that
during germ tube formation by C. albicans, the products of RNA polymerase I and
III directed synthesis increased. Quantitative information on the levels of
these RNA species would give an approximate indication of the in vivo activities
of the RNA polymerases.
i * l 4  TThe ratio of L Cj incorporated into RNA larger than 5 S to that smaller 
than 5 S approximates to the in vivo activities of RNA polymerases I and II to 
RNA polymerase III. Evidence that yeast C. albicans RNA polymerase III was 
responsible for the synthesis of 5 S rRNA and 4 S tRNA was provided in 4.3.12.. 
However, it was not possible to positively correlate the synthesis of the large 
rRNA precursor and hnRNA with RNA polymerases I and II by the same method. This 
was because RNA polymerase II exhibited unusual (for higher eukaryotes at least) 
sensitivity to °<-amanitin. It was assumed that RNA polymerases I and II from 
C. albicans yeast were responsible for the synthesis of rRNA and hnRNA respect­
ively. This is a characteristic attributable to all eukaryotes possessing three 
isozymes,which are resolvable by DEAE-sephadex chromatography (see 1.3.3).
Fig. 6.26 showed how the ratios, for RNA extracted from yeast in NAG or 
serum-containing buffer, changed over a 5 hr incubation. The ratio of RNA poly­
merase I and II directed synthesis to that of RNA polymerase III, of yeast in 
NAG-containing buffer, did not change markedly over this period. At the end of 
this period only 507. of yeast had germ tubes. In contrast, the ratio of isozyme 
activities decreased, over the same period, when yeast cells were incubated in 
serum-containing buffer. In this media, all yeast produced germ tubes after 4% hr 
incubation at 37° C.. These results Indicate that the period before the appear­
ance of germ tubes by yeast was associated with relatively high levels of RNA 
polymerase I and II directed synthesis. As soon as all the yeast had germ tubes
_  I  Amost of the (. CJ was associated with RNA synthesised by RNA polymerase III.
Hence, the levels of RNA species synthesised by the three RNA polymerases changed
/' /
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over the period of germ tube formation by yeast in serum containing buffer.
Ribosomes are required for protein synthesis. Continuous formation of 
ribosomes does take place throughout the life cycle of eukaryotic cells (222). 
The stimulation of rRNA synthesis has been reported in rapdily growing 
fibroblast cells (315)» It has been reported that there is a dramatic increase 
in rRNA synthesis in rapidly growing S. cerevisiae (390). This presumably 
represents the requirement for a higher level of protein synthesis during 
such growth periods as these. (In addition, there is amplification of the 
rDNA genes in cells undergoing rapid growth - such as Xenopus oocytes (222) ). 
Regulation of rRNA synthesis may operate by changing the number of active 
rDNA genes or the rate of transcription of these genes. It is evident (Figs. 
6.16 - 2 0) that, in serum-containing buffer, there is a decrease in the 
relative amount of RNA as rRNA in ribosomes, as all the yeast produced germ 
tubes. In contrast, there was no marked change in the proportion of RNA as 
rRNA over the 5 hr period the yeast were incubated in NAG containing buffer. 
These results suggest that there was a high level of protein synthesis 
associated with germ tube formation. Subsequent growth - i.e. germ tube 
elongation - was associated with lower relative levels of protein synthesis - 
at least when incubated in serum-containing buffer.
The synthesis of RNA polymerase III directed transcription is independent 
of the synthesis of the rRNA precursor in both higher (139) and lower 
eukaryotes (225) • This is especially surprising in the case of 5 S rRNA 
synthesis. This molecule is an integral part of the large (60 S) subunit, 
always present in a lsl molar ratio to the 25 - 28 S and 5.8 S rRNA species.
In addition, the number of gene copies per genome is about the same for 5 S 
rDNA and rDNA (379). The rate of 5 S rRNA synthesis in sea urchin has been 
found to fluctuate with the growth stage of the organism (225) which suggests 
the synthesis of this gene product responds to the stimulus of growth. The 
levels of tR)lA - also required for protein synthesis during periods of growth 
- have been found to increase during growth in S. cerevisiae (390)•
As protein synthesis requires mRNA for translation, one might expect an
/
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increase in the levels of these species during a period of growth. However, 
extraction and analysis of RNA, as described in the methodologies of 2.7.1 
and 2.8.1, is unlikely to yield information on mRNA levels during germ tube 
formation. This is because much lower levels of mRNA are found compared to 
the other more abundant RNA species. It is probable that the mRNA synthesised 
during the yeast-mycelial transformation contained sequences coding for the 
synthesis of such proteins as the large and small ribosomal subunit proteins 
and enzymes such as chitin synthetase pro-enzyme and other proteins concerned 
with changes in the cell wall. These proteins would respectively be required 
for new ribosome synthesis and also for wall morphogenesis - i.e. germ tube 
formation (see 6.4.2).
CHAPTER 7 GENERAL DISCUSSION
7.1 Introduction
This chapter will assess the suitability of RNA synthesis as a target 
site for novel inhibitors of C. albicans in relation to other sites for 
chemotherapy. The results from the thesis will be reviewed and discussed 
in relation to possible lines of future research.
7.2 RNA synthesis in C. albicans
The overall conclusion from results presented in this thesis is that 
RNA synthesis in C. albicans, whilst showing a few similarities to the same 
process in S, cerevisiae. is more typical of fungi imperfectii. This may 
be illustrated by the ex'—  amanitin insensitivity of RNA polymerase II from 
yeast form C. albicans. It was found this enzyme was insensitive to concen­
trations of 1 mg oc— amanitin/ml (see 4.3.12). The o<— amanitin sensitivity 
of this isozyme was completely unexpected. RNA polymerase II is usually 
sensitive to very low (less than 1 >ug/ml) concentrations of <x — amanitin.
It is only RNA polymerase II from fungi, especially fungi imperfectii, that 
show unusual sensitivity to this octapeptide (see 4.4.2). However, the 
monovalent and divalent cation sensitivities were similar to the results 
found for S. cerevisiae RNA polymerases I, II and III. The differences in 
oc — amanitin sensitivities between C. albicans and mammalian RNA polymerases 
suggest a potentially exploitable difference between the pathogenic fungus 
and it’s host.
A number of nucleoside analogues (78192, 82939 and 113786) were discovered 
to be very effective inhibitors when tested in an in vitro assay for RNA 
polymerase, but were less effective in an in vivo assay. This pattern of 
inhibition was the same for the two cyclizidine derivatives (95154 and 95464) 
and for aphidicolin and rapamycin. On the other hand nucleoside analogues 
69619, 78053 and 78191 showed greater inhibitory activity against in vivo 
compared to in vitro RNA synthesis. This suggests these compounds may be
metabolised to more potent inhibitors of RNA synthesis. Fairly high
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concentrations (1 mM) were used to establish whether the test compound 
showed any inhibitory activity. It would be necessary to show these 
nucleoside analogues were effective inhibitors of RNA synthesis at lower 
(1yuM) concentrations in order to warrant further investigation.
It was shown in chapter 6 that radioelabelled uridine was rapidly 
incorporated into RNA by yeast cells during germ tube formation. In fact 
the rate of incorporation of C ^ C ]  uridine into RNA by yeast during this 
process was more than seventeen-fold greater than that of exponential phase 
yeast cells (see 6.4.4). These results suggest that the yeast-mycelial 
transformation might be an excellent target for chemotherapy by inhibitors 
of RNA synthesis. It was found that the rate of incorporation of radio- 
labelled uridine into RNA was affected by the media used to promote germ tube 
formation (see 6.4.4). In addition, over the period all yeast produced germ 
tubes, the proportion of RNA synthesised by RNA polymerase III increased.
This suggests that in vivo. RNA polymerase activity of C. albicans responds 
to environmental stimulii.
7.3 Other potential sites for chemotherapy
Any drug that is used against C. albicans, as a pharmaceutical prep­
aration, must show differential sensitivity between fungus and host.
Present ethical and commercial demands dictate that any antifungal agent pro­
duced by a pharmaceutical company is demonstrably safe - whatever the 
mode of action.
At the present time, the sites which best hold the promise of new 
C. alblcans-specific agents are the cell wall and membrane. Differences 
between C. albicans and mammalian cell membranes are well documented.
Mammalian cells, of course, have no cell wall. Inhibitors specifically 
against C. albicans cell wall or membrane would, hopefully, show no activity 
against the mammalian cell. As the cell wall and membrane are the boundaries 
between cell and environment, any inhibitor of this site need not be trans­
ported into the cell. However, the enzymes responsible for the synthesis
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concentrations (1 mM) were used to establish whether the test compound 
showed any inhibitory activity. It would be necessary to show these 
nucleoside analogues were effective inhibitors of RNA synthesis at lower 
(1/¿M) concentrations in order to warrant further investigation.
It was shown in chapter 6 that radio»labelled uridine was rapidly
incorporated into RNA by yeast cells during germ tube formation. In fact
1 4the rate of incorporation of C C] uridine into RNA by yeast during this 
process was more than seventeen-fold greater than that of exponential phase 
yeast cells (see 6.4.4). These results suggest that the yeast-mycelial 
transformation might be an excellent target for chemotherapy by inhibitors 
of RNA synthesis. It was found that the rate of incorporation of radio- 
labelled uridine into RNA was affected by the media used to promote germ tube 
formation (see 6.4.4). In addition, over the period all yeast produced germ 
tubes, the proportion of RNA synthesised by RNA polymerase III increased.
This suggests that in vivo. RNA polymerase activity of C. albicans responds 
to environmental stimulii.
7.3 Other potential sites for chemotherapy
Any drug that is used against C. albicans, as a pharmaceutical prep­
aration, must show differential sensitivity between fungus and host.
Present ethical and commercial demands dictate that any antifungal agent pro­
duced by a pharmaceutical company is demonstrably safe - whatever the. 
mode of action.
At the present time, the sites which best hold the promise of new 
C. albicans-specific agents are the cell wall and membrane. Differences 
between C. albicans and mammalian cell membranes are well documented.
Mammalian cells, of course, have no cell wall. Inhibitors specifically 
against C. albicans cell wall or membrane would, hopefully, show no activity 
against the mammalian cell. As the cell wall and membrane are the boundaries 
between cell and environment, any inhibitor of this site need not be trans­
ported into the cell. However, the enzymes responsible for the synthesis
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of cell wall and membrane components are located on the inside of the 
membrane. Thus, only inhibitors of the relatively inert outer membrane or 
cell wall would avoid problems of membrane impermeability. Some inhibitors 
of these sites currently available, such as the polyene antibiotics, have 
the disadvantage of toxicity to mammalian cells (see 1.2.6).
Attempts could be made to produce antifungal agents that inhibit 
C. albicans-specific enzymes on the inner membrane, such as chitin synthet­
ase or /3 (1-3) glucan synthetase. Indeed, there are some inhibitors of 
chitin synthetase which have been tested for their efficacy against 
C. albicans. These compounds - the polyoxins - inhibit chitin synthetase 
activity in vitro (22). However, they have no effect on growth processes 
which require an increase in the amount of chitin, such as germ tube form­
ation. It has been suggested that the polyoxins are not getting to the site 
of chitin synthetase - possibly as a consequence of membrane impermeability 
(345).
7.4... Further research on RNA synthesis in C. albicans
It would be extremely satisfying, intellectually, to design an anti­
fungal agent that did not inhibit mammalian cells, based on the peculiarit­
ies of RNA synthesis in C. albicans. Subsequent research should concentrate 
on further exploring differences in RNA synthesis to those reported here. 
There are various techniques that could be used to achieve this aim.
7.4.1 Further research on RNA polymerases of C. albicans
Three RNA polymerase isozymes were obtained from yeast, and one from 
mycelial form C. albicans after ion exchange chromatography on DEAE-Sephadex 
(see 4.4.1). This is a similar result to that reported by Boguslawski 
e_t_al for RNA polymerases from mycelial and yeast forms of the fungus 
H. capsulatum (35). (However, three classes of RNA polymerases were 
recovered from the mycelial form and one from the yeast form of this 
dimorphic fungus). This group later reported that treatment of the cell
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free extract from yeast, with polymin P, resulted in three peaks of enzyme 
activity after ion exchange chromatography (203). It is possible that such 
a procedure might result in the resolution of three peaks of RNA polymerase 
activity when the cell free extract from mycelial C. albicans is chromat­
ographed on DEAE-Sephadex. Purification of these isozymes from mycelia 
would still be hampered by the need for large amounts of cellular material. 
As mycelial formation is only induced at low cell densities, large volumes 
of media (i.e. 100 L.) would thus be required.
Further research into RNA polymerases from C. albicans will require 
elucidation of the subunit composition of the three enzymes from both 
morphological forms. In addition, the divalent and monovalent ion optima, 
temperature and r<-amanitin sensitivities would show how comparable each 
RNA polymerase isozyme was. This would show if these enzymes from C, albicans 
had similar properties to those from other dimorphic fungi, such as 
H. capsulatura! (203).
Another approach to characterising RNA polymerases from C. albicans is 
on the basis of antibody specificity. It has been reported that antibodies, 
raised against RNA polymerase III from yeast form H. capsulatum showed 
only slight cross-reactivity against the same isozyme from the mycelial 
form (204-). This indicated there were structural differences between yeast 
and mycelial RNA polymerase III. However, other workers in this field 
(e.g. 138) believe that any subunit differences are a consequence of arte­
facts arising during purification. It would be interesting to investigate 
whether RNA polymerases from both morphological forms of C, albicans showed 
similar cross-reactivity to those reported for H. capsulatum. This would 
necessitate the purification to homogeneity of RNA polymerase enzymes from 
both morphological forms of C. albicans.
Production of antibodies, by conventional means, requires large (200 - 
300^ig) quantities of highly purified enzyme. However, the introduction of 
hybridoma cell lines to produce monoclonal antibodies has resulted in 
important advantages over production of antibodies by conventional means.
Unpurified molecules, that constitute only a small part of a complex 
mixture, may be injected into a test laboratory animal. The antibody- 
secreting B lymphocytes may be fused with tumour B lymphocyte cell lines 
and the hybridoma grown on selective media. The cells secreting antibodies 
against the enzyme may be selected from other clones. Such antibodies 
would constitute powerful tools for further investigations into RNA poly­
merases from C, albicans.
Factors which stimulate transcription by RNA polymerases have been 
purified from the nuclei of plants (218), animals (359) and lower eukaryotes 
(ICS). Purification of such a factor from C. albicans would potentially 
be very useful as a full understanding of the mechanism for stimulating 
enzyme activity is required for the design of specific inhibitors. Sawadogo 
et al have identified a protein from S. cerevisiae that stimulates RNA 
polymerase I and II on ds DNA templates (327). This basic protein, termed 
P37, (M.W. 37,000) does not stimulate wheatgerm or calf thymus RNA polymerase 
II (326).
Permeabilised cells present an excellent opportunity to study RNA poly­
merases, and the other components that direct accurate transcription in an 
almost in vivo state. This overcomes problems arising as a consequence of 
cellular membrane impermeability to large or charged molecules that may be 
used to probe RNA synthesis. Methods have been described for the preparation 
of permeabilised cells (298). These would require some modifications as the 
exact conditions to permeabilise the yeast cell depend upon the enzyme to 
be studied.
Isolated chromatin preparations present an opportunity to study trans­
cription of DNA in its natural state. However, the components that direct 
accurate transcription initiation are lost during isolation (see 3.A.3).
Thus, efforts should be made to isolate these components before any useful 
studies can be made on this in vitro system.
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7.4.2. Further research on RNA biosynthesis by C, albicans
Investigations were made into rRNA and tRNA synthesis by C. albicans 
during germ tube formation (see 6.4.6). Further research on the biosynthesis 
of these relatively abundant RNA species could be conducted during other 
growth periods, e.g. the regeneration of protoplast cell walls. It was 
found that a high proportion of RNA extracted from protoplast had high 
M.W. values (see 3.4.1). It would be interesting to see how the levels of 
these RNA species changed over the period of cell wall repair. In addition, 
rRNA and tRNA synthesis during exponential phase growth or mycelial develop­
ment could also be monitored. Results from these investigations would show 
if there were any similarities in biosynthesis of rRNA and tRNA by 
C. albicans in such widely differing situations.
Different approaches to those used for investigations into rRNA and 
tRNA synthesis are required for studies on mRNA biosynthesis. Most RNA 
extracted, as described in 2.8.1,is rRNA and tRNA (see 3.3.4). However, 
mRNA (and hnRNA from which it is derived) may be purified by the selective 
annealing of the poly A at the 3* end to a column containing covalently 
bound synthetic polynucleotides of T or II residues. The mRNA synthesised 
during various periods of growth could be radicactively labelled and 
extracted. Complementary DNA (cDNA) copies could be made of these RNA 
molecules using reverse transcriptase. These could be hybridised with 
mRNA synthesised during other periods of growth. This would show the 
extent of homology between mRNA synthesised during such periods.
Most studies on proteins synthesised during the yeast-mycelial trans­
formation have indicated the majority of such proteins are synthesised by 
both morphological forms (see 6.4.3). It is possible that any protein(s) 
responsible for regulating the dimorphic transformation may be present in 
minute quantities. Thus, previous attempts at radioactively labelling, 
extracting and analysing these proteins may not have been sufficiently 
sensitive for their identification. Amplification of the mRNA sequences that 
direct the synthesis of protein(s) responsible for regulation is possible
using cDNA copies. These cDNA copies could be cloned in a suitable vector. 
Thus, large amounts of DNA would be obtained that had sequences which could 
direct the synthesis of mRNA found in C, albicans during the yeast-mycelial 
transformation. This DNA could be sequenced and the amino acid sequence of 
proteins synthesised during germ tube formation elucidated.
Any comparative studies on RNA biosynthesis during different growth 
transitions should take into account the effects of changes in the purine 
and pyrimidine precursor pool sizes. It is possible these would change 
over the life cycle of C. albicans. These could be measured by techniques 
such as thin layer chromatography, as described by other workers (300).
Studies on the transport of drugs into C. albicans
Nucleoside analogue inhibitors were found which were very powerful 
when tested in an in vitro assay for RNA polymerase, but were not so 
effective in an in vivo assay (see 5.4.2). This may have arisen as a con­
sequence of cellular membrane impermeability - one of the major problems of 
drug design. One method that has been suggested for overcoming this problem 
is to covalently link the potential drug to a protein as a conjugate. 
Steinfeld et al chemically synthesised a 5FC-peptide conjugate using 
l-(ethoxycarbonyl)-2-ethoxy-l, 2-dihydroxyquinoline as the coupling agent 
and a variety of di and tripeptides (361). These were effective inhibitors 
of C, albicans growth at similar concentrations to 5FC (374). Tripeptides 
such as trimethionine have been suggested as "carriers" for inhibitors that 
were usually impermeable to the cell membrane (271). Hence, conjugates of 
drugs and peptides could enter C. albicans through the peptide transport 
system. Further research is required to obtain sufficient knowledge to 
suggest tripeptides that would be transported specifically into C. albicans. 
Thus, peptides covalently linked to some nucleoside analogues suggested in 
5.4.2 may be suitable carriers for these drugs.
It has been suggested that cellular membrane impermeability may account 
for some mammalian cell culture lines showing lower sensitivity to
/CX — amanitin than isolated RNA polymerase II. Hencin and Preston suggested 
the use of ot —  amanitin-B .S .A. conjugates to transport the amatoxin into 
susceptible cells. The covalent link would then be hydrolysed to result 
in free c<-amanitin (161). This finding seems in contrast to the results 
shown in 4.3.12. These revealed that, at a concentration of 200 >ig/ml, the 
amatoxin was able to enter C. albicans and inhibit RNA polymerase III 
directed synthesis. This suggests membrane impermeability to fx — amanitin 
may only be significant at very low concentrations of the amatoxin.
There are other oligo-peptides that are able to inhibit RNA synthesis 
in C. albicans. A protein has already been purified, from bull semen that 
inhibits this process in vivo. This protein, termed seminal plasmin (M.W. 
6,300), inhibits RNA synthesis in other micro-organisms (373). It would be 
interesting to study how this protein was transported into the cell and 
it's effect on the various components that control transcription.
7.4.4 Combination chemotherapy and alternative approaches to candidosis
Synergystic combinations of two or more antifungal agents has been 
suggested as a possible technique for reducing the effective cidal concen­
trations of these drugs when treating candidosis. The presence of sub- 
lethal concentrations of amphotericin B reduces the concentration of 5FC 
required to inhibit growth of C. albicans - presumably by disrupting 
membrane integrity (see 1.2.5). It is possible the efficacy of the nucleo­
side analogues that inhibited RNA synthesis in C, albicans might be increased 
by such an approach. This might provide an alternative method for over­
coming problems of cellular membrane impermeability shown by some nucleo­
side analogues to that suggested in 7.4.4 (i.e. by nucleoside analogue- 
peptide conjugates).
Other approaches have been made to antifungal chemotherapy over recent 
years. It has been reported that some micro-organisms may be inhibited 
when grown in the presence of furanoquinolines and UV light (377). If 
such UV mediated antibiotics had no side effects against mammalian dermis
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cells, there is a possible application for them as topical remedies against 
candidosis (376). However, as these compounds were mediated by UV 
radiation, they would only be applicable against superficial candidosis of 
cutaneous sites. Some workers have suggested vaccination against C. albicans 
as a possible treatment for candidal vaginitis (252). Later research has 
revealed that components which stimulate the granulocytic response include 
muramyl dipeptides (117, 243). These components could be used prophy- 
lactically to stimulate the host's immune response system against C. albicans. 
Some workers have even suggested a use for mannans from C. albicans as 
antiviral agents (201). However, such compounds that stimulate an immune 
response would not be useful against the most serious cases of candidosis, 
i.e. those in the immuno-compromised host (see 1.2.4).
7.5 Final conclusion
A start has been made on exploring RNA synthesis in C. albicans as a 
potential target site for antifungal agents. There are some results in 
this thesis which suggest RNA synthesis in higher eukaryotes might be 
sufficiently different to that in C. albicans. It is possible that these 
differences are worth pursuing to achieve a C. albicans-speclfic anti­
fungal agent.
Attempts to prepare suitable systems to study RNA synthesis in 
C. albicans were described in chapter 3. Protoplasts were successfully 
prepared from yeast cells in the exponential phase of growth. These were 
capable of incorporating radiolabelled uridine into RNA - most of which 
had a higher M.W. than 4 S. Protoplasts incorporated radiolabelled uridine 
into RNA at a slower rate than the exponential phase blastospores from which 
they were prepared. Thus, studies on in vivo RNA synthesis usually involved 
the use of exponential phase cells. The development of an in vivo assay 
to measure RNA synthesis in yeast cells was useful, as it allowed studies 
to be made on the effect of inhibitors on this process.
Nuclei were successfully prepared by the lysis of protoplasts. In view
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of the delicate nature of the nuclear membrane, and high degree of chromo­
somal organisation (see 1.3.1), it is perhaps not surprising that low yields 
of nuclei were obtained. The "high" DNA content of C. albicans nuclei is 
further indication that these organelles were disrupted during preparation. 
The assay conditions that supported RNA synthesis by C. albicans nuclei 
were similar to those described by workers using nuclei from other eukaryote 
There was evidence for disengagement of the RNA polymerases after transcrip 
tion termination, which is a characteristic often reported for nuclei from 
a wide variety of sources (e.g. 381). C. albicans nuclei showed higher 
levels of incorporation of . radiolabelled UMP into RNA at higher salt 
concentrations. It was found that a higher level of radiolabelled UMP 
was incorporated into RNA when the nuclei were incubated in buffer contain­
ing 100 mM compared to 10 mM MgC^. This is an unusual result compared to 
that found for nuclei from other organisms, where optima of 100 mM MgC^ 
are reported (251).
It is evident from the results discussed in 3.A.3 that RNase activity
was a considerable problem in the preparation of nuclei from C. albicans
protoplasts. The deleterious effect of these enzymes on the RNA species
rib - Isynthesised in vitro is evident (see 3.4.4). A greater proportion of 1. Cj
UMP was associated with the high M.W. RNA species, when nuclei were
incubated in buffer containing 100 mM compared to 10 mM MgC^. The
probable reason for this result was that high Mg+ *concentrations affect
the secondary structure of the RNA. At higher concentrations, there is an
increase in the extent of ds regions of RNA. The effect of RNases acting
on S 3 regions is therefore curtailed. Thus, the finding that C. albicans
14nuclei showed higher levels of incorporation of C CJ UMP into RNA in media 
containing higher MgCl2 concentrations, probably arose as an artefact of 
this particular system.
The purification of RNA polymerases from yeast form C. albicans, and 
the part-purification of those from the mycelial form was reported in 
chapter 4. Some characteristics of these enzymes were also reported in
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this chapter. The first step in the purification of the RNA polymerases 
was disruption of cells. The best method for this was homogenisation of 
the cells, with balotini, for 3 min at 0 - 4° C .. The following steps in 
the purification, needed to be carried out as quickly as possible. This 
was due to the degradative effects of proteases and RNases in the homo­
genate, which were not removed until the gel filtration step. RNA poly­
merase activiy was monitored after each step in the purification.
Initially this was done using the assay conditions that gave maximal incor­
poration of C14C] UMP into RNA by nuclei (see 3.4.3). However, it was 
found that the MgCl. concentration, of the assay "cocktail", had to be 
reduced to 10 mM to give optimal RNA polymerase activity in the homogenate. 
RNA polymerase activity appeared to decrease during the initial stages of 
purification, i.e. until the gel filtration step. It is probable that the 
methodologies used for these initial stages, i.e. high salt sonication and 
nucleic acid precipitation interfered with enzyme activity.
Ion exchange chromatography resolved the three RNA polymerases from 
yeast form C. albicans. In contrast, or'y one peak, of low activiy, was 
found for mycelial form RNA polymerases. RNA polymerases I and II from the 
yeast form were further purified by DNA cellulose chromatography. The 
KC1 concentrations, of eluting buffer, required to desorb these enzymes from 
DNA cellulose were similar to those reported for S. cerevislae. However, 
much higher salt concentrations were required to desorb C. albicans RNA 
polymerase III than those reported for the same isozyme from S. cerevislae. 
RNA polymerase III from C. albicans yeast was not chromatographed on DNA 
cellulose. The high salt concentrations required to elute this isozyme 
from the DNA would also have eluted the DNA from the cellulose.
Glycerol gradient centrifugation was the final stage in the purification 
of the three RNA polymerase isozymes from yeast form C. albicans. This 
step resulted in a drastic loss in the total activity of the three RNA 
polymerases. The specific activity of RNA polymerases I and II also 
decreased markedly. This indicates that the purified RNA polymerases are
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highly labile. Glycerol gradient centrifugation resulted in the purification, 
to electrophoretic homogeneity of the three isozymes. Only one band of 
protein could be visualised using the extremely sensitive staining technique 
devised by Merril et al (25P). Purification to homogeneity of the RNA poly­
merases from the mycelial form was hampered by the low RNA polymerase 
activity after ion exchange chromatography. Also, the low yields of mycelia 
obtained required very large volumes of growth media to cultivate the cells.
Some characteristics of partially purified RNA polymerases were discussed
in 4.4.2. The divalent cation optima for all three isozymes were 10 mM
|  |  |  |
and 0.5 m - l.OmM for Mg and Mn respectively. The salt optima for RNA 
polymerases I and II were 40 mM and 100 mM and biphasio optima at 100 mM 
and 240 mM for RNA polymerase III. These values are similar to those 
reported in the literature for S, cerevisiae. In addition, the Km for CTP 
of the three isozymes were estimated at 0.01, 0.02 and 0.06 mM respectively. 
These values are marginally higher than those reported for other eukaryotic 
RNA polymerases.
Possibly the most unusual finding of chapter 4 was that the three RNA 
polymerases from yeast C, albicans showed unusual sensitivity to 
amanitin. The o< — amanitin concentrations required to inhibit RNA poly­
merases I and III were similar to those reported for S. cerevisiae (138).
Much higher levels of the amatoxin were necessary to inhibit RNA polymerase 
II from C ■ albicans than found for this isozyme from most other eukaryotes.
It is worth remembering that RNA polymerase II from fungi in general, and 
fungi imperfectii in particular, show unusual sensitivity to <*— amanitin. 
Thus, the results shown in 4.3.12 may be a confirmation of this trend.
Chapter 5 dealt with some aspects of inhibitors of RNA synthesis in 
C. albicans. Initial investigations were conducted on the efficacy of 
lomofungin against growth and RNA synthesis of C. albicans. These studies 
revealed that lomofungin, at a concentration of 320 ¿jM, did not affect 
growth of C. albicans. This was in agreement with the findings of other
groups (1P4), who reported that concentrations of 1 mg/ml (3.2 mM) were
/necessary to inhibit growth of C. albicans. RNA synthesis, in protoplasts, 
was inhibited by the same concentration. In contrast, later studies revealed 
that concentrations of 1 mM, and even 0.2 mM, inhibited RNA synthesis in vivo. 
The most probable reason for this discrepancy lies in the relative insol­
ubility of lomofungin in water. Later studies used lomofungin, from a stock 
solution in DMSO. In this solvent lomofungin could be more easily mixed 
with the cell sample than when suspended in 5 mM NaOH. This illustrates 
the need for a suitable solvent, for dissolving a test drug, when studying 
the mode of action of inhibitors. Unpublished results (J.F. Ryley, personal 
communication) showed that lomofungin, at concentrations of 25 )ig/ml (80 ^ iM), 
inhibited growth of both morphological forms of C. albicans.
DMSO was the solvent used to prepare stock solutions of the uridine 
analogues tested against in vivo and in vitro RNA synthesis in C, albicans. 
These compounds were chosen from the collection of ICI Pharmaceuticals 
Division, on the basis of a similarity to uridine, a precursor nucleoside 
for RNA. The efficacy of these compounds was compared to other, well known 
inhibitors of transcription. It was found that 69619, 78053, 78192, 82939, 
113786, 113787 and 159391 inhibited RNA synthesis in vitro in cell free 
extracts. ICI compounds 69619, 78053, 78191, 78192, 113787 and 159391 
inhibited RNA synthesis in vivo in yeast cells. Potentially the most useful 
are those showing inhibitory activity against in vivo RNA synthesis.
RNA synthesis during the yeast-mycelial transformation was discussed in 
chapter 6. In order to achieve reproducible germ tube formation from 
C. albicans NCPF3153, the yeast had to be grown in nutritionally impoverished 
media and starved for at least 29 hr. Germ tube formation by C, albicans 
was induced when a small inoculum was incubated in buffer containing suitable 
inducing agents at temperatures above 37° C..
The time taken for all the yeast cells to have germ tubes depended upon 
the buffer in which the cells were incubated. Yeast cells incubating in 
buffer containing 57. serum showed the shortest time to form germ tubes. 
Lowering the concentration of serum increased the time taken for all the
-  206  -
yeast cells to form germ tubes and decreased the rate of Incorporation of 
radio labelled uridine into RNA. Yeast cells in buffer containing NAG, glu 
or glu plus gin were all able to form germ tubes. Varying the concentration 
of NAG or glu in the buffer did not affect either the time taken for all 
the cells to form germ tubes or the rate of incorporation of radiolabelled 
uridine into RNA.
3The rate of incorporation of [  H] uridine into RNA by yeast in buffer 
containing NAG, serum, glu or glu plus gin was measured over a 10 hr period.
A linear rate was obtained when yeast were incubated in buffer containing 
serum, glu or glu plus gin. When yeast was incubated in NAG-containing 
buffer, there was a non-linear increase in the rate of incorporation of 
label into RNA over 6 hr. After this period, there was no increase in the 
amount of label into RNA. These results indicated that [ H] uridine was 
incorporated into the intracellular uridine pool and into the RNA at a 
similar linear rate, whenever it was added to the cell suspension.
Chapter 6 also showed the results of studies on the effects of some 
inhibitors of RNA synthesis on germ tube formation. In agreement with other 
groups, these studies found that RNA synthesis was necessary for germ tube 
formation.
The ratio of high to low M.W. species was measured during germ tube 
formation by C. albicans. It was found that this ratio decreased during 
germ tube formation in serum-containing buffer. The ratio of high to low 
M.W. RNA, from yeast cells in NAG-containing buffer, did not change markedly 
over the same 5 hr period. All yeast, in buffer containing serum, had 
germ tubes after hr incubation. Only 507. of yeast cells, in NAG-containing 
buffer, had germ tubes after 5 hr incubation. These results indicated that 
the ratios of RNA polymerase I and II to RNA polymerase III directed RNA 
synthesis changed as the cells formed germ tubes.
The levels of RNA polymerase I directed synthesis were highest during 
the initial stages of germ tube formation - assuming, in C-i_albicans>, RNA
polymerase I was responsible for the synthesis of rRNA. It follows that
203
there was a high level of ribosome synthesis, impLying a high level of 
protein synthesis. Although the total RNA content of the cells increased 
during germ tube formation, there was no marked increase in total protein 
content. This apparent paradox may be explained by the synthesis of new 
proteins using amino acids from the pools of precursors found in the yeast 
cells.
In conclusion, the results presented in this thesis have indicated that 
RNA polymerases from C. albicans are different to those from higher 
eukaryotes. Thi3 suggests RNA synthesis is a possible target site for novel 
inhibitors. Some novel inhibitors were suggested in this thesis and these 
could be useful against growth transitions of C, albicans which are 
accompanied by high rates of RNA synthesis, such as germ tube formation.
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